<SEC-DOCUMENT>0001493152-25-005314.txt : 20250207
<SEC-HEADER>0001493152-25-005314.hdr.sgml : 20250207
<ACCEPTANCE-DATETIME>20250207093234
ACCESSION NUMBER:		0001493152-25-005314
CONFORMED SUBMISSION TYPE:	S-1/A
PUBLIC DOCUMENT COUNT:		12
FILED AS OF DATE:		20250207
DATE AS OF CHANGE:		20250207

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GT Biopharma, Inc.
		CENTRAL INDEX KEY:			0000109657
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				941620407
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-284032
		FILM NUMBER:		25599603

	BUSINESS ADDRESS:	
		STREET 1:		315 MONTGOMERY STREET
		STREET 2:		10TH FLOOR
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94104
		BUSINESS PHONE:		(800) 304-9888

	MAIL ADDRESS:	
		STREET 1:		315 MONTGOMERY STREET
		STREET 2:		10TH FLOOR
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94104

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	OXIS INTERNATIONAL INC
		DATE OF NAME CHANGE:	19940916

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DDI PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DIAGNOSTIC DATA INC /DE/
		DATE OF NAME CHANGE:	19850312
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1/A
<SEQUENCE>1
<FILENAME>forms-1a.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>As
                                            filed with the Securities and Exchange Commission on February 7, 2025.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Registration No. 333-284032</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>UNITED STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>WASHINGTON,
D.C. 20549</B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Amendment No. 2 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>FORM S-1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REGISTRATION
STATEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>UNDER</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>THE
SECURITIES ACT OF 1933</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>GT
BIOPHARMA, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Exact
Name of Registrant as Specified in Its Charter)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delaware</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2834</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>94-1620407</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(State
                                            or Other Jurisdiction of</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Incorporation
    or Organization)</B></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Primary
                                            Standard Industrial</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Classification
    Code Number)</B></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(I.R.S.
                                            Employer</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Identification
    Number)</B></FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>315
Montgomery Street, 10th Floor</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>San
Francisco, CA 94104</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(415)
919-4040</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Address,
Including Zip Code, and Telephone Number, Including Area Code, of Registrant&rsquo;s Principal Executive Offices)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Michael
Breen</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Interim
Chief Executive Officer</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>315
Montgomery Street, 10<SUP>th</SUP> Floor</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>San
Francisco, CA 94104</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(415)
919-4040</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Name,
Address, Including Zip Code, and Telephone Number, Including Area Code, of Agent For Service)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Copies
to:</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 49%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Roger
                                            W. Bivans</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Baker
    &amp; McKenzie LLP</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1900
    N. Pearl Street, Suite 1500</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dallas,
    TX 75201, USA</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(214)
    978 3000</B></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 49%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Charles
                                            Phillips</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ellenoff
    Grossman &amp; Schole LLP</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1345
    Avenue of Americas</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>New
    York, NY</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(212)
    370 1300</B></FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Approximate
date of commencement of proposed sale to the public</B>: As soon as practicable after the effective date of this registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the
Securities Act of 1933, check the following box. &#9746;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the
following box and list the Securities Act registration statement number of the earlier effective registration statement for the same
offering. &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company or an emerging growth company. See the definitions of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer,&rdquo;
&ldquo;smaller reporting company&rdquo; and &ldquo;emerging growth company&rdquo; in Rule 12b-2 of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large
    Accelerated filer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated
    filer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-accelerated
    filer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller
    reporting company</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
    growth company</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the
registrant files a further amendment which specifically states that this registration statement shall thereafter become effective in
accordance with Section 8(a) of the Securities Act of 1933, as amended, or until the registration statement shall become effective on
such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 4pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><B>The
information in this preliminary prospectus is not complete and may be changed. These securities may not be sold until the registration
statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell
these securities and it is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><B>SUBJECT
TO COMPLETION DATED <FONT STYLE="text-transform: uppercase">February</FONT> 7, 2025</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PRELIMINARY
PROSPECTUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Up
to 3,361,344 Shares of Common Stock</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Up
to 3,361,344</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B> Pre-Funded Warrants to Purchase
up to 3,361,344 Shares of Common Stock</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Up
to 3,361,344</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B> Common Warrants to Purchase
up to 3,361,344 Shares of Common Stock</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Up
to 201,680</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B> Placement Agent Warrants to Purchase
up to 201,680 Shares of Common Stock</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Up
to 6,924,368 Shares of Common Stock underlying up to 3,361,344 Pre-Funded Warrants,</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>up
to 3,361,344</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B> Common Warrants and up to
201,680 Placement Agent Warrants</B></FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="forms-1_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">This is a reasonable best
efforts public offering of up to 3,361,344 shares (the &ldquo;shares&rdquo;) of our common stock, par value $0.001 per share
(&ldquo;common stock&rdquo;) together with up to 3,361,344 common warrants to purchase up to 3,361,344 shares of
common stock at an assumed combined public offering price of $2.38 per share and common warrant (the last reported sale price
per share of our common stock on the Nasdaq Capital Market, on January 23, 2025). Each share of common stock is being offered
together with one common warrant to purchase one share of common stock. The shares of common stock and common warrants will be
separately issued. Each common warrant will be immediately exercisable upon issuance with an exercise price of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share (100% of the combined public offering price of each share of
common stock and accompanying common warrant in this offering) and will expire five years after the issuance date. This
prospectus also covers the shares of common stock issuable from time to time upon the exercise of the common warrants. See
&ldquo;<I>Description of Securities we are Offering &ndash; Common Warrants.</I>&rdquo;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are also offering pre-funded warrants to those purchasers, whose purchase of shares of common stock in this offering would result in
the purchaser, together with its affiliates and certain related parties, beneficially owning more than 4.99% (or, at the election of
the purchaser, 9.99%) of our outstanding common stock following the consummation of this offering in lieu of the shares of our common
stock that would result in ownership in excess of 4.99% (or, at the election of the purchaser, 9.99%). Each pre-funded warrant will be
exercisable for one share of common stock at an exercise price of $0.0001 per share. Each pre-funded warrant is being offered together
with the same common warrant to purchase one share of common stock described above that is being offered with each share of common stock.
The purchase price of each pre-funded warrant will equal the combined public offering price per share of common stock and common warrants
being sold in this offering, less the $0.0001 per share exercise price of each such pre-funded warrant. Each pre-funded warrant will
be exercisable upon issuance and will expire when exercised in full. The pre-funded warrants and common warrants will be separately issued.
For each pre-funded warrant that we sell, the number of shares of common stock that we are selling will be decreased on a one-for-one
basis. This prospectus also covers the shares of common stock issuable from time to time upon the exercise of the pre-funded warrants.
See &ldquo;<I>Description of Securities we are Offering &ndash; Pre-Funded Warrants.</I>&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have engaged Roth Capital Partners, LLC, or the placement agent, to act as our exclusive placement agent in connection with this offering.
The placement agent has agreed to use its reasonable best efforts to arrange for the sale of the securities offered by this prospectus.
The placement agent is not purchasing or selling any of the securities we are offering and the placement agent is not required to arrange
the purchase or sale of any specific number or dollar amount of securities. We have agreed to pay to the placement agent the placement
agent fees set forth in the table below, which assumes that we sell all of the securities offered by this prospectus. There is no arrangement
for funds to be received in escrow, trust or similar arrangement. There is no minimum number of shares of securities or minimum aggregate
amount of proceeds that is a condition for this offering to close. We may sell fewer than all of the securities offered hereby, which
may significantly reduce the amount of proceeds received by us, and investors in this offering will not receive a refund if we do not
sell all of the securities offered hereby. Because there is no escrow account and no minimum number of securities or amount of proceeds,
investors could be in a position where they have invested in us, but we have not raised sufficient proceeds in this offering to adequately
fund the intended uses of the proceeds as described in this prospectus. We will bear all costs associated with the offering. See &ldquo;<I>Plan
of Distribution</I>&rdquo; on page 36 of this prospectus for more information regarding these arrangements. This offering will terminate
no later than February 28, 2025, unless we decide to terminate the offering (which we may do at any time in our discretion) prior
to that date. The securities will be offered at a fixed price and are expected to be issued in a single closing. Investors purchasing
securities offered hereby will have the option to execute a securities purchase agreement with us. We expect that the closing of the
offering will occur one trading day after we price the securities offered hereby. When we price the securities, we will simultaneously
enter into securities purchase agreements relating to the offering with those investors who so choose. The offering will settle delivery
versus payment (&ldquo;DVP&rdquo;)/receipt versus payment (&ldquo;RVP&rdquo;). That is, on the closing date, we will issue the shares
of common stock directly to the account(s) at the placement agent identified by each purchaser; upon receipt of such shares, the placement
agent shall promptly electronically deliver such shares to the applicable purchaser, and payment therefor shall be made by the placement
agent (or its clearing firm) by wire transfer to us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock is listed on the Nasdaq Capital Market under the symbol &ldquo;GTBP.&rdquo; On January 23, 2025, the last reported
sale price of our common stock on the Nasdaq Capital Market was $2.38 per share. All share, common warrant and pre-funded warrant
numbers are based on an assumed combined public offering price of $2.38 per share or pre-funded warrant, as applicable, and common
warrants. The actual combined public offering price per share and common warrants and the actual combined public offering price per common
warrants and pre-funded warrants will be determined between us and investors based on market conditions at the time of pricing, and may
be at a discount to the current market price of our common stock. Therefore, the assumed public offering price used throughout this prospectus
may not be indicative of the final public offering price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should read this prospectus, together with additional information described under the headings &ldquo;<I>Incorporation of Certain Information
By Reference&rdquo; </I>and &ldquo;<I>Where You Can Find More Information</I>,&rdquo; carefully before you invest in any of our securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investing
in our securities involves a high degree of risk. See the section entitled &ldquo;<I>Risk Factors</I>&rdquo; beginning on page 9
of this prospectus and in the documents incorporated by reference into this prospectus for a discussion of risks that should be considered
in connection with an investment in our securities.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Per
                                            Share and Common Warrant</B></FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New oman, Times, Serif; font-size: 10pt"><B>Per Pre-Funded Warrant and</B></FONT></P>
<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common</B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>
Warrant</B></FONT></P></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total</B></FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 34%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Public offering price</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 18%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 18%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 18%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Placement Agent fees<SUP>(1)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds to us, before expenses<SUP>(2</SUP></FONT><SUP>)</SUP></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 0.5in"></TD>
  <TD STYLE="text-align: justify">(1) Includes a cash fee up to 6% of the gross proceeds raised in this offering; provided, however,
  the cash fee shall equal 3% of the gross proceeds raised in this offering for securities purchased by certain excluded investors, to
  be paid to the placement agent. We have also agreed to reimburse the placement agent for certain of its offering-related expenses in
  an aggregate amount up to $100,000. In addition, we have agreed to issue the placement agent or its designees warrants to purchase
  up to 201,680 shares of common stock (equal to 6% of the aggregate number of shares of common stock and pre-funded warrants
  sold in this offering, subject to a partial adjustment in the event certain investors participate) at an exercise price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  per share, which represents 125% of the public offering price per share of common stock and common warrants. We refer to these warrants
  in this prospectus as the &ldquo;placement agent warrants.&rdquo; See &ldquo;<I>Plan of Distribution</I>&rdquo; for a complete description
  of the compensation to be received by the placement agent.</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD STYLE="text-align: justify">(2) Because there is no minimum number of securities or amount of proceeds required as a condition
  to closing in this offering, the actual public offering amount, placement agent fees, and proceeds to us, if any, are not presently
  determinable and may be substantially less than the total maximum offering amounts set forth above. We estimate the total expenses
  of this offering payable by us, excluding the placement agent fee, will be approximately $390,531.</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
delivery of the shares of common stock any pre-funded warrants and common warrants to purchasers is expected to be made no later
than &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2025, subject to the satisfaction of customary closing conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neither
the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed
upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>Roth
Capital Partners</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
date of this prospectus is &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TABLE
OF CONTENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Page</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_001">ABOUT
    THIS PROSPECTUS</A></FONT></TD>
    <TD STYLE="border-top: black 1pt solid; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_002">CAUTIONARY
    NOTE REGARDING FORWARD-LOOKING STATEMENTS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_003">PROSPECTUS
    SUMMARY</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_004">THE
    OFFERING</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_005">RISK
    FACTORS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_006">USE
    OF PROCEEDS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_007">CAPITALIZATION</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_008">DILUTION</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#acxx_001">EXECUTIVE
    COMPENSATION</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#sj_001">CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS</A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">22</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#acxx_002">SECURITY
    OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#b_001">DESCRIPTION
    OF CAPITAL STOCK</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><A HREF="#b_002">description
    of securities we are offering</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#b_003">MATERIAL
    TAX CONSIDERATIONS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#b_004">PLAN
    OF DISTRIBUTION</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#b_005">I<FONT STYLE="text-transform: uppercase">ncorporation
    of certain information by reference</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#b_006">WHERE
    YOU CAN FIND MORE INFORMATION</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#b_007">LEGAL
    MATTERS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#b_008">EXPERTS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_001"></A>ABOUT
THIS PROSPECTUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
incorporate by reference important information into this prospectus. You may obtain the information incorporated by reference without
charge by following the instructions under &ldquo;<I>Where You Can Find More Information.&rdquo;</I> You should carefully read this prospectus
as well as additional information described under &ldquo;<I>Incorporation of Certain Information by Reference</I>,&rdquo; before deciding
to invest in our securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not, and the placement agent has not, authorized anyone to provide any information or to make any representations other than those
contained in this prospectus or in any free writing prospectuses prepared by or on behalf of us or to which we have referred you. We
take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. This
prospectus is an offer to sell only the securities offered hereby, and only under circumstances and in jurisdictions where it is lawful
to do so. The information contained in this prospectus or in any applicable free writing prospectus is current only as of its date, regardless
of its time of delivery or any sale of our securities. Our business, financial condition, results of operations and prospects may have
changed since that date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information incorporated by reference or provided in this prospectus contains statistical data and estimates, including those relating
to market size and competitive position of the markets in which we participate, that we obtained from our own internal estimates and
research, as well as from industry and general publications and research, surveys and studies conducted by third parties. Industry publications,
studies and surveys generally state that they have been obtained from sources believed to be reliable. While we believe our internal
company research is reliable and the definitions of our market and industry are appropriate, neither this research nor these definitions
have been verified by any independent source.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
investors outside the United States: We have not, and the placement agent has not, done anything that would permit this offering or possession
or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. Persons
outside the United States who come into possession of this prospectus must inform themselves about, and observe any restrictions relating
to, the offering of the securities and the distribution of this prospectus outside the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus and the information incorporated by reference into this prospectus contain references to our trademarks and to trademarks
belonging to other entities. Solely for convenience, trademarks and trade names referred to in this prospectus and the information incorporated
by reference into this prospectus, including logos, artwork, and other visual displays, may appear without the &reg; or TM symbols, but
such references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights
or the rights of the applicable licensor to these trademarks and trade names. We do not intend our use or display of other companies&rsquo;
trade names or trademarks to imply a relationship with, or endorsement or sponsorship of us by, any other company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_002"></A>CAUTIONARY
NOTE REGARDING FORWARD-LOOKING STATEMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some
of the statements in this prospectus are &ldquo;forward-looking statements&rdquo; within the meaning of the safe harbor from liability
established by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements regarding our current
beliefs, goals and expectations about matters such as our expected financial performance and condition, operating results, our business
strategy and our financing plans. The forward-looking statements in this prospectus are not based on historical facts, but rather reflect
the current expectations of our management concerning future results and events. The forward-looking statements generally can be identified
by the use of terms such as &ldquo;believe,&rdquo; &ldquo;expect,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;intend,&rdquo; &ldquo;plan,&rdquo;
&ldquo;foresee,&rdquo; &ldquo;may,&rdquo; &ldquo;guidance,&rdquo; &ldquo;estimate,&rdquo; &ldquo;potential,&rdquo; &ldquo;outlook,&rdquo;
&ldquo;target,&rdquo; &ldquo;forecast,&rdquo; &ldquo;likely&rdquo; or other similar words or phrases. Similarly, statements that describe
our objectives, plans or goals are, or may be, forward-looking statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forward-looking
statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements
to be different from any future results, performance and achievements expressed or implied by these statements. We cannot guarantee that
our forward-looking statements will turn out to be correct or that our beliefs and goals will not change. Our actual results could be
very different from and worse than our expectations for various reasons. The risk factors and cautionary language discussed in this prospectus
provide examples of risks, uncertainties and events that may cause actual results to differ materially from the expectations described
by us in such forward-looking statements, including among other things:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.7pt; text-align: justify; text-indent: -22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to develop and advance our current product candidates and programs into, and successfully complete, clinical trials;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">our financial condition raises substantial doubt as
    to our ability to continue as a going concern;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    financial performance and our ability to effectively manage our anticipated growth;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    period over which we estimate our existing cash and cash equivalents will be sufficient to fund our future operating expenses and
    capital expenditure requirements;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    impact of laws and regulations;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">general
    economic conditions;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    effects of the coronavirus and other communicable diseases on the continued or resumed disruption of supply chains, the global economy,
    on the global financial markets and on our business;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    timing, scope and likelihood of regulatory filings and approvals;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    continued reliance on third parties to conduct additional clinical trials of our product candidates;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    manufacturing, commercialization, and marketing capabilities and strategy;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    intellectual property position, including the scope of protection we are able to establish and maintain for intellectual property
    rights covering product candidates we may develop, including the validity of intellectual property rights held by third parties,
    and our ability not to infringe, misappropriate or otherwise violate any third-party intellectual property rights;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    rate and degree of market acceptance and clinical utility of our product candidates we may develop;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to hire additional qualified personnel and attract and retain key employees; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    result of any future financing efforts; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    failure to maintain compliance with the Nasdaq Capital Market&rsquo;s (&ldquo;Nasdaq&rdquo;) continued listing requirements could
    result in the delisting of our common stock.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
risks, among others, could cause actual results to differ materially from those implied by the forward-looking statements contained in
this prospectus. You should review carefully all information, including the discussion under &ldquo;<I>Risk Factors</I>&rdquo; in this
prospectus and in the documents incorporated by reference herein. Any forward-looking statements in this prospectus are made only as
of the date hereof and, except as may be required by law, we do not have any obligation to publicly update any forward-looking statements
contained in this prospectus to reflect subsequent events or circumstances.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should read this prospectus with the understanding that our actual future results may be materially different from what we expect. We
do not assume any obligation to update any forward-looking statements whether as a result of new information, future events or otherwise,
except as required by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<DIV STYLE="padding-right: 0.1in; padding-left: 0.1in; border: Black 1pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_003"></A>PROSPECTUS
SUMMARY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>This
summary highlights information contained elsewhere in this prospectus. This summary does not contain all of the information that you
should consider before deciding to invest in our securities. You should read this entire prospectus carefully, including the &ldquo;Risk
Factors&rdquo; section in this prospectus and under similar captions in the documents incorporated by reference into this prospectus.
In this prospectus, unless otherwise stated or the context otherwise requires, references to the terms &ldquo;GTBP,&rdquo; &ldquo;the
Company,&rdquo; &ldquo;we,&rdquo; &ldquo;us&rdquo; and &ldquo;our&rdquo; refer to GT Biopharma, Inc., together with its subsidiaries,
unless the context otherwise requires. This prospectus and the information incorporated herein by reference include trademarks, service
marks and trade names owned by us or other companies. All trademarks, service marks and trade names included or incorporated by reference
into this prospectus and the information incorporated herein by reference are the property of their respective owners.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Overview</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a clinical stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products based
on our proprietary Tri-specific Killer Engager (TriKE<SUP>&reg;</SUP>), and Tetra-specific Killer Engager (Dual Targeting TriKE&reg;)
fusion protein immune cell engager technology platforms. Our TriKE<SUP>&reg;</SUP> and Dual Targeting TriKE&reg; platforms generate proprietary
therapeutics designed to harness and enhance the cancer killing abilities of a patient&rsquo;s own natural killer cells, or NK cells.
Once bound to an NK cell, our moieties are designed to activate the NK cell to direct it to one or more specifically targeted proteins
expressed on a specific type of cancer cell or virus infected cell, resulting in the targeted cell&rsquo;s death. TriKE<SUP>&reg;</SUP>s
can be designed to target any number of tumor antigens, including B7-H3, HER2, CD33 and PDL1, on hematologic malignancies or solid
tumors and do not require patient-specific customization. We believe our TriKE&reg; and Dual Targeting TriKE&reg; platforms that activate
endogenous NK cells are potentially safer than T-cell immunotherapy because there is less cytokine release syndrome (CRS) and fewer neurological
complications. Our preclinical data suggests that this is explained by the TriKE&reg; dependent CD16 directed IL-15 proliferation of
NK cells but little effect endogenous T cells.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are using our TriKE<SUP>&reg;</SUP> platform with the intent to bring to market immuno-oncology products that can treat a range of hematologic
malignancies, solid tumors, and potentially autoimmune disorders. The platform is scalable, and we are implementing processes to produce
investigational new drug (IND) ready moieties in a timely manner after a specific TriKE<SUP>&reg;</SUP> conceptual design. Specific drug
candidates can then be advanced into the clinic on our own or through potential collaborations with partnering companies. We believe
our TriKE&reg;s may have the ability, if approved for marketing, to be used as both monotherapy and in combination with other standard-of-care
therapies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
initial work was conducted in collaboration with the Masonic Cancer Center at the University of Minnesota under a program led by Dr.
Jeffrey Miller, Professor of Medicine, and the Deputy Director at the Center. Dr. Miller is a recognized key opinion leader in the field
of NK cell and IL-15 biology and their therapeutic potential. We have exclusive rights to the TriKE<SUP>&reg;</SUP> platform and are
generating additional intellectual property for specific moieties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Product
Pipeline</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
current product candidate pipeline is summarized in the table below</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="vi_001.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<DIV STYLE="padding-right: 0.1in; padding-left: 0.1in; border: Black 1pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>GTB-3550</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">GTB-3550
was our first TriKE&reg; product candidate and its clinical development was suspended so that we could focus resources on second-generation
TriKEs&reg;. GTB-3550 is a tri-specific killer engager (TriKE) comprised of two single-chain variable fragments
(&ldquo;scFv&rdquo;) composed of the variable regions of the heavy and light chains of anti-CD16
and anti-CD33 antibodies and a modified form of IL-15. We studied this anti-CD16-IL-15-anti-CD33 TriKE&reg; in CD33 positive leukemias,
a marker expressed on tumor cells in acute myelogenous leukemia, or AML, and myelodysplastic syndrome, or MDS. The anti-CD33 antibody
fragment in GTB-3550 was derived from the M195 humanized anti-CD33 scFv We believe the approval of the antibody-drug conjugate gemtuzumab
validates the targeting of CD33.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
previously announced the interim clinical trial results for GTB-3550, which showed significantly reduced CD 33+ bone marrow blast levels
by 33.3%, 61.7%, 63.6%, 50% in Patient 5 (25 &micro;g/kg/day), Patient 7 (50 &micro;g/kg/day), Patient 9 (100 &micro;g/kg/day), and Patient
11 (150 &micro;g/kg/day), respectively. After the end of infusion, GTB-3550 and IL-15 concentrations declined rapidly with overall geometric
mean terminal phase elimination half-life (T1/2) of 2.2 and 2.52 hours, respectively. There was minimal CRS resulting from hyperactivation
of patient&rsquo;s T-cell population at doses 5&ndash;150 &micro;g/kg/day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Despite
the positive interim clinical trial results,</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> GTB-3550
was replaced by a more potent next-generation camelid nanobody TriKE&reg;, GTB-3650, that similarly targets CD33 on relapsed/refractory
AML and high-risk MDS. A key difference between GTB-3550 and GTB-3650 is the incorporation of camelid antibody technology instead of
a scFv; our preclinical experience showed markedly enhanced potency of TriKEs&reg; comprised of camelid components. This is illustrated
below by better tumor control of AML bearing animals with GTB-3650 (purple dots) compared to GTB-3550 (blue dots). This provided the
rationale for pausing further development of GTB-3550 and moving over to solely develop the second-generation, camelid-based TriKE&reg;
platform.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="vi_002.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>






<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<DIV STYLE="padding-right: 0.1in; padding-left: 0.1in; border: Black 1pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Second
Generation TriKE&reg;s Utilize Camelid Nanobody Technology</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
goal is to be a leader in immuno-oncology therapies targeting a broad range of indications including hematological malignancies and solid
tumors. A key element of our strategy includes introducing a next-generation camelid nanobody platform. Camelid antibodies (often referred
as nanobodies) are smaller than human immunoglobulin, consisting of two heavy chains instead of two heavy and two light chains. These
nanobodies have the potential to have greater affinity to target antigens, potentially resulting in greater potency. We are utilizing
this camelid antibody structure for all of our new TriKE&reg; product candidates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
develop second generation TriKE&reg;s, we designed a new humanized CD16 engager derived from a single-domain antibody. While scFvs consist
of a heavy and a light variable chain joined by a linker, single-domain antibodies consist of a single variable heavy chain capable of
engaging without the need of a light chain counterpart (see figure below).</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="vi_003.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
single-domain antibodies are thought to have certain attractive features for antibody engineering, including physical stability, ability
to bind deep grooves, and increased production yields, amongst others. Pre-clinical studies demonstrated increased NK cell activation
against CD33+ targets including enhanced NK cell degranulation (% CD107a+) and IFN&gamma; with the single-domain CD16 TriKE&reg;
(cam 16-wt15-33; GTB-3650) compared to the original TriKE&reg; (scFv16-m 15-33; GTB-3550) (see figure below). This data was published
by Dr. Felices M et al (2020) in Cancer Immunol Res.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>CD33+
HL60 Targets in Killing Assays</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purple line represents the GTB-3650 and the blue line represents GTB-3550.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="vi_004.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<DIV STYLE="padding-right: 0.1in; padding-left: 0.1in; border: Black 1pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GTB-3650</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">GTB-3650
is a TriKE&reg; which targets CD33 on the surface of myeloid leukemias and an agonistic camelid engager to the potent activating receptor
on NK cells, CD16. Use of this engager enhances the activity of wild type IL-15 included in GTB-3650. The TriKE&reg; approach provides
a novel way to specifically target these tumors by leveraging NK cells, which have been shown to mediate relapse protection in this setting,
in an anti-CD33-targeted fashion. We are advancing GTB-3650 to clinical studies based on pre-clinical data showing a marked increase
in potency compared to GTB-3550, which we anticipate could lead to an enhanced efficacy signal in AML and MDS. We advanced GTB-3650 through
requisite preclinical studies and filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA)
in December 2023. In late June 2024, the FDA cleared our IND Application for GTB-3650. We started study enrollment targeting patients
with relapsed/refractory AML and high grade MDS on January 21, 2025. This initial study is testing GTB-3650 as monotherapy
testing administration 2 weeks on and two weeks off (to prevent NK cell exhaustion) for at least 2 cycles of therapy, as agreed
on with the FDA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="vi_005.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>GTB-5550</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">GTB-5550
is a B7-H3 targeted TriKE&reg; which targets B7-H3 on the surface of advanced solid tumors (figure above). GTB-5550 is our first
dual camelid TriKE&reg;. B7-H3 is expressed on a broad spectrum of solid tumor malignancies, allowing our team to target these
malignancies through GTB-5550. Pre-clinical work has shown that this molecule has NK-cell targeted activity against a variety of
solid tumors, including head and neck cancer squamous cell carcinoma (figure below), prostate cancer, breast cancer, ovarian cancer,
glioblastoma, and lung cancer (amongst others). We are advancing GTB-5550 through preclinical studies and initiated a GMP
manufacturing campaign in anticipation of filing an IND in the first half of 2025. A pre-IND packet was submitted to the FDA in
October 2023 with a written response from the FDA in December 2023. The main question from the FDA was regarding pre-clinical
toxicology and a pivot to subcutaneous dosing. The initial trial expected in 2025 is designed as a basket trial for patients with
B7-H3+ solid tumors using Monday through Friday dosing (2 weeks on and 2 weeks off to prevent immune exhaustion), and is dependent
on manufacturing of clinical materials.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<DIV STYLE="padding-right: 0.1in; padding-left: 0.1in; border: Black 1pt solid">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="vi_006.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>GTB-7550</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">GTB-7550
TriKE&reg; is a product candidate in development for the treatment of lupus and other autoimmune disorders. GTB-7550 TriKE&reg; is a
tri-specific molecule composed of a camelid nanobody that binds the CD16 receptor on NK cells, a scFv engager against CD19 on malignant
and normal B cells, and a human IL-15 sequence between them.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Published data shows that
GTB-7550 effectively targets CD19+ malignant cell lines and primary chronic lymphocytic leukemia (CLL). Preliminary data shows that GTB-7550
can target and eliminate normal B cells, which we are continuing to test in mice. We are currently exploring and assessing potential
manufacturers of GTB-7550.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Litigation
Update</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
disclosed in our third quarter report on Form 10-Q for the period ended September 30, 2024, on November 14, 2023, former interim Chief
Executive Officer, Dr. Gregory Berk filed a lawsuit in the U.S. District Court for the District of Massachusetts alleging that the Company
discriminated and retaliated against Dr. Berk for engaging in protected whistleblowing activity in violation of the Sarbanes Oxley Act
(&ldquo;SOX&rdquo;). Although the Company vigorously defended this matter and believes it to be without merit, the lawsuit was dismissed
with prejudice on December 4, 2024 as a result of the parties&rsquo; settlement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> As disclosed in our third
quarter report on Form 10-Q for the period ended September 30, 2024, on May 24, 2023, TWF Global, LLC (&ldquo;TWF&rdquo;) filed a Complaint
in the California Superior Court for the County of Los Angeles naming the Company as defendant. The Complaint alleges that TWF is the
holder of two Convertible Promissory Notes (&ldquo;Notes&rdquo;) and that the Company did not deliver shares of common stock due on conversion
in February 2021. TWF was seeking per diem liquidated damages based on the terms of alleged Notes. On July 14, 2023, the Company filed
a motion to dismiss for improper forum because the terms of the Notes, as alleged, require disputes to be filed in New York state and
federal courts. TWF voluntarily dismissed its Complaint before the California Superior Court of Los Angeles without prejudice. The Company
subsequently filed a Summons and Complaint for Interpleader against TWF and Z-One LLC before the Supreme Court of the State of New York
County of New York, asking the Supreme Court to determine if the Company&rsquo;s shares of common stock are properly registered to TWF
or Z-One LLC, as both of these entities have made conflicting demands for registration of the shares of common stock. On February 5,
2024, the Company filed a motion for entry of default against TWF, seeking an order directing the Company to register the shares of common
stock in the name of Z-One and that the Company be released from all associated liability and claims. The Court denied the motion without
prejudice to reconsider the motion without further briefing upon the filing of a supplemental party affidavit. On May 9, 2024, Z-One
filed a motion for summary judgement seeking dismissal of the action, representing that Z-One and TWF have settled their dispute over
the entitlement to the Company&rsquo;s shares of common stock and there is no remaining dispute before the Court. On May 21, 2024, the
Company filed a supplemental affidavit in support of its motion for entry of default. On November 14, 2024, the Court held a hearing
on the parties&rsquo; motions, at which the Court found that the motion for entry of default was mooted by the settlement agreement between
Z-One and TWF. The Court ordered that the case be dismissed. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Implications
of Being a Smaller Reporting Company</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a &ldquo;smaller reporting company&rdquo; as defined in the Securities Exchange Act of 1934, as amended, or the Exchange Act, and
have elected to take advantage of certain of the scaled disclosures available to smaller reporting companies. Accordingly, we may provide
less public disclosure than larger public companies, including the inclusion of only two years of audited consolidated financial statements
and only two years of management&rsquo;s discussion and analysis of financial condition and results of operations disclosure and the
inclusion of reduced disclosure about our executive compensation arrangements. As a smaller reporting company, we are also exempt from
compliance with the auditor attestation requirements pursuant to the Sarbanes-Oxley Act. As a result, the information that we provide
to our stockholders may be different than you might receive from other public reporting companies in which you hold equity interests.
We will continue to be a &ldquo;smaller reporting company&rdquo; until we have $250 million or more in public float (based on our common
stock) measured as of the last business day of our most recently completed second fiscal quarter or, in the event we have no public float
or a public float (based on our common stock) that is less than $700 million, annual revenues of $100 million or more during the most
recently completed fiscal year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Corporate
Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock currently trades on the Nasdaq under the symbol &ldquo;GTBP.&rdquo; Our principal executive offices are located at
315 Montgomery Street, 10<SUP>th</SUP> Floor, San Francisco, CA 94104, and our telephone number is (415) 919-4040. We maintain a website
at <I>www.gtbiopharma.com</I>. Information contained on or accessible through our website is not, and should not be considered, part
of, or incorporated by reference into, this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>






<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<DIV STYLE="padding-right: 0.1in; padding-left: 0.1in; border: Black 1pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_004"></A>THE
    OFFERING</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common
    Stock to be Offered</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Up
    to 3,361,344 shares of common stock.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common
    Warrants to be Offered</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
                                            warrants to purchase up to 3,361,344 shares of our common stock. Each common warrant
                                            has an exercise price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share of common
                                            stock. Common warrants will become exercisable immediately after issuance and will expire
                                            five years from the date of issuance.</FONT></P>
                                                                              <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
                                                                              <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            shares of common stock and pre-funded warrants, and the accompanying common warrant, as the
                                            case may be, can only be purchased together in this offering but will be issued separately
                                            and will be immediately separable upon issuance. This prospectus also relates to the offering
                                            of the shares of common stock issuable upon exercise of the common warrants.</FONT></P>
                                                                              <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pre-funded
    Warrants to be Offered</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            are also offering to certain purchasers whose purchase of shares of common stock in this
                                            offering would otherwise result in the purchaser, together with its affiliates and certain
                                            related parties, beneficially owning more than 4.99% (or, at the election of the purchaser,
                                            9.99%) of our outstanding common stock immediately following the consummation of this offering,
                                            the opportunity to purchase, if such purchasers so choose, pre-funded warrants to purchase
                                            shares of common stock, in lieu of shares of common stock that would otherwise result in
                                            any such purchaser&rsquo;s beneficial ownership exceeding 4.99% (or, at the election of the
                                            purchaser, 9.99%) of our outstanding common stock. Each pre-funded warrant will be exercisable
                                            for one share of our common stock. The purchase price of each pre-funded warrant and accompanying
                                            common warrants will equal the price at which the share of common stock and accompanying
                                            common warrants are being sold to the public in this offering, minus $0.0001, and the exercise
                                            price of each pre-funded warrant will be $0.0001 per share. The pre-funded warrants will
                                            be exercisable immediately and may be exercised at any time until all of the pre-funded warrants
                                            are exercised in full. This offering also relates to the shares of common stock issuable
                                            upon exercise of any pre-funded warrants sold in this offering. For each pre-funded warrant
                                            we sell, the number of shares of common stock we are offering will be decreased on a one-for-one
                                            basis. Because we will also issue one common warrant to purchase one share of common stock
                                            for each share of our common stock and for each pre-funded warrant to purchase one share
                                            of our common stock sold in this offering, the number of common warrants sold in this offering
                                            will not change as a result of a change in the mix of the shares of our common stock and
                                            pre-funded warrants sold.</FONT></P>
                                                                              <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common
    Stock to be Outstanding Before this Offering</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,234,328
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common
    Stock to be Outstanding Immediately After this Offering</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,595,672
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares, (assuming full exercise of the pre-funded
    warrants and assuming no exercise of the common warrants). </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Use
    of Proceeds</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    estimate that the net proceeds from this offering will be approximately $7.1 million, excluding the proceeds, if any, from
    the cash exercise of the common warrants in this offering. We currently intend to use the net proceeds from this offering for working
    capital and general corporate purposes, including the further development of our product candidates that are currently undergoing
    clinical trials, our product candidates that we expect to submit an investigational new drug application for in the near term, and
    our product candidates that are pre-clinical. See &ldquo;<I>Use of Proceeds</I>&rdquo; for additional information. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risk
    Factors</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
    investment in our securities involves a high degree of risk. See &ldquo;<I>Risk Factors</I>&rdquo; beginning on page 9 of
    this prospectus and the other information included and incorporated by reference in </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">this
    prospectus for a discussion of the risk factors you should carefully consider before deciding to invest in our securities.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Nasdaq
    Symbol</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    common stock is listed on the Nasdaq Capital Market under the symbol &ldquo;GTBP.&rdquo; There is no established public trading market
    for the common warrants or pre-funded warrants, and we do not expect a market to develop. In addition, we do not intend to apply
    to list the common warrants or pre-funded warrants on any national securities exchange or other nationally recognized trading system.
    Without an active trading market, the liquidity of the common warrants and pre-funded warrants will be limited.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise stated in this prospectus, the number of shares of our common stock to be outstanding as of the date of this prospectus
and after this offering is based on 2,234,328 shares outstanding as of September 30, 2024, and excludes (a) placement agent warrants
to purchase up to 201,680 shares of our common stock issuable upon the exercise of warrants to be issued to the placement
agent in connection with this offering having an exercise price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, (b)
the shares of common stock issuable upon exercise of the common warrants and pre-funded warrants being offered by us in this
offering, (c) previously issued and outstanding warrants to purchase up to 1,133,762 shares of our common stock, and (d) outstanding
stock options to purchase up to 101,264 shares of our common stock. <I>See &ldquo;Note 7 &ndash; Common Stock Warrants and
Options&rdquo;</I> to our Third Quarter Report filed on Form 10-Q that is incorporated by reference into this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_005"></A>RISK
FACTORS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Investing
in our common stock involves a high degree of risk. You should carefully consider the risks and uncertainties described below in addition
to the other information contained in this prospectus and any prospectus supplement before deciding whether to invest in shares of our
common stock. The risks summarized below and others are discussed more fully in the section titled &ldquo;Risk Factors&rdquo; in our
Annual Report on Form 10-K for the year ended December 31, 2023, which is incorporated herein by reference. If any of the following risks
or the risks incorporated by reference occur, our business, financial condition or operating results could be harmed. In that case, the
trading price of our common stock could decline and you may lose part or all of your investment. In the opinion of management, the risks
discussed below and incorporated by reference represent the material risks known to us. Additional risks and uncertainties not currently
known to us or that we currently deem immaterial may also impair our business, financial condition and operating results and adversely
affect the market price of our common stock..</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to Our Business</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
related to our business risks include, but are not limited to, the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    financial condition raises substantial doubt as to our ability to continue as a going concern.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    business is at an early stage of development and we may not develop therapeutic products that can be commercialized.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    have a history of operating losses and we expect to continue to incur losses for the foreseeable future. We may never generate revenue
    or achieve profitability.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    will need additional capital to conduct our operations and develop our products, and our ability to obtain the necessary funding
    is uncertain.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    current and future indebtedness may impose significant operating and financial restrictions on us and affect our ability to access
    liquidity.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    cost of our research and development programs may be significantly higher than expected, and there is no assurance that they will
    successful in a timely manner, or at all.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    our efforts to protect the proprietary nature of the intellectual property related to our technologies are not adequate, we may not
    be able to compete effectively in our market and our business would be harmed.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Claims
    that we infringe the intellectual property rights of others may prevent or delay our drug discovery and development efforts.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    may desire, or be forced, to seek additional licenses to use intellectual property owned by third parties, and such licenses may
    not be available on commercially reasonable terms, or at all.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    we are unsuccessful in obtaining or maintaining patent protection for intellectual property in development or licensed from third
    parties, our business and competitive position would be harmed.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    we fail to meet our obligations under our license agreements, we may lose our rights to key technologies on which our business depends.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    reliance on the activities of our non-employee consultants, research institutions and scientific contractors, whose activities are
    not wholly within our control, may lead to delays in development of our proposed products.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clinical
    drug development is costly, time-consuming and uncertain, and we may suffer setbacks in our clinical development program that could
    harm our business.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    we experience delays or difficulties in the enrollment of patients in clinical trials, those clinical trials could take longer than
    expected to complete and our receipt of necessary regulatory approvals could be delayed or prevented.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Obtaining
    regulatory approval, even after clinical trials that are believed to be successful, is an uncertain process.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    will continue to be subject to extensive FDA regulation following any product approvals, and if we fail to comply with these regulations,
    we may suffer a significant setback in our business.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
    of our business practices are subject to scrutiny and potential investigation by regulatory and government enforcement authorities,
    as well as to lawsuits brought by private citizens under federal and state laws. We could become subject to investigations, and our
    failure to comply with applicable law or an adverse decision in lawsuits may result in adverse consequences to us. If we fail to
    comply with U.S. healthcare laws, we could face substantial penalties and financial exposure, and our business, operations and financial
    condition could be adversely affected.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    product candidates may cause undesirable side effects or have other properties that could delay or prevent their regulatory approval,
    limit the commercial profile of an approved label, or result in significant negative consequences following marketing approval, if
    any.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    may expend our limited resources to pursue a particular product candidate or indication that does not produce any commercially viable
    products and may fail to capitalize on product candidates or indications that may be more profitable or for which there is a greater
    likelihood of success.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    products may be expensive to manufacture, and they may not be profitable if we are unable to control the costs to manufacture them.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    currently lack manufacturing capabilities to produce our therapeutic product candidates at commercial-scale quantities and do not
    have an alternate manufacturing supply, which would negatively impact our ability to meet any demand for the product.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    business is based on novel technologies that are inherently expensive and risky and may not be understood by or accepted in the marketplace,
    which could adversely affect our future value.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    could be subject to product liability lawsuits based on the use of our product candidates in clinical testing or, if obtained, following
    marketing approval and commercialization. If product liability lawsuits are brought against us, we may incur substantial liabilities
    and may be required to cease clinical testing or limit commercialization of our product candidates.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    rely on third parties to supply candidates for clinical testing and to conduct preclinical and clinical trials of our product candidates.
    If these third parties do not successfully carry out their contractual duties or meet expected deadlines, we may not be able to obtain
    regulatory approval for or commercialize our product candidates. As a result, our business could be substantially harmed.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    failure to maintain compliance with the Nasdaq Capital Market&rsquo;s (&ldquo;Nasdaq&rdquo;) continued listing requirements could
    result in the delisting of our common stock.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
risks are described more fully in our Annual Report on Form 10-K for the year ended December 31, 2023, which is incorporated herein by
reference.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to our Business</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
financial condition raises substantial doubt as to our ability to continue as a going concern.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2024, we had approximately $6.5 million in cash and cash equivalents and restricted cash, and working capital of $2.1
million, and we have incurred and expect to continue to incur significant costs in pursuit of our drug candidates. <FONT STYLE="background-color: white">For
the nine months ended September 30, 2024, we recorded a net loss of approximately $9.4 million and used cash in operations of approximately
$10.4 million. </FONT>Our unaudited consolidated condensed financial statements for the nine month period ended September 30, 2024 have
been prepared assuming that we will continue to operate as a going concern, which contemplates the realization of assets and the satisfaction
of liabilities in the normal course of business. To date, we have not generated substantial product revenues from our activities and
have incurred substantial operating losses. We expect that we will continue to generate substantial operating losses for the foreseeable
future until we complete development and approval of our product candidates. We will continue to fund our operations primarily through
utilization of our current financial resources and additional raises of capital.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
conditions raise substantial doubt about our ability to continue as a going concern. For further information, please see Note 1 to our
third quarter unaudited condensed consolidated financial statements for the nine-months ended September 30, 2024. The Company has evaluated
the significance of the uncertainty regarding the Company&rsquo;s financial condition in relation to its ability to meet its obligations,
which has raised substantial doubt about the Company&rsquo;s ability to continue as a going concern. While it is very difficult to estimate
the Company&rsquo;s future liquidity requirements, the Company believes if it is unable to obtain additional financing, existing cash
resources will not be sufficient to enable it to fund the anticipated level of operations through one year from the date the accompanying
unaudited condensed consolidated financial statements are issued. There can be no assurances that the Company will be able to secure
additional financing on acceptable terms. In the event the Company does not secure additional financing, the Company will be forced to
delay, reduce, or eliminate some or all of its discretionary spending, which could adversely affect the Company&rsquo;s business prospects,
ability to meet long-term liquidity needs and the ability to continue operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to this Offering and Our Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>There
has been a limited public market for our common stock, and we do not know whether one will develop to provide you adequate liquidity.
Furthermore, the trading price for our common stock, should an active trading market develop, may be volatile and could be subject to
wide fluctuations in per-share price.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock is now listed on the Nasdaq Capital Market under the trading symbol &ldquo;GTBP&rdquo;; historically, however, there has
been a limited public market for our common stock. We cannot assure you that an active trading market for our common stock will develop
or be sustained. The liquidity of any market for the shares of our common stock will depend on a number of factors, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            number of stockholders;</FONT></P>
                                                                              <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            operating performance and financial condition;</FONT></P>
                                                                              <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            market for similar securities;</FONT></P>
                                                                              <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            extent of coverage of us by securities or industry analysts; and</FONT></P>
                                                                              <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    interest of securities dealers in making a market in the shares of our common stock.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
if an active trading market develops, the market price for our common stock may be highly volatile and could be subject to wide fluctuations.
In addition, the price of shares of our common stock could decline significantly if our future operating results fail to meet or exceed
the expectations of market analysts and investors and actual or anticipated variations in our quarterly operating results could negatively
affect our share price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
volatility of the price of our common stock may also be impacted by the risks discussed under this &ldquo;Risk Factors&rdquo; section,
in addition to other factors, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">developments
                                            in the financial markets and worldwide or regional economies;</FONT></P>
                                                         <P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements
                                            of innovations or new products or services by us or our competitors;</FONT></P>
                                                         <P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements
                                            by the government relating to regulations that govern our industry;</FONT></P>
                                                         <P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">significant
                                            sales of our common stock or other securities in the open market;</FONT></P>
                                                         <P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">variations
                                            in interest rates;</FONT></P>
                                                         <P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                            in the market valuations of other comparable companies; and</FONT></P>
                                                         <P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in accounting principles.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
outstanding warrants and options may affect the market price of our common stock</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this prospectus, we had 2,<FONT STYLE="background-color: white">234,328 </FONT>shares of common stock outstanding
and issued and had outstanding warrants for the purchase of up to 1,120,429 additional shares of common stock at a weighted average
exercise price of $18.85 per share, all of which are exercisable as of the date of this prospectus (subject to certain beneficial ownership
limitations). In addition, we had outstanding options for the purchase of up to 124,600 additional shares of common stock at a
weighted average exercise price of $32.69 per share, 105,154 of which are exercisable as of the date of this prospectus. The amount of
common stock reserved for issuance may have an adverse impact on our ability to raise capital and may affect the price and liquidity
of our common stock in the public market. In addition, the issuance of these shares of common stock will have a dilutive effect on current
stockholders&rsquo; ownership.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Because
our common stock may be deemed a low-priced &ldquo;penny&rdquo; stock, an investment in our common stock should be considered high-risk
and subject to marketability restrictions.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Historically,
the trading price of our common stock has been $5.00 per share or lower, and deemed a penny stock, as defined in Rule 3a51-1 under the
Exchange Act, and subject to the penny stock rules of the Exchange Act specified in rules 15g-1 through 15g-100. Those rules require
broker&ndash;dealers, before effecting transactions in any penny stock, to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">deliver
    to the customer, and obtain a written receipt for, a disclosure document;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">disclose
    certain price information about the stock;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">disclose
    the amount of compensation received by the broker-dealer or any associated person of the broker-dealer;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">send
    monthly statements to customers with market and price information about the penny stock; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    some circumstances, approve the purchaser&rsquo;s account under certain standards and deliver written statements to the customer
    with information specified in rules.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consequently,
the penny stock rules may restrict the ability or willingness of broker-dealers to sell the common stock and may affect the ability of
holders to sell their common stock in the secondary market and the price at which such holders can sell any such securities. These additional
procedures could also limit our ability to raise additional capital in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Financial
Industry Regulatory Authority (&ldquo;FINRA&rdquo;) sales practice requirements may also limit a stockholder&rsquo;s ability to buy and
sell our common stock, which could depress the price of our common stock.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the &ldquo;penny stock&rdquo; rules described above, FINRA has adopted rules that require a broker-dealer to have reasonable
grounds for believing that the investment is suitable for that customer before recommending an investment to a customer. Prior to recommending
speculative low-priced securities to their non-institutional customers, broker-dealers must make reasonable efforts to obtain information
about the customer&rsquo;s financial status, tax status, investment objectives and other information. Under interpretations of these
rules, FINRA believes that there is a high probability that speculative low-priced securities will not be suitable for at least some
customers. Thus, the FINRA requirements make it more difficult for broker-dealers to recommend that their customers buy our common stock,
which may limit your ability to buy and sell our shares of common stock, have an adverse effect on the market for our shares of common
stock, and thereby depress our price per share of common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
securities or industry analysts do not publish research or reports about our business, or if they issue an adverse or misleading opinion
regarding our stock, our stock price and trading volume could decline.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
trading market for our common stock may be influenced by the research and reports that industry or securities analysts publish about
us or our business. We currently have research coverage by only one securities analyst, and we may never obtain research coverage by
additional analysts. If no or few securities or industry analysts commence coverage of us, the trading price for our common stock may
be negatively affected. In the event that we receive additional securities or industry analyst coverage, if any of the analysts who cover
us issue an adverse or misleading opinion regarding us, our business model, our intellectual property or our stock performance, or if
our operating results fail to meet the expectations of analysts, our stock price would likely decline. If one or more of these analysts
cease coverage of us or fail to publish reports on us regularly, we could lose visibility in the financial markets, which in turn could
cause our stock price or trading volume to decline.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Anti-takeover
provisions may limit the ability of another party to acquire us, which could cause our stock price to decline.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delaware
law and our restated certificate of incorporation (&ldquo;certificate of incorporation&rdquo;), our restated bylaws (&ldquo;bylaws&rdquo;)
and other governing documents contain provisions that could discourage, delay or prevent a third party from acquiring us, even if doing
so may be beneficial to our stockholders, which could cause our stock price to decline. In addition, these provisions could limit the
price investors would be willing to pay in the future for shares of our common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
do not currently or for the foreseeable future intend to pay dividends on our common stock.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have never declared or paid any cash dividends on our common stock. We currently anticipate that we will retain future earnings for the
development, operation and expansion of our business and do not anticipate declaring or paying any cash dividends for the foreseeable
future. As a result, any return on your investment in our common stock will be limited to the appreciation in the price of our common
stock, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Purchasers
of our common stock in this offering will experience immediate and substantial dilution in the book value of their investment.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
offering price per share in this offering is substantially higher than the net tangible book value per share of our ordinary shares before
giving effect to this offering. Accordingly, purchasers of our securities in this offering will incur immediate dilution of approximately
$0.73 per share, representing the difference between the public offering price per share and our as-adjusted net tangible
book value per share as of September 30, 2024. Furthermore, if outstanding options or warrants are exercised, purchasers could experience
further dilution. For more information, including how these amounts were calculated, see &ldquo;Dilution.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
management will have broad discretion as to the use of the proceeds from this offering, and may not use the proceeds effectively.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management will have broad discretion as to the application of the net proceeds from this offering. Currently, we intend to use the net
proceeds from this offering for working capital and general corporate purposes, including the further development of our product candidates
that are currently undergoing clinical trials, our product candidates that we expect to submit an investigational new drug application
for in the near term, and our product candidates that are pre-clinical. See &ldquo;Use of Proceeds.&rdquo; Purchasers will not have
the opportunity, as part of their investment decision, to assess whether these proceeds are being used appropriately. Our management
may use the net proceeds for corporate purposes that may not improve our financial condition or market value, which could cause the price
of our securities to decline.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
will need additional capital to conduct our operations and develop our products, and our ability to obtain the necessary funding is uncertain.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have used a significant amount of cash since inception to finance the continued development and testing of our product candidates, and
we expect to need substantial additional capital resources to develop our product candidates going forward and launch and commercialize
any product candidates for which we receive regulatory approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may not be successful in generating and/or maintaining operating cash flow, and the timing of our capital expenditures and other expenditures
may not result in cash sufficient to sustain our operations through the commercialization of our product candidates. If financing is
not sufficient and additional financing is not available or available only on terms that are detrimental to our long-term survival, it
could have a material adverse effect on our ability to continue to function. The timing and degree of any future capital requirements
will depend on many factors, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">accuracy
                                            of the assumptions underlying our estimates for capital needs in 2025 and beyond&#894;</FONT></P>
                                                                              <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">scientific
                                            and clinical progress in our research and development programs&#894;</FONT></P>
                                                                              <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            magnitude and scope of our research and development programs and our ability to establish,
                                            enforce and maintain strategic arrangements for research, development, clinical testing,
                                            manufacturing and marketing&#894;</FONT></P>
                                                                              <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            progress with pre-clinical development and clinical trials&#894;</FONT></P>
                                                                              <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            time and costs involved in obtaining regulatory approvals&#894;</FONT></P>
                                                                              <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            costs involved in preparing, filing, prosecuting, maintaining, defending and enforcing patent
                                            claims&#894; and</FONT></P>
                                                                              <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    number and type of product candidates that we pursue.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional
financing through strategic collaborations, public or private equity or debt financings or other financing sources may not be available
on acceptable terms, or at all. Additional equity financing could result in significant dilution to our stockholders, and any debt financings
will likely involve covenants restricting our business activities. Further, if we obtain additional funds through arrangements with collaborative
partners, these arrangements may require us to relinquish rights to some of our technologies, product candidates or products that we
would otherwise seek to develop and commercialize on our own.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
sufficient capital is not available, we may be required to delay, reduce the scope of or eliminate one or more of our research or product
development initiatives, any of which could have a material adverse effect on our financial condition or business prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>There
is no public market for the common warrants or pre-funded warrants being offered by us in this offering.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no established public trading market for the common warrants or the pre-funded warrants, and we do not expect a market to develop.
In addition, we do not intend to apply to list the common warrants or pre-funded warrants on any national securities exchange or other
nationally recognized trading system. Without an active market, the liquidity of the common warrants and pre-funded warrants will be
limited.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Holders of warrants purchased in this
offering will have no rights as common stockholders until such holders exercise their warrants and acquire our common stock.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Until holders of warrants
acquire shares of our common stock upon exercise thereof, holders of warrants will have no rights with respect to the shares of our common
stock underlying such warrants. Upon exercise of the warrants, the holders will be entitled to exercise the rights of a common stockholder
only as to matters for which the record date occurs after the exercise date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>This
is a reasonable best efforts offering, no minimum amount of securities is required to be sold, and we may not raise the amount of capital
we believe is required for our business plans, including our near-term business plans.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
placement agent has agreed to use its reasonable best efforts to solicit offers to purchase the securities in this offering. The placement
agent has no obligation to buy any of the securities from us or to arrange for the purchase or sale of any specific number or dollar
amount of the securities. There is no required minimum number of securities that must be sold as a condition to completion of this offering.
Because there is no minimum offering amount required as a condition to the closing of this offering, the actual offering amount, placement
agent fees and proceeds to us are not presently determinable and may be substantially less than the maximum amounts set forth above.
We may sell fewer than all of the securities offered hereby, which may significantly reduce the amount of proceeds received by us, and
investors in this offering will not receive a refund in the event that we do not sell an amount of securities sufficient to support our
continued operations, including our near-term continued operations. Thus, we may not raise the amount of capital we believe is required
for our operations in the short-term and may need to raise additional funds, which may not be available or available on terms acceptable
to us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Purchasers who purchase our securities
in this offering pursuant to a securities purchase agreement may have rights not available to purchasers that purchase without the benefit
of a securities purchase agreement.</I></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to rights and remedies available to all purchasers in this offering under federal securities and state law, the purchasers
that enter into a securities purchase agreement will also be able to bring claims of breach of contract against us. The ability to
pursue a claim for breach of contract provides those investors with the means to enforce the covenants uniquely available to them
under the securities purchase agreement including, but not limited to: (i) timely delivery of shares; (ii) agreement to not issue
any shares or securities convertible into shares for a period of sixty days from closing of the offering, subject to certain
exceptions; and (iii) indemnification for breach of contract.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
common stock may be at risk for delisting from the Nasdaq Capital Market in the future if we do not maintain compliance with Nasdaq&rsquo;s
continued listing requirements. Delisting could adversely affect the liquidity of our common stock and the market price of our common
stock could decrease.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 31.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock is currently listed on Nasdaq. Nasdaq has minimum requirements that a company must meet in order to remain listed on Nasdaq,
including corporate governance standards and a requirement that we maintain a stockholders&rsquo; equity above $2,500,000 as set forth
in Nasdaq Listing Rule 5550(b)(1).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 31.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 21, 2024, the Company received a letter from Nasdaq notifying the Company that its amount of stockholders&rsquo; equity has
fallen below the $2,500,000 required minimum for continued listing set forth in Nasdaq Listing Rule 5550(b)(1).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 31.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq&rsquo;s
Letter has no immediate effect on the listing of the Company&rsquo;s common stock, and its common stock will continue to trade on The
Nasdaq Capital Market under the symbol &ldquo;GTBP&rdquo; at this time. Pursuant to Nasdaq Listing Rules, the Company provided
Nasdaq with a plan to achieve and sustain compliance on December 31, 2024. If Nasdaq accepts the Company&rsquo;s plan to regain
compliance, Nasdaq may grant an extension of up to 180 calendar days from the date of the Letter to evidence compliance. If Nasdaq does
not accept the Company&rsquo;s plan to regain compliance, the Company will have the opportunity to appeal the decision to a Nasdaq Hearings
Panel. The Company intends to submit to Nasdaq, within the requisite time period, a plan to regain compliance with Listing Rule 5550(b)(1).
There can be no assurance that Nasdaq will accept the Company&rsquo;s plan, that the Company will be able to regain compliance with Listing
Rule 5550(b)(1) or that the Company will be able meet the continued listing requirements during any compliance period that may be granted
by Nasdaq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 31.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the future, if we fail to maintain such minimum requirements and a final determination is made by Nasdaq that our common stock must be
delisted, the liquidity of our common stock would be adversely affected and the market price of our common stock could decrease. In addition,
if delisted, we would no longer be subject to Nasdaq rules, including rules requiring us to have a certain number of independent directors
and to meet other corporate governance standards. Our failure to be listed on Nasdaq or another established securities market would have
a material adverse effect on the value of your investment in us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 31.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_006"></A>USE
OF PROCEEDS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">We estimate that the net proceeds
from the offering will be approximately $7.1 million, based on the assumed public offering price of $2.38 per share and
common warrant, which is the last reported sales price of our common stock on Nasdaq on January 23, 2024 after deducting the placement
agent fees and estimated offering expenses payable by us, assuming no sale of any fixed combinations of warrants and pre-funded warrants
offered hereunder. We may only receive additional proceeds from the exercise of the common warrants issuable in connection with this
offering and, if such common warrants are exercised in full for cash, the estimated net proceeds will increase to $15.1 million.
However, because this is a reasonable best-efforts offering and there is no minimum offering amount required as a condition to the closing
of this offering, the actual offering amount, the placement agent&rsquo;s fees and net proceeds to us are not presently determinable
and may be substantially less than the maximum amounts set forth on the cover page of this prospectus. Based on the assumed public offering
price set forth above, we estimate that our net proceeds from the sale of 75%, 50%, and 25% of the securities offered in this offering
would be approximately $5.2 million, $3.4 million, and $1.5 million, respectively, after deducting the estimated
placement agent fees and estimated offering expenses payable by us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently intend to use the net proceeds from this offering for working capital to fund our clinical programs and general corporate purposes,
including the further development of: our product candidates that are currently undergoing clinical trials, our product candidates that
we expect to submit an investigational new drug application for in the near term, and our product candidates that are pre-clinical. This
expected use of proceeds from this offering represents our intentions based upon our current plans and prevailing business conditions,
which could change in the future as our plans and prevailing business conditions evolve. The amounts and timing of our use of proceeds
will vary depending on a number of factors, including the amount of cash generated or used by our operations. As a result, we will retain
broad discretion in the allocation of the net proceeds of this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_007"></A>CAPITALIZATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents a summary of our cash and cash equivalents and capitalization as of September 30, 2024:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on
    an actual basis; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on
    an as adjusted basis to reflect the issuance and sale of common stock and accompanying common warrants in this offering, after deducting
    placement agent fees and estimated offering expenses payable by us. The as adjusted basis assumes no pre-funded warrants are
    sold in this offering and excludes the proceeds, if any, from the exercise of any common warrants issued in this offering.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unaudited as adjusted information below is prepared for illustrative purposes only and our capitalization following the completion of
this offering will be adjusted based on the actual public offering price and other terms of this offering determined at pricing. You
should read the following table in conjunction with Management&rsquo;s Discussion and Analysis of Financial Condition and Results of
Operations and the historical financial statements and related notes in the Company&rsquo;s Annual Report on Form 10-K for the fiscal
year ended December 31, 2023 and our Quarterly Report on Form 10-Q for the period ended September 30, 2024, incorporated herein by reference.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">As of September 30, 2024</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1pt"></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Actual</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">As adjusted</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash and cash equivalents</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 18%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6,418,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 14%; text-align: right"><P STYLE="margin: 0">13,547,000</P></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stockholders&rsquo; equity:</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Convertible preferred stock, $0.01 par value,
    15,000,000 shares authorized Series C, 96,230 shares issued and outstanding</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Common stock: $0.001 par value; 250,000,000
    shares authorized; 2,234,328 shares issued and outstanding, actual; 5,595,672 shares issued and outstanding, pro forma as
    adjusted</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><P STYLE="margin: 0">6,000</P></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Additional paid-in capital</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">693,546,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"><P STYLE="margin: 0">700,671,000</P></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accumulated deficit</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(691,452,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><P STYLE="margin: 0">(691,452,000</P></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total stockholders&rsquo;
    equity</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,097,000</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><P STYLE="margin: 0">9,226,000</P></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
$0.25 increase (decrease) in the assumed public offering price of $2.38 per share would increase (decrease) each of cash and cash
equivalents, additional paid-in capital and total shareholders&rsquo; equity by approximately $790,000, assuming the number of
shares of common stock and common warrants offered, as set forth on the cover page of this prospectus, remains the same, and after deducting
estimated placement agent fees and estimated offering expenses. Similarly, each increase (decrease) of 100,000 shares in the number of
shares of common stock and common warrants offered would increase (decrease) cash and cash equivalents, additional paid-in capital and
total shareholders&rsquo; equity by approximately $223,720, assuming the assumed public offering price remains the same, and after
deducting estimated placement agent fees and estimated offering expenses payable by us. The pro forma as adjusted information discussed
above is illustrative only and will be adjusted based on the actual public offering price and other terms of this offering determined
at pricing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise stated in this prospectus, the number of shares of our common stock to be outstanding as of the date of this prospectus and
after this offering is based on 2,234,328 shares outstanding as of September 30, 2024, and excludes (a) placement agent warrants to purchase
up to 201,680 shares of our common stock issuable upon the exercise of warrants to be issued to the placement agent in connection
with this offering having an exercise price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, (b) the shares of common
stock issuable upon exercise of the common warrants and pre-funded warrants being offered by us in this offering, (c) previously issued
and outstanding warrants to purchase up to 1,133,762 shares of our common stock, and (d) outstanding stock options to purchase up to
101,264 shares of our common stock. <I>See &ldquo;Note 7 &ndash; Common Stock Warrants and Options&rdquo;</I> to our Third Quarter Report
filed on Form 10-Q that is incorporated by reference into this prospectus.</FONT></P>



<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_008"></A>DILUTION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you purchase shares of our common stock, your interest will be diluted immediately to the extent of the difference between the offering
price per share you will pay in this offering and the as adjusted net tangible book value per share of our common stock after this offering.
Net tangible book value per share represents our total tangible assets less total liabilities, divided by the number of shares of our
common stock outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2024, our net tangible book value was $2,097,000, or $0.94 per share of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
giving effect to the foregoing pro forma adjustments and the sale by us of 3,361,344 shares of common stock and/or pre-funded
warrants at an assumed public offering price of $2.38 per share and accompanying common warrant, and after deducting the placement
agent fees and estimated offering expenses payable by us, our as adjusted net tangible book value as of September 30, 2024, would have
been $9,226,469, or $1.65 per share. This represents an immediate increase in as adjusted net tangible book value of approximately
$0.71 per share to our existing stockholders, and an immediate dilution of $0.73 per share to purchasers of shares in this
offering, as illustrated in the following table. The information below is illustrative only and will change based on actual pricing and
other terms of this offering determined at pricing. The final public offering price will be determined through negotiation between us,
the placement agent and the investors in the offering and may be at a discount to the current market price. Therefore, the assumed public
offering price used throughout this prospectus may not be indicative of the final public offering price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 78%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumed
    public offering price</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; width: 18%"><P STYLE="margin: 0">2.38</P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    tangible book value per share as of September 30, 2024</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.94</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    increase in net tangible book value per share attributable to existing shareholders</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"><P STYLE="margin: 0">0.71</P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    adjusted net tangible book value per share after this offering</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"><P STYLE="margin: 0">1.65</P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dilution
    in net tangible book value per share to new investors in the offering</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; width: 18%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.73</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise stated in this prospectus, the number of shares of our common stock to be outstanding as of the date of this prospectus and
after this offering is based on 2,234,328 shares outstanding as of September 30, 2024, and excludes (a) placement agent warrants to purchase
up to 201,680 shares of our common stock issuable upon the exercise of warrants to be issued to the placement agent in connection
with this offering having an exercise price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, (b) the shares of common
stock issuable upon exercise of the common warrants and pre-funded warrants being offered by us in this offering, (c) previously issued
and outstanding warrants to purchase up to 1,133,762 shares of our common stock, and (d) outstanding stock options to purchase up to
101,264 shares of our common stock. <I>See &ldquo;Note 7 &ndash; Common Stock Warrants and Options&rdquo;</I> to our Third Quarter Report
filed on Form 10-Q that is incorporated by reference into this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="acxx_001"></A>EXECUTIVE
COMPENSATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Summary
Compensation Table</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes all compensation for the last two fiscal years awarded to, earned by, or paid to our Chief Executive Officer
(principal executive officer) and our two most highly compensated executive officers other than our CEO who were either serving as executive
officers at the end of our last completed fiscal year or for whom disclosure would have been provided but for the fact that the individual
was not serving as an executive officer at the end of our last completed fiscal year, whose total compensation exceeded $100,000 during
such fiscal year ends.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 96%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold">Name and Principal Position</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Salary <BR> ($)</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Bonus <BR> ($)</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stock
    <BR> Awards <SUP>(1)</SUP> <BR> ($)</B></FONT></TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Option
    <BR> Awards <SUP>(2)</SUP> <BR> ($)</B></FONT></TD><TD STYLE="font-weight: bold"><SUP>&nbsp;</SUP></TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">All <BR> Other <BR> Compensation
    <BR> ($)</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total <BR> ($)</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 34%; text-align: left">Michael Breen</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 4%; text-align: center">2024</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 6%; text-align: right">556,200</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 6%; text-align: right">417,150</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 6%; text-align: right">&ndash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 6%; text-align: right">&ndash;</TD><TD STYLE="width: 1%; text-align: left"><SUP>&nbsp;</SUP></TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 6%; text-align: right">213,622</TD><TD STYLE="width: 1%; text-align: left"><SUP>(3)</SUP></TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 6%; text-align: right">1,186,972</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Chairman, Interim Chief Executive Officer, and President</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2023</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">556,200</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">312,863</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">57,600</TD><TD STYLE="text-align: left"><SUP>(6)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">425,000</TD><TD STYLE="text-align: left"><SUP>(7)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">174,171</TD><TD STYLE="text-align: left"><SUP>(3)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,525,834</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left"><SUP>&nbsp;</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Alan Urban</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2024</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">187,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">87,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">40,681</TD><TD STYLE="text-align: left"><SUP>(8)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">27,643</TD><TD STYLE="text-align: left"><SUP>(4)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">343,324</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Chief Financial Officer</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2023</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left"><SUP>&nbsp;</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left"><SUP>&nbsp;</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Manu Ohri</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2024</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">203,540</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left"><SUP>&nbsp;</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">104,264</TD><TD STYLE="text-align: left"><SUP>(5)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">307,804</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Former Chief Financial Officer</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2023</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">432,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">172,800</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">57,600</TD><TD STYLE="text-align: left"><SUP>(9)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">425,000</TD><TD STYLE="text-align: left"><SUP>(10)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">42,271</TD><TD STYLE="text-align: left"><SUP>(5)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,129,671</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><SUP>(1)</SUP></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            amounts in this column represent the aggregate grant date fair value of restricted stock
                                            awards, determined in accordance with Financial Accounting Standards Board (FASB) Accounting
                                            Standards Codification (ASC) Topic 718. We determine the grant date fair value of the awards
                                            by multiplying the number of units granted by the closing market price of one share of our
                                            common stock on the award grant date. These amounts do not reflect the actual economic value
                                            that will be realized by the named executive officer upon the vesting or the sale of the
                                            common stock awards.</FONT></P>
    </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><SUP>(2)</SUP></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                            column represents option awards computed in accordance with FASB ASC Topic 718, excluding
                                            the effect of estimated forfeitures related to service-based vesting conditions. For additional
                                            information on the valuation assumptions with respect to the option grants, refer to Note
                                            1 of our financial statements in the Annual Report. These amounts do not correspond to the
                                            actual value that will be recognized by the named executives from these awards.</FONT></P>
    </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><SUP>(3)</SUP></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    compensation for 2024 includes $131,374 in paid time off payout, $60,000 in medical insurance, life insurance and long-term disability
    insurance premiums, and $22,248 in employer pension contributions. Other compensation for 2023 includes $128,833 in medical insurance,
    life insurance and long-term disability insurance premiums, and $45,338 in employer pension contributions.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><SUP>(4)</SUP></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
                                            compensation for 2024 includes $19,245 in medical insurance premiums, and $8,398 employer
                                            401(k) contributions.</FONT></P>
    </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><SUP>(5)</SUP></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    compensation for 2024 includes $78,300 in paid time off payout, and $25,964 in medical insurance premiums, life insurance and long-term
    disability insurance premiums, and medical expense reimbursements. Other compensation for 2023 includes $42,271 in medical insurance,
    life insurance and long-term disability insurance premiums, medical expense reimbursements and employer 401(k) contributions. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><SUP>(6)</SUP></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    the aggregate grant date fair value 6,666 shares of our common stock issued on August 11, 2023 at a closing market price of $8.70
    per share as compensation for service as our Interim Chief Executive Officer.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><SUP>(7)</SUP></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    the aggregate grant date fair value of options to purchase 16,666 shares of common stock issued on January 27, 2023, with 1/12<SUP>th
    </SUP>of the shares vesting on the monthly anniversary of January 1, 2023 as compensation for service on our Board of Directors.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><SUP>(8)</SUP></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    the aggregate grant date fair value of options to purchase 23,335 shares of common stock issued on October 17, 2024, with 1/36<SUP>th
    </SUP>of the shares vesting on the monthly anniversary of June 3, 2024 until fully vested, subject to acceleration</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><SUP>(9)</SUP></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    the aggregate grant date fair value 6,666 shares of our common stock issued on August 11, 2023 at a closing market price of $8.70
    per share.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><SUP>(10)</SUP></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    the aggregate grant date fair value of options to purchase 16,666 shares of common stock issued on January 27, 2023, with 1/12<SUP>th
    </SUP>of the shares vesting on the monthly anniversary of January 1, 2023</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Outstanding
Equity Awards at Fiscal Year End</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information regarding unexercised stock options for each named executive officer as of December 31, 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 82%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold">Name</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number
                                            of</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>securities</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>underlying</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>unexercised</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>options</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>exercisable
                                            (#)</B></FONT></P></TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number
                                            of</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>securities</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>underlying</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>unexercised</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>options</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>unexercisable
                                            (#)</B></FONT></P></TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Option</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>exercise</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>price
                                            ($)</B></FONT></P></TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Option</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>expiration</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>date</B></FONT></P></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 26%; text-align: left">Michael Breen</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 15%; text-align: right">1,666</TD><TD STYLE="width: 1%; text-align: left"><SUP>(1)</SUP></TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 15%; text-align: right">&mdash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 15%; text-align: right">74.40</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 15%; text-align: right">7/14/2032</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,666</TD><TD STYLE="text-align: left"><SUP>(1)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25.50</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">1/27/2033</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Alan Urban</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,537</TD><TD STYLE="text-align: left"><SUP>(2)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18,798</TD><TD STYLE="text-align: left"><SUP>(2)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.11</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">10/17/2034</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><SUP>(1)</SUP></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists
    of options granted to Mr. Breen as compensation for service on our Board of Directors. </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><SUP>(2)</SUP></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists
    of options granted to Mr. Urban that vest as follows: 1/36<SUP>th</SUP> of the shares vest on the monthly anniversary of June 3,
    2024 until fully vested, subject to acceleration. </FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pay
Versus Performance</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Year</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Summary
    Compensation Table Total for PEO<SUP>(1)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Compensation
    Actually Paid to PEO<SUP>(2)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Average
    Summary Compensation Table Total for Non-PEO NEO<SUP>(3)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Average
    Compensation Actually paid to Non-PEO NEOs<SUP>(4)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Value
    of Initial Fixed $100 Investment Based on Total Shareholder Return<SUP>(5)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Net
                                            Loss</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(In
                                            Thousands)<SUP>(6)</SUP></B></FONT></P></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 11%; text-align: center">2024</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">1,186,972</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">1,186,972</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">343,324</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">359,710</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">3.25</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">(a)</TD><TD STYLE="width: 1%; text-align: left"></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center">2023</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,525,834</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,258,279</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,129,671</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">862,116</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">8.15</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">7,597</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center">2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,892,293</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,498,165</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">944,544</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,029,311</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">28.31</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">20,884</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><SUP>(a)</SUP></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount
                                            will be reported on the Company&rsquo;s 2024 Form 10-K.</FONT></P>
    </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><SUP>(1)</SUP></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    dollar amounts reported are the amounts of total compensation reported in our Summary Compensation Table for each of 2024, 2023,
    and 2022 for Mr. Breen, our Interim Chief Executive Officer (our principal executive officer (PEO) from and after March 2, 2022).</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><SUP>(2)</SUP></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    dollar amounts reported represent the amount of &ldquo;compensation actually paid,&rdquo; as computed in accordance with SEC rules.
    The dollar amounts do not reflect the actual amount of compensation earned by or paid during the applicable year. In accordance with
    SEC rules, the following adjustments were made to total compensation to determine the compensation actually paid:</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Year</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0">Reported Summary</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">Compensation Table</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">Total for PEO</P></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0">Reported Value of</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">Equity Awards (a)</P></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0">Equity Award</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">Adjustments (b)</P></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0">Compensation Actually</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">Paid to PEO</P></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 12%; text-align: center">2024</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 18%; text-align: right">1,186,972</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 18%; text-align: right">&mdash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 18%; text-align: right">&mdash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 18%; text-align: right">1,186,972</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center">2023</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,525,834</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">482,600</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">215,045</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,258,279</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center">2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,892,293</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">800,584</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">406,456</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,498,165</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><SUP>(a)</SUP></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            grant date fair value of equity awards represents the total of the amounts reported in the
                                            &ldquo;Stock awards&rdquo; and &ldquo;Option awards&rdquo; columns in the Summary Compensation
                                            Table for the applicable year.</FONT></P>
    </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><SUP>(b)</SUP></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    equity award adjustments for each applicable year include the addition (or subtraction, as applicable) of the following: (i) the
    year-end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year;
    (ii) the amount of change as of the end of the applicable year (from the end of the prior fiscal year) in fair value of any awards
    granted in prior years that are outstanding and unvested as of the end of the applicable year; (iii) for awards that are granted
    and vest in same applicable year, the fair value as of the vesting date; (iv) for awards granted in prior years that vest in the
    applicable year, the amount equal to the change as of the vesting date (from the end of the prior fiscal year) in fair value; (v)
    for awards granted in prior years that are determined to fail to meet the applicable vesting conditions during the applicable year,
    a deduction for the amount equal to the fair value at the end of the prior fiscal year; and (vi) the dollar value of any dividends
    or other earnings paid on stock or option awards in the applicable year prior to the vesting date that are not otherwise reflected
    in the fair value of such award or included in any other component of total compensation for the applicable year. The valuation assumptions
    used to calculate fair values did not materially differ from those disclosed at the time of grant. The amounts deducted or added
    in calculating the equity award adjustments are as follows:</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Year</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Year End Fair Value of Outstanding
    and Unvested Equity Awards Granted During the Year</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Year over Year Change in Fair Value
    of Outstanding and Unvested Equity Awards Granted in Prior Years</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Fair Value as of Vesting Date of
    Equity Awards Granted and Vested in the Year</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Year over Year Change in Fair Value
    of Equity Awards Granted in Prior Years that Vested in the Year</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Total Equity Award Adjustments</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center">2024</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 15%; text-align: center">2023</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 13%; text-align: right">10,641</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 13%; text-align: right">&mdash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 13%; text-align: right">204,404</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 13%; text-align: right">&mdash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 13%; text-align: right">215,045</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center">2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">10,265</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(25,072</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">997,908</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(576,645</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">406,456</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><SUP>(3)</SUP></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    dollar amounts reported represent the average of the amounts reported for the Company&rsquo;s named executive officers (NEOs) as
    a group (excluding our CEO) in the &ldquo;Total&rdquo; column of the Summary Compensation Table in each applicable year. Mr. Urban
    is the only NEO included for purposes of calculating the average amounts in 2024, and Mr. Ohri is the only NEO included for purposes
    of calculating the average amounts in 2023 and 2022.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><SUP>(4)</SUP></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    dollar amounts reported represent the average amount of &ldquo;compensation actually paid&rdquo; to the NEOs as a group (excluding
    our CEO), as computed in accordance with SEC rules. The dollar amounts do not reflect the actual average amount of compensation earned
    by or paid to the NEOs as a group (excluding our CEO) during the applicable year. In accordance with the SEC rules, the following
    adjustments were made to average total compensation for the NEOs as a group (excluding our CEO) for each year to determine the compensation
    actually paid, using the same methodology described above in Note 2:</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Year</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Average Reported Summary Compensation
    Table Total for Non-PEO NEOs</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Average Reported Value of Equity
    Awards</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Average Equity Award Adjustments
    (a)</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Average Compensation Actually Paid
    to Non-PEO NEOs</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 12%; text-align: center">2024</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 18%; text-align: right">343,324</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 18%; text-align: right">40,681</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 18%; text-align: right">57,067</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 18%; text-align: right">359,710</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center">2023</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,129,671</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">482,600</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">215,045</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">862,116</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center">2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">944,544</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">448,515</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">533,282</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,029,311</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><SUP>(a)</SUP></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    amounts deducted or added in calculating the total average equity award adjustments are as follows:</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Year</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Average Year End Fair Value of Outstanding
    and Unvested Equity Awards Granted During the Year</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Year over Year Average Change in
    Fair Value of Outstanding and Unvested Equity Awards Granted in Prior Years</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Average Fair Value as of Vesting
    Date of Equity Awards Granted and Vested in the Year</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Year over Year Average Change in
    Fair Value of Equity Awards Granted in Prior Years that Vested in the Year</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Total Average Equity Award Adjustments</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 15%; text-align: center">2024</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 13%; text-align: right">49,157</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 13%; text-align: right">&mdash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 13%; text-align: right">7,910</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 13%; text-align: right">&mdash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 13%; text-align: right">57,067</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center">2023</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">10,641</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">204,404</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">215,045</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center">2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">97,175</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">436,107</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">533,282</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><SUP>(5)</SUP></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cumulative
    total stockholder return is calculated by dividing the sum of the cumulative amount of dividends for the measurement period, assuming
    dividend reinvestment, and the difference between the Company&rsquo;s share price at the end and the beginning of the measurement
    period, by the Company&rsquo;s share price at the beginning of the measurement period. Represents the value on the last trading day
    of each of 2024, 2023 and 2022 of an investment of $100 in our common stock on the last trading day of 2021. </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><SUP>(6)</SUP></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    dollar amounts reported represent the amount of net loss reflected in our audited financial statements for the applicable year.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Analysis
of Information Presented in the Pay versus Performance Table</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s executive compensation program reflects a variable pay-for-performance philosophy. While the Company utilizes several
performance measures to align executive compensation with Company performance, all of those Company measures are not presented in the
Pay versus Performance table. Moreover, the Company generally seeks to incentivize long-term performance, and therefore does not specifically
align the Company&rsquo;s performance measures with compensation that is actually paid (as computed in accordance with SEC rules) for
a particular year. In accordance with SEC rules, the Company is providing the following narrative disclosure regarding the relationships
between information presented in the Pay versus Performance table.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Compensation
Actually Paid and Cumulative Total Stockholder Return</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
fiscal 2023 and 2024, compensation actually paid to our PEO decreased from $1,258,279 in fiscal 2023 to $1,186,972 in fiscal 2024, and
average compensation actually paid to our named executive officers other than our PEO decreased from $862,116 in fiscal 2023 to $359,710
in fiscal 2024. During fiscal 2022 and 2023, compensation actually paid to our PEO decreased from $1,498,165 in fiscal 2022 to $1,258,279
in fiscal 2023, and average compensation actually paid to our named executive officers other than our PEO decreased from $1,029,311 in
fiscal 2022 to $862,116 in fiscal 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Over
the same period, the value of an investment of $100 in our common stock on the last trading day of 2021 decreased by $71.69 to $28.31
during fiscal 2022, further decreased by $20.16 to $8.15 during fiscal 2023, and further decreased by $4.90 to $3.25 during fiscal 2024,
for a total decrease from fiscal 2022 through fiscal 2024 of $96.75.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Compensation
Actually Paid and Net Loss</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
fiscal 2023 and 2024, compensation actually paid to our PEO decreased from $1,258,279 in fiscal 2023 to $1,186,972 in fiscal 2024, and
average compensation actually paid to our named executive officers other than our PEO decreased from $862,116 in fiscal 2023 to $359,710
in fiscal 2024. During fiscal 2022 and 2023, compensation actually paid to our PEO decreased from $1,498,165 in fiscal 2022 to $1,258,279
in fiscal 2023, and average compensation actually paid to our named executive officers other than our PEO decreased from $1,029,311 in
fiscal 2022 to $862,116 in fiscal 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
net loss during fiscal 2024 will be reported on the Company&rsquo;s 2024 Form 10-K. Our net loss decreased by $13,287,000 during fiscal
2023 (from a net loss in fiscal 2022 of $20,884,000 to a net loss in fiscal 2023 of $7,597,000).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Employment
Agreements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is party to employment agreements with both Michael Breen and Alan Urban, each of which are described below. The Company does
not currently have employment agreements with any of its other officers and directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Michael
Breen, Chairman, Interim Chief Executive Officer, and President</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 31, 2021, the Company entered into a one-year, annually renewable executive services agreement with Mr. Breen, effective November
8, 2021, and amended on June 17, 2022 and February 20, 2023. Under the terms of the amended executive services agreement, Mr. Breen will
receive an annual base salary of $556,200, reimbursement for executive life insurance premiums, a pension contribution equal to 4% of
Mr. Breen&rsquo;s gross annual salary, and right to receive any benefit and participate in any benefit plan generally available to the
most senior level of employees of the Company. Mr. Breen is eligible to participate in our performance bonus plan or as otherwise determined
by our Compensation Committee, with a target annual bonus of 75% of his annual base salary with a minimum guaranteed performance bonus
of 25% of base salary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the termination of Mr. Breen&rsquo;s services for any reason, Mr. Breen will receive his accrued but unpaid salary and vacation pay through
the date of termination and any other benefits accrued to him under any benefit plans outstanding at such time, and the reimbursement
of documented, unreimbursed expenses incurred prior to such date. Upon our termination of Mr. Breen&rsquo;s services without cause (as
defined in the his services agreement) or upon Mr. Breen&rsquo;s termination of his employment for good reason (as defined in his services
agreement) prior to the end of the term of his services agreement, Mr. Breen shall also receive (i) a lump sum payment equal to the greater
of the amount of his annual base salary (at the then-current rate) that he would have earned through the end of the term of the agreement,
and 50% of his annual base salary, plus (ii) a lump sum payment equal to the greater of the bonus paid or payable to Mr. Breen for the
immediately preceding year, and the target bonus under our performance bonus plan, if any, in effect during the immediately preceding
year, plus (iii) monthly reimbursement for the cost of medical, life and disability insurance coverage at a level equivalent to that
provided by our company for a period of the earlier of (a) one year and (b) the time Mr. Breen begins alternative services wherein said
insurance coverage is available and offered to Mr. Breen. Mr. Breen will also be designated for election to our Board of Directors during
the term of his services agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Alan
Urban, Chief Financial Officer</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 7, 2024, the Company entered into an Employment Agreement with Mr. Urban (the &ldquo;Employment Agreement&rdquo;). The Employment
Agreement is effective from June 3, 2024 (the &ldquo;Effective Date&rdquo;) and shall continue for a period of one year. The Employment
Agreement shall automatically renew for successive one year periods unless and until either party provides sixty (60) days&rsquo; advance
written notice prior to applicable renewal term. Pursuant to the Employment Agreement, Mr. Urban will receive an annual base salary of
$375,000 and is eligible to earn an annual discretionary bonus of up to 40% of his annual base salary each calendar year during the term,
subject to the achievement of applicable Company and individual performance goals, as determined in the Company&rsquo;s sole discretion.
Mr. Urban is eligible to receive a stock award of the Registrant&rsquo;s Common Stock following the three months after the Effective
Date. The Employment Agreement further provides that Mr. Urban will be eligible to receive any benefit and participate in any benefit
plan generally available to employees of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company may terminate the Employment Agreement without Cause (as such term is defined in the Employment Agreement) at any time and Mr.
Urban may terminate his employment for Good Reason (as such term is defined in the Employment Agreement) at any time. Upon a termination
of Mr. Urban&rsquo;s employment by the Company without Cause or by Mr. Urban for Good Reason, Mr. Urban will be entitled to receive (i)
for a termination or resignation that occurs during the first six months following the Effective Date, a cash severance equal to two
(2) months of Mr. Urban&rsquo;s then current Annual Base Salary (as such term is defined in the Employment Agreement) or (ii) for a termination
or resignation that occurs any time thereafter, a cash severance equal to five (5) months of Mr. Urban&rsquo;s then current Annual Base
Salary, in either case less deductions and withholding required by law, payable in a lump sum within seventy (70) days of the termination
of employment (or such shorter period as may allow the severance payment to be exempt from Code Section 409A). Upon a termination of
Mr. Urban&rsquo;s employment by the Company for Cause or by Mr. Urban without Good Reason, Mr. Urban will be entitled to the Accrued
Amounts (as such term is defined in the Employment Agreement). The Employment Agreement also contains certain non-disclosure covenants
that apply during his employment and thereafter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2022
Omnibus Incentive Plan - Summary</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2014 we established the 2014 Stock Incentive Plan (the &ldquo;2014 Plan&rdquo;) and in April 2022 we established the 2022 Omnibus Incentive
Plan, collectively (the &ldquo;Plans&rdquo;). The Plans were approved by our Board of Directors and stockholders. The purpose of the
Plans is to grant stock and options to purchase our common stock, and other incentive awards, to our employees, directors and key consultants.
The maximum number of shares of common stock that may be issued pursuant to awards granted under the 2022 Plan is 166,667. Following
adoption of the 2022 Plan by our stockholders we only grant incentive awards under the 2022 Plan. The shares of our common stock underlying
cancelled and forfeited awards issued under the 2022 Plan may again become available for grant under the 2022 Plan. As of December 31,
2024, there were no shares available for grant under the 2014 Plan. All outstanding incentive stock award grants prior to the adoption
of the 2022 Plan were made under the 2014 Plan, and all incentive stock award grants after the adoption of the 2022 Plan have been and
will be made under the 2022 Plan. The following table provides information as of December 31, 2024 with respect to the Plans.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 82%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Plan category</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number
                                            of securities</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>to
                                            be issued</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>upon
                                            exercise</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>of
                                            outstanding options,</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>warrants
                                            and rights</B></FONT></P></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Weighted
                                            average</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>exercise
                                            price of</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>outstanding
                                            options,</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>warrants</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>and
                                            rights <SUP>(1)</SUP></B></FONT></P></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number
                                            of securities</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>remaining
                                            available</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>for
                                            future issuance</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>under
                                            equity</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>compensation
                                            plans</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(excluding
                                            securities</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>reflected
                                            in column (a))</B></FONT></P></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">(a)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">(b)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">(c)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Equity compensation plans approved by stockholders (2014 Plan)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 34%; text-align: left; padding-bottom: 1pt">Equity compensation plans approved by stockholders (2022 Plan)</TD><TD STYLE="width: 2%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="width: 18%; border-bottom: Black 1pt solid; text-align: right">150,535</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="width: 18%; border-bottom: Black 1pt solid; text-align: right">32.69</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="width: 18%; border-bottom: Black 1pt solid; text-align: right">16,132</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt">Total</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">150,535</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">16,132</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><SUP>(1)</SUP></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    weighted average exercise price excludes restricted stock awards, which have no exercise price.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Director
Compensation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents information regarding compensation awarded or paid to our non-employee directors for our fiscal year ended December
31, 2024 for the services rendered by them to the Company in all capacities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 92%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Name</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fees</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>earned</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>or
                                            paid</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>in
                                            cash</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>($)</B></FONT></P></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stock</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>awards</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>($)</B></FONT></P></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Option</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>awards</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>($)</B></FONT></P></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Total ($)</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; text-align: left">Rajesh Shrotriya, M.D.</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">81,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">&mdash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">&mdash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">81,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Bruce Wendel</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">81,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">81,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Charles J. Casamento</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">65,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">65,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
fiscal 2024, our non-employee directors received annual cash compensation in the amount of $50,000 for service on our Board of Directors,
and annual compensation of $5,000 per committee for service on our Audit Committee, Compensation Committee and Nominating and Corporate
Governance Committee. Non-employee members of the Special Committee of our Board of Directors also received a monthly fee of $8,000 for
service on the Special committee for the months of January and February 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Indemnification
of Directors and Executive Officers and Limitation of Liability</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have entered into indemnification agreements with each of our current directors and certain key employees. The indemnification agreements,
our restated certificate of incorporation and Amended Restated Bylaws require us to indemnify our current and former directors and officers
to the fullest extent permitted by Delaware law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="sj_001"></A>CERTAIN
RELATIONSHIPS AND RELATED TRANSACTIONS<SUP></SUP></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Transactions
with Officers, Directors and greater than 5% stockholders</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than listed below, since January 1, 2024, there has not been, nor is there currently proposed, any transaction or series of similar
transactions to which we were or will be a party:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    which the amount involved exceeds the lesser of $120,000 or one percent of the average of our total assets at year end for the last
    two completed fiscal years; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            which any director, executive officer, stockholder who beneficially owns more than 5% of
                                            our common stock or any member of their immediate family had or will have a direct or indirect
                                            material interest.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 7.25pt; text-align: justify"></P></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Cytovance</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2020, the Company entered into a Master Services Agreement with Cytovance Biologics, Inc. (&ldquo;Cytovance&rdquo;), to perform
biologic development and manufacturing services, and to produce and test compounds used in the Company&rsquo;s potential product candidates.
The Company subsequently executed numerous Statements of Work (&ldquo;SOWs&rdquo;) for the research and development of products for use
in clinical trials. On August 24, 2022, the Company entered into a Settlement and Investment Agreement with Cytovance that amended existing
SOWs and allowed for future invoices to be settled in in a combination of cash and issuance of the Company&rsquo;s common stock. The
Agreement also set Cytovance&rsquo;s beneficial ownership limitation at 4.9% of the issued and outstanding shares of the Company&rsquo;s
common stock. On April 25, 2024, the Company entered into an Amendment to the Settlement and Investment Agreement with Cytovance that
increased Cytovance&rsquo;s beneficial ownership limitation to 9.9% of the issued and outstanding shares of the Company&rsquo;s common
stock. On June 30, 2024, Cytovance became a related party as their beneficial ownership exceeded 5% of the issued and outstanding shares
of the Company&rsquo;s common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the nine months ended September 30, 2024 and 2023, the Company recognized research and development expenses of $1,365,000 and $3,691,000,
respectively and made cash payments amounting to $3,432,000 and $1,710,000, respectively to Cytovance. In addition, the Company issued
127,597 and 57,437 shares of common stock to Cytovance to settle accounts payable valued at approximately $810,000 and $1,120,000, respectively.
As of September 30, 2024 the Company&rsquo;s commitments in relation to unbilled and unaccrued SOWs and any related Change Orders from
Cytovance for services that have not yet been rendered as of September 30, 2024, amounted to approximately $1.3 million. As of September
30, 2024 and December 31, 2023, accounts payable to Cytovance amounted to $638,000 and $3,515,000, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="acxx_002"></A>SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth certain information, as of January 9, 2025, with respect to the holdings of (1) each person who is the beneficial
owner of more than five percent of our common stock, (2) each of our directors, (3) each named executive officer, and (4) all of our
directors and executive officers as a group.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial
ownership of our common stock is determined in accordance with the rules of the Securities and Exchange Commission and includes any shares
of common stock over which a person exercises sole or shared voting or investment powers, or of which a person has a right to acquire
ownership at any time within 60 days of January 9, 2025. Except as otherwise indicated, and subject to applicable community property
laws, the persons named in this table have sole voting and investment power with respect to all shares of common stock held by them.
The address of each director and officer is 315 Montgomery Street, 10<SUP>th</SUP> Floor, San Francisco, California 94104. Applicable
percentage ownership in the following table is based on 2,234,328 shares of common stock outstanding as of January 9, 2025 plus, for
each person, any securities that person has the right to acquire within 60 days of January 9, 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 77%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1pt solid">Name of Beneficial Owner</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number
                                            of</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shares
                                            Beneficially Owned</B></FONT></P></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Percentage
                                            of</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shares</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Outstanding</B></FONT></P></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Five Percent or Greater Stockholders</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 64%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cytovance Biologics,
    Inc. <B><SUP>(1)</SUP></B></FONT></TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; text-align: right">219,457</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; text-align: right">9.8</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert A. Marzilli <B><SUP>(2)</SUP></B></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">200,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9.0</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bristol Investment Fund,
    Ltd. <B><SUP>(3)</SUP></B></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">190,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7.8</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Executive Officers and Directors:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael Breen <B><SUP>(4)</SUP></B></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">46,872</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.1</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alan Urban <B><SUP>(5)</SUP></B></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,537</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.2</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bruce Wendel <B><SUP>(6)</SUP></B></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">31,753</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.4</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rajesh Shrotriya, M.D.
    <B><SUP>(7)</SUP></B></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">32,047</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.4</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charles J. Casamento <B><SUP>(8)</SUP></B></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,666</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.7</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors and officers
    as a group (5 persons) <B><SUP>(9)</SUP></B></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">131,875</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.7</TD><TD STYLE="text-align: left">%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><SUP>(1)</SUP></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    address for Cytovance Biologics, Inc. is 800 Research Parkway, Suite 200 Oklahoma City, OK 73104.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><SUP>(2)</SUP></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    address for Robert A. Marzilli is 457 Sunset Beach Rd., Richmond Hill, Ontario, L4E 3J3, Canada. This information is based on information known to the company through a non-objecting beneficial ownership report
(the &ldquo;NOBO Report&rdquo;) as of December 31, 2024. Mr. Marzilli has not provided or verified the information appearing on the NOBO
Report, and so this information may not be accurate for a number of reasons, including, but not limited to, if Mr Marzilli has divested
such ownership through private contractual or other means not reflected in the NOBO Report, or is the beneficial owner of other shares
not disclosed in the NOBO Report.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><SUP>(3)</SUP></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    address for Bristol Investment Fund, Ltd. is Citco Trustees (Cayman) Limited, 89 Nexus Way, Camana Bay, PO Box 311063, Grand Cayman
    KY1-1205, Cayman Islands. Includes shares underlying warrants to purchase 190,000 shares of common stock at $4.35 per share.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><SUP>(4)</SUP></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    shares underlying options to purchase 1,666 shares of common stock at $74.40 per share, and 16,666 shares of common stock at $25.50
    per share.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><SUP>(5)</SUP></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    shares underlying options to purchase 4,537 shares of common stock at $2.11 per share.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><SUP>(6)</SUP></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists
    of shares underlying options to purchase 3,332 shares of common stock at $74.40 per share, and 16,666 shares of common stock at $25.50
    per share.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><SUP>(7)</SUP></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists
    of shares underlying options to purchase 15,381 shares of common stock at $74.40 per share, and 16,666 shares of common stock at
    $25.50 per share.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><SUP>(8)</SUP></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    shares underlying options to purchase 16,666 shares of common stock at $10.50 per share.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><SUP>(9)</SUP></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    shares underlying options to purchase 91,580 shares of common stock.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="b_001"></A>DESCRIPTION
OF CAPITAL STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
following summary of the rights of our capital stock is not complete and is subject to and qualified in its entirety by reference to
our Charter and Bylaws, copies of which are filed as exhibits to our Annual Report on Form 10-K for the year ended December 31, 2023,
filed with the SEC on March 26, 2024, and the Certificate of Designations and forms of securities, copies of which are filed as exhibits
to the registration statement of which this prospectus forms a part , which are incorporated by reference herein.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 20.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following summary describes the material terms of our capital stock. The summary is qualified in its entirety by reference to our certificate
of incorporation and our bylaws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 20.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Authorized
Shares</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
authorized shares consists of 250,000,000 shares of common stock and 15,000,000 shares of preferred stock, $0.001 par value per
share (the &ldquo;Preferred Stock&rdquo;). Our common stock is registered under Section 12(b) of the Exchange Act and is listed
on the Nasdaq under the trading symbol &ldquo;GTBP.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 2, 2024, the Company effectuated a reverse stock-split of its common stock, par value $0.001 per share, at a ratio of 1 for
30. The Company&rsquo;s common stock began trading on a reverse stock-split-adjusted basis on The Nasdaq Capital Market on February 5,
2024 under the existing trading symbol &ldquo;GTBP.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the reverse stock-split, every thirty (30) shares of issued and outstanding common stock were automatically combined into
one issued and outstanding share of common stock, without any change in the par value per share. No fractional shares will be issued
in connection with the reverse stock split. Stockholders who otherwise would be entitled to receive fractional shares of common stock
will be entitled to receive their pro-rata portion of the net proceeds obtained from the aggregation and sale by the exchange agent of
the fractional shares resulting from the reverse stock-split (reduced by any customary brokerage fees, commission and other expenses).
The reverse stock split reduced the number of shares of common stock outstanding on the effective date of the reverse stock-split from
41,419,000 shares to 1,380,633 shares, subject to minor adjustments due to the treatment of fractional shares. The number of authorized
shares of common stock remains unchanged at 250,000,000 shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proportionate
adjustments have been made to the per share exercise price and the number of shares of common stock that may be purchased upon exercise
of outstanding stock options and warrants for the Company&rsquo;s common stock, and to the number of shares of common stock reserved
for future issuance pursuant to the Company&rsquo;s 2022 Omnibus Incentive Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
share and per share information within this report have been adjusted to retroactively reflect the reverse stock-split as of the earliest
period presented.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common
Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of our common stock are entitled to one vote for each share of common stock held of record for the election of directors and on all matters
submitted to a vote of stockholders. Holders of our common stock are entitled to receive dividends ratably, if any, as may be declared
by the board of directors out of legally available funds, subject to any preferential dividend rights of any preferred stock then outstanding.
In the event of our dissolution, liquidation or winding up, holders of our common stock are entitled to share ratably in our net assets
legally available after the payment of all of our debts and other liabilities, subject to the liquidation preferences of any preferred
stock then outstanding. Holders of our common stock have no preemptive, subscription, redemption or conversion rights. The rights, preferences
and privileges of holders of common stock are subject to, and may be adversely affected by, the rights of the holders of shares of any
series of preferred stock currently outstanding or that we may designate and issue in the future. All outstanding shares of our common
stock are fully paid and non-assessable. Except as described below in &ldquo;Anti-Takeover Provisions Under Our Charter and Bylaws and
Delaware Law,&rdquo; holders of a majority of the outstanding shares of stock entitled to vote shall constitute a quorum for the transaction
of business, and a vote of the majority of the voting power represented at such meeting at which a quorum is generally required to take
action under our certificate of incorporation and bylaws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Preferred
Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board is authorized, without action by the stockholders, to designate and issue up to 15,000,000 shares of preferred stock in one or
more series. In the past the Board has designated series lettered A through K and issued shares in those series (other than Series K).
As of the date of this prospectus, only preferred shares in the series designated C have shares issued and outstanding. Our Board can
fix or alter the rights, preferences and privileges of the shares of each series and any of its qualifications, limitations or restrictions,
including dividend rights, conversion rights, voting rights, terms of redemption, liquidation preferences and the number of shares constituting
a class or series. The issuance of preferred stock could, under certain circumstances, result in one or more of the following adverse
effects:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">decreasing
                                            the market price of our common stock;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">restricting
                                            dividends on our common stock;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">diluting
                                            the voting power of our common stock;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">impairing
                                            the liquidation rights of our common stock; or</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">delaying
                                            or preventing a change in control of us without further action by our shareholders.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board will make any determination to issue such shares based on its judgment as to our best interests and the best interests of our stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Series
C Preferred Stock</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
a discussion of the terms of our Series C Preferred Stock, see Note 6 to our audited financial statements, <I>Stockholders&rsquo; Equity</I>,
incorporated in this document by reference.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Warrants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
warrants for the purchase of up to 740,000 shares of common stock (the &ldquo;2024 Common Warrants&rdquo;) were issued pursuant
to a securities purchase agreement between us and certain institutional investors, dated as of May 21, 2024 (the &ldquo;2024 Purchase
Agreement&rdquo;) in registered form and entitle the registered holder to purchase one share of our common stock at a price equal to
$4.35 per share, subject to adjustment as discussed below, terminating at 5:00 p.m., New York City time, on the fifth anniversary of
the date of issuance. Also pursuant to the 2024 Purchase Agreement, we had an additional number of outstanding placement agent warrants
for the purchase of up to 88,800 shares of common stock at an exercise price of $5.4375. (the &ldquo;2024 Placement Agent Warrants,&rdquo;
and together with the 2024 Common Warrants, the &ldquo;2024 Warrants&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
warrants to purchase up to an aggregate of 216,667 shares of the Company&rsquo;s common stock (the &ldquo;2023 Common Warrants&rdquo;),
pre-funded warrants to purchase up to 96,667 shares of the Company&rsquo;s common stock (the &ldquo;Pre-Funded Warrants&rdquo;), and
placement agent warrants to purchase up to 13,000 of the Company&rsquo;s common stock (the &ldquo;2023 Placement Agents Warrants,&rdquo;
and together with the 2023 Common Warrants and Pre-Funded Warrants, the &ldquo;2024 Warrants&rdquo;) were issued pursuant to a purchase
agreement dated December 30, 2022. The 2023 Common Warrants have an exercise price equal to $30.00 per share, are exercisable commencing
six months following issuance, and have a term of exercise equal to five years following the initial issuance date. The Pre-Funded Warrants
had an exercise price of $0.003 per share, are immediately exercisable and could be exercised at any time after their original issuance
until such Pre-Funded Warrants were exercised in full. The 2023 Placement Agents Warrants have an exercise price equal to $37.50 per
share, are exercisable commencing six months following issuance, and have a term of exercise equal to five years following the initial
issuance date. The 2023 Shares and 2023 Common Warrants were sold at an offering price of $30.00 per share and accompanying 2023 Common
Warrant and the Pre-Funded Warrants and 2023 Common Warrants were sold at an offering price of $29.997 per Pre-Funded Warrant and accompanying
2023 Common Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of 2023 Warrants and 2024 Warrants (together, the &ldquo;Warrants&rdquo;) may exercise such warrants on a &ldquo;cashless&rdquo; basis
if an effective registration statement is not available with respect to the offering of shares of common stock upon exercise of
such Warrant. In such event, the Holder may elect instead to receive upon such exercise (either in whole or in part) the net number of
shares of common stock determined according to a formula set forth in the Warrants. The exercise price and number of shares of common
stock issuable upon exercise of the Warrants may be adjusted in certain circumstances, including in the event of a stock dividend, extraordinary
dividend on or recapitalization, reorganization, merger or consolidation. The Warrants may be exercised by delivery of a notice of exercise
and the aggregate exercise price (assuming no cashless exercise has been elected if an effective registration statement is not available
with respect to the offering of shares of common stock upon exercise of such Warrant) to us as specified in such Warrant. Holders
of Warrants do not have the rights or privileges of holders of common stock and any voting rights until they exercise their Warrants
and receive shares of common stock. After the issuance of shares of common stock upon exercise of the Warrants, each holder will be entitled
to one vote for each share held of record on all matters to be voted on by stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Anti-Takeover
Provisions Under Our Charter and Bylaws and Delaware Law</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
provisions of Delaware law, our certificate of incorporation and our bylaws contain provisions that could have the effect of delaying,
deferring or discouraging another party from acquiring control of us. These provisions, which are summarized below, may have the effect
of discouraging coercive takeover practices and inadequate takeover bids. These provisions are also designed, in part, to encourage persons
seeking to acquire control of us to first negotiate with our Board. We believe that the benefits of increased protection of our potential
ability to negotiate with an unfriendly or unsolicited acquirer outweigh the disadvantages of discouraging a proposal to acquire us because
negotiation of these proposals could result in an improvement of their terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amended
and Restated Certificate of Incorporation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Undesignated
Preferred Stock</I>. Our Board has the ability to issue preferred stock with voting or other rights or preferences that could impede
the success of any attempt to change control of us. These and other provisions may have the effect of deferring hostile takeovers or
delaying changes in control or management of our company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Special
Meetings of Stockholders</I>. Our bylaws provide that special meetings of our stockholders may be called only by our Chairman, President
or a majority of the entire Board of Directors, thus prohibiting a stockholder from calling a special meeting. This provision might delay
the ability of our stockholders to force consideration of a proposal or for stockholders controlling a majority of our capital stock
to take any action, including the removal of directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Board
Vacancies Filled Only by Majority of Directors</I>. Vacancies and newly created seats on our Board may be filled only by a majority of
the directors then in office. Only our Board may determine the number of directors on our board. The inability of stockholders to determine
the number of directors or to fill vacancies or newly created seats on our Board makes it more difficult to change the composition of
our Board, but these provisions promote a continuity of existing management.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>No
Cumulative Voting</I>. The DGCL provides that stockholders are not entitled to the right to cumulate votes in the election of directors
unless our certificate of incorporation provides otherwise. Our certificate of incorporation and bylaws do not expressly provide for
cumulative voting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Directors
Removed Only by Special Meeting of Stockholders</I>. A director can be removed only by the affirmative vote of a majority of the votes
of the issued and outstanding stock entitled to vote for the election of directors of the corporation given at a special meeting of the
stockholders called and held for this purpose.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Amendment
of Charter Provisions</I>. In order to amend certain of the above provisions in our certificate of incorporation and our bylaws, the
Board is expressly authorized to adopt, alter or repeal the bylaws, subject to the rights of the stockholders entitled to vote. Stockholders
can vote at any stockholder meeting and repeal, alter, or amend the bylaws by the affirmative vote of a majority of the stockholders
entitled to vote in such meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delaware
Anti-takeover Statute</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to Section 203 of the DGCL. In general, Section 203 prohibits a publicly held Delaware corporation from engaging in a &ldquo;business
combination&rdquo; with an &ldquo;interested stockholder&rdquo; for a period of three years after the date of the transaction in which
the person became an interest stockholder, unless the business combination is approved in a prescribed manner. A &ldquo;business combination&rdquo;
includes mergers, asset sales and other transactions in which the interested stockholder receives or could receive a financial benefit
on other than a <I>pro rata</I> basis with other stockholders. An &ldquo;interested stockholder&rdquo; is a person who, together with
affiliates and associates, owns, or within three years did own, 15% or more of the corporation&rsquo;s outstanding voting stock. This
provision has an anti-takeover effect with respect to transactions not approved in advance by our Board, including discouraging takeover
attempts that might result in a premium over the market price for the shares of our market price. With approval of our stockholders,
we could amend our amended and restated certificate of incorporation in the future to avoid the restrictions imposed by this anti-takeover
law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
provisions of Delaware law and our amended and restated certificate of incorporation could have the effect of discouraging others from
attempting hostile takeovers and, as a consequence, they may also inhibit temporary fluctuations in the market price of our common stock
that often result from actual or rumored hostile takeover attempts. These provisions may also have the effect of preventing changes in
our management. It is possible that these provisions could make it more difficult to accomplish transactions that stockholders may otherwise
deem to be in their best interests.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Transfer
Agent and Registrar</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
transfer agent and registrar for our capital stock is Computershare. The transfer agent&rsquo;s address is 8742 Lucent Blvd., Suite 225,
Highland Ranch, CO 80129, and its telephone number is (303) 262-0600.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Existing
Trading Markets</B></FONT></P>

<P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock is listed on the Nasdaq Capital Market under the trading symbol &ldquo;GTBP.&rdquo; The closing sale price of our common
stock on the Nasdaq Capital Market on January 23, 2025, was $2.38 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Listing
on the Nasdaq Capital Market</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock is listed on the Nasdaq Capital Market under the symbol &ldquo;GTBP.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 20.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="b_002"></A>DESCRIPTION
OF SECURITIES WE ARE OFFERING</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are offering up to 3,361,344 shares of our common stock (or pre-funded warrants in lieu of) and up to common warrants to purchase
up to 3,361,344 shares of common stock. Each share of common stock is being offered together with one common warrant to purchase
one share of common stock. We are also offering pre-funded warrants to those purchasers whose purchase of shares of common stock in this
offering would result in the purchaser, together with its affiliates and certain related parties, beneficially owning more than 4.99%
(or, at the election of the purchaser, 9.99%) of our outstanding shares of common stock following the consummation of this offering in
lieu of the shares of common stock that would result in such excess ownership. Each pre-funded warrant will be exercisable for one share
of common stock. Each pre-funded warrant is being offered together with one common warrant to purchase one share of common stock. No
warrant for fractional shares of common stock will be issued, rather warrants will be issued only for whole shares of common stock. We
are also registering the shares of common stock issuable from time to time upon exercise of the pre-funded warrants and common warrants
offered hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common
Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
material terms and provisions of our common stock are described under the caption &ldquo;<I>Description of Capital Stock</I>&rdquo; in
this prospectus and are incorporated herein by reference.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common
Warrants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>General</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of certain terms and provisions of the common warrants that are being offered hereby is not complete and is subject
to, and qualified in its entirety by, the provisions of the common warrant, the form of which will be filed as an exhibit to the registration
statement of which this prospectus forms a part. Prospective investors should carefully review the terms and provisions of the form of
common warrant for a complete description of the terms and conditions of the common warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Duration,
Exercise Price and Form</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
common warrant offered hereby has an initial exercise price per share equal to $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. Each common warrant is exercisable for one share of
common stock. The common warrants are exercisable immediately following issuance, and have a term of exercise equal to five years following
the initial exercise date. The exercise price and number of shares issuable upon exercise is subject to appropriate adjustment in the
event of stock dividends, stock splits, reorganizations or similar events affecting our common stock and the exercise price. The common
warrants will be issued in certificated form only.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Exercisability</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
common warrants are exercisable immediately after issuance, at the option of each holder, in whole or in part, by delivering to us a
duly-executed exercise notice accompanied by payment in full for the number of shares purchased upon such exercise (except in the case
of a cashless exercise as discussed below). A holder (together with its affiliates) may not exercise any portion of such holder&rsquo;s
common warrants to the extent that the holder would own more than 4.99% (or 9.99%, at the holder&rsquo;s election) of our outstanding
common stock immediately after exercise, except that upon notice from the holder to us, the holder may decrease or increase the limitation
of ownership of outstanding stock after exercising the holder&rsquo;s common warrants up to 9.99% of the number of shares of our common
stock outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance with the
terms of the common warrants, provided that any increase in such limitation shall not be effective until 61 days following notice to
us. No fractional shares will be issued in connection with the exercise of a common warrant. In lieu of fractional shares, we will either
pay the holder an amount in cash equal to the fractional amount multiplied by the exercise price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Cashless
Exercise</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,
at the time a holder exercises its common warrants, a registration statement registering the issuance of the shares of common stock underlying
the common warrants under the Securities Act, is not then effective or available for the resale of such shares, then in lieu of making
the cash payment otherwise contemplated to be made to us upon such exercise in payment of the aggregate exercise price, the holder may
elect instead to receive upon such exercise (either in whole or in part) the net number of shares of common stock determined according
to a formula set forth in the common warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Fundamental
Transactions</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of any fundamental transaction, as described in the common warrants and generally including any merger with or into another
entity, sale of all or substantially all of our assets, tender offer or exchange offer, or reclassification of our shares of common stock,
then upon any subsequent exercise of a common warrant, the holder will have the right to receive as alternative consideration, for each
share of common stock that would have been issuable upon such exercise immediately prior to the occurrence of such fundamental transaction,
the number of shares of common stock of the successor or acquiring corporation or of our company, if it is the surviving corporation,
and any additional consideration receivable upon or as a result of such transaction by a holder of the number of shares of common stock
for which the common warrant is exercisable immediately prior to such event. In addition, upon a fundamental transaction, the holder
will have the right to require us to repurchase its common warrant at its fair value using the Black Scholes option pricing formula in
the common warrants; provided, however, that, if the fundamental transaction is not within our control, including not approved by our
board of directors, then the holder shall only be entitled to receive the same type or form of consideration (and in the same proportion),
at the Black Scholes value of the unexercised portion of the common warrant, that is being offered and paid to the holders of our common
stock in connection with the fundamental transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Transferability</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to applicable laws, a common warrant may be transferred at the option of the holder upon surrender of the common warrant to us together
with the appropriate instruments of transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Exchange
Listing</I></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no trading market available for the common warrants on any securities exchange or nationally recognized trading system. We do not
intend to list the common warrants on any securities exchange or nationally recognized trading system. Without an active market, the
liquidity of the common warrants will be limited.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Right
as a Stockholder</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as otherwise provided in the common warrants or by virtue of such holder&rsquo;s ownership of our common stock, the holders of the common
warrants do not have the rights or privileges of holders of our common stock, including any voting rights, until they exercise their
common warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pre-Funded
Warrants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><I>General</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of certain</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> terms and
provisions of the pre-funded warrants that are being offered hereby is not complete and is subject to, and qualified in
its entirety by, the provisions of the pre-funded warrant, the form of which will be filed as an exhibit to the
registration statement of which this prospectus forms a part. Prospective investors should carefully review the terms and provisions of the form of pre-funded warrant for a complete
description of the terms and conditions of the pre-funded warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Duration,
Exercise Price and Form</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 40.8pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
pre-funded warrant offered hereby has an initial exercise price per share equal to $0.0001. Each pre-funded warrant is exercisable for
one share of common stock. The pre-funded warrants are exercisable immediately, and will be exercisable until exercised in full. The
exercise price and number of shares issuable upon exercise is subject to appropriate adjustment in the event of stock dividends, stock
splits, reorganizations or similar events affecting our common stock and the exercise price. The pre-funded warrants will be issued in
certificated form only.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 40.8pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Exercisability</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 40.8pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
pre-funded warrants are exercisable immediately, at the option of each holder, in whole or in part, by delivering to us a duly-executed
exercise notice accompanied by payment in full for the number of shares purchased upon such exercise (except in the case of a cashless
exercise as discussed below). A holder (together with its affiliates) may not exercise any portion of such holder&rsquo;s pre-funded
warrants to the extent that the holder would own more than 4.99% (or 9.99%, at the holder&rsquo;s election) of our outstanding common
stock immediately after exercise, except that upon notice from the holder to us, the holder may decrease or increase the limitation of
ownership of outstanding stock after exercising the holder&rsquo;s pre-funded warrants up to 9.99% of the number of shares of our common
stock outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance with the
terms of the pre-funded warrants, provided that any increase in such limitation shall not be effective until 61 days following notice
to us. No fractional shares will be issued in connection with the exercise of a pre-funded warrant. In lieu of fractional shares, we
will either pay the holder an amount in cash equal to the fractional amount multiplied by the exercise price or round up to the next
whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 40.8pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Cashless
Exercise</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 40.8pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
holder, in lieu of making the cash payment otherwise contemplated to be made to us upon such exercise in payment of the aggregate exercise
price, may elect instead to receive upon such exercise (either in whole or in part) the net number of shares of common stock determined
according to a formula set forth in the pre-funded warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 40.8pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Fundamental
Transactions</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 40.8pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of any fundamental transaction, as described in the pre-funded warrants and generally including any merger with or into another
entity, sale of all or substantially all of our assets, tender offer or exchange offer, or reclassification of our shares of common stock,
then upon any subsequent exercise of a pre-funded warrant, the holder will have the right to receive as alternative consideration, for
each share of common stock that would have been issuable upon such exercise immediately prior to the occurrence of such fundamental transaction,
the number of shares of common stock of the successor or acquiring corporation or of our company, if it is the surviving corporation,
and any additional consideration receivable upon or as a result of such transaction by a holder of the number of shares of common stock
for which the pre-funded warrant is exercisable immediately prior to such event.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 40.8pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Transferability&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 40.8pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to applicable laws, a pre-funded warrant may be transferred at the option of the holder upon surrender of the pre-funded warrant to us
together with the appropriate instruments of transfer.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Exchange
Listing</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no trading market available for the pre-funded warrants on any securities exchange or nationally recognized trading system. We do
not intend to list the pre-funded warrants on any securities exchange or nationally recognized trading system. Without an active market,
the liquidity of the pre-funded warrants will be limited.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Right
as a Stockholder</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as otherwise provided in the pre-funded warrants or by virtue of such holder&rsquo;s ownership of our common stock, the holders of the
pre-funded warrants do not have the rights or privileges of holders of our common stock, including any voting rights, until they exercise
their pre-funded warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Placement
Agent Warrants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of certain terms and provisions of the placement agent warrants that are being offered hereby is not complete
and is subject to, and qualified in its entirety by, the provisions of the placement agent warrant, the form of which will be filed as
an exhibit to the registration statement of which this prospectus forms a part.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
Prospective investors should carefully review the terms and provisions of the form of placement agent warrant for a complete description
of the terms and conditions of the placement agent warrants.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
placement agent warrants are substantially similar to the common warrants, except that each placement agent warrant will have an exercise
price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share (which represents 125% of the public offering price per share of common
stock and accompanying common warrants sold in this offering) and will expire five years from the commencement of sales of the
offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="b_003"></A>MATERIAL
TAX CONSIDERATIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a discussion of material U.S. federal income tax consequences generally applicable to the acquisition, ownership, and disposition
of common stock, common warrants, and pre-funded warrants issued pursuant to this offering. This discussion does not address tax consequences
other than those pertaining to U.S. federal income taxation. For example, this discussion does not address any consequences relating
to estate or gift taxation, the alternative minimum tax, or the Medicare tax on investment income. Nor does this discussion address any
aspects of U.S. state or local or non-U.S. taxation. This discussion applies only to holders that hold our common stock, common warrants,
and pre-funded warrants as &ldquo;capital assets&rdquo; within the meaning of Section 1221 of the U.S. Internal Revenue Code of 1986,
as amended (the &ldquo;Code&rdquo;). This discussion does not address all aspects of U.S. federal income taxation that may be relevant
to holders in light of their particular circumstances or status, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">financial
                                            institutions or financial services entities;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">broker-dealers;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S
                                            corporations;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">partnerships
                                            (including entities or arrangements treated as partnerships for U.S. federal income tax purposes);</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">taxpayers
                                            that are subject to the mark-to-market accounting rules;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">tax-exempt
                                            entities;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">governments
                                            or agencies or instrumentalities thereof;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">insurance
                                            companies;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulated
                                            investment companies or real estate investment trusts;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">expatriates
                                            or former long-term residents or citizens of the United States;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
                                            for whom our common stock or pre-funded warrants constitute &ldquo;qualified small business
                                            stock&rdquo; within the meaning of Section 1202 of the Code;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
                                            that hold our securities as part of a straddle, constructive sale, hedging, conversion or
                                            other integrated or similar transaction;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
                                            subject to the alternative minimum tax;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
                                            persons whose functional currency is not the U.S. dollar;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">controlled
                                            foreign corporations;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">accrual
                                            method taxpayers that file applicable financial statements as described in Section&nbsp;451(b)
                                            of the Code; or</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">passive
                                            foreign investment companies.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a partnership (or any entity or arrangement treated as a partnership for U.S. federal income tax purposes) holds common stock, common
warrants, or pre-funded warrants, the tax treatment of such partnership and a person treated as a partner of such partnership will generally
depend on the status of the partner and the activities of the partnership. Partnerships holding any common stock, common warrants, or
pre-funded warrants, and persons that are treated as partners of such partnerships, should consult their tax advisors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
discussion is based on the Code, Treasury Regulations promulgated under the Code, and judicial and administrative interpretations thereof,
all as of the date hereof. U.S. tax law is subject to change, which change could apply retroactively and could affect the tax considerations
described herein. We have not and do not intend to seek any ruling from the U.S. Internal Revenue Service (the &ldquo;IRS&rdquo;) regarding
any U.S. federal income tax considerations described herein. There can be no assurance that the IRS will not take positions inconsistent
with the considerations discussed below or that any such positions would not be sustained by a court.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EACH
PROSPECTIVE INVESTOR SHOULD CONSULT ITS TAX ADVISOR WITH RESPECT TO THE PARTICULAR TAX CONSEQUENCES TO SUCH PROSPECTIVE INVESTOR OF THE
ACQUISITION, OWNERSHIP, AND DISPOSITION OF COMMON STOCK, COMMON WARRANTS, AND PRE-FUNDED WARRANTS, INCLUDING THE EFFECTS OF U.S. FEDERAL,
STATE AND LOCAL, AND&nbsp;NON-U.S. TAX LAWS.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CHARACTERIZATION
OF COMMON STOCK, COMMON WARRANTS, AND PRE-FUNDED WARRANTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Allocation
of Purchase Price Between Common Stock, Common Warrants, and Pre-Funded Warrants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
U.S. federal income tax purposes, each holder that acquires common stock (or pre-funded warrants) and common warrants pursuant to this
offering should allocate the purchase price paid by such holder between the underlying common stock or pre-funded warrant (as applicable)
and common warrant based on their relative fair market values at the time of issuance. The amount of purchase price allocated to each
share of common stock or pre-funded warrant (as applicable) and each common warrant should establish the applicable holder&rsquo;s initial
tax basis in such share of common stock or pre-funded warrant (as applicable) and such common warrant. We do not intend to advise holders
with respect to the relative fair market values of common stock, common warrants, and pre-funded warrants. Each holder is accordingly
urged to consult its tax advisor with respect to the allocation of purchase price between common stock, common warrants, and pre-funded
warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Characterization
of Pre-Funded Warrants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
the characterization of the&nbsp;pre-funded&nbsp;warrants for U.S. federal income tax purposes is not entirely clear, we intend to take
the position that each pre-funded warrant is treated for U.S. federal income tax purposes as a share of our common stock. This is because
the exercise price of each&nbsp;pre-funded&nbsp;warrant is a nominal amount equal to $0.0001. The remainder of this discussion assumes
that the characterization of pre-funded warrants described above will be respected for U.S. federal income tax purposes.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
HOLDERS</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
used herein, a &ldquo;U.S. Holder&rdquo; is a beneficial owner of our common stock, pre-funded warrant, or common warrant (as applicable)
that is, for U.S. federal income tax purposes:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                            individual citizen or resident of the United States,</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            corporation (or other entity that is treated as a corporation for U.S. federal income tax
                                            purposes) that is created or organized (or treated as created or organized) in or under the
                                            laws of the United States or any state thereof or the District of Columbia,</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                            estate whose income is subject to U.S. federal income tax regardless of its source, or</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            trust if (1) a U.S. court can exercise primary supervision over the administration of such
                                            trust and one or more U.S. persons have the authority to control all substantial decisions
                                            of the trust or (2) it has a valid election in place to be treated as a U.S. person.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Distributions
on Our Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently anticipate that we will retain future earnings for the development, operation and expansion of our business and do not anticipate
declaring or paying any cash dividends for the foreseeable future. If we do make distributions with respect to our common stock, a U.S.
Holder generally should be required to include in gross income as a dividend the amount of any cash distribution or the fair market value
of any other property distributed with respect to shares of our common stock, to the extent the distribution is paid out of our current
or accumulated earnings and profits, as determined under U.S. federal income tax principles. Amounts treated as a dividend that we pay
to a U.S. Holder that is a taxable corporation may qualify for a dividends received deduction, provided certain holding period and other
requirements are satisfied. Amounts treated as a dividend that we pay to a non-corporate U.S. Holder may be taxed as &ldquo;qualified
dividend income&rdquo; at preferential tax rates accorded to long-term capital gains, subject to certain exceptions and provided certain
holding period and other requirements are satisfied. Distributions in excess of current and accumulated earnings and profits should generally
constitute a return of capital that is applied against and that reduces (not below zero) the U.S. Holder&rsquo;s adjusted tax basis in
its shares of our common stock. Any remaining excess should generally be treated as gain realized on the sale or other disposition of
our common stock and should generally be treated as described below under &ldquo;&mdash;<I>U.S. Holders&mdash;Sale, Exchange, or Other
Taxable Disposition of Our Common Stock, Pre-Funded Warrants, or Common Warrants</I>.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Sale,
Exchange, or Other Taxable Disposition of Our Common Stock, Pre-Funded Warrants, or Common Warrants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
a sale, exchange, or other taxable disposition of our common stock, pre-funded warrants, or common warrants, a U.S. Holder generally
should recognize capital gain or loss equal to the difference between the amount realized on such sale, exchange, or other taxable disposition
and the U.S. Holder&rsquo;s adjusted tax basis in the applicable shares of our common stock, pre-funded warrants, or common warrants.
Any such capital gain or loss generally should be long-term capital gain or loss if the U.S. Holder&rsquo;s holding period for the shares
of our common stock, pre-funded warrants, or common warrants so disposed of exceeds one year. Long-term capital gains recognized by non-corporate
U.S. Holders may be eligible to be taxed at reduced rates. The deductibility of capital losses is subject to limitations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exercise
of a Pre-Funded Warrant</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
described in &ldquo;<I>&mdash;Characterization of Common Stock, Common Warrants, and Pre-Funded Warrants&mdash;Characterization of Pre-Funded
Warrants</I>&rdquo; above, we intend to take the position that each pre-funded warrant is treated for U.S. federal income tax purposes
as a share of our common stock. Based on this characterization, a U.S. Holder generally should not recognize taxable gain or loss as
a result of the acquisition of shares of our common stock upon exercise of a pre-funded warrant for its nominal exercise price. The U.S.
Holder&rsquo;s tax basis in the share of our common stock received upon exercise of the pre-funded warrant should be an amount equal
to the sum of the U.S. Holder&rsquo;s tax basis in the pre-funded warrant and the nominal exercise price of such pre-funded warrant.
The U.S. Holder&rsquo;s holding period in the share of our common stock received upon exercise of the pre-funded warrant should include
the U.S. Holder&rsquo;s holding period for the pre-funded warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exercise
or Lapse of a Common Warrant</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
U.S. Holder generally should not recognize taxable gain or loss as a result of the acquisition of shares of our common stock upon exercise
of a common warrant for cash in the amount of its exercise price. The U.S. Holder&rsquo;s tax basis in the share of our common stock
received upon exercise of the common warrant generally should be an amount equal to the sum of the U.S. Holder&rsquo;s tax basis in the
common warrant and the exercise price of such common warrant. It is unclear whether a U.S. Holder&rsquo;s holding period for the shares
of our common stock received upon exercise of the common warrant will commence on the date of exercise of the common warrant or the day
following the date of exercise of the common warrant. In either case, the holding period should not include the period during which the
U.S. Holder held the common warrant. If a common warrant is allowed to lapse unexercised, a U.S. Holder generally should recognize a
capital loss equal to such U.S. Holder&rsquo;s tax basis in the common warrant. The deductibility of capital losses is subject to limitations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
U.S. federal income tax treatment of a cashless exercise of common warrants is unclear under current law and could differ from the treatment
described above. A cashless exercise could be considered a taxable event. U.S. Holders are urged to consult their own tax advisors regarding
the cashless exercise of a common warrant and the U.S. federal income tax treatment thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Possible
Constructive Distributions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms of each common warrant provide in certain circumstances for an adjustment to the exercise price of the common warrant or an increase
in the shares of our common stock issuable upon exercise. An adjustment made pursuant to a bona fide, reasonable, adjustment formula
which has the effect of preventing dilution generally is not taxable. The U.S. Holders of the common warrant would, however, be treated
as receiving a constructive distribution from us if, for example, the adjustment increases the U.S. Holder&rsquo;s proportionate interest
in our assets or earnings and profits (e.g., through a decrease to the exercise price or an increase in the number of shares of our common
stock that would be obtained upon exercise) as a result of a distribution of cash or other property with respect to shares of our common
stock. Such a constructive distribution to a U.S. Holder of common warrant would generally be treated as if such U.S. Holder had received
a cash distribution from us in an amount equal to the fair market value of such increased interest, taxed under principles similar to
those described in &ldquo;<I>&mdash;U.S. Holders&mdash;Distributions on Our Common Stock</I>.&rdquo; The rules governing constructive
distributions as a result of certain adjustments with respect to a common warrant are complex. U.S. Holders are urged to consult their
tax advisors on the potential existence and tax consequences of any such constructive distribution with respect to a common warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Information
Reporting and Backup Withholding</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
backup withholding and information reporting requirements may apply to distributions on our common stock, constructive distributions
on common warrants, and the receipt of proceeds from the sale, exchange, or other disposition of our common stock, pre-funded warrants,
or common warrants. Backup withholding generally should not apply, however, to a U.S. Holder who furnishes a correct taxpayer identification
number and makes other required certifications, or who is otherwise exempt from backup withholding and establishes such exempt status.
Backup withholding is not an additional tax. Amounts withheld as backup withholding may be credited against a U.S. Holder&rsquo;s U.S.
federal income tax liability, and a U.S. Holder generally may obtain a refund of any excess amounts withheld under the backup withholding
rules by timely filing the appropriate claim for refund with the IRS and furnishing any required information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NON-U.S.
HOLDERS</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
used herein, a &ldquo;non-U.S. Holder&rdquo; is a beneficial owner of our common stock, pre-funded warrant, or common warrant (as applicable)
that, for U.S. federal income tax purposes, is or is treated as an individual, corporation, estate or trust that is not a U.S. Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Distributions
on Our Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently anticipate that we will retain future earnings for the development, operation and expansion of our business and do not anticipate
declaring or paying any cash dividends for the foreseeable future. If we do make distributions with respect to our common stock, any
such distribution made to a non-U.S. Holder with respect to our common stock should generally constitute a dividend for U.S. federal
income tax purposes to the extent paid out of our current or accumulated earnings and profits, as determined under U.S. federal income
tax principles. Provided that any such dividend is not effectively connected with such non-U.S. Holder&rsquo;s conduct of a trade or
business within the United States (and, if required by an applicable income tax treaty, attributable to a U.S. permanent establishment
or fixed base maintained by such non-U.S. Holder), and s<FONT STYLE="background-color: white">ubject to the discussion below regarding
backup withholding and FATCA (defined below), </FONT>such dividend should generally be subject to withholding tax from the gross amount
of the dividend at a rate of 30%, unless such non-U.S. Holder is eligible for a reduced rate of withholding tax under an applicable income
tax treaty and provides proper certification of its eligibility for such reduced rate (usually on an IRS Form W-8BEN or W-8BEN-E, as
applicable). Any distribution not constituting a dividend should generally be treated first as reducing (not below zero) the non-U.S.
Holder&rsquo;s adjusted tax basis in our common stock and then, to the extent such distribution exceeds the non-U.S. Holder&rsquo;s adjusted
tax basis, as gain realized from the sale or other disposition of our common stock, which should generally be treated as described below
under &ldquo;<I>&mdash;Non-U.S. Holders&mdash;Sale, Exchange or Other Taxable Disposition of Our Common Stock, Pre-Funded Warrants, or
Common Warrants</I>.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends
paid by us to a non-U.S. Holder that are effectively connected with such non-U.S. Holder&rsquo;s conduct of a trade or business within
the United States (and, if required by an applicable income tax treaty, attributable to a U.S. permanent establishment or fixed base
maintained by such non-U.S. Holder) should generally not be subject to U.S. withholding tax, provided such non-U.S. Holder complies with
certain certification and disclosure requirements (usually by providing an IRS Form W-8ECI). Instead, such dividends should generally
be subject to U.S. federal income tax, net of certain deductions, at the same graduated individual or corporate rates applicable to U.S.
Holders. If the non-U.S. Holder is a corporation, dividends that are effectively connected income may also be subject to a &ldquo;branch
profits tax&rdquo; at a rate of 30% (or such lower rate as may be specified by an applicable income tax treaty).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Sale,
Exchange, or Other Taxable Disposition of Our Common Stock, Pre-Funded Warrants, or Common Warrants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Subject
to the discussion below regarding backup withholding and FATCA, a</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">non-U.S.
Holder generally should not be subject to U.S. federal income tax on gain realized from a sale, exchange, or other disposition of our
common stock, pre-funded warrants, or common warrants unless:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">such
                                            non-U.S. Holder is an individual who was present in the United States for 183 days or more
                                            in the taxable year of such disposition and certain other requirements are met, in which
                                            case any gain realized will generally be subject to a flat 30% U.S. federal income tax;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            gain is effectively connected with a trade or business of such non-U.S. Holder in the United
                                            States (and, if required by an applicable income tax treaty, attributable to a U.S. permanent
                                            establishment or fixed base maintained by such non-U.S. Holder), in which case such gain
                                            will be subject to U.S. federal income tax, net of certain deductions, at the same graduated
                                            individual or corporate rates applicable to U.S. Holders, and any such gain of a non-U.S.
                                            Holder that is a corporation may be subject to an additional &ldquo;branch profits tax&rdquo;
                                            at a rate of 30% (or such lower rate as may be specified by an applicable income tax treaty);
                                            or</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">subject
                                            to certain exceptions discussed below, we are or have been a U.S. real property holding corporation
                                            (a &ldquo;USRPHC&rdquo;) at any time during the shorter of the five-year period preceding
                                            such disposition and such non-U.S. Holder&rsquo;s holding period, in which case (a) gain
                                            recognized by such non-U.S. holder on the sale, exchange, or other disposition of our common
                                            stock, pre-funded warrants, or common warrants should generally be subject to tax at generally
                                            applicable U.S. federal income tax rates and (b) a buyer of our common stock, pre-funded
                                            warrants, or common warrants from such non-U.S. Holder may be required to withhold U.S. federal
                                            income tax at a rate of 15% of the amount realized upon such disposition. </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of item (iii) immediately above, we will generally be classified as a USRPHC if the fair market value of our &ldquo;United States
real property interests&rdquo; equals or exceeds 50% of the sum of the fair market value of our worldwide real property interests and
our other assets used or held for use in a trade or business, as determined for U.S. federal income tax purposes. Although there can
be no assurance, we believe that we are not currently a USRPHC and we do not anticipating becoming a USRPHC. Even if we are or become
a USRPHC, a non-US Holder should generally not be subject to U.S. federal income tax under the rules discussed in item (iii) with respect
to gain realized on a sale or other disposition of our common stock if (A) our common stock is considered to be regularly traded on an
established securities market and (B) such non-U.S. Holder has not owned and is not deemed to have owned more than 5% of our common stock
at any time during the shorter of the five-year period preceding such disposition and such non-U.S. Holder&rsquo;s holding period. There
can be no assurance that shares of our common stock qualify as regularly traded on an established securities market for purposes of these
rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exercise
of a Pre-Funded Warrant</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
U.S. federal income tax treatment of a non-U.S. Holder&rsquo;s exercise of a pre-funded warrant generally should correspond to the U.S.
federal income tax treatment of the exercise of a pre-funded warrant held by a U.S. Holder, as described above under &ldquo;<I>&mdash;U.S.
Holders&mdash;Exercise of a Pre-Funded Warrant</I>.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exercise
or Lapse of a Common Warrant</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
U.S. federal income tax treatment of a non-U.S. Holder&rsquo;s exercise of a common warrant generally should correspond to the U.S. federal
income tax treatment of the exercise of a common warrant held by a U.S. Holder, as described above under &ldquo;<I>&mdash;U.S. Holders&mdash;Exercise
or Lapse of a Common Warrant</I>.&rdquo; If a common warrant is allowed to lapse unexercised, a non-U.S. Holder generally should recognize
a loss equal to such non-U.S. Holder&rsquo;s tax basis in the common warrant. However, subject to additional conditions and restrictions,
a non-U.S. Holder generally cannot utilize a loss recognized upon expiration of a common warrant to reduce the non-U.S. Holder&rsquo;s
U.S. federal income tax liability unless the loss is effectively connected with the non-U.S. Holder&rsquo;s conduct of a trade or business
within the United States (and, if an income tax treaty applies, is attributable to a U.S. permanent establishment or fixed base maintained
by the non-U.S. Holder) or if the loss is treated as U.S.-source and incurred by a non-U.S. Holder that is an individual during a taxable
year in which the non-U.S. Holder is present in the United States for at least 183 days.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
U.S. federal income tax treatment of a cashless exercise of common warrants is unclear under current law and could differ from the considerations
described above. A cashless exercise could be considered a taxable event. Non-U.S. Holders are urged to consult their own tax advisors
regarding any cashless exercise of a common warrant and the U.S. federal income tax treatment thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Possible
Constructive Distributions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
described above under &ldquo;<I>&mdash;U.S. Holders&mdash;Possible Constructive Distributions</I>,&rdquo; certain adjustments with respect
to the common warrants may give rise to a constructive distribution, the consequences of which to a non-U.S. Holder would be similar
to those described above under &ldquo;<I>&mdash;Non-U.S. Holders&mdash;Distributions on Our Common Stock</I>.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Information
Reporting and Backup Withholding</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
backup withholding and information reporting requirements may apply to distributions on our common stock, constructive distributions
on common warrants, and the receipt of proceeds from the sale or disposition of our common stock, pre-funded warrants, or common warrants.
A non-U.S. Holder may have to comply with certification procedures to establish that it is not a U.S. person for U.S. federal income
tax purposes, to otherwise establish an exemption from information reporting and backup withholding requirements, or to claim a reduced
rate of withholding under an applicable income tax treaty. Backup withholding is not an additional tax. Amounts withheld as backup withholding
may be credited against a non-U.S. Holder&rsquo;s U.S. federal income tax liability, and a non-U.S. Holder generally may obtain a refund
of any excess amounts withheld under the backup withholding rules by timely filing the appropriate claim for refund with the IRS and
furnishing any required information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Foreign
Account Tax Compliance Act</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sections
1471 through 1474 of the Code and the Treasury Regulations and administrative guidance promulgated thereunder (commonly referred as the
&ldquo;Foreign Account Tax Compliance Act&rdquo; or &ldquo;FATCA&rdquo;) generally impose withholding at a rate of 30% in certain circumstances
on dividends in respect of securities (including our common stock), and <FONT STYLE="background-color: white">(subject to the proposed
Treasury Regulations discussed below) the gross proceeds derived from the sale or other disposition of our common stock,</FONT> which
are held by or through certain foreign financial institutions (including investment funds), unless any such institution (i) enters into,
and complies with, an agreement with the IRS to, among other things, comply with specified due diligence, report, on an annual basis,
information with respect to interests in, and accounts maintained by, the institution that are owned by certain U.S. persons and by certain
non-U.S. entities that are wholly or partially owned by U.S. persons and to withhold on certain payments, or (ii) if allowed under an
intergovernmental agreement between the United States and an applicable foreign country, reports such information to its local tax authority,
which may exchange such information with the U.S. authorities. An intergovernmental agreement between the United States and an applicable
foreign country may modify these requirements. Accordingly, the disclosure of the ownership of the entity through which our securities
(including our common stock, pre-funded warrants, and common warrants) is held will affect the determination of whether such withholding
and reporting is required. <FONT STYLE="background-color: white">Withholding agents may, however, rely on proposed U.S. Treasury Regulations
that would no longer require FATCA withholding on payments of gross proceeds. A withholding agent, and not GT BIOPHARMA, INC., will determine
whether or not to implement gross proceeds FATCA withholding. </FONT>Similarly, dividends in respect of our common stock held by an investor
that is a non-financial non-U.S. entity that does not qualify under certain exceptions will generally be subject to withholding at a
rate of 30%, unless such entity either (i) certifies to the applicable withholding agent that such entity does not have any &ldquo;substantial
United States owners&rdquo; or (ii) provides certain information regarding the entity&rsquo;s &ldquo;substantial United States owners,&rdquo;
which may in turn be provided to the U.S. Department of Treasury. All holders should consult their tax advisors regarding the possible
implications of FATCA on their investment in our common stock, pre-funded warrants, and common warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="b_004"></A>PLAN
OF DISTRIBUTION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
engaged Roth Capital Partners, LLC (&ldquo;Roth&rdquo; or the &ldquo;placement agent&rdquo;), to act as our exclusive placement agent
to solicit offers to purchase the securities offered by this prospectus on a reasonable best efforts basis subject to the terms and conditions
of the placement agency agreement dated &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2025. Roth is not purchasing or selling
any securities, nor are they required to arrange for the purchase and sale of any specific number or dollar amount of securities, other
than to use their &ldquo;reasonable best efforts&rdquo; to arrange for the sale of the securities by us. Therefore, we may not sell the
entire amount of securities being offered. There is no minimum amount of proceeds that is a condition to closing of this offering. The
placement agent does not guarantee that it will be able to raise new capital in this offering. The terms of this offering were subject
to market conditions and negotiations between us and prospective investors in consultation with the placement agent. The placement agent
will have no authority to bind us. This offering will terminate no later than February 28, 2025, unless we decide to terminate
the offering (which we may do at any time in our discretion) prior to that date. We will have one closing for all the securities purchased
in this offering. The combined public offering price per share (or pre-funded warrant) and accompanying common warrant will be fixed
for the duration of this offering. Roth may engage one or more sub-placement agents or selected dealers to assist with the offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will enter into a securities purchase agreement directly with the institutional investors, at the investor&rsquo;s option, who purchase
our securities in this offering. Investors who do not enter into a securities purchase agreement shall rely solely on this prospectus
in connection with the purchase of our securities in this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Placement
Agent Fees and Expenses</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table shows the per share and accompanying common warrants, and per pre-funded warrant and accompanying common
warrants, and total placement agent fees we will pay in connection with the sale of the securities in this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 42%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 16%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Per
    Share and Common Warrant</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 16%; vertical-align: bottom"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Tims New Roman, Times, Serif; font-size: 10pt"><B>Per Pre-Funded Warrant and</B></FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common Warrant</B></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 16%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public
    offering price</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Placement
    Agent fees<SUP>(1)</SUP></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds
to us, before expenses<SUP>(2)</SUP></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="font: 10pt Times New Roman, Times, Serif; width: 25%"><DIV STYLE="font: 10pt Times New Roman, Times, Serif; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
Includes a cash fee up to 6% of the gross proceeds raised in this offering; provided, however, the cash fee shall equal 3% of the gross
proceeds raised in this offering for securities purchased by certain excluded investors, to be paid to the placement agent. We have also
agreed to reimburse the placement agent for certain of its offering-related expenses in an aggregate amount up to $100,000. In addition,
we have agreed to issue the placement agent or its designees warrants to purchase up to &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
shares of common stock (equal to 6% of the aggregate number of shares of common stock and pre-funded warrants sold in this offering,
subject to a partial adjustment in the event certain investors participate) at an exercise price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
per share, which represents 125% of the public offering price per share of common stock and common warrants. We refer to these warrants
in this prospectus as the &ldquo;placement agent warrants.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Because there is no minimum number of securities or amount of proceeds required as a condition to closing in this offering, the actual
public offering amount, placement agent fees, and proceeds to us, if any, are not presently determinable and may be substantially less
than the total maximum offering amounts set forth above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
estimate that the total expenses of the offering, including registration, filing and listing fees, printing fees and legal and accounting
expenses, but excluding placement agent fees, will be approximately $390,531, all of which are payable by us. This figure includes
the placement agent&rsquo;s accountable expenses, including, but not limited to, legal fees for placement agent&rsquo;s legal counsel,
that we have agreed to pay at the closing of the offering up to an aggregate expense reimbursement of $100,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><B>Placement
Agent Warrants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">In
addition, we have agreed to issue to the placement agent, or its designees, warrants to purchase up to 201,680 shares of common
stock (equal to 6% of the aggregate number of shares of common stock and pre-funded warrants sold in this offering, subject to
a partial adjustment in the event certain investors participate) at an exercise price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, which represents 125%
of the public offering price per share of common stock and accompanying common warrant, and exercisable for five years from the date
of the commencement of sales in this offering. We refer to these warrants in this prospectus as the &ldquo;placement agent warrants.&rdquo;
The placement agent warrants are in substantially similar form to the common warrants being issued to investors as part of this offering
other than as described herein. The placement agent warrants and underlying shares of common stock are registered on the registration
statement of which this prospectus is a part. The form of the placement agent warrant will be included as an exhibit to this registration
statement of which this prospectus forms a part.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Other
Relationships</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
placement agent may, from time to time, engage in transactions with or perform services for us in the ordinary course of its business
and may continue to receive compensation from us for such services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Determination
of Offering Price</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
combined public offering price per share and common warrant and the combined public offering price per pre-funded warrant and
common warrant we are offering and the exercise prices and other terms of the warrants were negotiated between
us and the investors, in consultation with the placement agent based on the trading of our common stock prior to this offering, among
other things. Other factors considered in determining the public offering prices of the securities we are offering and the exercise prices
and other terms of the warrants include the history and prospects of our company, the stage of development of our business, our business
plans for the future and the extent to which they have been implemented, an assessment of our management, general conditions of the securities
markets at the time of the offering and such other factors as were deemed relevant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 41; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Transfer
Agent and Registrar</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
transfer agent and registrar for our capital stock is Computershare. The transfer agent&rsquo;s address is 8742 Lucent Blvd., Suite 225,
Highland Ranch, CO 80129, and its telephone number is (303) 262-0600.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
Nasdaq Capital Market Listing</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock is currently listed on the Nasdaq Stock Market LLC under the symbol &ldquo;GTBP.&rdquo; On January 23, 2025, the
reported closing price per share of our common stock was $2.38. The final public offering price will be determined between
us, the placement agent and the investors in the offering, and may be at a discount to the current market price of our common stock.
Therefore, the assumed public offering price used throughout this prospectus may not be indicative of the final public offering price.
There is no established public trading market for the common warrants or pre-funded warrants, and we do not expect such markets to develop.
In addition, we do not intend to apply for a listing of the common warrants or pre-funded warrants on any national securities exchange
or other nationally recognized trading system.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Indemnification</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have agreed to indemnify the placement agent against certain liabilities, including certain liabilities arising under the Securities
Act, or to contribute to payments that the placement agent may be required to make for these liabilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lock-up
Restrictions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">We
have agreed for a period of sixty days following the closing of this offering not to issue, enter into an agreement to issue or
announce the issuance or proposed issuance of shares of our common stock or any other securities convertible into, or exercisable or
exchangeable for, shares of common stock or file any registration statement or amendment or supplement thereto, subject to limited exceptions.
This agreement does not apply to, in addition to certain customary exceptions, the issuance by us of equity or debt securities pursuant
to acquisitions or strategic transactions approved by a majority of our disinterested directors, where not for the purpose of raising
capital, provided that, in each case, such securities are issued as &ldquo;restricted securities&rdquo; (as defined in Rule 144 under
the Securities Act), and carry no registration rights that require or permit the filing of any registration statement in connection therewith
during the sixty day lock-up period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have also agreed for a period of one year following the closing date of this offering not to (i) issue or agree to issue equity
or debt securities convertible into, or exercisable or exchangeable for, shares at a conversion price, exercise price or exchange price
which floats with the trading price of our shares or which may be adjusted after issuance upon the occurrence of certain events or (ii)
enter into any agreement, including an equity line of credit, whereby we may issue securities at a future-determined price, subject to
certain conditions and exceptions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
directors, executive officers and certain stockholders have also entered into customary lock-up agreements. Under these agreements,
these individuals have agreed, subject to specified exceptions, not to sell or transfer any shares of common stock or securities convertible,
exchangeable or exercisable into, shares of our common stock during a period ending sixty days after the closing of this
offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">The
placement agent may waive these prohibitions in its sole discretion and without notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Regulation
M</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
placement agent may be deemed to be an underwriter within the meaning of Section 2(a)(11) of the Securities Act and any fees received
by it and any profit realized on the sale of the securities by it while acting as principal might be deemed to be underwriting discounts
or commissions under the Securities Act. The placement agent will be required to comply with the requirements of the Securities Act and
the Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), including, without limitation, Rule 10b-5 and Regulation M under
the Exchange Act. These rules and regulations may limit the timing of purchases and sales of our securities by the placement agent. Under
these rules and regulations, the placement agent may not (i) engage in any stabilization activity in connection with our securities;
and (ii) bid for or purchase any of our securities or attempt to induce any person to purchase any of our securities, other than as permitted
under the Exchange Act, until they have completed their participation in the distribution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 42; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Electronic
Distribution</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
prospectus in electronic format may be made available on a website maintained by the placement agent and the placement agent may distribute
prospectuses electronically. Other than the prospectus in electronic format, the information on these websites is not part of this prospectus
or the registration statement of which this prospectus forms a part, has not been approved and/or endorsed by us or the placement agent
and should not be relied upon by investors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="b_005"></A>INCORPORATION
OF CERTAIN INFORMATION BY REFERENCE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SEC allows us to &ldquo;incorporate by reference&rdquo; the information we file with it, which means that we can disclose important information
to you by referring you to those documents instead of having to repeat the information in this prospectus. The information incorporated
by reference is considered to be part of this prospectus, and because we are a smaller reporting company, later information that we file
with the SEC will automatically update and supersede this information. We incorporate by reference the documents listed below and any
future filings (including those made after the initial filing of the registration statement of which this prospectus is a part and prior
to the effectiveness of such registration statement) we will make with the SEC under Sections 13(a), 13(c), 14, or 15(d) of the Exchange
Act until the termination of the offering of the shares covered by this prospectus (other than information furnished under Item 2.02
or Item 7.01 of Form 8-K):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    Annual Report on Form 10-K for the year ended December 31, 2023 filed with the SEC on <A HREF="https://www.sec.gov/Archives/edgar/data/109657/000149315224011332/form10-k.htm" STYLE="-sec-extract: exhibit">March 26, 2024</A>;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    Quarterly Report on Form 10-Q for the quarter ended March 31, June 30 and September 30, 2024, filed with the SEC on <A HREF="https://www.sec.gov/Archives/edgar/data/109657/000149315224019970/form10-q.htm" STYLE="-sec-extract: exhibit">May
    15, 2024</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/109657/000149315224032143/form10-q.htm" STYLE="-sec-extract: exhibit">August
    14, 2024</A>, and <A HREF="https://www.sec.gov/Archives/edgar/data/109657/000149315224045892/form10-q.htm" STYLE="-sec-extract: exhibit">November
    14, 2024</A>, respectively;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    definitive proxy statement on Schedule 14A, filed with the SEC on <A HREF="https://www.sec.gov/Archives/edgar/data/109657/000149315224016949/formdef14a.htm" STYLE="-sec-extract: exhibit">April 29, 2024</A>;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    Current Reports on Form 8-K filed with the SEC on <A HREF="https://www.sec.gov/Archives/edgar/data/109657/000149315224004587/form8-k.htm" STYLE="-sec-extract: exhibit">February
    1, 2024</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/109657/000149315224017209/form8-k.htm" STYLE="-sec-extract: exhibit">April
    30, 2024</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/109657/000149315224021078/form8-k.htm" STYLE="-sec-extract: exhibit">May
    23, 2024</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/109657/000149315224023195/form8-k.htm" STYLE="-sec-extract: exhibit">June
    7, 2024</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/109657/000149315224025269/form8-k.htm" STYLE="-sec-extract: exhibit">June
    26, 2024</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/109657/000149315224025382/form8-k.htm" STYLE="-sec-extract: exhibit">June
    27, 2024</A>; <A HREF="https://www.sec.gov/Archives/edgar/data/109657/000149315224036381/form8-k.htm" STYLE="-sec-extract: exhibit">September
    16, 2024</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/109657/000149315224047085/form8-k.htm" STYLE="-sec-extract: exhibit">November
    21, 2024</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/109657/000149315224047994/form8-k.htm" STYLE="-sec-extract: exhibit">November
    27, 2024 </A>, and <A HREF="https://www.sec.gov/Archives/edgar/data/109657/000149315225003707/form8-k.htm" STYLE="-sec-extract: exhibit">January 27, 2025</A>; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    description of our common stock contained in <A HREF="https://www.sec.gov/Archives/edgar/data/109657/000149315223009812/ex4-3.htm" STYLE="-sec-extract: exhibit">Exhibit
    4.3</A> to our Annual Report on Form 10-K for the year ended December 31, 2023 filed with the SEC on March 26, 2024, including any
    amendment or report filed for the purpose of updating such description.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
documents the Company subsequently filed with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, except as to
any portion of any report or documents that is not deemed filed under such provisions, (1) on or after the date of filing of the registration
statement containing this prospectus and prior to the effectiveness of the registration statement and (2) on or after the date of this
prospectus until the earlier of the date on which all of the securities registered hereunder have been sold or the registration statement
of which this prospectus is a part has been withdrawn, shall be deemed incorporated by reference in this prospectus and to be a part
of this prospectus from the date of filing of those documents and will be automatically updated and, to the extent described above, supersede
information contained or incorporated by reference in this prospectus and previously filed documents that are incorporated by reference
in this prospectus. Any statements contained in a previously filed document incorporated by reference into this prospectus is deemed
to be modified or superseded for purposes of this prospectus to the extent that a statement contained in this prospectus, or in a subsequently
filed document also incorporated by reference herein, modifies or supersedes that statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nothing
in this prospectus shall be deemed to incorporate information furnished but not filed with the SEC pursuant to Item 2.02, 7.01 or 9.01
of Form 8-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
written or oral request, we will provide without charge to each person to whom a copy of the prospectus is delivered a copy of the documents
incorporated by reference herein (other than exhibits to such documents, unless such exhibits are specifically incorporated by reference
herein). You may request a copy of these filings, at no cost, by contacting GT Biopharma, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
maintain a website at https://ir.gtbiopharma.com. You may access our annual reports on Form 10-K, quarterly reports on Form 10-Q, current
reports on Form 8-K and other reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act with the SEC free of
charge at our website as soon as reasonably practicable after such material is electronically filed with, or furnished to, the SEC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 43; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
have been no material changes to the Company&rsquo;s affairs that have occurred since December 31, 2023 that have not been described
in a Form 10-Q or Form 8-K filed under the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="b_006"></A>WHERE
YOU CAN FIND MORE INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have filed a registration statement on Form S-1 under the Securities Act with the SEC with respect to this offering. This prospectus
was filed as a part of that registration statement but does not contain all of the information contained in the registration statement
and exhibits. Reference is thus made to the omitted information. Statements made in this prospectus are summaries of the material terms
of contracts, agreements and documents and are not necessarily complete; however, all information we considered material has been disclosed.
Reference is made to each exhibit for a more complete description of the matters involved and these statements are qualified in their
entirety by the reference. You can find, copy and inspect information we file at the SEC&rsquo;s public reference room, which is located
at 100 F Street, N.E., Washington, DC 20549. Please call the SEC at 1-800-SEC-0330 for more information about the operation of the SEC&rsquo;s
public reference room. The SEC also maintains a web site (http://www.sec.gov) that contains this filed registration statement, reports
and other information regarding us that we have filed electronically with the SEC. For more information pertaining to our company and
this offering, reference is made to the registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="b_007"></A>LEGAL
MATTERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
validity of the securities offered hereby will be passed upon for us by Baker &amp; McKenzie LLP, Dallas, Texas. The placement agent
is being represented by Ellenoff Grossman &amp; Schole LLP, New York, New York.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 20.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="b_008"></A>EXPERTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial statements of GT Biopharma, Inc. at December 31, 2023, and for the year in the period ending December 31, 2023, incorporated
by reference into this prospectus, have been audited by Weinberg &amp; Company, P.A., an independent registered public accounting firm,
and the financial statements of GT Biopharma, Inc. at December 31, 2023, and for the year in the period ending December 31, 2023, incorporated
by reference into this prospectus, have been audited by Weinberg &amp; Company, P.A., each as set forth in their report thereon incorporated
by reference herein, and are included in reliance upon such reports given on the authority of such firms as experts in accounting and
auditing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 44; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Up
to 3,361,344 Shares of Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-right: 0; margin-left: 0"> <B>Up to 3,361,344</B> <B>
Pre-Funded Warrants to Purchase up to 3,361,344 Shares of Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-right: 0; margin-left: 0"> <B>Up to 3,361,344</B> <B>
Common Warrants to Purchase up to 3,361,344 Shares of Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-right: 0; margin-left: 0"> <B>Up to 201,680</B> <B>
Placement Agent Warrants to Purchase up to 201,680 Shares of Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-right: 0; margin-left: 0"><B>Up to 6,924,368 Shares of
Common Stock underlying up to 3,361,344 Pre-Funded Warrants,</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <B>up to 3,361,344</B> <B> Common Warrants and
up to 201,680 Placement Agent Warrants</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>
<P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><IMG SRC="forms-1_009.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PRELIMINARY
PROSPECTUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>Roth
Capital Partners</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
date of this prospectus is &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 45; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PART
II</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INFORMATION
NOT REQUIRED IN PROSPECTUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
13. Other Expenses of Issuance and Distributions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table indicates the expenses to be incurred in connection with the offering described in this registration statement, other
than underwriting discounts and commissions, all of which will be paid by us. All amounts are estimated except the Securities and Exchange
Commission registration fee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 20.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">SEC registration fee</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,541</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">FINRA filing fee</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,990</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accounting fees and expenses</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">35,000</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Legal fees and expenses</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">350,000</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Miscellaneous</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">*</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">390,531</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
14. Indemnification of Directors and Officers</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
145 of the DGCL provides that a corporation may indemnify directors and officers as well as other employees and individuals against expenses
(including attorneys&rsquo; fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in
connection with any threatened, pending or completed actions, suits or proceedings in which such person is made a party by reason of
such person being or having been a director, officer, employee or agent to us. The DGCL provides that Section 145 is not exclusive of
other rights to which those seeking indemnification may be entitled under any bylaw, agreement, vote of stockholders or disinterested
directors or otherwise. Our certificate of incorporation provides for indemnification by us of our directors, officers and employees
to the fullest extent permitted by the DGCL.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
102(b)(7) of the DGCL permits a corporation to provide in its certificate of incorporation that a director of the corporation shall not
be personally liable to the corporation or its stockholders for monetary damages for breach of fiduciary duty as a director, except for
liability (i) for any breach of the director&rsquo;s duty of loyalty to the corporation or its stockholders, (ii) for acts or omissions
not in good faith or which involve intentional misconduct or a knowing violation of law, (iii) for unlawful payments of dividends or
unlawful stock repurchases, redemptions or other distributions or (iv) for any transaction from which the director derived an improper
personal benefit. Our certificate of incorporation provides for such limitation of liability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
15. Recent Sales of Unregistered Securities</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
December 2021, the Company made the following issuances of its unregistered securities pursuant exemptions contained in Section 4(a)(2)
or 3(a)(9) of the Securities Act and/or Rule 506 of Regulation D promulgated thereunder:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 46; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    August 24, 2022, the Company entered into a revised agreement with this third-party manufacturer and issued 40,742 shares of common
    stock with a fair value of approximately $3.2 million as part of a payment arrangement.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
    the year ended December 31, 2022, the Company issued 11,257 shares of common stock upon conversion of notes payable.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
    the year ended December 31, 2022, the Company issued 23,654 shares of common stock to officers, employees, and board of directors
    with a fair value of approximate $2.5 million. This included 12,602 shares with a fair value of $938,000 that were granted during
    the year.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
    the year ended December 31, 2022, the Company issued 17,562 shares of common stock to consultants with a fair
    value of approximately $2.1 million.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
    the year ended December 31, 2022, the Company issued 57,437 shares of common stock to settle approximately $700,000 of vendor payables.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">During the year ended December 31, 2023, the Company
    issued 14,237 shares of common stock to officers, employees, and board of directors with a fair value of approximate $267,000. This
    included 13,333 shares with a fair value of $115,000 that were granted during the year.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">During the year ended December 31, 2023, the Company
    issued 1,545 shares of common stock to consultants with a fair value of approximately $162,000.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    January 4, 2023, the Company entered into a purchase agreement signed on December 30, 2022, between the Company and an institutional
    investor for the issuance and sale, in a registered direct offering of 120,000 shares of the Company&rsquo;s common stock,
    pre-funded warrants to purchase up to 96,667 shares of the Company&rsquo;s common stock, warrants to purchase up to an aggregate
    of 216,667 shares of the Company&rsquo;s common stock and placement agent warrants to purchase up to 13,000 of the Company&rsquo;s
    common stock. The Company raised $6.5 million from the offering.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    April 30, 2024, the Company issued 36,018 shares of common stock to settle $278,500 of vendor accounts payable. The shares were valued
    at the month-end closing price of the Company&rsquo;s common stock for the months for which services were provided by the vendor.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    May 23, 2024, the Company issued <FONT STYLE="background-color: white">740,000 common warrants, each to purchase one share of common
    stock at an exercise price</FONT> equal to $4.35 and are exercisable immediately upon issuance and will expire on the date that is
    five years following the date of issuance.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 23, 2024, the Company issued placement agent warrants to the placement agent to purchase up to 88,800 shares of common stock as part
of the compensation payable to the placement agent in connection with such offering at an exercise price of $5.4375 per share and will
expire five years from the commencement of sales of the offering.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    June 30, 2024, the Company issued 91,579 shares of common stock to settle $531,300 of vendor accounts payable. The shares were valued
    at the month-end closing price of the Company&rsquo;s common stock for the months for which services were provided by the vendor.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
    December 2021, we have issued 29,935 shares of common stock with a fair value of approximately $1,053,000 in
    connection with compensation of the Company&rsquo;s officers and directors.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 47; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
16. Exhibits and Financial Statement Schedules</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibits</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 21.1pt; text-indent: -21.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 20.9pt; text-align: center; text-indent: -20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
Index</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 20.9pt; text-align: center; text-indent: -20.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 5%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
    Number</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center; width: 2%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 47%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
    Description</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center; width: 2%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 8%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center; width: 2%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 5%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center; width: 2%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 5%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center; width: 2%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 8%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>File
    No.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 10%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Filed
    Herewith</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.1</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000103221002000530/dex3a.txt" STYLE="-sec-extract: exhibit">Restated Certificate of Incorporation as filed in Delaware September 10, 1996 and as thereafter amended through March 1, 2002</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-KSB</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">04/01/02</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.A</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.2</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000151316011000020/ex32.htm" STYLE="-sec-extract: exhibit">Certificate of Amendment to the Restated Certificate of Incorporation of GT Biopharma, Inc., dated February 9, 2011</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">03/31/2011</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.3</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495418002596/gtbp_ex31.htm" STYLE="-sec-extract: exhibit">Certificate of Amendment to the Restated Certificate of Incorporation of GT Biopharma, Inc., effective as of July 19, 2017</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K/A</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">03/15/2018</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.4</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495421001479/gtbp_ex31.htm" STYLE="-sec-extract: exhibit">Certificate of Amendment to the Restated Certificate of Incorporation of GT Biopharma, Inc., effective as of February 10, 2021</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">02/11/2021</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.5</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000149315223009812/ex3-5.htm" STYLE="-sec-extract: exhibit">Certificate of Amendment to the Restated Certificate of Incorporation of GT Biopharma, Inc., effective June 13, 2022</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">03/30/2023</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.6</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000149315222031139/ex3-1.htm" STYLE="-sec-extract: exhibit">Amended and Restated Bylaws of GT Biopharma, Inc., effective November 3, 2022</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/09/2022</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.7</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000149315224004587/ex3-1.htm" STYLE="-sec-extract: exhibit">Certificate of Amendment of Restated Certificate of Incorporation of GT Biopharma, Inc., effective February 1, 2024</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">02/01/2024</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.1</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000093979819000017/exhibitthreeone.htm" STYLE="-sec-extract: exhibit">Certificate of Designation of Preferences, Rights and Limitations of Series J-1 Preferred Stock of GT Biopharma, Inc., dated April 3, 2019</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">04/04/2019</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.2</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495421004295/gtbp_ex42.htm" STYLE="-sec-extract: exhibit">Certificate of Designation of Preferences, Rights and Limitations of Series K Preferred Stock of GT Biopharma, Inc., dated February 22, 2021</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">04/16/2021</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.3</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000149315223009812/ex4-3.htm" STYLE="-sec-extract: exhibit">Description of the Registrant&rsquo;s Securities Registered pursuant to Section 12 of the Securities Exchange Act of 1934, as Amended</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">03/30/2023</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.4</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000093979817000002/debenture.htm" STYLE="-sec-extract: exhibit">Form of 10% Senior Convertible Debenture (related to Securities Purchase Agreement, dated January 9, 2017)</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">01/13/2017</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.5</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000093979817000002/warrant.htm" STYLE="-sec-extract: exhibit">Form of Common Stock Purchase Warrant (related to Securities Purchase Agreement, dated January 9, 2017)</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">01/13/2017</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.6</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495418000646/gtbp_ex102.htm" STYLE="-sec-extract: exhibit">Registration Rights Agreement, dated January 22, 2018, among GT Biopharma, Inc. and the buyers named therein</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">01/23/2018</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.7</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495418000646/gtbp_ex103.htm" STYLE="-sec-extract: exhibit">Form of Senior Convertible Note (related to Securities Purchase Agreement, dated January 22, 2018)</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">01/23/2018</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.8</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495418000646/gtbp_ex104.htm" STYLE="-sec-extract: exhibit">Form of Warrant to Purchase Common Stock (related to Securities Purchase Agreement, dated January 22, 2018)</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">01/23/2018</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.9</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495418008406/gtbpex4_1.htm" STYLE="-sec-extract: exhibit">Form of 10% Senior Convertible Debenture (related to Securities Purchase Agreement, dated August 2, 2018)</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">08/03/2018</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.10</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495418009975/gtbp_ex41.htm" STYLE="-sec-extract: exhibit">Form of 10% Senior Convertible Debenture (related to Securities Purchase Agreement, dated September 7, 2018)</A></U></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">09/07/2018</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.11</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495418010637/gtbp_ex41.htm" STYLE="-sec-extract: exhibit">Form of 10% Senior Convertible Debenture (related to Securities Purchase Agreement, dated September 24, 2018)</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">09/28/2018</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 48; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 5%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
    Number</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center; width: 2%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
    Description</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center; width: 2%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 8%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center; width: 2%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 5%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center; width: 2%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 5%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center; width: 2%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 8%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>File
    No.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: bottom; text-align: center; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 10%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Filed
    Herewith</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>4.12</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495419001122/gtbp_ex41.htm" STYLE="-sec-extract: exhibit">Form of Secured Convertible Note (related to Securities Purchase Agreement, dated February 4, 2019)</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">02/06/2019</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.13</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000093979819000027/exhibittentwo.htm" STYLE="-sec-extract: exhibit">Registration Rights Agreement, dated May 22, 2019, among GT Biopharma, Inc. and the purchasers named therein</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">05/24/2019</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.14</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000093979819000027/exfourone.htm" STYLE="-sec-extract: exhibit">Form of Convertible Note (related to Securities Purchase Agreement, dated August 20, 2019)</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">05/24/2019</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.15</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495419009972/gtbp_ex103.htm" STYLE="-sec-extract: exhibit">Registration Rights Agreement, dated August 20, 2019, among GT Biopharma, Inc. and the purchasers named therein</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">08/20/2019</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.16</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000093979819000027/exfourone.htm" STYLE="-sec-extract: exhibit">Form of Convertible Note (related to Securities Purchase Agreement, dated May 22, 2019)</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">05/24/2019</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.17</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495420005654/gtbp_ex102.htm" STYLE="-sec-extract: exhibit">Registration Rights Agreement, dated January 30, 2020, among GT Biopharma, Inc. and the purchaser named therein</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Q</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">05/15/2020</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.18</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495420005654/gtbp_ex102.htm" STYLE="-sec-extract: exhibit">Registration Rights Agreement, dated January 30, 2020, among GT Biopharma, Inc. and the purchaser named therein</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Q</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">05/15/2020</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.19</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495420005654/gtbp_ex103.htm" STYLE="-sec-extract: exhibit">Form of Convertible Note (related to Securities Purchase Agreement, dated January 30, 2020)</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Q</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">05/15/2020</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.20</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495420005654/gtbp_ex105.htm" STYLE="-sec-extract: exhibit">Form of Registration Rights Agreement among GT Biopharma, Inc. and the purchaser named therein (executed in April/May 2020)</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Q</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">05/15/2020</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.21</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495420005654/gtbp_ex106.htm" STYLE="-sec-extract: exhibit">Form of Convertible Note (related to Securities Purchase Agreement executed in April/May 2020)</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Q</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">05/15/2020</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.22</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495420007499/gtbp_ex103.htm" STYLE="-sec-extract: exhibit">Registration Rights Agreement, dated July 7, 2020, among GT Biopharma, Inc. and the purchaser named therein</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">07/09/2020</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.23</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495420007499/gtbp_ex41.htm" STYLE="-sec-extract: exhibit">Form of Convertible Note (related to Securities Purchase Agreement, dated July 7, 2020)</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">07/09/2020</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.24</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495420006839/gtbp_ex102.htm" STYLE="-sec-extract: exhibit">Form of Convertible Note, dated June 19, 2020 (related to Settlement Agreement, dated June 19, 2020).</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">06/19/2020</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.25</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495420006839/gtbp_ex103.htm" STYLE="-sec-extract: exhibit">Form of Pre-Funded Warrant to Purchase Common Stock, dated June 19, 2020 (related to Settlement Agreement, dated June 19, 2020).</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">06/19/2020</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.26</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495420010329/gtbp_ex41.htm" STYLE="-sec-extract: exhibit">Form of Convertible Note (related to Securities Purchase Agreement, dated September 16, 2020)</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">09/22/2020</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.27</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495420012026/gtbp_ex41.htm" STYLE="-sec-extract: exhibit">Form of Secured Convertible Note</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/09/2020</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.28</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495420012364/gtbp_ex1020.htm" STYLE="-sec-extract: exhibit">Form of Settlement Note, dated November 9, 2020.</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Q</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/13/2020</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.20</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.29</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495420013901/gtbp_ex102.htm" STYLE="-sec-extract: exhibit">Settlement Note, dated December 22, 2020, by GT Biopharma Inc. payable to Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B.</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/28/2020</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.30</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495421001050/gtbp_ex10-2.htm" STYLE="-sec-extract: exhibit">Form of Amendment to Convertible Note, dated January 31, 2021</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">02/01/2020</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.31</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000149315223000198/ex4-1.htm" STYLE="-sec-extract: exhibit">Form of Common Warrant</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">01/03/2023</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.32</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000149315223000198/ex4-2.htm" STYLE="-sec-extract: exhibit">Form of Pre-Funded Warrant</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">01/03/2023</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.33</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000149315223000198/ex4-3.htm" STYLE="-sec-extract: exhibit">Form of Placement Agent Warrant</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">01/03/2023</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.34</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000149315224021078/ex4-1.htm" STYLE="-sec-extract: exhibit">Form of Common Warrant</A></U></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">05/23/2024</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><B>4.35</B></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000149315225003718/ex4-35.htm" STYLE="-sec-extract: exhibit">Form of Common Warrant</A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> S-1/A </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> 01/27/2025 </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 4.35 </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><B>4.36</B></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000149315225003718/ex4-36.htm" STYLE="-sec-extract: exhibit">Form of Pre-Funded Warrant</A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> S-1/A </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> 01/27/2025 </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 4.36 </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><B>4.37</B></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000149315225003718/ex4-37.htm" STYLE="-sec-extract: exhibit">Form of Placement Agent Warrant</A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> S-1/A </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> 01/27/2025 </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 4.37 </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><B>4.38</B></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000149315222011622/fromdef14a.htm" STYLE="-sec-extract: exhibit">GT Biopharma, Inc. 2022 Omnibus Incentive Plan<SUP></SUP></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">DEF 14A</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">04/29/2022</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.1</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex5-1.htm">Opinion of Baker &amp; McKenzie LLP</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> X </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.1</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495417007377/oxis_ex103.htm" STYLE="-sec-extract: exhibit">Exclusive License Agreement, dated July 18, 2016, between the Regents of the University of Minnesota and Oxis Biotech, Inc.</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Q</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">08/11/2017</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.2</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495417007377/oxis_ex104.htm" STYLE="-sec-extract: exhibit">License Agreement, dated September 3, 2015, among Daniel A. Vallera, Jeffrey Lion and Oxis Biotech, Inc.</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Q</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">08/11/2017</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.3</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495420005654/gtbp_ex107.htm" STYLE="-sec-extract: exhibit">Clinical Trial Agreement, dated September 2019, between the Regents of the University of Minnesota and GT Biopharma, Inc.</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Q</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">05/15/2020</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 49; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 5%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
    Number</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center; width: 2%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
    Description</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center; width: 2%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 8%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center; width: 2%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 5%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center; width: 2%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 5%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center; width: 2%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 8%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>File
    No.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: bottom; text-align: center; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 10%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Filed
    Herewith</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>10.4</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495420005654/gtbp_ex101.htm" STYLE="-sec-extract: exhibit">Securities Purchase Agreement, dated January 30, 2020, among GT Biopharma, Inc. and the purchaser named therein</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">10-Q</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">05/15/2020</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.5</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495420005654/gtbp_ex104.htm" STYLE="-sec-extract: exhibit">Form Securities Purchase Agreement among GT Biopharma, Inc. and the purchaser named therein (executed in April/May 2020)</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Q</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">05/15/2020</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.6</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495420007499/gtbp_ex101.htm" STYLE="-sec-extract: exhibit">Securities Purchase Agreement, dated July 7, 2020, among GT Biopharma, Inc. and the purchaser named therein</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">07/09/2020</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.7</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495420006903/gtbp_ex101.htm" STYLE="-sec-extract: exhibit">Form of Standstill and Forbearance Agreement, dated June 23, 2020, between the Company and certain holders of convertible notes and debentures</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">06/23/2020</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.8</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495420006839/gtbp_ex101.htm" STYLE="-sec-extract: exhibit">Settlement Agreement, dated June 19, 2020, among GT Biopharma, Inc., Empery Asset Master Ltd., Empery Tax Efficient, LP and Empery Tax Efficient II, LP, Anthony Cataldo and Paul Kessler.</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">06/19/2020</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.9</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495418012574/gtbp_ex1017.htm" STYLE="-sec-extract: exhibit">Executive Employment Agreement, dated October 19, 2018, among GT Biopharma, Inc. and Raymond W. Urbanski</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Q</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/14/2018</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.17</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.10</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495418001758/gtbp_ex103.htm" STYLE="-sec-extract: exhibit">Consultant Agreement, dated February 14, 2018, among GT Biopharma, Inc., Georgetown Translational Pharmaceuticals, Inc. and Anthony J. Cataldo</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">02/21/2018</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.11</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495420009193/gtbp_ex1011.htm" STYLE="-sec-extract: exhibit">Employment agreement with Anthony Cataldo</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Q</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">08/14/2020</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.12</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495420009193/gtbp_ex1012.htm" STYLE="-sec-extract: exhibit">Employment agreement with Steven Weldon</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Q</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">08/14/2020</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.13</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495420010329/gtbp_ex101.htm" STYLE="-sec-extract: exhibit">Securities Purchase Agreement, dated September 16, 2020, among GT Biopharma, Inc. and the purchasers named therein</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">09/22/2020</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.14</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495420010850/gtbp_ex101.htm" STYLE="-sec-extract: exhibit">Master Services Agreement, dated October 5, 2020, between Gt Biopharma, Inc. and Cytovance Biologics, Inc.</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/06/2020</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.15</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495420011842/gtbp_ex101.htm" STYLE="-sec-extract: exhibit">Form of First Amendment and Extension of Standstill and Forbearance Agreement</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/04/2020</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.16</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495420012026/gtbp_ex101.htm" STYLE="-sec-extract: exhibit">Securities Purchase Agreement</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/09/2020</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.17</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495420012364/gtbp_ex1019.htm" STYLE="-sec-extract: exhibit">Settlement Agreement, dated as of November 9, 2020, by and among Adam Kasower, East Ventures, Inc., A British Virgin Islands company, SV Booth Investments III, LLC, a Delaware limited liability company and Theorem Group, LLC, a California LLC and GT Biopharma Inc., a Delaware corporation.</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Q</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/13/2020</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.19</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.18</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495420012364/gtbp_ex1021.htm" STYLE="-sec-extract: exhibit">Steve Weldon Letter of Resignation, dated November 11, 2020</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Q</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/13/2020</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.21</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.19</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495420012364/gtbp_ex1022.htm" STYLE="-sec-extract: exhibit">Board Service Agreement with Bruce Wendel, dated November 11, 2020</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Q</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/13/2020</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.22</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.20</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495420012364/gtbp_ex1023.htm" STYLE="-sec-extract: exhibit">Board Service Agreement with Greg Berk, dated November 11, 2020</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Q</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/13/2020</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.23</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.21</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495420012364/gtbp_ex1024.htm" STYLE="-sec-extract: exhibit">Consultant Agreement with Michael Handelman, dated November 13, 2020</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Q</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/13/2020</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.24</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.22</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495420013851/gtbp_ex101.htm" STYLE="-sec-extract: exhibit">Form of Amendment to Convertible Note &amp; Standstill Agreement</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/23/2020</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.23</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495420013901/gtbp_ex101.htm" STYLE="-sec-extract: exhibit">Settlement Agreement, dated as of December 22, 2020, by and among Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B, Anthony Cataldo, Paul Kessler and GT Biopharma Inc., a Delaware corporation.</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/28/2020</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.24</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495421001050/gtbp_ex101.htm" STYLE="-sec-extract: exhibit">Form of Second Amendment and Extension of Standstill and Forbearance Agreement.</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">02/01/2020</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.25</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495421001271/gtbp_ex1069.htm" STYLE="-sec-extract: exhibit">Board Service Agreement with Rajesh Shrotriya, dated January 12, 2021.</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1/A</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">02/08/2021</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.69</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 50; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
    Number</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: bottom; text-align: center; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
    Description</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: bottom; text-align: center; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 8%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: bottom; text-align: center; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: bottom; text-align: center; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 5%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: bottom; text-align: center; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 8%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>File
    No.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: bottom; text-align: center; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 10%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Filed
    Herewith</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>10.26</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495421001271/gtbp_ex1070.htm" STYLE="-sec-extract: exhibit">Board Service Agreement with Michael Breen, dated January 12, 2021.</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">S-1/A</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">02/08/2021</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.70</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.27</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495421001271/gtbp_ex1071.htm" STYLE="-sec-extract: exhibit">Amendment to Settlement Note with Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B.</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1/A</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">02/08/2021</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.71</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.28</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495421001271/gtbp_ex1072.htm" STYLE="-sec-extract: exhibit">Form of Securities Purchase Agreement - December 2020 / January 2021 Notes</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1/A</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">02/08/2021</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.72</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.29</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495421001271/gtbp_ex1073.htm" STYLE="-sec-extract: exhibit">Form of December 2020 / January 2021 Note</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1/A</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">02/08/2021</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.73</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.30</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495421005897/gtbp_ex101.htm" STYLE="-sec-extract: exhibit">Amended and Restated Employment Agreement with Anthony Cataldo, dated April 23, 2021.</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Q</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">05/17/2021</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.31</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495421005897/gtbp_ex102.htm" STYLE="-sec-extract: exhibit">Amended and Restated Employment Agreement with Michael Handelman, dated April 23, 2021.</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Q</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">05/17/2021</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.32</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000165495421005897/gtbp_ex103.htm" STYLE="-sec-extract: exhibit">Amended and Restated Employment Agreement with Dr. Gregory Berk, dated April 23, 2021</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Q</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">05/17/2021</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.33</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000149315222007883/ex10-73.htm" STYLE="-sec-extract: exhibit">Exclusive License Agreement with Regents of the University of Minnesota, dated March 26, 2021</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">03/28/2022</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.73</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.34</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000149315222007883/ex10-74.htm" STYLE="-sec-extract: exhibit">Research Agreement with Regents of the University of Minnesota, dated June 16, 2021.</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">03/28/2022</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.74</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.35</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000149315222007883/ex10-75.htm" STYLE="-sec-extract: exhibit">Sublease Agreement dated November, 2021, between Aimmune Therapeutics, Inc. (Sublandlord) and GT Biopharma, Inc. (Subtenant)</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">03/28/2022</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.75</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.36</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000149315222007883/ex10-76.htm" STYLE="-sec-extract: exhibit">Employment Agreement with Michael Breen, entered into as of December 31, 2021 with an effective date of November 8, 2021</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">03/28/2022</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.76</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.37</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000149315224011332/ex10-77.htm" STYLE="-sec-extract: exhibit">Amendment No. 1 to Employment Agreement with Michael Breen, dated as of June 17, 2022.</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">03/26/2024</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.77</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.38</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000149315224011332/ex10-78.htm" STYLE="-sec-extract: exhibit">Amendment No. 2 to Services Agreement with Michael Breen, dated as of February 20, 2023.</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">03/26/2024</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.78</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.39</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000149315222013539/ex10-1.htm" STYLE="-sec-extract: exhibit">Board Service Agreement with Michael Breen dated November 11, 2020</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Q</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">05/16/2022</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.40</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000149315222013539/ex10-2.htm" STYLE="-sec-extract: exhibit">Employment Agreement with Manu Ohri dated May 15, 2022</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Q</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">05/16/2022</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.41</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000149315224011332/ex10-81.htm" STYLE="-sec-extract: exhibit">Amendment No. 1 to Employment Agreement with Manu Ohri, dated as of February 17, 2023</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">03/26/2024</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.81</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.42</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000149315222030019/ex10-1.htm" STYLE="-sec-extract: exhibit">Settlement and Investment Agreement dated August 24, 2022, by and between GT Biopharma, Inc. and Cytovance Biologics, Inc.</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Q</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/31/2022</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.43</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000149315223000198/ex10-1.htm" STYLE="-sec-extract: exhibit">Form of Securities Purchase Agreement, dated December 2022, by and between GT Biopharma, Inc. and the purchasers named therein.</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">01/03/2023</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.44</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000149315224017209/ex10-1.htm" STYLE="-sec-extract: exhibit">Amendment No. 1 to Settlement and Investment Agreement, dated as of April 25, 2024, by and between GT Biopharma, Inc. and Cytovance Biologics, Inc.</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">04/30/2024</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.45</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000149315224032143/ex10-2.htm" STYLE="-sec-extract: exhibit">Amended and Restated Exclusive Patent License Agreement with the Regents of the University of Minnesota, dated May 13, 2024</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Q</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">04/30/2024</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.46</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000149315224032143/ex10-3.htm" STYLE="-sec-extract: exhibit">Sponsored Research Agreement with the Regents of the University of Minnesota dated May 20, 2024</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Q</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">04/30/2024</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.47</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000149315224021078/ex10-1.htm" STYLE="-sec-extract: exhibit">Form of Securities Purchase Agreement</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">05/23/2024</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.48</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000149315224021078/ex10-2.htm" STYLE="-sec-extract: exhibit">Form of Placement Agency Agreement</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">05/23/2024</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.49</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000151316015000022/ex141.htm" STYLE="-sec-extract: exhibit">Code of Ethics</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">03/31/2015</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.50</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000149315224047085/ex10-1.htm" STYLE="-sec-extract: exhibit">Investigator Initiated Clinical Trial Agreement</A></U></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/18/2024</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.51</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000149315225003718/ex10-51.htm" STYLE="-sec-extract: exhibit">Form of Securities Purchase Agreement</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1/A</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">01/27/2025</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.51</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="margin: 0"></P><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.52</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000149315225003718/ex10-52.htm" STYLE="-sec-extract: exhibit">Form of Placement Agency Agreement</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1/A</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">01/27/2025</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.52</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="margin: 0"></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.53</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000149315224023195/ex10-1.htm" STYLE="-sec-extract: exhibit">Employment Agreement between the Company and Alan Urban, dated as of June 7, 2024</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">06/07/2024</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>21.1</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000151316015000022/ex211.htm" STYLE="-sec-extract: exhibit">Subsidiaries of GT Biopharma, Inc.</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">03/31/2015</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>23.1</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex23-1.htm">Consent of Weinberg &amp; Company</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 51; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 5%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
    Number</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center; width: 2%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
    Description</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center; width: 2%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 8%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center; width: 2%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 5%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center; width: 2%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 5%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center; width: 2%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 8%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>File
    No.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: bottom; text-align: center; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 10%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Filed
    Herewith</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>23.2</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="ex5-1.htm">Consent of Baker McKenzie LLP (incl. in Exhibit 5.1)</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">X</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>24.1</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000149315224051873/forms-1.htm" STYLE="-sec-extract: exhibit">Power of Attorney (included on signature page of the initial filing).</A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/23/2024</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>101.INS</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Instance Document</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>101.SCH</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Taxonomy Extension Schema Document</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>101.CAL</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Taxonomy Extension Calculation Linkbase Document</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>101.DEF</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Taxonomy Extension Definition Linkbase Document</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>101.LAB</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Taxonomy Extension Label Linkbase Document</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>101.PRE</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Taxonomy Extension Presentation Linkbase Document</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>107</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/109657/000149315225003718/ex107.htm" STYLE="-sec-extract: exhibit">Filing Fee Table</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> S-1 </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><P STYLE="margin: 0"> 01/27/2025 </P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">107</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="margin: 0"></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&dagger;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Confidential
    treatment granted from the Securities and Exchange Commission as to certain portions, which portions have been omitted and filed
    separately with the Securities and Exchange Commission.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">+</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedules
    have been omitted pursuant to Item 601(b)(2) of Regulation S-K. GT Biopharma, Inc. will furnish copies of any such schedules to the
    Securities and Exchange Commission upon request.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">**</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">To be filed by amendment.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
17. Undertakings</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    undersigned registrant hereby undertakes:</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    include any prospectus required by Section 10(a)(3) of the Securities Act;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent
    post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set
    forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if
    the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end
    of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if,
    in the aggregate, the changes in volume and price represent no more than 20 percent change in the maximum aggregate offering price
    set forth in the &ldquo;Calculation of Registration Fee&rdquo; table in the effective registration statement; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    include any material information with respect to the plan of distribution not previously disclosed in the registration statement
    or any material change to such information in the registration statement; provided, however, that paragraphs (1)(i), (1)(ii) and
    (1)(iii) above do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained
    in reports filed with or furnished to the Securities and Exchange Commission by the registrant pursuant to Section 13 or Section
    15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement.</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 52; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">That,
    for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a
    new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be
    deemed to be the initial bona fide offering thereof.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the
    termination of the offering.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">That,
    for the purpose of determining liability under the Securities Act of 1933 to any purchaser, each prospectus filed pursuant to Rule
    424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other
    than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of
    the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus
    that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration
    statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior
    to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the
    registration statement or made in any such document immediately prior to such date of first use.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">That,
    for the purpose of determining liability of the registrant under the Securities Act to any purchaser in the initial distribution
    of the securities, the undersigned registrant hereby undertakes that in a primary offering of securities of the undersigned registrant
    pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the
    securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will
    be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule
    424 (&sect; 230.424 of this chapter);A</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by
    the undersigned registrant;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant
    or its securities provided by or on behalf of the undersigned registrant; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    other communication that is an offer in the offering made by the undersigned registrant to the purchaser.</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of
    the registrant&rsquo;s annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each
    filing of an employee benefit plan&rsquo;s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference
    in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and
    the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</FONT></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 53; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    undersigned registrant hereby undertakes that:</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    purposes of determining any liability under the Securities Act, the information omitted from the form of prospectus filed as part
    of this registration statement in reliance on Rule 430A and contained in a form of prospectus filed by the undersigned registrant
    pursuant to Rule 424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as
    of the time it was declared effective; and</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the purpose of determining any liability under the Securities Act, each post-effective amendment that contains a form of prospectus
    shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities
    at that time shall be deemed to be the initial <I>bona fide</I> offering thereof.</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insofar
    as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons
    of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the
    SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event
    that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid
    by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted
    by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in
    the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the
    question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the
    final adjudication of such issue.</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 54; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIGNATURES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf
by the undersigned, thereunto duly authorized in the City of Los Angeles, State of California, on February 7, 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 20.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GT
    Biopharma Inc.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    February 7, 2025</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Michael Breen* </I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    Breen</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interim
    Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">Pursuant to the requirements of
the Securities Act of 1933, as amended this registration statement has been signed by the following persons in the capacities dates indicated
below.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 50%"><I>/s/ Michael
    Breen * </I></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    Breen, Executive Chairman of the Board and</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interim
    Chief Executive Officer</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
    7, 2025</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; font: 10pt Times New Roman, Times, Serif"><I>/s/ Alan Urban</I></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alan
    Urban, Chief Financial Officer</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
    7, 2025</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; font: 10pt Times New Roman, Times, Serif"><I>/s/ Bruce Wendel* </I></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bruce
    Wendel, Vice Chairman of the Board</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
    7, 2025</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; font: 10pt Times New Roman, Times, Serif"><I>/s/ Rajesh Shrotriva* </I></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rajesh
    Shrotriva, Director</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
    7, 2025</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; font: 10pt Times New Roman, Times, Serif"><I>/s/ Charles J. Casamento* </I></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charles
    J. Casamento, Director</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
    7, 2025</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; width: 3%; text-align: justify"> <FONT STYLE="font-size: 10pt">*By</FONT> </TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 47%"> <FONT STYLE="font-size: 10pt"><I>/s/ Alan Urban</I></FONT> </TD>
    <TD STYLE="width: 50%"> &nbsp; </TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom"> <FONT STYLE="font-size: 10pt">Alan Urban,<BR>
    Attorney-in-fact</FONT> </TD>
    <TD> &nbsp; </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 40.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 55; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>ex5-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><B>Exhibit 5.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex5-1_001.jpg" ALT=""></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 40%"><P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Baker
                                            &amp; McKenzie LLP</FONT></P>
    <P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1900
    North Pearl Street, Suite 1500<BR>
    Dallas, Texas 75201<BR>
    United States</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel:
    +1 214 978 3000</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fax:
    +1 214 978 3099</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">www.bakermckenzie.com</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 30%">
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0"><B>Asia Pacific</B></P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Bangkok</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Beijing</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Brisbane</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Hanoi</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Ho Chi Minh City</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Hong Kong</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Jakarta</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Kuala Lumpur*</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Manila*</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Melbourne</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Seoul</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Shanghai</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Singapore</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Sydney</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Taipei</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Tokyo</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Yangon</P></TD>
    <TD ROWSPAN="4" STYLE="width: 70%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">February 7, 2025</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">GT Biopharma, Inc.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">315 Montgomery Street, 10th Floor</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">San Francisco, CA 94104</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Ladies and Gentlemen:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have acted as counsel to GT Biopharma, Inc., a
    Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), in connection with its filing with the Securities and Exchange Commission (the
    &ldquo;<U>SEC</U>&rdquo;) of a registration statement on Form S-1 (File Number 333-284032) (the &ldquo;<U>Registration Statement</U>&rdquo;)
    under the Securities Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;) including a related prospectus filed with the Registration
    Statement (the &ldquo;<U>Prospectus</U>&rdquo;), with respect to the offering and resale by the Company of (i) up to 3,361,344 shares
    of common stock, par value $0.001 (the &ldquo;<U>Common Stock</U>&rdquo;) per share (the &ldquo;<U>Shares</U>&rdquo;), (ii) up to 3,361,344
    pre-funded warrants exercisable for one share of common stock at an exercise price of $0.0001 per share (the &ldquo;<U>Pre-Funded Warrants</U>&rdquo;),
    with each Pre-Funded Warrant to be sold reducing the number of Shares to be sold on a one-for-one basis, (iii) up to 3,361,344 common
    warrants to purchase 3,361,344 shares of the Company&rsquo;s common stock (the &ldquo;<U>Common Warrants</U>&rdquo;), (iv) up to 201,680
    warrants to Roth Capital Partners, LLC as placement agent (the &ldquo;<U>Placement Agent</U>&rdquo;) to purchase up to 201,680 shares
    of common stock at an exercise price equal to 125% of the public offering price of the Shares for a five-year term (the &ldquo;<U>Placement
    Agents Warrants,</U>&rdquo; and together with the Pre-Funded Warrants and the Common Warrants, the &ldquo;<U>Warrants</U>&rdquo;), and
    (v) up to 6,924,368 shares of Common Stock issuable from time to time upon the exercise of the Warrants (the &ldquo;<U>Warrant Shares</U>&rdquo;).</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In connection therewith, we have examined originals
    or copies certified or otherwise identified to our satisfaction of (i) the Registration Statement, (ii) the Prospectus, (iii) the form
    of securities purchase agreement filed as exhibit 10.51 to the Registration Statement, (iv) the form of placement agent agreement filed
    as exhibit 10.52 to the Registration Statement, (v) the Restated Certificate of Incorporation of the Company, as amended and supplemented
    to date, (vi) the restated Bylaws of the Company, as amended to date, (vii) the form of Common Warrant, form of Pre-Funded Warrant and
    form of Placement Agent Warrant filed as exhibits 4.35, 4.36 and 4.37, respectively, to the Registration Statement (viii) such other corporate
    records, agreements, documents and instruments and certificates or comparable documents of public officials and officers and representatives
    of the Company as we have deemed necessary or appropriate for the expression of the opinions contained herein. As to any facts material
    to our opinion, we have made no independent investigation of such facts and have relied, to the extent that we deem such reliance proper,
    upon certificates of public officials and officers or other representatives of the Company.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
rendering the opinions contained herein, we have assumed (i) the truthfulness of all information contained in all of the documents reviewed
by us, (ii) the genuineness of all signatures on all documents examined by us, (iii) the legal capacity of all natural persons signing
such documents, (iv) the due authority of all parties signing such documents, (v) the authenticity of all documents submitted to us as
originals, and (vi) the conformity to the originals of all documents submitted to us as copies.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0pt; margin-top: 0; margin-bottom: 0">Based upon
and subject to the foregoing, we are of the opinion that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0pt; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">1. The Shares have been duly and validly authorized
and, when sold in accordance with the Registration Statement and the Prospectus, will be validly issued, fully paid and non-assessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0pt; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">2. The Warrants have been duly authorized and, when
the Warrants have been duly executed and delivered by the Company, and when paid for by the purchasers in accordance with the terms of
the Prospectus and the securities purchase agreement, will constitute the legal, valid and binding obligations of the Company, enforceable
against the Company in accordance with their terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0pt; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">3. With respect to the Warrant Shares that may be
issued from time to time upon the exercise of the Warrants, when issued and paid for upon the exercise of the Warrants in accordance with
their respective terms, such Warrant Shares will be duly and validly authorized and will be validly issued, fully paid and non-assessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0"><B>Europe, Middle East &amp; Africa</B></P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Abu Dhabi</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Almaty</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Amsterdam</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Antwerp</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Bahrain</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Baku</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Barcelona</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Berlin</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Brussels</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Budapest</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Cairo</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Casablanca</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Doha</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Dubai</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Dusseldorf</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Frankfurt/Main</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Geneva</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Istanbul</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Jeddah*</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Johannesburg</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Kyiv</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">London</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Luxembourg</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Madrid</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Milan</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Moscow</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Munich</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Paris</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Prague</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Riyadh*</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Rome</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">St. Petersburg</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Stockholm</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Vienna</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Warsaw</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Zurich</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0"><B>The Americas</B></P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Bogota</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Brasilia**</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Buenos Aires</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Caracas</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Chicago</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Dallas</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Guadalajara</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Houston</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Juarez</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Lima</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Mexico City</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Miami</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Monterrey</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">New York</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Palo Alto</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Porto Alegre**</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Rio de Janeiro**</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">San Francisco</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Santiago</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Sao Paulo**</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Tijuana</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Toronto</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Valencia</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">Washington, DC</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">* Associated Firm</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0">** In cooperation with Trench, Rossi e Watanabe Advo</P></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex5-1_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
opinions expressed above are limited to the General Corporation Law of the State of Delaware and the federal laws of the United States
of America. We do not purport to cover herein the application of the securities or &ldquo;Blue Sky&rdquo; laws of the various states.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
opinion letter is limited to the matters stated herein, and no opinion is implied or may be inferred beyond the matters expressly stated.
We hereby consent to the use of our opinion as herein set forth as an exhibit to the Registration Statement and to the use of our name
under the caption &ldquo;Legal Matters&rdquo; in the prospectus forming a part of the Registration Statement. In giving this consent,
we do not hereby admit that we come within the category of persons whose consent is required under Section 7 of the Securities Act or
the rules and regulations of the SEC promulgated thereunder or Item 509 of Regulation S-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly yours,</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <I>/s/ Baker &amp; McKenzie LLP</I> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BAKER &amp; McKENZIE LLP</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>ex23-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
23.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Consent
of Independent Registered Public Accounting Firm</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
hereby consent to the incorporation by reference in the foregoing Amendment No. 2 to the Registration Statement on Form S-1 (File
No. 333-284032) of our report dated March 26, 2024, relating to the consolidated financial statements of GT Biopharma, Inc. and Subsidiaries
as of December 31, 2023 and 2022 which appear in GT Biopharma, Inc.&rsquo;s Annual Report on Form 10-K for the fiscal year ended December
31, 2023 filed with the Securities and Exchange Commission on March 26, 2024. We also consent to the reference to our firm under the
caption &ldquo;Experts&rdquo; in such Registration Statement and related Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Weinberg &amp; Company, P.A.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Los
    Angeles, California</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> February 7, 2025</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>forms-1_009.jpg
<TEXT>
begin 644 forms-1_009.jpg
M_]C_X  02D9)1@ ! 0$ 9 !D  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !> ,@# 2(  A$! Q$!_\0
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MO &E7RR:3?\ QHOHU\):[?VMY:?#R+Q5:6DNO'[@M?\ 5GKP^"&QN!")NW8
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M'4)SP6;NO4PF9TW"KA,544I5,1&-6$Y.-:-2]*5*M"EB)3A-<D[29_76&QF
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MCDU;,,\Q>=<:9##B/)L@RC!X7&7S;-89=+$O&T:%3!4<&\%B74Q$:%/ZQ+]
M@<YY!Y[?U]Z6OS\^#O[47Q?@^.K?LX?M)^"?"'AOQSJN@/XF\%>*? $NI?\
M"*>*]-B:="$MM6U;6;FVGN%L[MHF?4?.2Y@ELIK!0D=W-X-I'[:/[7?B+PY\
M7OB?X:^'/P1UKX<_!_QEK&@:YI+/XMTOQ?=:;H[)+<W5K?S^*[FRE:*SECD-
MU%H,GGOO-KILH0QUZ-#POXGKU\9257(:>'PN&R3&4\SJY[A8Y1F5#B/$XG!Y
M)/*LPCA*M/&?VCC<)B,'1YJ&"4,33=*O+#RU7F8OQ^X"P>&P-:5#B^OC,7F'
M$^68G(\+PGC:_$.1XS@S+\)FW$]+B')EF=/$97_9&5X_!YCB6L1F+E@Z\,10
MCB*5Y'Z^4A. 2>@!/Y5^=.H?MK^(=6\6?L6P^"?#>@IX2_:=@UVY\21>(H-3
MG\1>&VT2?1;&YL=(N=-U6UT_S[;4+^_MIKJ[L=1@N/LL#V\:I,6KU#XK?M$^
M+_ O[2?P"^#.D:5X:O/#7Q4LM<N/$.J:A:ZH^M64VGW @M(M(EM]7MK"VR,O
M<I>V.I2,N"H@!&?,_P!0^)5C*.7SPF'IXRME?$><?5ZF-P\9TL)PIB,TPN=P
MKJ/M%2Q6'Q&2YE3HX9N4L5]7YJ-7DJ4YS]Q>,/ T\!CLTI8W'UL!@.(."^&I
MXFEEM24,3F/B!@N'\PX9G@>;&4Y8O!8K"<3Y-6Q&*A&F\&L3)5<+4=&H?8RL
M& (Z'^AQ2U^;O[9W[9GQ"^ GB/PEX1^$?@_PSXUUU_"'B;XC^/H/$%MJ\XT'
MP1H5S%!;7=M%IFNZ(8'O_L7B-FO;F6]AMFTRUB:Q=K^(M[+\4_VD]0\-?LFW
M_P"T?X%L-$U>Y?P5X<\4Z/9:M'?3:.TVMW6G6UQ!?)97]E>O%9R7<T&R*\MW
M:X10\JA74J' O$4\%PKF"H818?C+,O[*R52QU&-?ZU*I3A0EF-!TW4RS#8R,
MYUL#B<7[F,H8;%5:$)+#SC)U/&#@>GFW'^2?7<?4S#PTR6>?<40I996G1A@:
M%.K/&PRO$O$PH9MC,LJ4X87,\)AY4*F!QF*P6&K5'/%4YKZ]HK\JK7]L?]I?
MX=WOP/USXY?#KX57WPX^..H:1I6DZO\ #:;Q%8:[H-UK$=M/!+>:?K?B+Q#_
M &@4BOK<FSAM[-)&BECCU$SS0P!?CG^WA\4/@[^TCJWP^7P-X/U7X0>#)/A_
M)X]U\P:W_P )5I.E^-I+6T?5;>]AUT::%L[NZC6"U?PY<+=336>G/>P2W8NX
MO:I>$_%^(S"&6X..3X^K6R_-\PPE?!9SAJ^#QT<CS#^R<SP>"Q#PM!U\RH9K
M;+8X)X>C*MC)0I4:]13A4E\M7^D?X98+)JF=9I6XER>EAL\X:R#'9?FO"^.P
MF<9;B.+LGK\0Y!C\?E\,=C/8Y-C<AP]7.)9G2QN,AA<!'VV*PE!\U.'ZJ45\
M2?M@_M2^(?@)X2\)+\-="T'QC\1/'FHZC_PCFEZT+Z;1U\.^'=&N]=\2^()H
M]+U&PN;V"QL(;=X8H=1L]\,T]Z9&BLIHCL_"K]IR[\0_LDV_[27Q!TW2-,O+
M3P9XG\4:UI.A+=6UA+<^'KG4K6'3],BU*_O[F.?5;FSM[*SM9K^ZF>^NTMDD
MD<J#\Z^#L^60Y9Q&\-2_L_.<XGD>74OK$7F&)QT)PI7CEZI.O'"U*\GAZ6)E
M-1J5Z5>G&E>A5E#[1^*?!D>,,^X'EC\3#/.&N&5Q;G-2>!K1RC"9.J,\35E_
M:[K+"5<7A\-&.(Q6%IQ<L/2K8>52NG7IQ?V%17YS_L9?MA?$;XZ>(O%G@CXP
M^$_"W@_Q;8>'/#_COPK#X;MM4T^UUKP7XA3=9WK1:OXB\0SW,I66UN%NK>6W
M@,%PJFV5LN"N3B7AW,N$LXQ.1YRL)3QV%C1J2EA,91QV#K4L11A6I5L+C<.O
M88FE*,G!U*3<8U:5>DWST:B7J\#<<9#XB\-X/BKAB6/KY5C:F*H1CC<OJY?C
M\-B,'B)X?$8;'8"K6KU<'B(2C"JJ-2K.4L/B,+7TCB()?57C'X-:=X\ED77O
M'7Q?M].NMRSZ3X4^)OB3P)IX@(P8/M/@:3PWK7E2(2D@.IJ[+N!E/#5Y7H?[
M"'['WAF^GUJ+]GWX>>(?$%S;W%I=>*/'>F3?$;Q9-;7D$EK=0R>)_'USXBUW
M9/!-,D@74%R97?[[%J^K-1&I-:3)I,UC#?N@2WFU&TN;RU$@S\]S;V=S9R-&
M3C"I/"6Y =."/FKQ9\)/VA/&5Q-'>_M7ZW\/= FAFMWMO@Q\(/AWH&NA9BP\
MR+Q)\5#\:/LT]LF52XM=&LWW*9$7<0H\BE5J0LUB'02:E*3<U*/*T^9>Q49-
MQLFK-.Z5G?4^IJ0C*\5'F;7*HM)QES*W+)2=G%[/R;/XN?\ @FAX/'_!)/\
MX+Z?&O\ 97^(^LVW@WX4^,_"_P 3?#7@?Q;XIU2VT?PYJWPGUI5^+/P+\1ZC
MK6HS:?IB)8Z%IUQX-UR]-Q]DL?%^A:_IJO;D -K_ +;7[47PEU_]JCX]V/[)
MMI<?M36FO>,)M9TC5OAE.Z_"^&[\3:7:7_B"/5OB?/;OH;VVE^)+G6[6=_#A
MU9M\4D*W,+1RB#]&/^"R?_!+'PUX-\#?"K_@H+X*/Q0_:+^)O[(OQ!\'>/\
M]H'2?C[XTUSXS:I\7_V7M(\20ZGX^\+-H>N1MX=L;7P'876J^++;P]X:\+:3
MIHT^XU[_ $*61(=GI/\ P59\%^"M#\9?L^>,OAAH_AW0O 7CGX.M:Z!IW@[2
M].TCPVUAH^H6VN:+=6%OHUO:Z9Y4VE>+XVM%MX%C:W0R1G97]<>$G$V!S7Q
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M;AUB9X++\P_^"K_Q\_X)._M2?%G]CZZ_X)>?#K0_^%L^(OCMJ_C7]H"Z\%_
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MPYPQALJRY93G&&S'"9+D^"X:PD*]#,,SQT\]IU\7',X.G7EA#\;_ -L+X*^
MC\:O^"?OP)L8=8T3P$J^-?"5FFBZF]IK5MIMD/!D$5Q!K,XE*:A)Y8N;Z]>V
MGO;F>:68$&>XWYNM_L^>"/V?OVXOV4M-\%ZIXPU.W\2V7B+4+P^,O$(\02I+
M82F'%G(]M9+!#'$3-*1 V<!CL;<:_:&[T'1+^ZL+V^TC3+R]TIY)=,O+JQMK
MBZTZ24*)9+&XEC>:T>0(@=H'C9]B[B=HP76@:'?7MEJ5[H^F7>HZ:DT>GW]S
M8VT]Y8QW"A9TM+F6-IK=)E $JQ.@D'WP:G >+>;X3+\!E-98[$X"EPQQCDN:
MTY9BV\YS7BNOG&(6?8I3PLY0Q.#JYJI2IT\5&.)EAN>I%SQ%=RO-OHV\.9AF
M^=9]AZ.18/-Z_B!X;<6\-XZGE%6%;AO(^ \)PS@ZW"^'5'&0PU3#8^AP_*EA
MI?4'0PE'$TH>R_V6BX?B7X,G^./Q\^-/[3/QK^%?@;X<^./!?B>34OV?=*N?
M'6M:C86UKX5TNQTQM0'AVRM=5LUE&HVXT:XU61XCY6IK.T#J)KU9?/\ PEXN
MUBR_8$_:L_9[\:C['XV^ &M6FC7^FF[:XFMO#WB/Q9976E!Y95FW00:GI?B&
M"S<[(XK."UCDN!([RM^^NFZ%HFC6[6FD:1IFEVKS27#VVG6-M90-<3$&:<Q6
MT4<9EE(!DD*[W(&XFJ$W@[PE<2:M-/X8T":77TABUV272+"1]9CMW,D":JS6
MY.H+#(2\2W9F$;EF7!))[EXM81U(4)<*82&6Y=F' V/R&&'Q=6GF6#EP0Z%#
M#1Q^*J2Q&$QLL5@*N;X=U:&7X&=&>.A53K.E*_CS^C7F2A6QU/Q"S"OGF=Y1
MXI91Q;/'8#!2RC,J?BC3QF)S*KEE'!8+!YK@'A\YH<,XYQQ69YE[6CD;I4)8
M">(<G^#EWX$M/V;?$7[&'Q\\=:_XA^+/PD\0V6BZ%JEG\2+LZI'\)?$FKZ=I
M^K:;K_A%K1-.M+<VL=N]_H]CJ&GZG(EMX>UVV6\EOKS2Y;3VSQQ\,[+XV?M>
M?MG?#FX"/)XF_9K\-_V+<-\\-MXFTF?PAK/A/5$19LR?V?XDLM,U*SE\D;UM
M_D=DE9&_7^]\,^'-2T^WTG4=!T>_TNU:%[73KW3;.ZL;9[9#';O;VD\+P0M
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>BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>forms-1_001.jpg
<TEXT>
begin 644 forms-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !I -\# 2(  A$! Q$!_\0
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MBBBN$] **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_KKSKXL^,X?AS\+OB3\19L-#X$\">+_&DH(!!'AGPU?:P5Y[,EH>/?FO2 ,
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MHEDQZ*3N/UPPSQFOB3]=+-%%% !1110 44W) ^8]_P#/;ZTZ@ HHHH ****
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MT:"_W2E8P;\X.6"G\*O^"E'[;/QY_P""\_QY\/\ [!__  3:^'_B+QE^S?\
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MFR?FT[6&\0:"B #Y=%MR,[F*^(:)\#OC!^T+^T_\<_B[+XJ^)/P,L/"U[:>
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M]9\V_M23S)<><T?>XJRS*G%\+*&5WEEE3-4GS)Q?<?\ !/OQ7J7PT\9_$?\
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M8OT445_)Q_JN%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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0 !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>vi_001.jpg
<TEXT>
begin 644 vi_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" 'D U(# 2(  A$! Q$!_\0
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MJ]5_M'2]35XY,$*54!AD*3GC/\9O_!TM^S[\$/@Q\"_V9-1^%/PD^'/PUO\
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MMIT0OG^1^QVX8SD8QG.>WK4?G)]>O.5P0.X^;I[U_%QH/_!9'_@M+\>?A?\
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M;6&D:L-;@^WZ;&R*Z_VJ"QP'+J03R0:Z,+B5A<6I:[-KYJW?MZF.(V>MKO\
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M,%5G.UF4-\M?\%.H#:_\'&?[.%LS!WM_&_[+4#N#G>T6JVJ%NW+;2W(!]AC
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 5+B 3$J1U7KGZ\=,^^>F>.]>6>,8_&OE/9^"](\+S7-Q#+#+?
M>(KNZ@M86G21 LME:V1-ZC[44H+R*3YR&5>&/KV><=^M5Y4B))8')'( [<\D
M[3CIZ^^*GVRA4A/=4F[W5^MWII?IZ]'U(JT_;14-K+2U^COT\^Z9_(I\4OV
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MZ\06$%EJGBC58Y([QENWF\26[6%W"+H("+2.':MG""-D*QXX !^RU5QR5C4
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MZ?IOA8W'EH1EW"E%/!!/%:\GA?QK%?'3+C_@H;XOMM57Q7_PA3:5-I'P&BU
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M[*79?=_P#XD_X9W_ &@?^CUOBU_X0GPC_P#F&H_X9W_:!_Z/6^+7_A"?"/\
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M^$?_ ,PU?;@9<#D]!T+>GMQ2Y7U/YM5:O6V^OWZA[)]E_6O8^(O^&=_V@/\
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MK[:DDB1"SG*]/XCGZ#OQZ=L]LU E[:E1LEVKS@8  YYZCU]^IH#V4NB3^7_
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MV%QYFH2JYSA@%XR"3^I+M\Z8/&XD?4(1WYKXQ_9(.=<_:?!YQ^TAXLXZ\?\
M".^&OS_S[5'M4KKMOHM+:?U<+-)WZ=%<KG]G?]H#J/VU_BV0>1GP)\(\@'Z^
M!!Z>G(Q2?\,[_M _]'K?%K_PA/A'_P#,-7VX&'\1.?Q''X?C2Y7U/YM5)\RY
MEUU#V;>MEK_7;R/B+_AG?]H'_H];XM?^$)\(_P#YAJ/^&=_V@?\ H];XM?\
MA"?"/_YAJ^W"R $DG !)Y;H.:@%S;-DAA@':3@J,_I]?H#V%&O8/9/LONO\
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M/VM?V8]G[G]H'X1*1TQ\0?"3#VZZD!^7KTK\>];_ &4OV6-'\=_&GQ-\'_\
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MA^?5/"=CK^F0>,K#Q#XTUG5-5AU46FI6]C/I\5W;::L-K:(%Q& J-C]>IO\
M@M!_P3TL?#.J>);WXUS#3M*^(&A_#6]L3X!^(47B63Q9XI\/ZGXI\+VEKX:E
M\/'Q!=6'B?1-&O'\-ZE#:7>E^(;BSDLM-GE= IZ#3/\ @K]^P)K>L_"FRT7X
MU->:K\9(]=N? EK_ ,(+\0$-S;>']<;P]XC'B+?X6=O"4GAS5X FO1Z_+IAT
MJRC?4K]8;&(./P_^,'[ 'PVU33?V?M9\#_MV:;X[^,M_^T'\"O&GQD^*OBGX
MK?!U?%'PS\%?!WX:^-O#WA1/!>D1V$'A;4XO#&I>*9M0F2YT^\U#5O.-Q=&>
M1FD'WA\#?V*/^"?/PA\6Z+XMN_VN?!_C_4X_A;\9?AIXN/BSXA?#E;CX@W_Q
MV\6?\)=X^\<:K<:9;V4MIXBN+N2*SLWT^."./2DM(%'!% 'VIX3_ ."P?[!O
MCA_B-_PBOQBU#7[CX7>'(?&'B*RTSX<?$EM2U;PA<:_!X>'BSP;IB^$S=>.=
M @UR:&V.J^$TUJQ2*ZCN99T@E5R77_!7[]@<?#OX??%*S^-%SJ/AOXI^+?$'
M@/P78:3X&\>:AXXU'Q/X6N(;7Q/I<GPXTSPS>^,+6/0I&635+[5-%M;*Q>_L
M$EF"W\1;\OD_X)I?L*SZ3XCT36/^"BFLW]QI'POT?X,_!W69_B%\*-/E^#/P
MSL?&%AXMMO"UK906,2>+=,O]1T6PT34AXUM]1?4-"@GTWS<2JPZ#P%_P3>_8
M<^%.B^ W^$W_  4)F\#?%'X9?$GXF_$?0_B=IOC/X*S:O+8?&"#28?&_AZ_\
M/S:./##Z-='P[93VC1Z5;RZ5]GQI\RH@%%GV?W/_ "%[5::[/NM+:=S[%_9S
M_P""PGP-^*?[1'Q/_9N^(C2?#+XE:;^T#KWP4^%FCO8^*=5T[XB1:?X>L?$]
MCK5_K]QX3MM(\+Z[J]C)=0V/A[6=6@EG73V6U5@%)_:RSD,EM&6);Y%!)P0V
M0!V9\Y]V;KPS#!K\ +#]DC]A#2?%-AXOC_;*\)W^KQ?MC6'[;#7>H_$'X>_:
M;_QIIG@J3P&OAF2YB993H%VKFZNG!>07 *1E1NK]<+?]K/\ 9B2V1&_:#^#Y
M=6P[-X_\);BW0EMFI*FXGYB5"\]% Z Q_P"V 0/V6_VAQ_U1[QR!^&@:A_05
MWWP8(_X53\,CD\>"/"_IVT6T/I^'U/TKY+_:I_:?_9MU7]FSXZZ?I_QY^$M[
M>S_"CQUY-I;>._#=S>2EO#VHX\F-=3W%CG(4?* ".G([;X1?M3_LU:?\,_A]
M97G[0/PBM;FT\$^&K:XM;OQ]X92Z@GATFU25)X_[4(CD1E(9>S#&3CF?]IMH
MEU6SVV2V_E_ QTV\_P +_/T/M0*I X[#N?\ &HYU AE('\#=SZ'WKYV'[6?[
M,6!_QD%\(CQU'Q!\*8/N,ZD3@]LDG'6G_P##6/[,C(?^,A/@[M(Z'X@>&B>>
M<';JF,_3CT':I_VCLM.MGOTZ&R;LO1?H?ES^UM^W[^V#^S]^V7\$/V8_ _P"
M^"?C7P]^T?\ \)_/\+?%GB/XI^)]&UR+2?A7X2M/%/C6[\4Z%8^ ]5^Q&$RW
MEMHMMI=QJT^H^0@)MU?>OKVD_P#!9G]@-?A[XW\<ZU\:=4TO2?A7>>$-+^(0
MU;X<?$71=2\/W?CO4I-$\.7@T/6/#%KK-YX?N]7AFLK/7(;.:QW^4MQ)YS*3
MQW[4GPV_8V_:>^./[/WQTUC]KCPCX/U?]G_1?C7X;\.6W@_XE>"=.DO9/C;X
M0G\':]JESJ$EZ]Q;W>B6;KJ6AO9NLRW[,UR&R=OYZ>"?^"4O_!/#PGH7BZTU
M#]O>W\5W/Q"N_@3)JNK:YXS^#UM*UO\ !3Q@WBW1[6>/1;'2H-4N=9=8K+4]
M7U(ZGJMW,)[NYNKF61B=+/JG?KH]^OXB]ITYGIINM+?-'ZHZG_P6$_8$T/QC
MX;^'^K_'"ZC\4^,$\ 2Z=I2?#WXA.NFW7Q,>U@\#Z-XEU"'PS+;^&]=UI+JR
MNHM(\12Z;K$%K(-0N+6*Q=37$_%;_@M1^Q'\.?!_[0GB30/B'/\ $75O@!X;
M\2:[X@\(>'?#'B^>?79O#-W)H>HVOA/6FT&73?$FFVOB*XL]'UC5M':YTGPU
M/,;C6+VWMV45^,'[5?[/-]\5/VZ-=G^%'Q2^$_@#]E_QY\9/V?OC1\6OB!??
MM*_"J7PKXA;X06.D"[N[/X?P>&8O&UGJMS_8<7A^R@'C&/0&OX3JDUF#*GV+
MZX^'/_!-[_@G=\+D_: \.:%^UUX"'@;X\?#OXP>!=/\ #MS>_ >37_A;;_&F
M[6_UN]\-_$,6$'CN]M--DGG72]-U76M0LO**FXBF=$<@S]W/V6_V@O"?[5/P
M+^&_QQ\&VVN6_AWXD>&-.\26$>N:7JNA:S:+>X2XL);+4K>QOE6UFC$?V^"V
M33[\1FYMSY$B,?IR-08T)4 [1P#D#CH""0<>Q-?G'^R]\2/V=_V>_@/\./@]
M>?M>^ OB0?AWH,7@_3O&OB7QOX LM9U#2;.7[+H@OH-$O;72IVL+"*&R>40"
MZN#"9G_>RN#]'1?M8_LR)&BM^T#\( RJ 1'X_P#"BQY P=BG4B0OH"<@=>:A
MK$:V5UTNG\NG8#Z+<*%;G&,^N<[OH>*^*O#I_P",[/B223_R;E\,.<#K_P )
MQ\0<YXQP.W\Z]%?]K3]EXAB?V@O@_P#>.2?B!X3/Y_\ $UQC/4XZ]J^3M&_:
M8_9V'[:/C?7F^.GPL71Y_P!GOX?6D.IOX_\ #(TF2\A\;>-,P)_Q- K72%@K
M,IPI^4G<<5>KM=:K?;?J]N]S%JA=W6KNG=IW>NFC[W_R/U&55(!QU /4^GUH
MPGM^?_UZ^<H_VL_V90B"3]H/X/B0*N\#XA>&\!L#(XU3'!XJ)OVMOV8 S _M
M"_![()S_ ,5_X5/?U.J9/U/)[U#6(Z*-O-2VZ=.UC9/16VLK>G3\+'N>J2I;
M6UY=#:_V59[R,2/Y0$L$  A!P2PFR5^K8QFOQ0^'W_!;_P#96T#X4:)X\_:B
M\07?P<\2^)/%/QJAT/PSHOA3QYXZCF\)_!GQ]JO@'6/$=U>>&/#=Y#;6P^Q1
MZE?K=O);Z?'<%FE:.%F7])]2_:R_9?D@DMX_V@_@VB7<4EM(TGQ"\)HJ)<0S
MFXE@ U//GX4M\W&1N' ;'XER_P#!/G_@G_\ V'=:(W[9GAV\CF^&G[37PIE:
M?QU\,V_LS3/VI?$%]XH\4ZM;O([3_P!J^'+B_#Z7++,Q:T\M7,A+ VKV5]^N
MG7K^(77<]]_:B_X+8_LU_"2?P;X0^#VL:/\ %_XE>+_%/P4M7\-1P>)[7P]I
M?A3XUZC8IHVM:IXHMO#M[X>TG5)?#5Y;Z_I7AVXU6TUF_M)FN7T^/ #>G^#_
M /@K%^SKI/P]\(>,OC'X_P##^D:[X^^(GQ$^'W@/P]\)] ^(_P 1=5\1+X%U
M^\T/4]4BT*'P1'XJMK72;BW:Q\17[Z%=>'[?5%@%OJ\T3QRR?GTW_!,+]@.R
METFTT'_@H'>:+X)-_P# +5O%'@BP\=_!ZYT;QS\0O@!H^CZ7X7U[5=0U+3+W
M6K:?4M*\/QF]T/1M2L[66Z22YVB-0B^D6G[#G[$/A$?"W7_@]_P4 _X5;\3?
MAEK'Q8>Q^(N@_$?X:ZK?>)/"?Q<\97GC;Q?X5OM&\1&_T7[%#JEY&(-5MK2+
M5X/L2N;LRHCJ ?>?Q"_X*Y?L>?#O5_C#X+G\5>)K[XC_  =\ >/?'&K?#X_#
MSQWHVJ:_IGP\M&OM>B\(WVK^&K'2_$4HB,?VN72+J:WLT;[1*XA1I!X;\#_^
M"R7P.^,EQX%\<WVM:#\//A3XD_95UG]I;Q7/XX'C+1O%GAF+0?%^B^'=1M([
M'4O!>G>'=<T'3[W4#I%KK6DZW/>:M?Q^7I=CJ$;1W+?,.A?\$]?V!M+^/^K_
M +0>J_MUOXVU/Q'8_&_29M"\2_$CX3201Z)\=M'FM?$-E-XCM+2W\4ZA:Z7/
M,PT2>^UB]N--B@MK.W4VJL6I6G_!.?\ X)^WWAFR\(_$3]M_3_B)HFG?LMZG
M^R;X?35/B#\+]&U'2? $WC71O'7A*>TO= M+9KG7?!]SX?M1IC7=K?V^IQ6@
M;41-YDP<)=:DNJNKWNUTTZ/I9K[NI^A4?_!9G_@GN? 3>.+KXX3:9H9^(6E?
M"N;2M1\ >/K#Q-'XQUS2Y-?T"QN_">J>&8_%5K8^(])AD;3[Z71FT^\6-DL;
MR1X]Q^Z?V=/VB_A%^U5\*?#_ ,:?@CXHM_&_PV\4_P!HVVC:Y;V=YI\LLVFZ
MI<:3JMK>:;J4%MJ%A/9WMM)%+:7L$%U$\;+-$K+MK\%--_X)[?L-OXKT;XB^
M/?V]+7XF_%RP^-OPM^,WB+Q[XD\>?"K3%UBR^"7AO5?!O@7P3>Z!X=CTS1+#
M0X+'6KNXFNK32S?7]]F;4)6<A3^D?[%47['?[%WP8'P+\'_M/?#KQ)IEIXV\
M<>,1JGB'QYX'@U![WQ[XIU/Q?=V;0:7<VD,4-G)J;Q6V+>(F)%8HOW0#NNZ^
M]?YGZD(0$4-AB%&6 &"?4>Q[4[<G]W]!7S:/VM_V7T 1?V@?A+A1@9^(7A0G
M ]2^I[\^N[YO7FE_X:Y_9@_Z. ^$G_AP?"/_ ,LZSY:_2*MTT>W0S]W^67WH
M\_\ VX,'X<_#C&<#]H_]G?(R,@'XM>$^V>G!QUK[0V$X(QR!U^GTK\N/VR?V
MEOV=M>\"_#B#1OCG\+[^>']H3X 7=^FG^/\ PRTD-E9?$WP_>R27875.;9$&
M^10#\I+8*]/KA?VN?V80H _:$^$) &,Q_$'PF$/^X#J>=OIGG%5;$Z:+RT?^
M7?\ IDN-"UNN[U>[7E\_^'/I((N!D<]^37(>);M=.T_4M22..4:=9:CJ*QL<
M-)+:6DCY2X!)B=O+-HJ 9_>9Y KQS_AKK]F+_HX+X2_A\0O"6/PSJE<WXB_:
MJ_9>U#3+_3Y/V@_@T(;ZSNH;B2X^(OA,-#;7.8KFZ7_B9<2VB2%[9A\JN!N(
MR,"6)OLM=]'K^!M=66JM96UZ67GV/PB_9J_X.#8O'&N^']=_:3^'/@/X5_ _
MQEX*^+7C"W\8?#OQCJGQ+\6_#JT^$/BN#PQJW_"X/!.G>'OMOABU\122*=$N
M(/MZW+NB0M*"[I^D(_X+-_\ !/FT\&>'/B'>_&K5;'P_XJUG5M)T2:[^&WQ%
M@OM1M_#MEIM_K6O+IMQX1CU*W\&Z9;ZQIT=[XHFL+/P];7$LT,NH^<DBCXM\
M+_\ !/\ _P""6W@W]C7QU^QWH7QX^#.F:I\1EOK#QU\>K77_ (56GQ:\0VVH
M>.V\>6=MKVM1#[1J4=K<&/3[&&Z:;?IZ1F<M,-YZ+]J+]C']@[]HG4/@?KEU
M^U]\-?!/B?X#^#-7^'5K>V^H?!/Q;IGB[P3K,>EMJFE^(_"/C33-6\+QW,QL
MX6BO(=/-S$',BR[BH6K/JM>NCWZ_C<'56U_+=7^?O?U^7Z2_M8?MJ>!_V;?V
M;-=_:!M[9_B#L/A2R\%>$O"U[;7-YXO\2^/M2T[1?!>DV5[)LATRQUN]U?38
M!K,BM9P6T\TQ69E42?&$O[??[8/PF^(_P!\ _M0?LX?"?X>/^T#<^+KC0KWP
MC\5M5\86_A_1_"7PE\4_$;4[/7;67PMIRQ:OH]YH&G6FL3:?#>6AM]0=]*:_
ME0BL7XD?L?\ _!*SXC^&OC/I.J?%GX=>'O$?QV\->%?#7BKQOX7^-]II][IP
M\ G19/!&M^$M G\07'A+P?KGAW4/#VEWUM_PC_AZVL6ET]8Y(&B)B;@]"_9?
M_9]U#Q=\,_%GQE_X*6ZG\>-=^$DGB;3?A]<^._B!\*;6WTC0/$GPO\3?#U[9
M[7PU#IL=U<_9/%$UU=^(+A/[8U'4=/L1<O) BL"S[?@'M5W7WK3_ ,F_K?NS
MWW0_^"T?['GA?P5\)+_]H'XD^'? 'COXF_#3PY\3WTKPIH?Q"\6^&[+PMXKU
MVYT'1_$,&LIX+TR>TT^]O5EM[^75X-/ET:62*2XC:SFCO)=W1?\ @JE^S[X9
MB^,_B/XT^._"/AC1_ /[1FK_  '\%V'@+3_B-XT\3^+M2L?#6D:]%8CPS:^%
M$U*]UNULM56YUFW\.:;KVD:= ?M1U/!,@^)+[_@G/_P3RU+P5J'A.+]M'P_"
MFJ_LL>#_ -E2/5?^$X^&DEQ9>&O"'CB7QQ'KL0<!CK.H7EVEE=JV56R944^8
M$8;^I?L*?L.27$WBKP1^WE8^!/BE8_M&^)?VC_"GQ0T'QW\*+G6/#OB+QM\.
M]+^'GB/P]!I6JV^HZ!J&B:EI6E6<]PEYIXNE=V-O=1YY NGK=:^:_P S]"O$
M'_!3G]D^V\?V/P@L/'.K6GQ;UOPRNM>$O#7BCP/X_P##/AKQ1>7G@G_A86GZ
M+'XVUSPS'X:&HWGAT1W:Z:;I-6@D5[)XH+I)+=/:_P#@GK^T[JG[8W[(?P?_
M &B]9\+6?@S4OB+I.I7MUX<L+^34[/3WT_6M0TH""\ECCDE29;(3@.@:/S-A
MR5R?Q?U/_@GY^PQXE_:0TC]HWQ%_P4 O?%'B/0O%&G^/X])UCXA?"C4;/_A+
M=/\  A^'VM:B-5U.VN=?32-;A2"ZC\.V.K1>'=,O4GMK>P@A6*&']2/V.-;_
M &0/V0/V<OAO^SQX3_:;^'.O:#\.=/OM.LM6\0_$+P>-6O!>:K>ZE*]TMCJ,
M=JFV:[=(DB7"1*BDD@T!==U]Z_S/TF)4$Y&>?0'L/6HI&4H0 0<$\8&<*?3/
MK^=?.C_M;_LPJQ4_M _",D8Y7XA>$R.G^WJA;\__ *U03?M;_LOYC/\ PT%\
M'P<-G?\ $#PF2!SU/]JJ!TQQQZU%J][Q4;;Q=GMT_ R?+=[WN];JV_:Y^:OQ
MS_;%TW]B>[_;0^)J^#]6^)'C3Q9^TU\)?A9\*OAOIUW;Z,?&OQ-\;?"?X=:;
MX:T8:S?1BQTVUN999'UG5BMU+;:;;MY<4CQ1Q'Y+^,O_  6K^-'P+^!'Q!\<
M:S\(/@#\4OBU\._B_P##?X8W_P +/@;\;=1\=?8O^$S/B!;_ $SQ$K>'-/O]
M"\4Z'+X;O;6.PN=*FBOGMI)[222!XV;W7XHZ7^QC^U[%^V=\+_B=\?O!/A'2
M]7^/7PU\9^!O'WASXF>%],\0^$_%_ACX9_#B?PO\0/!NH7E]);6E_IFL:==6
M3&""ZBO/L\UK)@"9#XEX:_8$_8AL];\5>-?B!^WMIWQ/^)/C'XW_  +^+7BW
MQ;K7BWX+Z#>>)KOX%VU[:^#/#UQI'ANQTW3/LVLC5=4&N:FT$>LZE%A)I7D+
MR2='O65[[*]K[V5^G>Y-+ZKSMMIN\N:[5[W=UJ[)7OY?@:_C_P#X+NV>F?M+
M?"/X-?"CX06WCSP%\2_V<M9^-&O_ !'U'Q++9-X=\6V?P7\0?&71_ *Z/%:.
MDUW)HFD:;+JL@:U,,.NV[O ' $OKG_!-O_@K-X\_;7^-]O\ !CQ_\)/ '@R]
MUG]G7PM^TIX7\4?"WXC'X@Z':>'_ !)K,>CR>"?'Z_V-H\WAKQVCSVUP=&<W
M9Q%*2S+&2_S_ .%?^";'_!-;P3'X(3P]^V+H$$_A'Q+\?-:-Q<?$_P $R7%[
M+\>? 3_"R;15FOI)[JUTCX>^$'LM-\(Z?:S^3$UFD,X R*_1C]C;PA_P3P_8
M@^%'ASX<_!SXC_L[:%J?A_P[X=\,^+?&5GKGPY\-^*?'=]H=H;6WU;QOJFBR
MB?5=6NI6>YD:X9MTTKN079BV;3N]'N^C[^AO[2*>DE9:+5;;+3F[>7^9\$Q?
M\%VQI_BS_@H-X'\<?!3^Q==_9#O]?TGX*QV_B8RQ?'V]TCQ=;^!!IIFOM,L%
MTC6!XEU7PO:7T%L]\T=OXC555RD;R^X?LT?\%J_V<O'/[-O[._QA_:9FN?@%
MXY^/EOJ,%OX8T[PSX\\4^#O#=S:?$/4_AUIR:GXXL?#+^&] DDUNRBMI+G5Y
MK%(6N?\ 620^7/)XQJ?_  3J_P"";NN_&/3_ (R:[^UCX;U?6M%_:)^)G[1O
M]FO\2_ UEI6KWWQ0FT.[;PGJZ63*UWX4T'QCX8T;Q'HR7QF;^W+60E<.N/FO
MQ5_P2)_X)]^)_!'@?X9/_P %#+JV\-> M ;P]!I#>./@SJ/V^ZL_BIKOQ;L[
MU/[5M+V;2;B/6-7;3-431GTLZO8Z+;F_,KPJSJS[?@P]M0ZO7KK%Z[.UWIK]
MWFS]?X/^"O\ ^P/+\2M8^#47QN7_ (6/H7B/XB^%;[29/ WC\Z7;^)_A7HMU
MK_C718M>E\-#26O-,TRRO+JT>&9EU: QKIT-Z\B(?'?VP/\ @LY^RM^S?\#=
M>^+7A_4M2^)?CD? KP?\>_A_X&T_PWXOAMO$_@;QUJX\.^"=<UC6K3P]/8:%
MI$^O74(D&L0QZE8[D#Z7%=30^=X'X<_8&_X)Z:'JMIXAN_VPO"^KVP_:$^,G
M[0-_:ZGX_P# <\5WJ'QN\!3_  _USPO%J$,BW4.BV%C<_;M-;S&O9;MW,CDL
MK)XII/\ P3!_89C\->/M \;?\%$M5\?-XJ^ /AW]F;1#KWCSX06T/@WX:^!O
M&MEXL\+:5H-OIMI:12?V9)I"0E]4N;B\GL+BY>1Q<-^[+/L_N?\ D)5H])*S
MT6L=NG7^OS_2OX2_\%5/V?=9N?@AX"^-_C:V^%7QX^,?AGPSJ&F^'I/#?Q(M
M/AW<:SXMTVXU[PWI6G_$#QMX*T#0$UF_TZ&:VM-.U.;3=3GU+?I+6GVV&*)?
M*/V@/^"Y7[$WPM^"OQ"^-GA#Q%XU^,VC?"WQWX9^'NIQ> _ /CF+P_KGB#Q3
MKFI^%E;1?&SZ!;^'M>TO2I](UBXDUG3=0O=+GGM4M;6234;S38V^>/BY_P $
M_OV"_C1^TIX7_:3\2_MRVTJ:#X^^%7Q/TCX;P>//A1=>$TU#X8Z%9>&$M;'4
M[ZRN-?M/#6KV4:SOHEOKEO9V]]>7FHVJ&>1%CETS]A;]B.P_9K^*'[([?M^O
M-\#/%NL:5K'PO\,7WQ!^%4;?!6?P]\0[WX@P'PSJZ6Z7WBB*?6[U8K=_$\FL
MB&TM$M)61HA&KL^S^Y_Y#]K?6Z^^-^_\Q[A<?M%_\$B?B)\7O#W[1'C;0_"V
MI_':T^)/PH^$=EXL\6?"WQS%XHT7XG?$_P -IK7PUT"?3]:\,*=/OY=#(>*]
MN;>*+1G18[J^AN9"*[C1O^"M_P"S?\1?&WPD\/\ [/7C70/$_ACQG\2=<^'?
MBG4-?\-_$SP?;Z#-X:TCQ-K&JV/@WS/ 5QX:U_Q!I7_",:I<7UM-JFEP65FM
MOYDURM[9%OCSQ%_P3D_8L\4_&:T^+FL_\%#[F2Y;XF? ?XQ>*O#(\9?!R#PS
MXS^)/P0T2TT'1O%&KQ0Z7!J=K=ZK9VWF74.DW6G6#7%^S)!)&L:I[1X/_9'_
M &#_  -X+_9F^'NE?M9^&=1@_9L^)/QA^)V@:G-X_P#AL)_$FJ_&*'Q:VNQZ
M\;4P7I@L3XPU(:*MH 1]DC2]\Z-5(6O]?\,9NMN[_E^/O'TCX6_X+7?\$X?&
M>G^--7T;]H:T@TGX=^ S\2O$6JZMX/\ &_A^WN?!T.K1^'Y;_1AK6@:>?$DK
M:]=VFAV>F^&9-4U$Z[?0V"6+7 "-SNJ_MT?LX?MG7OP8N/V?_'-UXG/PX_::
M^&>F^.;2]\+>)?"E[H>H>)_"^LZKIVFW5GXMT#3KRXN+BUDCDE2T6.6W:3;=
M>449#^8'QX_X)S?L-Z7\"8[#X<_M":!\7_&7P_\ V<$^"W@;P6WQO^%7P_DU
MN1/BYIWQ8T?Q4/%%QI^KVFD:[I&O:5 5FN],U#3[ZUABMKFT9C(]8?[$?A*Y
M^!V[XK_M(_'SX/W?Q4^.O[9GPT\7:WH,'Q<\ ^,M7\+^&_!'@K4_".EOXCUO
MPU:^&/#,]U>V]K!>I)I.AV,,$%U!')"LT;*NB3TM?;]'Y!4=X7?5)_.\?T;/
MZ]+9EEA1]C)G/RN?F&"1R QQ]"<CH0,5-M3V_/\ ^O7S3!^UY^S$T2M_PT#\
M) 3G<!\0_")^8,0>1JA'4?4#@@'BGG]K?]F G)_:$^$ )[/X_P#"9;\2-4P<
M]1[8K&2Q'-+E4;7=FT]KZ;7Z%TW[D-_ACOZ'TIM7T_4_XUGW@RLB(0C,DD8+
MC<NXQ[@[1DX<80J">AX[<?/@_:Y_9A P/V@OA&1ZK\0?"07\ =4S]??-5KK]
MJ[]F(I+=C]H#X0,R0[V1OB%X5_>H%GB1+C=J?E>3O<E<8RX&3P:26([)?)_\
M.5<_ J^_X+M?$S1?C/\ $SP;?_ /X9W7@WP;\:OVA/@9H\6@?%1]1^+<GBCX
M+>&=<\06OB;7O SZ.'TWP/KL>BKIMUKUK=W:Z:7=94C80Q/]W?LQ?\%F_P!D
MWXQ? .7XJ^)/$^H:%XK\'_#WX<^._B_X!\/^"?B-XDO/ Y^),L-AI$7AQ+3P
M7'J/C'3FU:6XL+G4M!MK^ULKF.2.69$&\>5?#/\ 9&_X)C_#_1?VIKJ#XX?
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MSG'^LK[&P/?\S_C1@>_YG_&CZUY_C_P1:?TO^"?'G_#OO]BCC_C&3X28[?\
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M6UO2/V;OA5::SHWPY\;:M8W]MH-F;N"]L/#%[=:2(07P5$UO,,$=,9'.*W_
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M-.T347:_B>>-9M0BD'FJLC,!O&ABI:Q=U))K5M6>JU6G7OW[!9VN:'_#OO\
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M^"??[$_7_AF3X2X!+#_B1V@P1G+=>"H)YSD GGDT?\.^OV)^,?LQ_"/C./\
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M</BC_AWM^Q3_ -&S?"'_ ,$5M_\ '*^Q%!*@E=A(R4&5"_[( .!CIBEP/?\
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MBOS-_P"'\?@C_HW7Q+^'C:P/_N)Q^M+_ ,/X? ^"?^&=_$I/7GQM89SC./\
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MOVK7$>%W';C_ ,B=_P!?-^747_$??"+;_7#_ ,U#S_Q)_H?IO_P[\_8F//\
MPS-\).N>=!M,Y/4_?')/-+_P[\_8GY_XQG^$G)R?^)#:<GU/[SD^YYK\R/\
MA_%X(_Z-U\2?^%OIX_GI-'_#^+P3_P!&Z^)/_"XT_P#^55<:\-O$:*Y8Y3[J
MT6VRT77L;+Q^\(++_C,.B_YH]_I.Q^FW_#OW]B8=?V9/A(3C!/\ 85J,@$G!
MPQ&,\@$]?FQFC_AW[^Q)G/\ PS%\(\YSG^P;;.>><YZ\G\S7YD'_ (+R>!QP
M?V=O$F1_U.^G_P#RII/^'\G@?_HW;Q)_X6^G_P#RII_\0W\1_P#H4,/^(_>%
M/V>,7R]/^,0>W3[78_3G_AWQ^Q0XR/V9OA$%/\)T*V/3C_GH/3TXH_X=]_L3
MCY3^S-\)..O_ !(;3!)YR,R9[\^^:_,@?\%X_!!Y'[.OB3'_ &/&G_UTJC_A
M_%X)_P"C=?$G_A<:?_\ *JC_ (AQXC?]"C\O\Q_\1_\ "&WO<8>]U_XPY[]?
MM'Z;?\._?V)0 /\ AF/X1D#@?\2*U' /H&( XX]L&@_\$_?V)3C/[,7PC.!@
M9T*V.!G.!STSS]>:_,@_\%Y/ XX/[.WB3(_ZG?3_ /Y4TG_#^3P/_P!&[>)/
M_"WT_P#^5-'_ !#?Q'_Z%#%_Q'[PI^SQB^7[/_&(2VZ?:['Z<_\ #OC]B=OF
M_P"&8/A(V?XO[#M!QP.[@] !SZ<<8H_X=]?L3KQ_PS)\)$(XQ_85ID9]#YG?
M.>/7%?F1_P /XO!)&1^SIXF(_P"QVL,?^FFE_P"'\7@H=/V=/$X_[G:Q_P#E
M36Z\+_$>24O['6J3W2WU,GX_>%=W_P +;J:_Q/9?5^?^_P#5[?N.;?V7_+N_
M+T/TU_X=]_L38_Y-D^$@[?\ (!L\8SC^\,<]!SG& >X\&^.'[#/['6B:K\#8
M]*_9T^&6F1ZU\;O"?A_5Y++0K/&I6>IZ=K^[3ILMD;A!G(Y (YKR3X"?\%F/
MA+\8_BKX8^&GB;X<:U\+H/%-R+.Q\6:IKFGZUH\-](=NGV]\K0P?9GFN^$;R
MTX()R""?T%_:*'_$U_9X)5 3^T+X5=WBEBFBF9]&UUOM4<D1,;1W63/&%)"*
MX4'Y37R^<9#Q%PS7A3SJ'LXU+N5.U^2[UCY\KTWMH?=\,<9Y!QO@L1BN&*GM
M,%A;K%U-+SE%/GGW]ZS?W''O_P $]?V)Q)($_9>^$D:>;*43^PK/*(9&**<R
M#YE4@-_M TW_ (=Z_L4_]&P?"3_P16?_ ,<K[(<?.^2<EF/4^I]Z:,#?_N-U
M/LG'7O\ G7DO%*[Y7[MWR[;=.O8^GIN$J<)4OX;A%P_P->[U['QS_P .]?V)
MR>?V7_A$3C)_XIRU<X]2PDP1VSVZ=J7_ (=\?L3+E3^S%\(U[%?^$>=>^>5B
M?RQSSA>_)^8FOMOP5,TGBF^LF:!XY-*0B-USC_2'SDYQSD].>:]B\FU!8?9[
M889ACCLQ'IWQFN>6*U?O=7U_X)?U?FUMOK]^O8_,+_AWQ^Q)_P!&Q_"/J#_R
M+\W4=#]_J.U'_#OC]B3G_C&/X1\YS_Q3\W.>N?GYS@9]<5^GFRU!*I;6Y?&3
MBW,GK@EA@$8P,^@P.F:/LS-\PM[8 ]/W13_QWMQ@^F/FZ&E]:_O?C_\ ;!]6
M\OZ^X_,/_AWU^Q..!^S'\(\>H\,SM[<MN^;Z9(' [<+_ ,.]?V)V^8?LO?",
MYQ\P\,1#('M(X?C_ &CVXXQ7Z=&V*]8;4#DDE2 <=<9 _/D?IE?+V<&WM^!V
M'8G@C*^_N#UQR,GUI?S?C_P1UL++#P4\3;V4HJ<5UY&KQTO?;?0_,,?\$]OV
M)ER/^&8/A(,<#_BGF3"G!QMB)0#O@'GJ><TO_#O3]B=N3^R[\)&R>O\ PC<3
M9_X%*WF'_@6/0# %?IT0F<&T@)ZG&WIV/W2<8QS_ "I46++DVUN,@ 9"\ \;
MLX ('H/7&:/K2_G7W_\ VQK3P4:D(5(?!.$9PNW\,E==;;=4[>9^8G_#O/\
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MY7EG/IMP<GOGJ?3BH+E(=DDBV\:/#&\@9   /+? .1USSDC&".U'UG^]^/\
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MI:6]S-;#X9>)&6 M$S(,,S')PV"!R*_?N-MWH"!@C.3T4\CMUR!Z'/4U^0V
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M;>BZO=]$N;7Y'] VU\[1&X/4C:22.^01Z<DGH.>E*2>FTYP>#C_'IZU^$O\
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M]I#!:V\!96\F&WC2"*/,>(SY<:*HV (,?( *5?6]MFDX[;-::KRL'9)OK?\
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M_P *-Z^OZ'_"IM\G]ZW_ .^E_P :-\G]ZW_[Z7_&@/J_]7?_ ,B0[U]?T/\
MA1O7U_0_X5-OD_O6_P#WTO\ C1OD_O6__?2_XT!]7_J__P!J0[U]?T/^%&]?
M7]#_ (5-OD_O6_\ WTO^-&^3^];_ /?2_P"- ?5_ZO\ _:D.]?7]#_A1O7U_
M0_X5-OD_O6__ 'TO^-&^3^];_P#?2_XT!]7_ *O_ /:D.]?7]#_A2[A[_D?\
M*EWR?WK?_OI?\:3"MR_DECU(=0/0<?3% GA[;1O\TOSB1[OK^3?X4A8=SS[@
M_P"%2[8_^F7_ '\6EW,O"- %'0%E)]3SGUS0"P[>\;>K3_\ ;2'>OK^A_P *
M-Z^OZ'_"IM\G]ZW_ .^E_P :-\G]ZW_[Z7_&@?U?^K__ &I#O7U_0_X4;U]?
MT/\ A4V^3^];_P#?2_XT;Y/[UO\ ]]+_ (T!]7_J_P#]J0[U]?T/^%&]?7]#
M_A4V^3^];_\ ?2_XT;Y/[UO_ -]+_C0'U?\ J_\ ]J0[U]?T/^%&]?7]#_A4
MV^3^];_]]+_C1OD_O6__ 'TO^- ?5_ZO_P#:D.<YYR.. #W'L.]!/'!(_ X_
M'(-284DES$6/7#C'' P.<<?_ %J/*!Y#0*"> 9%SCD'\>,^@SS5U_@C_ (8]
M/*(+#N^L5;N[6Z+^5L=$LCL3 \T<L022&X0D?9KF*7SHI%(.00RK@Y'4^@K^
MD']BO]L;5/VA?A]\#_A_X_COI/%WP>^/GPYMKOQ1+ T>BZSX6?3/$MK8?;;I
MC\VJV7R6D([0P1EO4_SQ^#O#7B'QCXGT'P;X6TN?7O$/BO4H=%TK2=.0SS7]
MS<E5M4;8&,$5K.SW-U.<*L'#''-?U8?"7]DW2?V4OA%^S5X)U">'4O&7BG]H
M3P7K?Q"OP%1'UHZ+K[MI5IMCR(=/#+: EBDCP-,!\^:_!?&/&9(\I>'K2A_:
MW(EAHWM-M+I=.Z;2O'2]K71_3GT9<KXHEQE/%Y;3K2X<I8=?VO.*O2C:*]IS
M:*S7O:I)6\]OV#T*ST;Q(LRZ5XGT#49(WV3P6>HB6XB,1V%6A)!\U=F) !RX
M//2NXM_"FD6SCSC+<2*%+^:NR-R5R %/&%'''7@XR<5\;^(/@+I#:S)K_AW4
M[SPWK:7DMW#/;7,MU 99)#* ]NKA#C(W*P/.01Z];;?$3X[^#_).MZ7X?^)N
ME6RHGF1)<Z)KMO"@&'7#-9W$B+P@V$,%7?\ -FOY%BJD8Q56ZJI)5$]^=+WK
M_,_T.DZ$I2>&:>&;;H-;.D_X;7_;MCZZ@TRRLF>2RLX86<8=X>)   ,G(SC/
MX=P#5J, *-K.P.3F3[^2<D'\3Q[8KR?X>?&#2OB6^JZ>-$\5^']9TNUMY[ZT
MURWMA'*1.=@M[FV5(I(U0J R#.W ;+ UZQ+CY0NW>9&8K&20-Q9D4$GJ <D$
M8!X.!6+W?J_S-5LO1'XQ?MU_'WXDZ%\;O$'P\M?B%XS^&O@CP/\ ![_A85C8
M?#_6/"OA/Q;\2]7FU!8KV*V\5^-2NCKI7AFPM[N:[T2)OM%W).60%F%9/AR^
M^)?C7]H7X2PZ;^TM\=].\(>.?V9+GX\MX6FU?18XX/$.E7&@:7!HDY_LV>*:
MPU6VOKBXO+2UE-Q<SQ2W%D4M9(:^Z/CU\#_V7/VJ_&5M\*OC5X3/BCQ1X"M+
M3Q5:PRMXA\-16D6MG[+I;?\ "0V92SU/S9;2Z!TH3-&^UD>,NK5;UV#]F7X3
M?$K1-8UF.W\+>(/!/P8O] TOQ%J<>N6WA'2?A==7>F:1>1MJMQ:#0[C5KB:.
MP@M+6358;KS _E(6&#\5F&75:M>M/$X^4*,JU5TX.<8I0E*Z@VH)6A'W8ZM]
M9KXK_P!1Y%Q]PEE_!N58'!9%G6%S"APIGE/,L'3X0R#$T<WQE'#992J8^AB<
M3D6)S#$8'&XCFJXC-95)YI2K3^KX"=;!2YH_EG_P3[_:W^*EW\5H+?XS_$3X
MJ>-- \7^"-9O=.T.]TZU^)YO-:M?$D]I_;.CZ;X*TV35O".DV=E'%'-9>*=@
MEE5KEE"-D[OQ6_:9^-GPA^-/[0Z^%?B;XXU3P]<?#;7M?\%Z5XMU#PEXOM;+
M7(-?TJ$^(-#L/#"+J/A+2O#UIJ7V;4M(\4Q1^5*]LQS$A)_0#]E7X _L=_!7
MQ7\1?$/[/7AIO"_B+2[Z+P]XJU*YOM<^PNNH0V.LC_A'K_Q)->:9J]JUI);P
MR'29B)I'D="=PK5^&O[,G[&FE^.OV@#X+T'P_>?$;QC87>C_ !MLU\3:MK5S
M8VWB28ZGJ,=S9ZC=0KHRZ@+I;MFLC''$&C1 1$A&%#+<?4R2O1I9@U"&8U*=
M/6+<8PE*$;>ZG>23NNF^KBV_<SWQ,\/J/'W$G$-7P]XBAE\<AX=P>.I3X*X?
MP]*,FL"JD<>\)P[)Y?3I*=.&$J95S/'.<*>9>R6(E%?DE9_M%?$1OA_X"UV;
MXG_M%KH'@/QEXHL/C7JEM\2OA?!XZ_M*\_X0ZZ\.67AZ9P^C^(/":6M]<M=>
M'O#MI?Z] UT]C(\=U#)&GTG^S'^T7\7_ !O^UOX;@U+XG:YXDT/XA>)_B]X8
MUGX4:S#IB6GP_P##7@:TL/\ A$M:BTI&?4-.O-6DBLX;Z2X93->ZK-<"*%66
M-?H7XF?L=_\ !/\ ^!W@[X?>-?&?@B/1_"'P9\0/K/@^\@UWQ'=QQ:YKNNVM
MTLVH6']HS2>(8)+WRSY\BW$48D$(8+& /:]9^'7[*_[,.L_%']L/5/#J>%M;
MU[1+2U\=^,M,_MG6IQI-\]E%;V=MX>M#J)AU+[1;VAD6P@CN3;/']I!FSBZ6
M4UYOVD\Q:E07LOXD4U[-J,V]M5R--2]UMSGNK+IS?BW@K'Y#FN!RGPWSG$XS
MC#!9GPKPA*MPQD4*^(3SEU\PH+#4U&G3J*GQ#[2?U6G2GAX0PV#ITX4TXGY#
M_$CXW?M=7?Q+_:?U/X8>./C1>>&OASXK^+=GK\MQ'I[?"KPGX&L_"%S=:6^E
MWKV$]_!XPT_67L[FSW2,8XV8*/*V"O?++_@IO\2? 7PU_LCQA\-/!]U\2/#.
ME?#V33_[:\9ZLL7Q T7Q5X(D\1MXBN+W3/"&KW]AXHOHK'[2UM#826[3.RO<
M1$\?;OP5UW]E/XOZ9\5? 7@#0_$AT/XU0:UXT^*%AXB\*^//!EMX@M=>A_L*
M_!U'Q1IVFI827=Q%"UCIMO*+F]CC:YMY!!*@JM\5_P!DK]B4Z'=>(_BGX?T"
MPT.P'@:WOM4O/$M_;113^%83H7AEDGL=4E9+;3[*>.V2()_I0D:*<O)%+BZ&
M7YC1^LUL'Q(J<IU)U.55:;C!.525G%<S]U.,9>\DK*ZMHJQO%G V=Y_EO#W%
M?A#1PV!RC%9*Z<LOPF(P?$E>&'X>PN'3CA,N<<LKSJ5,'7J*GC:?-5E.3OSM
MRE\GW7_!5[6HO&?P[T@?!;2]/\&^-?#'AW7-2\8:MXNNA<_:-9T:+5+KPYHE
MOH_AV_9]=>\D:UT^;4KG3'E5DDG6U=O*'TS^Q;^V+XG_ &L_^$[MM1^&A\!Q
M:!I^G:UX:\0Z5J$VN:?J]GJCSBSM-6CU:TLWC\4:7)9R2W<%HUW83PFYC2Y:
M82QQ=%HG_!/7]CG1/&GASXG6'PO@M]:\.6FGV_AS7)O%&O7=LUK8:>FG:2+7
M3[F]71[N.33DA^SW6U692LKMO#$^G_ W]F']G[]FK7?&NN_!_P -6_AC4/B?
M?6.I^+M_B"^UB?7;K3;S5;ZS&F6U]JIL-/BLY]3U%KW^S4\ADE@BR67;7H92
ML\J9ARYAF<I8?ZH^63E']XN1>^G&.JD_>BDKJZLY7/SSCW./ C%<(YI@>&O#
M#BRAF6=2RO"O$9M3Q[J5)9?C8UI5*.2Y0\1A&W&G'VE+&^SIJ4>1QIQYHKYY
M_9/\<?%PQ_MH:;XB\;7/Q/\ %OPS^)&L6'@:\UR"WT73V^Q^%K;5+'1[?3+6
MRN$TS3EOITCL[8R;KJWC5VP),GX\^&__  4'_:$\5_!O1=&UOP7X*U?Q=XB^
M'_Q<\7:MXXT'QFNB7N@>'_"&JWFG275A97?ARYL]-UK3XU$<=D7\T-81W+ "
M<9_3/X;^(OV=/#/B[6=(^'VK0:GKOQI\=>*)->N-#35];TRZ\<^%]#E3Q*VN
M7\%G/8^&9+2VMXEBMKR\V7D3QBU1'!<XOA?]B7]E3P++J4_ASP/IVF#7]+\9
M:!JKR>([ZXM9;#QXOF>)K>R$NJR16ZZA>6XN) SB2Q\W+)&DB@S4PM?%THQP
M>:3G&@VHJ$[^[&I5E%*ZE>4>9+?1-V[+UX\5<$3XBSS,>*.!L_KT\7C.#L7E
MF!JY!5RN--<,Y9EF$G3_ ++PE/#TL%"=2A7J5*5.E'VDI*<TZE:I)_G-<?\
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M_P"Q]\=?^JR\3U^O,?1?^!_^AU^0W_-R_P"R5_V/OCK_ -5EXGK]>8^B_P#
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M=H7CB[O8O FFZUJTEK>'Q/!$UU<6UO Y=O)0"Y>PQ/PU9WT22J277_&M%O\
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M''=72JK331@RREB7ZU]$]N.>..>OX_UKAZFQ\U?%9)W^/7[+?DHTF-5^)K8
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M1/4_\UX^)WK_ -A^FL3'NGZ6_P F;^PNE=VLEY=%V?YGF7E2'!VMQT^6?O\
M\!KYYT^.Y3]KCQ(R1S*T?P#\ 2(Z0L&5U\>^,RDBMM!W+@%7/S# .:^US_P3
M_P#A((R/^%@?M"@@ #'QX^)F[@#_ *C_ %//;-?*VD?L3_#&Y_;#\=^%CXU^
M/*VFF? /X?7T5Z/C?\2%U*X.K>-?&*RP-=#7!*UO8G3%>)&8K$;R=@%,I:MU
MBE:VR[6TV[;/[C%X=W=K]>K[]NQZR(Y2$R/N$.@*R#8XV?,%"X5OW<><#JBY
M^Z*:QN-[-MRY01&0Q2ES$LAE5-^TML$G[P*&V[_FZ\UZ<?\ @GY\)'.X>/\
M]H@!N<+\>/B;M&>PQK^,?3BI1_P3[^$>!_Q<']HCH/\ FO/Q-]/^Q@K%XI?S
M-6ON_P MK&GU6*6R=]](O\T>5YGSG8 >.1#*#PYD )" D>82^"<;_FZ\TW;-
MR?+&2<DB*8$GU)"YSR?S->K_ /#OOX1_]%!_:(_\/S\3?_E_1_P[[^$?_10?
MVB/_  _/Q-_^7]+ZROYE^)7L'Y_A_F>5>7.>?*!SSGRY><_\!H\N?_GD/^_4
MO_Q->J_\.^_A'_T4']HC_P /S\3?_F@H_P"'??PC_P"B@_M$?^'Y^)O_ ,OZ
M/K*_F1BZ#N]]WW[OS/*O+G_YY#_OU+_\31Y<_P#SR'_?J7_XFO5?^'??PC_Z
M*#^T1_X?GXF__+^C_AWW\(_^B@_M$?\ A^?B;_\ +^CZS'^:/X"]A+S_ !_S
M/*O+G_YY#_OU+_\ $T>7/_SR'_?J7_XFO5?^'??PC_Z*#^T1_P"'Y^)O_P O
MZ/\ AWW\(_\ HH/[1'_A^?B;_P#+^CZS'^:(>PEY_C_F>5>7/_SR'_?J7_XF
MG^5+Q\K=!_!,,'N!A>GI7J7_  [[^$?_ $4']HC_ ,/S\3?_ )?U"W_!/SX1
M9/\ Q<#]HGJ?^:]?$WU_[#QH6)CWB_Z^8?5V]T_O?_!/A_\ :FBD_P"$*\!@
M@#'QW^!;?,D^-Q^)'AX _=QGD_0BL;XB_L&_LH?%;QEX@^('Q#^"^@^(O%GB
M25&UK7;R^\06DDTELJ0QW$_V?6(EEG>&..-=L:*(U1$5$55'J?[6G[%7PP\*
M>"_A_J5CXU^.-P;CX^? 73+D:M\:OB/J,!@O?B7H.G9M[>?7WAANHWG61;H1
MK(LL:2;PR@U]3'_@G[\)#P?B%^T0PR&R?CU\3CDCE6.?$'4>OZ]Z]7#YS5PC
MYL+5KX>;BE*6&JUJ$W9)6E*A4HR:_P 4F<.99%EV;TX4LSH8>O2I_P .&(P]
M#$0@[:N$,11K0B^K<8Q?=W9^9O\ P[)_88;YA^SSX78-R&_MCQ4N[/.=IUG(
MSUP>?6C_ (=D?L,_]&[^%_\ P=>*?_ES7Z;G_@G_ /"9CN;Q_P#M$,6Y+'X]
M_$[))ZD_\5#U)ZT?\._?A+_T/W[0_P#X?OXF_P#S05T?ZU\1=,_QJ71/%XYM
M+HFWC;MI63;W:N>3_J#P;_T(,%+^\L!@;/S7^Q;/=>31^9/_  [(_88/7]GC
MPQZ?\AGQ3VX_Z#0]*/\ AV/^PQ_T;QX8_P#!SXI_^7=?I:W[ ?PGW$#QY^T/
M@$@?\7\^)8Z<=_$.:3_A@/X4?]#Y^T/_ .']^)7_ ,T-/_6GB7_H?XW_ ,*\
M;_\ -I'_ !#WA'_HB>'9?WI3H1E+^]**PUHRE\4HK12DTM$C\T_^'8_[#'_1
MO'AC_P '/BG_ .7='_#L?]AC_HWCPQ_X.?%/_P NZ_2S_A@/X4?]#Y^T/_X?
MWXE?_-#1_P ,!_"C_H?/VA__  _OQ*_^:&C_ %HXE_Z'^._\*\9_\VA_Q#WA
M+_HA^&__  91_P#F8_-/_AV/^PQ_T;QX8_\ !SXI_P#EW1_P['_88_Z-X\,?
M^#GQ3_\ +NOTL_X8#^%'_0^?M#_^']^)7_S0T?\ # ?PH_Z'S]H?_P /[\2O
M_FAH_P!:.)?^A_CO_"O&?_-H?\0]X2_Z(?AO_P &4?\ YF/S3_X=C_L,?]&\
M>&/_  <^*?\ Y=T?\.Q_V&/^C>/#'_@Y\4__ "[K]+/^& _A1_T/G[0__A_?
MB5_\T-'_  P'\*/^A\_:'_\ #^_$K_YH:/\ 6CB7_H?X[_PKQG_S:'_$/>$O
M^B'X;_\ !E'_ .9C\U!_P3)_89/_ #;OX7&./^0QXH.0.AYUJH_^'9_[#:%P
MG[._AA]H'RG6O%( .,X &M<>_3J>,\U^FR?\$_OA*ZAO^$^_:'!Z$#X]_$SL
M<?\ 0P'GZ4C_ /!/SX3 ,1X__:&!P!D?'CXF;NP^]_;^?\]*I<8<1QT_M[%Z
M:?[UC.G_ '.E?Z@<&I*_#F7P?6G3P6#J4Z;7V(3>";G&.T9-MM)-O4_%?X7?
M\$]?V/M?^)'[1>CZC\ ] N=.\(^/?"ND:!&VJ^)E@T*QU+X;>%-7NT7.M![A
M);^^NKG@8229L8.37N__  [+_899G/\ PSQX7.UWC#+K7BH[]C% XW:WE?,P
M7"Y&W(&/3W[X&?L4_#'6OC1^UCID_C7X\*OACXJ^%M'M)K3XW_$FVNYXKOX1
M^![]KC5+J/7E>]EA>[>."2=G,,:Q1H J!1]:+^P!\)"H#?$']H=BH(9V^/7Q
M-W,5."21X@Y8X))S\QR3ZTZW&'$2A'_A?Q=[)W^N8SJE?_F-6VWK>S)H\ <'
M*<G_ *OX.S;T^H8'^9V7^X_A_2_,S_AV3^PR>O[/'A@8X_Y#/BCT_P"PW_C1
M_P .Q_V&/^C>/#'_ (.?%/\ \NZ_2YOV OA,K$+X^_:'8#O_ ,+[^):Y/7H?
M$.?\_6F_\,!_"C_H?/VA_P#P_OQ*_P#FAK./%7$DDG_;^-U2?^]XWJO^PT<O
M#WA%RDUP5P]45W:I4E0A.:N_?G!89*$I;RBDE%MI(_-/_AV/^PQ_T;QX8_\
M!SXI_P#EW1_P['_88_Z-X\,?^#GQ3_\ +NOTL_X8#^%'_0^?M#_^']^)7_S0
MT?\ # ?PH_Z'S]H?_P /[\2O_FAI_P"M'$O_ $/\=_X5XS_YM%_Q#WA+_HA^
M&_\ P91_^9C\T_\ AV/^PQ_T;QX8_P#!SXI_^7='_#L?]AC_ *-X\,?^#GQ3
M_P#+NOTL_P"& _A1_P!#Y^T/_P"']^)7_P T-'_# ?PH_P"A\_:'_P##^_$K
M_P":&C_6CB7_ *'^._\ "O&?_-H?\0]X2_Z(?AO_ ,&4?_F8_-/_ (=C_L,?
M]&\>&/\ P<^*?_EW1_P['_88_P"C>/#'_@Y\4_\ R[K]+/\ A@/X4?\ 0^?M
M#_\ A_?B5_\ -#1_PP'\*/\ H?/VA_\ P_OQ*_\ FAH_UHXE_P"A_CO_  KQ
MG_S:'_$/>$O^B'X;_P#!E'_YF/S0/_!,S]AL$@?L]>&5 X &L^*0/K_R&^_^
M?4L/_!,K]AHG)_9Z\,D^IUGQ0?\ W-5^G"_\$_?A(ZACX]_:'!.<_P#%^OB8
M>AQU_P"$@/Z<>E._X=]_"3_H?OVA_P#P_7Q,_P#E_5?ZX<2)<KS[&.VFN+QC
MVTZXU]BEX?\ !JWX<R^D^M.G@L%.$'_)";P+E.$=HR;;:2;9\$?"_P#8?_99
M^#GBRR\;_#/X*>&O#GB_3/,.EZPMQX@O);/S$\N5[>2_N;J".1TRCM&^2"%;
MG(K4_:'29]7_ &=VD;+G]H;PKN++(,,-%UT!0(U5=JC"H<<(!QU%?<0_X)]_
M",E@WC[]H7 P>?CS\3#R .?^1@'/N>!^E?*/[3O[%/PT\,:K^SJ]CXW^.-P=
M3_:$\'Z?,=4^-GQ'O?+@;1O$.Y[/SM<?[-=_PB:/9( J88 "N2OG>(S*2_M&
MK4KN&BK5)U*LF[?$I5*E22O:_NR5K^A[> RC Y%2G1R?"T,)'$1M*G0H4,-S
M1>T:GU>A051*]G[13NKW/8)HI$FD"Q*/G8@^5+GDDDYVDYR3SFA4FY8;@6&&
M_P!<N0. ",9QCUZUZ?'_ ,$_?A(T:$_$#]H@?*H_Y+U\3B3@8W,3K^2YQEL_
MQ9YIK?\ !/KX2%CCX@?M$]NGQY^)WH/^H_7ESQ%-3GROFCS.U[<S5]')OF;?
M>[;ONST(4)*,4_=:BDU&T8II*ZBHV22Z)))+HCA? L<B>,]49H&V#0(RL@5@
M/^/CDC<N<@DC/Y>M>PGR=Q8)+DECD#GD@G)R#Z#\".>M<)I/[//@_P"!7BV_
MO?#/B;XE:R=7T!8+E/'/Q#\4^,TB/VAE3[#;Z]?WH@? RS)M!)_/N79ML7WU
M.<$-P3@D9(!P-V,\?CS7+)WDWT;;7SU-Z*L[/6S:U=]N;U/RI_:G_9#^,OQE
M^-^L>+=%AAD^'FL:C\"/MF/%<FCWG]A^#O$^HWGCTB"!UECO'T*62*P;.\R'
M<A&ZOE7Q%_P3E_:)\1>"O$/A6[AT"YTBT\">/--\$Z1JGCF\NHVUK4/BI:^+
M/!^FW5Q*SN;>?P_:_9A*QQIUW,TJ;"2U?2__  40_;%\??"BY\5_!GX<1Z%X
M:U>3X6_\)[JWQ!UKQ6WAW6=)LY-6CTS3T\#65O#G7-8^U+,EW;RR&2U@<R\1
MR*#PN@_\%1/'T>JII+?";P_XAT>WL_$WAC3V_P"$\5/B1-XH\)>$M*U'4-9U
M[P]);6&G:=X6UJ_DF-KK$VKJSVTML\<;&0)7Y_C:.4U,7BOKV)<%]8K.5ZD]
M+S<''6=N6.EDH^Z[63M=?VYP;C/'FEP7D6:9!EW"M?+I87 91DL\16P[Q-/#
M4:-)82I).#J8?%U\-&-.LXU(RG3IRISE"/)&7A_C;]@;]KG5/"?B7PYX8\#^
M!=#\/ZKXDM_$6D>'IOB',=1\%+;_  WTK0+#^P-1!-K*VF>(["^:YBOTDD>[
M6&:#&(VJ+Q5_P3L_:<.K?%F]\'Z3H46I^/O#OPNU*_\ $,?CS4([[Q9J6B:)
MI]I\0O"FI+!%>+:V&KZO;ZCJO]K2V\A,2K"BF&6,5ZCH_P#P5J\;:K!\-H-/
M^$O@[7O%7B+[;J/B_2]'\4ZS!9Z?:V7BZ'0$T#P[?W/A_=?^++-H9+G5(+Z*
MVT^<2QNFM26IB<]5\(/VU?B9^T#^V'\'M"@MK'P-\.+G4_C9H7_"":=XN$^O
MZO+X2M&T=?\ A/=#LTAGL+N'4K&9]+&GSF&18%NA+*\AD;'#X7AZMST:2QLH
M<S;=/$XB,).[C[11C7C&TFV](ZIQ2;2NOI/[8^D;ET,;GN:9?PA&AD_#^;9S
M5AB,3"K3K1RG,J5"M[:-3VSKSG+ANO.3K1J.3>)G5;G7FJGS-XM_X)W?M::K
MX<T#0KO1M*\26BZ!H^B:-;>+/B]?ZI/\*)[+Q>NN:E:Z;;6UEIVG>,-*O=/5
M8;9]0T]9K;"PLTIC,C?I=\5?V>?&_CW]C?XE?!WP]\/=*^'GC7Q7K\]]!I*?
M$";7-/O!/XBCU&?7AK,I-WI>H^((S<ZD+2V*K9&1;)/EMT \4\>?\%,_%7@W
MXI>,O"ME\+?"UWX/\-^+/&?@NS>3Q7/#\03K_@#2KW6Y]0O_  M)I=U!8^"+
MS^S5M+;6&E>=XYUE#9EKV']G3]L'XA?&BW^,MKXL^'7A[PAKWA+X:>'OBKX+
M3PYX@N_$-EJUCX@T75[_ $^*ZN3!;+:7274:(BR6Y21G+$-O)/HX/^QL+B,9
MA:%2<I3PK?LYU'4G!N+3NYN;YW=^\Y.3=T[61\1Q5+QGQ%+A'BS.^'>"LH7"
MV=_ZT99C,EQ&'J5\1ALUQW#&%IXBKA*/)3A5KO&X6KBX4\-2O5<9U7B*LIS7
MS5\4_P!@#XP7>N:9I/@/7?$VN^!AX0^&>DZC=>*/B/J!\27&I:1X^AUOQA#%
MK,\SWB:9%HQNK'2WE=X7MO+L[-(9PSGQSQ[_ ,$W/C9X@U']H>RT[P5X=3P1
MK-SX7U/X<Z=XL^)FK:UX@U&+PSXDLIK/3K75A(Y\+Z%J&AV=WI\<&IM/=6.I
MSO-$0'R<7X>_'']H#Q=\+/V@KO0OVEO&EYJ=E^S5:?&G4M=$OAW5KGX9>/;F
M[U]KOX;Z1,+1;31AJ5CI?]E+#+BYT^.S-[\DESN/V%'\8_%7CC1/@YI5W\6?
M$?PY\,?"[]FZ+XU?M _$C3+V#[=%)XG\.)IWA+1Y1>":&]O\#6?$4MO.C0I/
M8V$L2*K1&N&AE^45,/+$5,+BY.ES>UE&K4C"=1N2G9PJJ+3<N9MW6NB;BTOI
MEF_B9PGC5B*&?<(8S%X)_5*V!7"^?RQRK0AB.(LLP^9RPU"E3Q.,><8K#\-U
M9\L_:0SO!8?F^JSP])7_ -NKPEXJ7X&?LM^!]&\&O!XAD^(/PZ\*:CX*A\4:
MTME*8]$^QW/A&\\6:&4NI=':Y0V8UF[/DO-MEE^;FOD$?L!_MFPW/PB633?"
MT>F^&+ZRU2">Q^(>I2ZGX&T74?&U]J^M^ S]NDDFUVWLM OK>")XGCNKBXAF
MRS!4%>T_#OQ5\9-7_9$_:-\8>&?V@/$<MM8/X@\8?!_4_$.H^&O&7Q<L_ EA
M;6UU;6^MW=NLD6CZGJ\L5U/9O>2FYTRVO;2X 1XTV^@V?Q?\4^//"WP+T"?X
MN>(/ .B_#_\ 9CT3X^?M _%+2+X2ZO%-K'A5[;PY;ZS<7>ZVO[MY5UCQ*\2*
MRS76G-;R0LD@,F\L'@JN)P[IX7'*G++J:C:OB(TW'DE:3M52LGLVDFE%I)JQ
MS9#FG&'!6&GDO#U7@_#8[+*_&67YSFF-X8QV(QE7&9G"&>XG,JE+%4)UX8O)
MLRS:'">24?:U*^)Q5?V,YUHJ"7S58?\ !/+]H_P]<^+]#\"V&B^ ;>/QC\<;
M[3/B#IGC;4)KS4H?'/AR^L?!T_\ 9T5O)?6%W!-<2VC&:=OLTUU;W"#= N(_
M W_!.S]HR;PMX=T3QSI]SH>C6VJ?$*^UWPQ)\8!J>G@:MX'M;'13H,UC;V=W
M;W6H>)8K274=-E!66[2[OI9));IR?/+[XV_&&W\):+8/^T_XY\(_"[Q?KOQ(
M\:_#?QWK7BKPY?\ Q).F^&/!\E[X2T/QAKBQW%E:)XHU4'6+/PS<@:C)87R6
MUML:)57U3P)\;_B[\2O'.@7?@']H#Q-_PEX^!(U3XN^"_$/B/0?#O@#P[XNU
MOP%#=^%_#?@O1=7%IK<GB6#4'E\3:WJ7]H@:5&Z^?B"6-*\6BLAH05.=/&TJ
MD.:$X0Q5>FW)5'>T(5H<UURR3LG*+<GLSZC-\9XHPI\]?/\ @BMB*U7 TZN)
M?"V,JSP]:EE^#P]>G7Q53"5*F'KT\1A\3AL;1=27U?,(8C#6;=U]&?LE_L?_
M !9^"7[1.C?$KQIX:T+5#JWP&\+>%_&'B\>.)YM<\/\ C?1[)[2\L+G0[XR_
MVO::Y;QVEE%?"0BW:T("J22?U><1FSN7B(>.6!G5RCHY/D,LB2JQSO@F62W!
M3".L2R*/G.?SG_X)L>/M<\;> OB+HGC77OB-XF\>>$_%5O9^,#XZ\8:'XXM[
M6:YTBSOIAX1\4^'(8M+OM)F><7)L$DN;JTEDFM+B9O*1$_1R=&EM[H<O#+8M
M 9-Q@#I/:I&6AVXD@N($.5=2K(_S*022/T;AN=+"X7GH.I]7Q5/FH^TG.<^2
M3DO>E-N4FI1DG=MZ-7:2/Y(\9L=GF9\:5\#Q17HO$8*FL)&M@*-3 X3'4J5&
MC.FHX92BWAFJR<*5:,XV]]THN3BOG30DE.EP;8\CSKWDH[?\OD_ VKC\, UK
M^7/_ ,\A_P!^I?\ XFNW\-?L&?"74-)AU&7QW\?(I=1>:^ECLOCA\1+2S26Y
MD:21;6VLM<BMX(0Y8)$D:A!P!W.^?^"?OPC;D?$#]H<8XX^/'Q.'OW\0=>:]
MCVZCI=*UUK;NW^I^-K#R2M91M=*,5RQ23:222BDK):**7D>4^7/_ ,\A_P!^
MI?\ XFCRY_\ GD/^_4O_ ,37JO\ P[[^$?\ T4']HC_P_/Q-_P#E_1_P[[^$
M?_10?VB/_#\_$W_Y?T_K,?YH_@'L)>?X_P"9Y5Y<_P#SR'_?J7_XFCRY_P#G
MD/\ OU+_ /$UZK_P[[^$?_10?VB/_#\_$W_Y?T?\.^_A'_T4']HC_P /S\3?
M_E_1]9C_ #1_ /82\_Q_S/*O+G_YY#_OU+_\308Y@I8QXPV"=DPQD#T'TZ?X
MUZK_ ,.^_A'_ -%!_:(_\/S\3?\ Y?TQO^"?WPB'!^('[1)[_P#)>/B:1Z?]
M!_KQ1]9C_-'\P^KR\_Q_S/G<1NO[2?[)>Y-I_P"$]\<GA&'7X9>)CR6 /K[8
MZ5^N<73_ (%)_P"AU^5OB']ESP+\'/VEOV2_$?AKQ3\5=9O)O'/C:U-OXW^)
M_C#Q7IL:?\*U\5$M'IVNZG>0"8Y&'6,' Z^GZIQ#"CKD[R<^I8=!Z>F>?85-
M:2G&,EU2^].5S:C%PERO=-?C\[DM%%%<L/A7S_\ 2I'6%%%%4 4444 ?E1\;
MW6#]MGQ!=N\44</[,^@S2O(%)58/&'B*;?SU,85F!QPPR.>:^!/AI^V_XY^*
MD>I_%;3/@+/H?['ND:GXITZ\_:!\0>/(Y]4N=#\'Q7L&N^*+#X?6VBR7@T&X
MU72S;6!CUDW.5"HO %??WQQ@AN/VUM;AGC26&;]G'0X94< J\4GB_P 1HZ'/
M8JQ'MFOS,B_X)S>-]!\*>.?A1\,_VP_BQ\.O@3XIU3Q1?Z!\-]"\*^';ZY\)
MMXNO9KJ2WT;QQ(J:M<:'9ZQ<3WL?A664745M-*P<+(U>_A%;!KUW]?Z_,\C%
M?:_KHSZ$3]OO]D&7P58_$:'XZ>%8/"&M>(;KPG9ZE<6VJ@)XJTG3!K,FES:;
M%H)U8?\ $K5;IHVC(S\Y)ZUH^&OVZOV2/%<'B"Z\-_'[P+>0^%_!P^(.OW%O
M/=VEO8>"1 (1J(N[ZWC.H2_VB!;?8K(R-]JQI>W>!'7RK\/_ /@EKX=\#WV@
M:WJ?QG\1>+-3TKXMW7QAGO\ 6O"6B6"ZSJ%WX(;P-<:=#;0:ABV26U;[3+$5
M D;YG!)R,BY_X)$_#/4/ VB> ]5^*'B6YL-!^#'B+X41WMAH6DV4UQJMW\2]
M3^*FB^)7FBU&.26Y\,:M<6VGW^F.7L]32)(VW ##5'*TURUFD[WM-QMHVGI)
M7N]+=-Q*>*L_<6RLK;^NG;5;GN>N?\%"?A=<ZY\';'X2SZ3\4O"/Q5M/C*R>
M+K;Q!>>%K?P=K'P>\+:IXTU2SU[2-4TA[J'^T[O3XK6T62'FTGM=116"HQY?
MXE_\%,O@K\)_@%H?Q,U:_P##-_\ %7Q+X!\/?$7P_P#!G0?$UY?+=6/B35=,
MM(67QE!HK6D)MH[JZ&GIJ^D)/J0AV1:4P&ZN=\*_\$S-%TAO 6JZS\7IM;\3
M>&9/C'+J/B+2/A_X;\-7?BR7XM_#!?AD]SJFEV-W%;&?PI8HDFE2RJTFL!1]
MI=BH(XCQ'_P23T'4/"J>%="_:'\8^$M!UKX-_"[X2?$33[;P7X8U&/QKI_PC
MN?M/A/Q''J&MV]S=Z!(9!_Q,+>P*%F)+9/%"I9:[WK26BM>I+N[[2NM+:=Q7
MKZ?NH7OK[D?*WV+=S];M&U";4]'T?5) UH=;TO3]6>V8F=8'U:%3"P&  \:.
M41PBG;D +G U=[G82[DIC82S$KMC6(;<GC$:)'Q_ JKT K+TC3AI.D:+I44[
MRK8:5::<)RWSN+.-8[=B1]T(J9C &(RWR@5HCH/H.O7\:X,2[7LVM]FUW[-&
M_+'^6/\ X#'_ .1%!(D\T$B3,A\P$A\R_P"L.X'/[S^/^]WIS,SN'9F9PP<,
M6)8,&+A@2>"')?/]XYZ\TVBCFEW?WO\ S#EC_+'_ ,!7^0'EBYY8G<6/+$^I
M/4_T[4444BCSBWS%^U+^RP3P?M'Q@!/\05/"2;1G/11]WD@'.#7H7A%?'WPK
M\:?%[PGJGP=\2>,=:^)7Q+UCQCX+^,.GZ?H6I^');35;*WM_#%IXFNCJ*:GH
MTW@R.&UMMUUIL\,FGZ;#-$9;N<*."LOF_:F_94W -_IGQ:'(SPW@Y2PY[$\D
M=">M?5&N_MF_L[^&M5LM!\1_$"&PU'^T_B19+:R:%K/S3_">V&I>-Q<J-,9;
M4Z/9[+B DI_:Q"2:>91@A8JZE)7V=M+K;F?3S*PSNE?SW\^7O<_.G3? _P"U
MEJ?@'Q99Z):?M#:!X\U3X-ZGI'Q<U'Q7\1I)=-UOXM7OB+3;>QU;X1W$NNBT
M\.Z=!';>(G^WZ'!X<L8M#NM.F$"W"1(FQXE_9_\ VG_#?B'4=<^'FO?'C47\
M-?M)>"I/!=GJ7Q?O;W2M0^#%UX$\-WOC2WU.PUWQ'/8Z]X;?QNVM1K#>))XK
M.R>*PN%TQK9%^G;O]NOPK;:OH.A:=I&N>+KSQAIOQ=U;PWK>F>$?&=GX:L%^
M%KK<6NA^*?[1T6232KJ5;F$7MVBQ$SP;@'0H#[%^SC^U'X!_:,T&PET,:E9^
M+X?#/@SQAKWA_6_#/B/2;:WL_$]E<3V6J>%;KQ#9:0_B/1I;BWO+:WU_23>6
MSFU*(OR[1S?6*^'MS4XR\I1BT]WK>+?E;MNCH<:%=:/J_A=GV>S5N]UUV[GY
M?Z#\#OVB_#>A>-M-^'WA;XY>!_&LB?M47GBR_P!4\;3R> ?%FA^-=1\7:O\
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MX7RS'_PF_CLMC)QN:.%@1W!!Z\5]OO\ Q?\  OZU\36-JDG[<'Q*5WC1+O\
M9K^&]NBL,D,WC+QXKS,3GB-ID(/\.21CO-#KUTV^;]3-WNM=+*_S;.K\(?M/
M^!?$7PFL_C'KFL6_PZ\"SZMJ^B76L^,+ZQT:RT^YTKQ%J'AE;K[9=SBU5;Z^
ML@+*WD9_.BNK6;9%ME4=U:?'3X:7FGG5[#XD^#KS3EMO#MU),GB+3)H57Q:T
M5OX58W-MJ$\$9\5":,>'XF9QJMQ(JVWSMQ^:&L_L-_&Z_P#AWX0^$FK^+?A[
M<:1\*/B?XC^*G@.73]3\=^&;_P 3+X@U+Q,FH:!XINM U"Q.GFVTKQD19WMC
M>3-=:A:QS-9QQRS(NA)^P1\2-.ET_P /^!O$W@CPQ\/]:U#X >(/&MCJ+^)?
M%NNZ=KWP7\<VWBBYT_PYK6M/+>W^E^(X5^Q1:GJ$PGTB2)C CJZB/1PPUW[_
M %>VV[\_ZV)YJ_\ )=;IV^[R^=_.W0^T_"/[8?PA\2>"KGQEJ_C30O!?V&QU
MS6-5T7Q;KNCZ'K&E:1H'B.X\*R:[J5E=ZO"MCI-SJUC)!:SR7'E3-<0*Q5V*
M5TE]^U'\$["+0[M_C7\+T@\5VMM-X8DN?&>CH=>6[U*7386TM([R2.Y\VY@N
M8K%(#(][>1R6GF0/"U?G&_\ P3;\::+X'\?>!M-^)>EW^D>,_'6E?%[4-1O(
M->L?$D?C31O'D7BFP\-P:SI5[!K5GX!U.Q@2P_LN"Z^U:'J;7%]I1>%A8Q=+
M)_P3>;7/#7C?3)7\%Z?=^._ /AKPQ.MPNN^-;:QU>R^*.M_$/7M4M/$'BR2^
MU:2UU:#4X%CMWDV0:@OWL(H$_5</OSMWU6[T>NU_Z["YZ_\ (D_Z_K5?E8^_
MM#_:0^'GB:;P[>>$_&WA3QAX1UVW\3K)XMT?Q;X:N])L;CPI%#+J2S-!J<5Q
M-) DMQ_:/V"*\.G);1R7D=LLH8]M\-_BGX1^*VGR>(/A[XV\->-=!$ITV?6/
M"6KV6N::FHP1E[FPCO+74;B&.]MQ*EVZ2P+(UL\8 <8Q\%ZQ^PWXV@\6>*_&
M'@/QUH_A'4=1U'XGZIH9'AL7%OHI\=_#OPKX-MI8[1'6VFDL-5\+C4Y[0(L%
M['>+<;'N(AGT+]E/]ECQE\%O#GQ=T?QMXP;4T^+/BA=<$?AWQ#XG:\T6TG\$
MZ3X8N8--\5:YJ$NNWFISW&D_VG:W:3VZ::)!;V'D1Q(M+ZK0L_?>O2[_ ,_U
M*N^M_/\ K<_12(EHP2220.N0>@ZY (/KP#[#I7Q(_P"V;X*'C7X^^$(](\67
M%U\"?#5_XGGODL[)=+\?V.D6EQ<>(+/P!.;]1J>H>%[OR]%UY+A(EMM2D@B;
M!:O1? GP,L?AB^L7WA+Q=\2-5UG5M&.EVK>/_B!XR\9Z3!=HD@@NH]/UO5;R
M*SEMR@:>:*.)[D<,Y8DGX:/_  3DUW2?#7AO4-"^*?B!?BK+I7Q4TKXF:]K/
MB+Q1J?A3Q/;?&*TU2\\;OI?AB]O)+'0(H_&<VEZYID6GQQ(T>DQQMDS;P^6*
MT25EILM;65]NMKA5;2NK[+OV\FNMCVZ\_P""A7PF@^"/P1^.4.F^*;K3?CEX
MN\)^!?#/A:SMUD\3:9KWB;68]&U6WU>Q\QDA/A:^6<:M.Q>VC$21P2,+A-WT
MW\%?C/H_QM\.>(_$NAV.J:5!X;\?^/\ X?30ZP%AFFU+P%XDU#PUJ=[:HA82
M6-S=:?-+:F0AO**$\'C\]++_ ()S>(--EN&A^),+Z391?"6_\*>'IM#>VT;P
M[XI\-ZUX.U/XH:W9QP2@))XZM?!FE)8I"J?V9J%SJMTF9;ZY+>Q_!_X0?M0_
M!W4M8\)Z7J/PAO/AOXA^-WC?XA7NI_9?$T'BE/#GCSQ=JWBBZTDVMQ="PFU.
MVCODM);J*[>%W0L+%%P@VJPP_*M5LK[1Z)O;JM4_,(MM+5[*_7HK_CY['Z.H
M"$4$DD*,DC!/'4@8QFG55LL_9802Q(C4$N6+<*!\Q=5;/'.Y5.<Y .:GD^Z<
M$CE>AP>6'<5BE'HE;IHMNG0U/BO]MO9_PKGX? <G_AH_]GH9;)X_X6WX4;'T
M#<@= <'L37Y&?MC?\%XM9_93_:5^)7[/UO\ LY0>-H? %]IMJOB=/B!)I4=[
M;ZAHVEZL0^G?\(S<FWFA_M&.)BL\JJ1PY'-?KA^W#G_A67P_;.UO^&C/V<3D
M9YW?&'PF#SGJRG;[C(Q7\1/_  6"DQ_P4>_:55>7&K^&XP>22C>!O#C%.F=K
M-'&2 ""40D<"OU+PCX<RGB3/\9@,]PE?,:'U1SA1PLITYQESI1?[MQ>D-&KJ
M[U=^GX-X_P#%W$'!O">!S/AC%TL!B/KDH5*N(C"?-#ENTE5YD[S<K73T:5DM
M#];?^(F_6%)5OV1H8V4X9#\6L%&'52/^$/X(/7/-'_$3AJ__ $:1!_X=K_\
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M4>WKZU_+&7A/.\#VR!^A%(3 <9=3CID@X_2C_B"G GVN"Z/-]I?VEQ&]>O\
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M+>$32L6:23:78DECDUU4W)+'EMLO)Z_ZH#KUZ #Z >E8P^'7[0('-YX!B/\
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M6A;R'GKGN<?_ !52+;/M&5R>>P/<XYSZ5_=!_P 0^O[ O_0.^*'_ (75[_\
M(]+_ ,0^O[ Z_,-/^*//('_">7N./0"WR/?C^=+_ (CEP2]993B>9_%^YCOU
MWJ]P?T6/%/3_ &[A3_PZUOPLD?PMM 0Q!!'3T';TIAADS\JDCC!R/3GOZ_\
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M+76.^FM^M[GVJ$7'W5ZGJ >^/Z"EV)_=7_OD?X4HZ?BW\S2U%-MPBWJ]=_\
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M]_\ "^\>?_,-7T7@_P!]_P#OHT8/]]_^^C1[>'9?='_Y$/G^#/G3^T_VN?\
MH2?V??\ POO'G_S#4?VG^US_ -"3^S[_ .%]X\_^8:OHO!_OO_WT:,'^^_\
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M"1>&G-))^]9VUM?O]W];OFEW9]")^TG^V.H3_BU7[/F57 9OBMXNWX."<_\
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MS\"K6W7X\_!*XBDT_P")_BVZN6O;+XD^'KNQ@GM9/A^$B@N;^&&S^U!R[(_
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M  [4O_EA]L?\-*_MB?\ 1)OV?/\ PZ?CK_YUU'_#2O[8G_1)OV?/_#I^.O\
MYUU?$_\ P\>_8I_Z+_X2_P# ;6?_ )44?\/'OV*?^B_^$O\ P&UG_P"5%'^J
M&<_]";C#_P ,]7_Y2'_$0>"?^A]P=_X=J7_RP^V/^&E?VQ/^B3?L^?\ AT_'
M7_SKJ/\ AI7]L3_HDW[/G_AT_'7_ ,ZZOB?_ (>/?L4_]%_\)?\ @-K/_P J
M*/\ AX]^Q3_T7_PE_P" VL__ "HH_P!4,Y_Z$W&'_AGJ_P#RD/\ B(/!/_0^
MX._\.U+_ .6'VO\ \-)?MAGG_A4O[/?/_55/'0_3_A5XJ-_VD?VPF^3_ (55
M^STF>N?BGXSX&#W;X>0OU_Z9CCU')^+Q_P %'?V)R!G]H#PD#_U[ZQ_\J*:W
M_!1_]B@;Q_PT%X3P ,?Z/K'<#G_D$]%_#KWI?ZJYLM/["XMNM+_V/.[:ZO\
M<7\]1/Q!X*UMGW!WI_:M+]:R7W':_!OXZ_M3:?\ %W]JVYL?AO\  FXO]2^)
M/A"\UR*^^*/B^WLK>[3X5>"HK:'2[B/X?^9<"2UB@>0-RLK.G09/U'_PTE^V
M"<[/A/\ L^%02/WGQ1\;J^0<$$1_#*9>#D B1LC!."<#\K_A5^WY^R#HOQ/_
M &@=8U7XY>%;72_%?Q!\*:GX?O6BUF2/5+*U^&OAO1;N98CI1V&VU&QG@#@
MAH@W45[TO_!1[]BLJH?]H'PH&50C%X=9D=V4!6D=SI66:1@7)/.6Y)ZT?ZKY
ML]\BXM?_ '2)?I0783XVX2E[ZXKX%@I:J,LUH<T4]5%_O&VX[/>SZZGVK_PT
MI^V(.!\)OV>_P^*?CK'_ *J[_/TII_:2_;"SD_"K]GI2<<'XJ>,\CZ[_ (=P
MM^<:_CU/Q4?^"CW[%.?^2_\ A(^_V;6?_E11_P /'_V*O^C@/"?_ (#:S_\
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MB_\ 1,/V>_\ PZGC#_YW]?%'_#QS]BG_ *. \(?^ ^L__*BC_AXY^Q3_ -'
M>$/_  'UG_Y44_\ 4_.?^A+Q?_X9ZG_R@/\ 7[A7_HL.!?\ P\4__EQ]K?\
M#3/[8I.?^%8?L]DG'_-5?&'X=/A_QTSZ@9.*=_PTS^V21D?"S]GT@]Q\5O&
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M(QJ0J8>:J8><9I2C.A--J=*2:=.2;YH-.[N-_P"&E_VRO^B4_L^_^'5\7_\
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M9SE9W;6ZZ[_U\NAF#]I?]LG''PM_9\/8G_A:OC!>1U&#X 'MS2_\-+_ME?\
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M4I)1E._-**22492<4DDDDDE\$*T@50&;  QS[?[X_D*7?+_>;\__ +.D+<G
M&,X& PX'3^&DW'T_]"_^)K^LU4J))*I.R27QS[+^\?Y^MXB[M2@U=V?)'57=
MOL]K#M\G]YOS_P#LZ-\O]YOS_P#LZ;N/I_Z%_P#$T;CZ?^A?_$T_:5/^?E3_
M ,#G_P#)"OB?^?,/_ (__(CM\O\ >;\__LZ-\O\ >;\__LZ;N/I_Z%_\31N/
MI_Z%_P#$T>TJ?\_*G_@<_P#Y(+XG_GS#_P  C_\ (CM\O]YOS_\ LZ-\O]YO
MS_\ LZ;N/I_Z%_\ $T;CZ?\ H7_Q-'M*G_/RI_X'/_Y(+XG_ )\P_P# (_\
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M4:6,K*,YU:7/.G&-1^_*Q9$<@CS464JH&U1*OF;1QP!NQCMTH "@JH<*>H
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MR4Z4J,T[2I2^*#LO=EMKL_FC:7^+_>-.IJ_Q?[Q_I3JZ9_%+U_1'+3^!?/\
M]*84445)84444 %%%% !1110!P7_ #<Q^R5_V/OCK_U67B>OUY09 SSG>>>>
M=W7!K\AO^;E_V2O^Q]\=?^JR\3U^O,?1?^!_^AUAB/L^D?\ VXTH-\SU?Q/J
M^[\QX '0 =^!CGUI:**Y(?"OG_Z5([ HHHJ@"BBHY20H()'/8XZ*Q_F.E 'Y
M6_&<9_;=UX=C^SKX1R/7_BX&O]?7T^G%:H4+G  SMSCC[LB2K_WS+&DB^CHK
M#E1CA_C[IGQEUG]MW5(?A1X$\+>,9(OV=_"2ZPWB'QC/X4:P)\:>)9%\HPZ/
MK(N#\N[[O!Y+9P2\^#/VSLG_ (L/\+__  \5U_\ ,=7<FG%)[);/;=]&FOP/
M/:N]4GZJ^UNYVPX#J.%E?S)%'1WY^9AT9N3R<GFA1L!5?E!QD#@':689'3AG
M<CT+,1U-<3_PAG[9W_1!_A?_ .'BNO\ YCJ/^$,_;._Z(/\ "_\ \/%=?_,=
M57\QZWOK?O=W^^]_Q.V_B+?Q,6)/<ET1'/\ P)(T1O544'@"@?*  2 H*J >
M "-I '8%>/IQTKB?^$,_;._Z(/\ "_\ \/%=?_,=1_PAG[9W_1!_A?\ ^'BN
MO_F.HNNX:^?WO_,[38FQX]H\N0Y=,?*Y!W L.APW(]#R*7 P1V+1,1S@M!'Y
M4+$=S%'^[0_PI\HP*XK_ (0S]L[_ *(/\+__  \5U_\ ,=1_PAG[9W_1!_A?
M_P"'BNO_ )CJ&T]]?77\[AKY_>_\SMJ*XG_A#/VSO^B#_"__ ,/%=?\ S'4?
M\(9^V=_T0?X7_P#AXKK_ .8ZBZ[BL^QVU%<3_P (9^V=_P!$'^%__AXKK_YC
MJ/\ A#/VSO\ H@_PO_\ #Q77_P QU%UW"S['D7Q5^7X]?LM8_P"@]\3B.G5O
M!1+=NAQ\PX!YS53QC^R/\,?B%<^,8]?UWXBQ>$_'>O6GC;Q#X!T7Q/-IO@^]
M\:V%G;)8^+;$Q:8-1L]6L]1LK2\MS_;HT)+FU@D%L6C7',?%+PS^U?!\>?V8
MK;4O@U\.K;67U;XE/HVG)\6YGCU(W'@QA=M)(?!F83:A28RIRO5*^D?^$+_;
M/R3_ ,*%^%^6ZD_&&Z)/S;N3_P (;S\QS]:Z'B8]7'[E_P#(F/++L^W1;V?=
M=-3F_$_P;T#QEX3\.>'=>\0>,7UGP-J=MK7A_P >VVIKIGC;2-9L8)+6;5/[
M6MM+V7,VKVLLEO>6QT9O#UY%(R36T@=L\9=?LV:7<WD'B2T^)WQBTCQI9Z'>
MZ+K'C?2_$NE6_BGQ3I5UJ=]JECHOB.2;P]>>&VM]*:_O!9/:Z=I.K6PO+@B5
M3*QKUC_A"OVRR0?^%%_##*E6!_X7%=\%?NG/_"%\%>Q[=J;_ ,(7^V>"C?\
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M;XGMX?@I\.3KL'P%\#_;='/Q?N/*^RQ^.?&MS8WB77_"&DC[7(SQ-'G!10C
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M;4+G3M';0C86TEAI-OI,,$4=S;ELR>0),R%I&959SN&:^F?VGO"W[7-MX/\
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M  \5U_\ ,=1_PAG[9W_1!_A?_P"'BNO_ )CJ+KN%GV.VHKB?^$,_;._Z(/\
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M_P#DNOR$V#V_(_\ Q5&P>WY'_P"*H_XBC7_Z J?W0_\ D _MNK_SZC_X&_\
MY _7O_A8G@G_ *&G0?\ P<6'_P ET?\ "Q/!/_0TZ#_X.+#_ .2Z_(38/;\C
M_P#%4;![?D?_ (JC_B*-?_H"I_=#_P"0#^VZO_/J/_@;_P#D#]>_^%B>"?\
MH:=!_P#!Q8?_ "71_P +$\$_]#3H/_@XL/\ Y+K\A-@]OR/_ ,51L'M^1_\
MBJ/^(HU_^@*G]T/_ ) /[;J_\^H_^!O_ .0/U\'Q'\%#@>*?#O7H=5T\GH!R
M?M8S_/\ KT5AJNFZY9B^TN]M+^V4L/,M)8IX)-K%6*O%)*C%2&7AFPP(.""*
M_&+ '8^Y&1_,^A(XR?3'%?2'[/GQ:F\&ZU'X;UJZ!\.ZO((K4R$XTZ]D.0=S
M$B.UD9BT@&!N9F.2>?4R'Q&IYCF$<%B81I>TE9>2;VM9));:;:&U#-%.5Y+E
M;=W[S=F[Z;+2_ET^[U+]G$(_QU_;84+]WXQ^#64D $'_ (4Q\/B#]0,8/4#C
MVK[<2-0B@JI..I )/U)%?$/[.$B2_'/]M6:-T=9?B_X-D62,@HX;X+?#\AE(
M)!!!X(/2ON%>@^@_E7ZQ6C"44U&+3C!IN,7=.,6KZ:Z-:^?GKZJDVD[O5)[]
MTGW\QGE)V Q[8Q_*CRD]/T'^%/7H/I_/FEKDCAU**E9:I/9=1W?=_>_\R/RD
M]/T'^%)Y,?\ ='Y+_A4M%/ZLNR_ +ON_O?\ F1>3'_='Y+_A1Y,?]T?DO^%2
MT4_JR\OP"[[O[V,$:@8&0/08 _E2>6O^<?X5)12>%B]U%^J3_.XB/RD]/T'^
M%'E)Z?H/\*DHJE0:22;26B2DTDNR2DDEZ)!9=E]R_P AH10,;1^0Y^O%>#_%
M7C6M(4  &TE8@ 8)\T')]\QQGZHIZ@5[U7QM^U-\3+3X7W_PVNM2T?6-<7QY
MXOM?AQHUKHD >Y@UK6$%_;3S,1_JEBTZY7)/"R2#HQ!Z(IJ*5V[)+5M[?,5D
MNB^Y .?F(&YB68XY+,2S,3ZLQ))[DFC:#G(SG!/H<=,CVKSN3QOKBR2 _#?Q
MP#YCD@V4&.6)^4+P%/50!T(IO_"<:W_T3CQO_P" 4-'+%N[C%ONXQ;^]JY:G
M.*:C.:4E:24I)27:24DFO)IKR/1\=_\ /_UJ*\X_X3C6_P#HG'C?_P  H:/^
M$XUO_HG'C?\ \ H:++LON7^1GR0T]R&FB]V.B\O=T^5CT0\'//.>,G![ 8YS
M_3J1T%5=4L(M8TF_T>>26.VOK&]MYI+:Y&GSQF_@DLPT=W+E!<6D<DEQ;,H#
M022,Z[223PG_  F^LD@_\*W\<<<_\></4?Y],CIR!R'QOK/3_A6_C?&2V/L4
M.,D8S@8Y XSZ4GA^9/3W9:N-DXN_>/POYQ9K@\5/!8NGCFK8S#M+"4HMQC4A
M!_NVXQLFVDG?E>][ZGQWHG_!-CX#:9X#U_X>1>*?C#?>'M?U)=2TY[KX@RSW
M/A+Q1;ZA+JS>(? TZ3!=.UR[N965[N#R6<95Y2=V7^'_ /@G-\#?#7C'PKX\
M\$^*OBYX,U[PIIL.BVEMX;\?3:?;WUA8:A>Z]J4>L/#:.]Q<^(-4>Y76XI)I
M([FYEG1BR5]A'QQK9+$_#GQPQ9!&V;*+E%X5#_LC ( Z'I33XVUHDD_#?QN2
M0@.;* Y$98ISC/REF(]-QQR:\]Y?@%.3^H5N;F=Y4[P3?,V^3D<>6-VW%*R2
M=EH?<TO%/CVG@\1@_P#6O,,+0KQKP_L^&5TZF%I4L1+GJ85P>&E2K4G)1=12
MIRC7J05:I&=7]X>;?!O]ESX=_ WQ5XL\>Z1KGCSQ=XS\:*MI?^)O'GB.X\4Z
MO%I]O<-/;:9IMY=#S+73;64[K>UA2*&-AYBKORY^CD7"*@& $P!DD#'J.QYS
MTR"2#@BO.E\:ZRC*Z_#?QNKJ-H864091Z Y./\\4O_";:R,X^&_CCDD_\><7
M4\M^)/?Z]C@=].$*<%&$.2/*EROXMDK5'O.2LE)S<F[:MGR6:YMFN>5:-;-*
MU3%N%*E3JU:T7%5XT_AO1E>G3AO*&'C3C1H7Y:=*E%6/1@%(S@?D*7 ].^?Q
M]:\Y_P"$XUOM\-_&_P"-E":/^$XUO_HG'C?_ , H:?+'^6/_ (#'_(XN9J3E
M3;ANDXMQ:C>+23BXNR<(-+17A!V3A#D]&P/RY_S_ (=*,#T_^M]/3\*\W7QW
MK32O:?\ "MO&YE>..XC:.QB9U5YDML.&&W&\[@.G*FN,\)?'4^.+KQE:Z+\,
M_B"6\"^+K[P1J[76G6R%]6TVSL;R=XA&-IB,5_#ANI8,.U5=V2OHE9+HES*=
MDMDN=*=DDN=*5N9*2SY8MW<8MIN2;C%M-OF;3M=-R]YM--RU;;U/>&53NRH.
M\+&V1G<CAPR$'JK #(Z''-?1_P -0#X.TG(!VK.JY X59W"J/8#@#L.*^+HO
M&FO2R*I^''C:%"&0R2V,7E1LXPKM@9!4G.<<=CDFOM;X=036_A#28YXY89#"
MTC0S1^7+$9&+['7CYAG)/O3N^[ZO=[MMM[]6VWW;;=VVV[).Z23LU=)7LVVU
M>U[-MMJ]FVV]6V^U,:$YP!GK@#D^O3K2>4GI^@_PJ2BN>5*4FWS2LW>W,[?=
MS HQ6R2]$E^A'Y2>GZ#_  H\I/3]!_A4E%3[%_S/_P "?_R0679?<O\ (C\I
M/3]!_A1Y2>GZ#_"I**/8O^9_^!/_ .2"R[+[E_D1^4GI^@_PH\I/3]!_A4E%
M'L7_ #/_ ,"?_P D%EV7W+_(:$4#  _(?X5%(H+=/X1[=V]*GII523D \#J
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ML/0DD4)M;-KT;7Y-&+=WKK;OKY];GX;>.O\ @G/\:/$7[/'_  4@^$5GXN\
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M8R<#)QN;'TW$#H#BI::BA455Z*H QTP!^/\ .G5-EV7W+_( HHHI@?%O[<!
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M<"R?&65HPMTUZ=.G:Q\([3Z_^A?_ !5&T^O_ *%_\57W=_PR+H7_ $-.I?\
M@';_ .%'_#(NA?\ 0TZE_P" =O\ X4O]0N)O^@?_ ,EC_D']CXW^2'W_ / /
MA':?7_T+_P"*HVGU_P#0O_BJ^[O^&1="_P"AIU+_ , [?_"C_AD70O\ H:=2
M_P# .W_PH_U"XF_Z!_\ R6/^0?V/C?Y(??\ \ ^$=I]?_0O_ (JC:?7_ -"_
M^*K[N_X9%T+_ *&G4O\ P#M_\*/^&1="_P"AIU+_ , [?_"C_4+B;_H'_P#)
M8_Y!_8^-_DA]_P#P#X1VGU_]"_\ BJ-I]?\ T+_XJON[_AD70O\ H:=2_P#
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M$>N^_P#BD;MW;>P44458@HHHH **** "BBB@ I.Y^@_FU+119=E]R_R ^/\
MX_\ _)>/V0?^RF>,O_56^+_\37UQ!T [;5_]!2OD7]H#_DO7['WO\2O&>?\
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MW_HU+QO_ .'$^%W_ ,T-86Q/[J_]\C_"C8G]U?\ OD?X4<D/Y(_^ K_(+O\
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M;7UW"[?7^M7W/4_^&U?B]_T:GXX'L/B+\+\#Z?\ %14?\-J_%_\ Z-3\<?\
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M<=!DCXC_  P4]!G/_%1<DXZ\\Y/U^9=*_:N^*-O^UWXM\0M^S!XP:^U#X!^
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M_P *-B?W5_[Y'^%+DA_)'[E_D+FEW?WO_,WA^VI\7@,#]E/QQ@<#_BXOPO\
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M^&S_ (M=OV3_ !L/8?$3X7__ #14P_MG?%F7?&/V3_'!.,$'XB?# )@X./\
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M^5?O-_"/[Q]J-B?W5_[Y'^%*<(*<THJRE)+KHG9:O<5[Z]_Z[F]_PVK\7_\
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MVK\7_P#HU/QQ_P"'%^%__P T5'_#:OQ?_P"C4_''_AQ?A?\ _-%6#L3^ZO\
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M_=7_ +Y'^%&Q/[J_]\C_  I\L?Y8_<*_]?TS>_X;5^+_ /T:GXX_\.+\+_\
MYHJ/^&U?B_\ ]&I^./\ PXOPO_\ FBK!V)_=7_OD?X4;$_NK_P!\C_"CEC_+
M'[@O_7],WO\ AM7XO_\ 1J?CC_PXOPO_ /FBH_X;5^+_ /T:GXX_\.+\+_\
MYHJP=B?W5_[Y'^%&Q/[J_P#?(_PHY8_RQ^X+_P!?TS>_X;5^+_\ T:GXX_\
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M>%@G]5ESVNM;.]NN[LGT7;KT##/;6Z;[M]M'?^F?1U% Z#^G3\**X#<****
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M(_\ MQ=#XG_B?YLDHHHKDA\*^?\ Z5([0HHHJ@"BBF29",02#C@@X/X?Y^M
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MQTW+O;!ZC<<=:1@&4JWS*>JMR#QMZ'CIQ].*\Z_M;X]_]&E?&/\ \'/PQ_\
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M?'O_ *-*^,?_ (.?AC_\VM'-Y_C_ ,$%&VT;>BM^21Z( % 50 H   &  .@
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M_P"?^#_OA/\ &C^UOCQ_T:7\8?QUCX8 _B!XU('T!/UH_M;X\?\ 1I7QA_\
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M5\8__!S\,?\ YM:+KNOO7^86?9_<_P#(]'_AA_Z_!_Z*KYR^ ?\ R$/V@O\
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MG28_#<NG3>*#9>%;F"^NFN+XB!2/0?BC?_MIV>M^(/B-HVK_ !DFU;0?C_\
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MW_9 VJHS\2O&8. !D'X7^+B0<=1D X/<"OKF#H/]T?J%)_,DD^I.:^1_C_\
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M+\D%%%% PHHHH **** *[_Q?\"_K7PY:1L_[;_Q.4J ]Q^S5\.88D'^LW_\
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M#/C\/:CZGA_YY?>_\P^M?X?Z^9WG_#?/@_\ Z([^T)_X:W6O_C]'_#?/@_\
MZ(]^T)_X:W6OZSX_/BN#WR_\])O^_G_V5&^3_GI,?8R<'Z_-1]2H?SR^^1M[
M=>7WK_,\8^+/[:O@[4_V@/V7];;X4_'*VAT74OB4)K>\^&E\MU=M_P (8X8V
M6V;<#M8#$8.X$@\<GZA_X;W\&X('P<_:#P0!_P DLUK&!TX$_;M7QM\6)91\
M=OV675W#KJWQ:V,&;*[/!B[,'.0%Z#T_&OI%GE(^:=T\QRH21T$CW>1^XM3
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M6_BN2WWR7P_9\\&0P22RE8)6G\9^.(UB7/%NMNL4 GN!MP&9F/-.A@\+S/\
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M@T2OCX-_M _*SJ&7X6:NPVENBLLV"IP#D  ]<#I7QA^U'(Y\'?#XAWR/CO\
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MUX/89'P>_:%()."WPNU<DX)&<Q2JA!QD;1TQGG-?&/P6EEC^+?[5XCDD4/\
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M )Z3?]_/_LJ/J5#^>7WR#VZ\OO7^9WG_  WSX/\ ^B._M"?^&MUK_P"/T?\
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M$K>S^#'U6QD1Q:6]NME'ILA>""YUF:\MKR.WO;67[0.5T>9MV>K;WW;;??\
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M9:-+^WQ+&KXSN!P:O @\C..V1@X]QQ_*O@7]B3QAJ_Q#O/'WQ \5)(^M^)_
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MRGI]U_J?_0%I!RKLON7^1\U_!55/Q>_:NR ?^+G>"NP_Z))X+KZ5F 6:8*
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M4?,#S70L/*RO=.VUVM;*_43Q$5LDUYI.ZV3^&_\ PYB67[6_P0N/@GXQ^/\
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M_=?:>EM-_P"OO%]8BM%9I;-I7:Z-^[=_,^D]W+=/O/U..CD>E&[_ '?^^O\
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MA\5_VX-4C\4WWBNS&D_LY^$VLCX9\8:SX:VEO'OB*-C*=*NK/[22O'[_ ,S
MP!SR4_X8]^$N,_V_\8?K_P +?\< $8(Y_P")W[YKUSQ^[+^V]XH )P/V=?"'
MR]0<>/\ Q ,8/MQ7IBM*[3;#<;_L^_R'$TDL;?WHX8H51P<]#=,!C.*_0\EI
M4JF4<U6$)OFLG.*EU?=.V[\NY^0<18O%T\XS6-/$XBG&FHNG&%:I%4_=A\"4
MDH[O:Q\J_P##'7PC_P"@]\8O_#P>-_\ Y<T[_ACSX1_]!SXP?^'?\;__ "ZK
MZKD=HE\R5C%GHS29MNG'(?S!GZG!/KBF!II!YB,VPGYPIN,0^H+316_YG/!X
MS7JK"X7IAZ'_ (*IO_VUG@_VAC_^@W%_^%%7_P"2/E?_ (8\^$?_ $'/C!_X
M=_QO_P#+JC_ACSX1_P#0<^,'_AW_ !O_ /+JOJDLP/FR2M''Y_DC#RFWV#K.
M;KR3$%)X] <]:<ZW$>#MN09(Q,$D$IC:,G]Z;2Z2'R'%L!\_F ^^<BCZOA5_
MS#T-=OW5/7R7NZ_+UVU#Z_C_ /H-Q?\ X45O_DCY4_X8\^$?_0<^,'_AW_&_
M_P NJ/\ ACSX1_\ 0=^, ]_^%O\ C?CW_P"0S7U6!*,%VF3S>!YQEM]WI]CM
MWB\]R?\ IHQZ^G 3]\SF)G9)5C,\L $L4ZQ=MAE9D8$=2,^O>A8;"O\ YAZ&
MO_3JG_\ (A]?Q_\ T&XO_P **O\ \F?*W_#'OPD_Z#OQA_\ #O\ CC_Y=4G_
M  QY\(_^@Y\8/_#O^-__ )=5]5[F_OO_ -]M_P#%4;F_OO\ ]]M_C5_5Z'_/
MFE_X+C_D8?VAC_\ H-Q?_A15_P#DSY4_X8\^$?\ T'/C!_X=_P ;_P#RZH_X
M8\^$?_0<^,'_ (=[QO\ _+FOJO<W]]_^^V_QHW-_??\ [[;_ !H^KT/^?-+_
M ,%Q_P @_M#'_P#0;BO_  HJ_P#R9^9/Q3_94^&MK\=/V8])AUKXJK!KFJ_%
M;[67^+?C221?*\&$)Y<KZP[V^T?\\&C]_2OHW_AC[X3 8_M_XQ<#_HL'CCM_
MW&JN_%MV_P"&@/V5CN.6UOXM*3GG;_PAK# /;IU&#[U].9EX*L[[OL:0H%F*
MNLN?,N'NPWD!3@\8"]@,UE&A0]]NC2LI22_=QTLVNVW],Z'F&/\ ^@W%[?\
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M,>?"+_H/_%X_7XS>,R?S.L4?\,>?"+_H/_%W_P /+XR_^7%?SV?\/_/V@O\
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MG_PQY\(O^@_\7?\ P\OC+_Y<4?\ #'GPB_Z#_P 7?_#R^,O_ )<5_/9_P_\
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M  7]_:")R?@W\+?_  .UK_Y(IOPKXM?_ #"8+S?+A]?P[A_Q';AG_H89FO\
MN9Q'Y<Q_0E_PQY\(O^@_\7C]?C-XS)_,ZQ1_PQY\(O\ H/\ Q=_\/+XR_P#E
MQ7\]G_#_ ,_:"_Z(W\+?_ [6O_DBC_A_Y^T%_P!$;^%O_@=K7_R12_XA5Q;_
M - F"_\  <-_D+_B.O#'_0?F7_A1B/\ Y,_H3_X8\^$7_0?^+O\ X>7QE_\
M+BC_ (8\^$7_ $'_ (N_^'E\9?\ RXK^>S_A_P"?M!?]$;^%O_@=K7_R11_P
M_P#/V@O^B-_"W_P.UK_Y(H_XA5Q;_P! F"_\!PW^0O\ B.G"_P#T'YE_X48C
M_P"3/Z$_^&//A%_T'_B[_P"'E\9?_+BC_ACSX1?]!_XN_P#AY?&7_P N*_GL
M_P"'_G[07_1&_A;_ .!VM?\ R11_P_\ /V@O^B-_"W_P.UK_ .2*/^(5<6_]
M F"_\!PW^0?\1TX7_P"@_,O_  HQ'_R9_0G_ ,,>?"+_ *#_ ,7?_#R^,O\
MY<4?\,>?"+_H/_%W_P /+XR_^7%?SV?\/_/V@O\ HC?PM_\  [6O_DBC_A_Y
M^T%_T1OX6_\ @=K7_P D4?\ $*N+?^@3!?\ @.&_R#_B.G"__0?F7_A1B/\
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M]H.]L/!GBS5+&[UO1%L=3T[1=3O;6X/_  BVB1OY4EO8/&RP7(>/*LV3P6;
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MJLJ[D=6 ((-6#\.?'O!_X5WXX!95<J_A77HV3>H;84.G$C;G .3D8.>:;S;
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M>_\ E=1_:^!_Z&N#_P#!D/\ Y8']F8O_ *$6<?\ @NM_\J.+^T-_<'_?M?\
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M-<P:KI$]K#83I#!)=7LO]HR6TBSSR"SL7MW97N#-"&+*5KQO]J[X<^-OB]\
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M>O\ ?]L'ZTX$;"@63:>./E(R6?AO-!!#,3P1@A<#Y%(Y.[_8D\,6<,US<?M
M_M&06EM'-<75U-\3[N%(4M<F9IS)9!4A49D,AQA06'R\GYY/A3]D:*1HW_;[
M\9QO&Y1U?]HS1U=64E75T(!5@P(93@A@01D U=+B#!XQ/ZCEN:8F:;4N26*D
ME*^MER2>]]4K;=#BQW"JR^I&CB\YR?*Y3BFI8^5"*Z7<?;3I+E;>EGHK'UB
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M>A^E,T_L=A_T#;/_ , K2C['8?\ 0-L__ *TK,_X82T3_HOW[2?_ (<FZ_\
MD*C_ (82T3_HOW[2?_AR;K_Y"H_UJP7_ #[QW_@^J'_$.<?_ #9;_P"$]'_Y
M6:?V.P_Z!MG_ . 5I1]CL/\ H&V?_@%:5F?\,):)_P!%^_:3_P##DW7_ ,A4
M?\,):)_T7[]I/_PY-U_\A4?ZU8+_ )]X[_P?5#_B'./_ )LM_P#">C_\K-/[
M'8?] VS_ / *TH^QV'_0-L__  "M*S/^&$M$_P"B_?M)_P#AR;K_ .0J/^&$
MM$_Z+]^TG_X<FZ_^0J/]:L%_S[QW_@^J'_$.<?\ S9;_ .$]'_Y6:?V.P_Z!
MMG_X!6E?,/[2=A8+JG[.3)IUI%]I_:)\%6TW^CVL(E@_LKQ#*23%M:6/S(HP
MT<I9&*8*LO%?1?\ PPEHG_1?OVD__#DW7_R%7/Z]_P $YO WB>;0+C6OC=^T
M;?3>&-;M?$>BM-\2[P?8M8L8KF&UO$46861HXKRY3RI T3^9ED+*I"EQ3@VF
ME''1;35U6JO=--6NM'?7_@C7AUCDTV\M:36U"@NJ_P"G9VHTNP0;5TZS11T'
MV"QY_P!H;=JD/]X$ 9!&><T?V=8_\^%G_P" %G_C64?V#]!&%'Q[_:3VJJJN
M?B5>'Y5 4#_CSZ8%-_X8/T+_ *+Y^TG_ .')N_\ Y"I_ZU8+K3Q_K[>KK][O
M]XO^(=8_OEW_ (3X?_Y6:QLK!3@Z=9G'?[%:#WZ4GV.P_P"@;9_^ 5I68/V$
M=#' ^/O[2?\ X<FZ_P#D*C_AA+1/^B_?M)_^')NO_D*C_6K!?\^\=_X/JA_Q
M#G']\M_\)Z'_ ,K-/['8?] VS_\  *TH^QV'_0-L_P#P"M*S/^&$M$_Z+]^T
MG_X<FZ_^0J/^&$M$_P"B_?M)_P#AR;K_ .0J/]:L%_S[QW_@^J'_ !#G'_S9
M;_X3T?\ Y6:?V.P_Z!MG_P" 5I1]CL/^@;9_^ 5I69_PPEHG_1?OVD__  Y-
MU_\ (5'_  PEHG_1?OVD_P#PY-U_\A4?ZU8+_GWCO_!]4/\ B'./_FRW_P )
MZ/\ \K-/['8?] VS_P# *TH^QV'_ $#;/_P"M*S/^&$M$_Z+]^TG_P"')NO_
M )"H_P"&$M$_Z+]^TG_X<FZ_^0J/]:L%_P ^\=_X/JA_Q#G'_P V6_\ A/1_
M^5FI_9U@W/\ 9]F,]OL-I[^XSW/XTTZ5II96.FV!*LSY_LZR^<LNPB7G]ZFT
M !)-RC P 0*S#^PAH1.3\??VD_\ PY-W_P#(5)_PP?H7_1??VD__  Y-W_\
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M?Q#5EFCJU<)*K1C5DYQ4924TFDES/1MW3;NNJ\C]4\/O[-X9QG#LN)<'2S7
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M[G5=9O;B.WU2U2ROM-N[_P#LY)VB2:%2@ T_VF[7]KGXC_\ !33XW^&_V?\
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M@!&C"@,, Q$99BQ_Y>AW8D<8YQTXH$I XFC7VQ#^!YN3]/PKJ1^RE\,N<GQ
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MQ:NO)W5CYM7Q/K*@+_;&I\#'_'[.>GN9<_GSZTO_  E.L_\ 08U/_P #9O\
MX[7T6?V3?&1)_P")QHW4_P#+6X'Z>2<?3)QTR>M)_P ,F>,O^@QHW_?ZY_\
MC%?!2R'CCF=L+B+7=O>K;7=OMGSSPM5MMRJ-MMMN<KMMMMOW]VVV_-GSB?$.
MNG)76=2^8DY^V3_=.3G[_7YAWSC&*O:5XT\2Z'JVGZO;:O>M>6M[#=PI<7<Q
MC MT\IDP6VF.ZC&V2(C9)NW,I;FOH ?LH>,^1_;.A #IF6ZYQD<_N.>.I[^]
M:>D_LG^)!?VCZQKFDG3TNXIKZ*UAGFDN;6)E(B#2$-'\HQF+RR>O2KAPYQ@J
M^65Y4L4JSKVG5]I5Y[*5E&4^:_+%+E2;LDDM+(VH8:I>-^9NF^:#<I/D;>\;
M2?*V^OGWN?7_ ,+_ !C#XY\(Z5K\5I<6CW2B"[M98S''!=PKBX:'."\#N,Q-
MD@K@@<XKTE0 /J!GN#61H>DV&D:39Z9I]NMM9VD$4$448,>$A18U+<[BQ51N
M+$L?XB36S7[_ (*,XT:=.I\4:5.-1='4C3A&I=:J[FIW=W=MOJ?5)MJ/,W*5
MHW;=VWRI-W?5N^OF'2BBBN[;1;(84444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !113"2,GYCTX 4^GKS]<G]* 'T4@.1G!'L
M>#UQ2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 A4,,, 0>QY'Y?UIGE1_P!T
M#OP2/3T/L*DHH C,49!&W@_[3=_QIBVT*G(4Y_WF/]:GHIIN-[-J^]M+^IG*
ME3FU*=.$I1^%RBFUZ-[$301L""#\Q)."0>>O((_Q]Z1((XP0H8 YX+,>O<9)
MYJ:BGS2M;F=M[7-;NSC?W6[M=&]-6K:O1:O71=B(0(.F[KGEB?YYQ^%!A0YS
MNYZ_,0>.1R.>PJ6BES2[O[PN[WN[]^OY$ MHAV;KGEF/]>/PJ3RTQC'MU/M[
M^PI]%2TF^9I<S=V[:M][[DV7,Y6]YN[EU;VNV1^4GH3]6/\ C1Y4?]W]6_QJ
M2BF/<:JJOW1C\3_4]??K2@ = !]!BEHH **** "BBB@ H/0_Y_GQ^=%% 'QY
M^W+XW\4_#;]DC]H+Q[X*UV?P_P"+?"'PM\5Z]X>UJV,"OI6KZ;ILD]E,WVM)
M[!WBF"MY5Q;RQ.!B1'&0?Y^_#?\ P4@^._[&WB+PO:^./C)XD_;.\._$S]F[
MX7_$8:-KS^"])\0?#7XP^.]>TS2(/#VL^)O NDPV^D>#K^+46N&BO_#.K:Q
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
BHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>vi_002.jpg
<TEXT>
begin 644 vi_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" *F D # 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH ***^!O\ @I5XT\8?#+]@W]K#
MQ_\ #?Q)KG@[QSX3^$'BC6O#GBOPD,^(]!U  XU3P^?^@X/PYQ@YX(!]\T5_
M+/XZ_:'^+WPOM_CEX3^'7Q3_ &\_A_8ZA^SGIWCOPY:?MKZ5_97Q'O?B?HOQ
MX^%OAO5-4_9\U;6=#_X2!M"\.?#GQSK!^-OA[D*=9^&A\'<_\)2:_2WQQ_P4
MELOAO\+_ (8_&#QA\.;BV\+^+/CO^UC\*/%ATOQ&-5O_  IX6_98_P"&D,^,
MM((T,'Q-KGB/_A2"G_A'Q@C_ (2('TP ?K717XN_LF?\%+?&/[5?BR^^'OA7
MX2?#^U\8:AX"\,?$_P ,7.E?$KXR>(_!&C^"&\9>&]&\;>#OB7XWUO\ 9S\%
M#1/C%X<T35O[?'A[P\/%7A;Q7D?\5;US\X7?Q:^+?Q5_9_\ 'G[=?B3]HW]J
MCX77]Q\5/CAX;^$W@#]F[X8GXI_#KX ^%O@GXR\>^&])_P"%W?#+1/"GB3_A
M8!_XHC5?$'QN\0^,F!_XG!\(^#SX6(Y /Z,:*_!3XH>"?$?Q#_:I_8CF\)_M
M>?M=Z9\-/VP_!'QQ^(GBS2/!/Q=U3P/X<_XH3X=> _'?@@>"=(.B?V_\/]!;
M_A(?$!'AX')X5@&6OC[P?^TA\7_!MX/B5-\5OV[[K7]"_P""@GBGX5^(O'_C
M_1AXC_89LO@>/VJ?^%5:MH/C;5O[# T0GX<D>'O"?B'PZ?\ A*?^%T'0>U%U
MW7WK_,#^JRBORQ^-GCW2/VI?!/BI_P!F/]H#XGWT7P UGQ3-\7_AO^R?-X-T
M3XT>-O%']A8\$?#GP]XW^(.- ^'Q_MO'B%AC'BDZ0,$]:_.#4/B_^UY\2OA?
M\#?CIXSU7]J#QA\%/ ?[&Y\2_M ^./V5/BA\.?@'JO\ PO'1_&?B3_A=Q\0^
M"-;_ .$;\0ZUXW^%.A_#/5O#P^%_AWPR /%.LZ]C XH _IMHK^>"Y^-_QI\"
M?'#Q-^T]\8XOVL[;X$?$'XOZAIG[,FKZ/\:OAS_PR]>^%?$GP;T;_A26E^-O
M@YHG_%P/[#^*GBHZJ?\ A(,8_P"$JUG0.F01ZY^QEXU^/'A_XG?L<W_COXZ_
M$CXS6'[<_P"QQXY_:#^('A_QP-,'ASX??%'1C\!_'>E?\*Q&C:(/^%?_  Z.
MA_&[Q%X/'A#)!/ASPBW/% '[AT45_+;XX\3?M">-OB!^W=I7P<U__@H_KG[1
MGAW]JOQQX#_9SU/X:Z[JND_LH^"_[(\&?"UO!&E>-AK9'PO'PZ\.>*O$.KGQ
M8/$:Y_X10," >0 ?U)45^/?B;_@H)X^\'_"_6_&%YX#\#WVL:'^VQ\2?V3+K
M['K.IFQN]/\ A9X.\>>)6\9<@_\ $[)\$$?\(_VR<=C7BVB?M^_MZ:]H]SJB
M?L[_ +-#C2/V*?A_^W-XCLKSXO?$>S%EX(\>#QX?^%2Z1JW_  KDC6/B,-#\
M#:J1XP./"@;!ZF@#][:*_FSA_P""H/Q%\+^.?'WA_P"'D/\ PFVJ_&3XW>*/
MBK\.;CXL6GQ&U;PM\,?@?X;_ &:?V5M9'@W_ (1[X2>%O$FOC7?$7Q&^)IR,
M'PKX6_MC7?%Q/3/U#\8OVKOVBO%O[(WP@^)7AG2I_P!G.7]JGQY^S3\#-/U_
M7]&U4?%KX!>)_C7\9?\ A _B9XQU?P[K>AOH!_X1SPJ5'P2/B$<^*]8T$^,
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MP2_X5E^T%_8?AOQ%HO@CQ%_:WB'Q!XL\/#PSX6SXJ\!D?\BAU /Z4Z*_/_\
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M:_$SX>^#M+\!CX0>+?"G@#XO_$C0?#OQ@^&!U[Q+K%YX-^-UF?% _P"%@?\
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M2AX>OY];\4^'?$?AXW_V[^P?&_@3QCXC\"^-M+.K!5&LD:[I&JA3\PP 22S
MC$Y#M?A3\+/ /P5\ >&_A9\,O#]AX8\ ^#-&&C^'/#VF'(L]/XX ]^N3SGV
M ]7HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M!X3\;:CX<U"P\$>+[C1E\167A?Q,=+(TK7CI#8_MH)K9W, =V <9/RG\PO\
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M+_PCY9O^$6;PT<.-ZJH!^WE?GE^RU^TWXQ^.'[2/[>OP6\1^&](T3P]^R?\
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M*Z1_:W]B@>(='_X55HAU3PZ ?^1L_P"$DW@_\4VHK]S* /S<\*_M5>+O$/\
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M'QS_ ."W1Z_L ?L31>O_ !G)XR8=?;]G*J'_  2"_P"1A_X*T_\ :8+]J_\
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MTHH _(/?_P %[/\ GS_X)&_^#?\ ;'_^4=4MG_!?7_GC_P $BO\ P._; _\
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MP3_9.E$?\3K&N\$<X4C(Y K](** "BBB@ HHHH **** "BBB@ HHHH ****
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M_4U_-DO[,'QNTOP1#+\6OV%=*^*^G:W^S]J'P:^"/A/PI\.?@/XPTKX W_\
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M:AX0B^-?AH?L77_[7VG_ +=^I_ \_"Q?^%FGXP?\)FOQ4_X5R/B;_P )5_8
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M.2!R!0![11110 4444 %%%% !1110!X9\9OB%K'PC^&7CWXEZ9\/?''Q1O\
MP1X3UGQ':_#3X9Z8/$7CCQK?Z.I_LGP?X*TC<N[6_$7 V\\X)QMR/@+X4?M]
M_$B/XM?$GX(_M7_ 8_!_XH^!OV=+']JVUTSX0>*]1^.XNOAAJWC ^$5\'OH^
MC>%E\1'XP?VZ/^$>'AY/#9/BIF'_  AX"$LOW?\ '_4OCAIGP4^)NJ_LYZ%X
M3\3?'&S\)ZA_PK#P]X_U,^'?!^I^-MI&DCQ!JX(":)N(.>>!T!/'YQ_\$W?A
M1^T;\)=4\=ZA^U'^SW<>'OC!\2]/\,:[\7OVK_$'[1?@[XQ^-OC5\0-'(TD>
M#AX1T3X=>&Q\/_AUX<T1=5_X1+P]X>!\,>%O"Q)4CGQ20#Z8_8&_:R?]L_X6
M?$/XHS?"SQ9\%AX/^//Q?^"__"#_ !!N?(\<68^%NN_V/_:?C72>#X7ULMR?
M"#9_X18EAW%?H+7YV?L$?L]?$;]GWPU^TWI_Q-AT.&_^*/[:W[2OQW\)C0=2
M-\1X&^*GC(:QX*_M<\8UP*&R",YQG'0_HG0 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7G'B_Q;HG
M@7P?XG\:>*I1;:#X/\.ZAXA\1SP6[7IM--T?3#J^K$:6 3NV*S@ ;LA02@^8
M>CT4 ?R[_P#!*K_@J'^UO^T-^VO^T!\.OVK?@YXQ^'/P5^.'B(^._P!B[[9H
MX\_X<:/H_P +_ GCT?";XF8&=$\5>,O@YXW\$?&_'B%@!XJ;Q<<YP!_417YL
M?L<6T/\ PTI_P5 N\B4G]K[P.1]!^Q?^S:".?4-@?_6K])Z "BBB@ K^53QO
M_P %@/VC?#__  5QA\-V7PQ\6?\ #M#0+74/V<_&7C#_ (1P?VK>?%#_ (6-
MX;\!ZM^T9I.E?\C#_P *Y\&?&+5O#WP/_P"$@X\*_P#$XU[Q<,YQ7]5=?E;J
MD,)_X++^$H?L]OY7_#M/QOG_ ,2J\!<=/K^?I0!^J5%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445_
M,!_P5S_X**_MJ_LJ_M1>(O W[/VMZ=I_@'X9?L0>&?VI/%,&I_#CX<>,/#C:
MC_PO?QWX"U_5/B=JWQ!^(_@KQ!X8^'0T'257=\+/^$G\5?+TVA10!_3_ $5_
M/-KO_!2CXN)^QW_P5=^,>C^.OA/_ ,+;_94^+WQ?\._L_60T;:1X)\"?!WX5
M^/?#VJ:KX)UH_P!OZT-WC;Q#N!R&!P<C<#Z7_P %%?V^_CU^SYK%YI7P6\/>
M"]4UCX<?L#_'#]LSQE9^-_\ 0?#GB34/#>N^ _ O@G2QJV0!HGAW^UO&WB_Q
M7[:1X3' (H _<ZBOY^_B!_P7"\+_  CT;QK#XP^"$]_XP^&'B3]J7P;XL\/^
M'_BAX.OOMFH?LL_LZ:/\>/$6O>'>?^0'XS&K'P]X3]#G.:X^Z_X+CZO\/X_'
MOB3XU_LA>*_!_@_P)8_&WP[?ZIX4^-W@WXCZK=_$_P"%GPF^%GQW/@[2=)T5
M@1HOB/X<?$SP4/\ A(<_\4IXJ.NDAO!P/B@@']&E%?A1\*_^"JWCSXE?%3X<
M? )/V49K;XR^)?C=XU^%_P 6++1OCOX8\1?#OP)X8^%_@WX6?%+5_B/X*^)>
MB:'M^+>?AU\3=))\/>'E'B=?%>CGPFPXR.&^+7_!5KQ_\ _VA_VE/A%>?#)/
MC-K'AKXY?\(;\$?#7_"9^&/@[X<T+X<?#K]D3P'^T?\ $W5/&_Q,UP_\(\=;
M_P")KJW_  B>@$9\4#*J<>'"" ?T(45_.%\0?^"^GPZ\(:W+>P?!GQ7K_P +
M_P#AG34/CM:Z_H_BS2['QO8^)]'^!/@7X[?\*Y^)G@C6M#)^'^N_V#XWT@$_
M\)1XG'A?'_"7^+E'@XD5TW[.W_!1+]I+Q_\ M(>!O#_Q.\-^ /#OA/QG^V]\
M7OV0M3^'_@?Q)X/^(P\+#2?V1/ ?[2'@G7]*^)>AL#K9_MQ?&W_"5]\>)-#'
M3PZ<@']"]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 ?.GQL^*>H?"?2/"5_HW@J\\?:UXY\>>&?A]X<\/V^L:7X</]
MHZS@@ZKJ^M$J,?V4V0R$GC)X^;G/^%L_M1?]&F6?_A_O!_\ \RM1_M+_ /'[
M^S-_V<Y\-_\ TU>(Z^2/VMOVBOCI\,OC9)X?^$VLZ&/#'@#]F:__ &H/&/A2
MY\/:9?:KXI\,?"SX[^ M&^)>E:1JK#"EO@[J_C8>$E'!\5:1H/!+'(!]=?\
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M/TK]3*_+:0_\;H$/:W_X)B?^_58!(]QZ?TH _4FBBB@ HHHH **** "BBB@
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M51I6E$_\3H^(]";2/AAW_P"$J_XD?A DY&?SU\(?\$)OV>_ 6CZ-=^'OBO\
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M.WL=-L/$GP?M;:SM[8V5C9V ^,G@+  .0%QU QSS@DDUT&D?'O\ 91T4ZD=
M^,'P/T<W]T=8UG^R_&7@VQ%[?GKJ>J@,H#9'#$'!Z9R:\(_:[_:&^!?BKX$^
M)]!\.?&#X;:SK&H^+?@_;6NF:5XQT#5-5O#_ ,+D\!C']DEB?Q Q[CN ?I'7
MY;+S_P %H+H]1!_P3$T__P!:JU?N/7C_ ".?U)K\LX?^4T/B+_M%_P"%O_6J
MO'M 'ZF4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MDZ!XN.1XD%?>OP\_;5^.-]^R?^V=^TIXO\-6\/Q:^$%UXX-K^R//HR_\)%\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_A:O@S_H3=8Z_P#$\[X.<>O7.,^P_LZ?\F]_ G_LD'PQ_P#4/T>@#VNBBB@
MHHHH **** "BBB@ K\+?VX?^"HWQ=^%?[47@;]@/]AG]G6']J;]LWQ)X-/Q&
M\6Z-XL\5CP/\)?A!\-P3_P 3_P <>-\D?VVX  '#*&T+(W>) %_=*OY*?''Q
MC\!_\$U_^#A?X]?'G]K/6S\+?@#^W/\ LJ^!_!OP?^/'B?CX<V?CCP&O@1?$
M/@[Q9XVZ>&>/!/ ((_XJ3PC[$ 'UO^S=_P %._VTM3^/'Q9_8?\ VP/V']"^
M%G[5]E\"/''Q?_9^N_ASX]U/QE\ ?CZ=%T$G_A&!XW.AY\&-XAUX#DG ([$Y
M/R7XB_X+&_\ !9'P=^TS\+_V/O%7_!+/X":;^T=\9/ ?B#XC_#KP"?VJ5O1K
MWA?P+_;'_"0:H=7&A_\ "/:+@:1JZKSD@<Y(!KQ+]E?]NK]K3Q#_ ,%@_P!F
M_P#9F\(?\%0O"?\ P41^ _C]OC!XS^+]E\(?@WH'AWP=\'_"Z^#]8UCP/X/U
M;QOHA\2#6^FD,OB#_A)MPX^ZW ^W?VKIH1_P<Z_\$P8O.M_-_P"&'_VAQ]G[
M M_PM3'KUY SZ&@#$^//_!6__@I5\-?VC?V5OV/O!/\ P3U^$GC/]J/X^_LN
M:A\>/'?PHUC]HP:4?!/B?PWXS\>>&_$'@_2/&QT3_A'M9T4Z%X*TKQ!P>?[9
MP3C&/I/]AG_@J?\ M#_%G]L37?V"/VZ?V/K;]E+]I4?" _'?P39^$OB-I?Q5
M\'>*_ ZZJ=&U@#5UYT5E8$%.1PRL,FOR"_X+AP?!Z\_X+G_LCZ3\=_VNO$G[
M$7P[N?V!_%%UJ?[1?@;QY_PKGQQX4U#_ (6+^T"-)TK2/$&./^$B/_%/X^8\
MXYX%><_\$]O&OA;X2?\ !7?6_AC_ ,$^_P!KK_AYI%\=/V0O&]_\2_VD/CO_
M ,7'\2?!_P ;>!-,UC_A6.@CXQZ,/^2<MK?]D_\ "6>'@,_\5+A6S@T ?U9?
MM^?M67_[%G[-WB;XRZ)\%OB1^T/XQ_MC0/ G@/X5_#/1M4U75=?\4>,-4_L?
MP]_:VJ\CPUH//_%6>(">..^"/@S]A;_@JQ\8/C!\=OVAOV3?VV/V6/\ AE+]
MI?\ 9\^#'_#1>L^'_#WCW3/B-X/UWX0C^QU&O?VNG&CZV&U;2]ROD9))9=H4
M\I;_ +<O[??[ GPT^(WQQ_X*\>%O@-K'P9&O?"_P5X2U3]A"U\9^,?$7@G7_
M !WJOB,>(O&7Q+'Q!;P2FB_#H!-)SKZDE&P<?-\WY)? /Q[\#/ 7_!0+_@H!
MX!_9.^.?Q&_;P_9X^/G_  3]^)OQN_:D_:$\$VNE_&?]HKX/>(<^(QX=^'/P
MS^)VM?\ %/:UHA\+:L/^$1^%Q!RWB10"&\% @ _2/]CS_@LW^W)^V-XL^#6J
M>#/^"4OQ/MOV:?BQX[_L6']H_3/B+I6K>%-"\$_V_J^CZKXS(_L-2=$4Z3D8
M9<\X/1JV_CW_ ,%D/VM_#O[5?[3?[-G[)G_!-#X@?MC:=^R_XC\+^$_&7C?P
M7X\TNPQXH\2>#?#GCO\ LO\ LG_A%F(.-6P2#_S"..M?@)\#=9_9&^!WBK_@
MD+XW_P""1O[8'[1WQ.^/WQ7^/'@;X5?%W]F_X@?%$:OJO_"D58GQOI?Q8^".
MB:Z?#OPE_P"$<\+#5F5O#A_X14Y_X2W P"W4_M?^'_\ @FIH][_P5P^-.D?M
ME_ML_L[_ /!03X4?M#^-_&7@/X:?$#XC:7\%KZ\^, U,#P3_ ,*G^&7P^UO_
M (NW\.O$(QX?\*>(/$7_ !50\*]NF0#^@3]K[_@K+^T'\*OB?\!OV7/V4OV(
MM5_:'_;*\:_LZ6/[37QH^$?B'QZ/!^E_!+P.VA9U?0?$&KD'^V?B*=="^'PO
M3H,?\5&*_1#_ ()T?ML^"?\ @H-^RUX!_:.\&^'-<\#/XBO_ !1X<\9?#_Q+
M<+?ZKX(\<^#]5_X1WQKX/U7.?N:X,C*GG!.2#7\S_P !/VI(OV3_ /@KA\(_
MVK/^"C'C&P^#6I?M0?\ !&+X/B^\6^/P/#ECK'Q'T<^ _$?C?3#D@:-K>/!&
MK%O#^=Q\4:N=OS8K](_^#8CPKK>G_P#!.SQ1\0M2L+BUT#XZ?M:?M#_%_P"&
MLMQ;?8C>^"/$?B :/I6I@=PQT#5ATR!\O+8- '](E%%% !1110 4444 ?A=_
MP54_X*$_'?\ 9X\?_LU_L4_L1> /"GC_ /;=_:ZUG6(? 5QX^W#X=?#/P1HV
M!J_Q/\;* 3K(R.%&0PT?7>23BO(?AG\1O^"X/[,/[5'P%^'_ .UQX=^$O[;O
M[._Q^U@>'/&7Q6_9=^$_C/P=XC_9KU ,,:[XU !4>"1NWEFP2/[=!^;:I\F_
MX+":-\5/V6?V_P#]A#_@K1X1^&OC3XT_"'X#>'/''P9_:9\/?#31CXC\<>"?
M WCHXTKXBZ3I.3NT-?[6U4.-V0<$XRM?DS\=_P!I/_AL#_@H9\$?'/\ P3+_
M &J/^"E_QT\0_%?]HOX7^+?C1\&].T;XR?#G]E[X/_"_1QX;TCQ%IA_MKPIX
M;Q@Z2=?\5X)\*G&NG/7 !^A/[<G[8G_!=C]C?XR_ CP5?>._^"?DV@_M;?M(
M:A\#/@1]C^$'Q'O=5TC?K^?!/_"R_P#BXH!_XD>K:3D^'<D'.<$XKN/VT?VS
M/^"PO['OPV_8S^'WBWQG^QC?_M4?M3?M?:]\(+#Q7IGPO\9_\*DL_!!\&Z.?
M!)U72M;^(O\ PD&C:V=;;Q /%FO@E1X6&!@BO2?^"\&DZMJG[0O_  1:GT[1
MM=U"'2_V^M%N[ZXT?1M>U7[%@>&O^0J=% _L8,03ELY)(X  'B/_  =$:/X&
MUBP_X)IQ_%;PKXS\8?!JR_:SUX_&FR\#^'/$_B+Q&/A>?!N/&V!X8Y .B<\Y
M.<]A0!ZQX"_;V_X*I_LX?MX_LE_LL_MPS?L7_&_P-^V'K7B?PYX=U?\ 9;M?
M&?ASQO\ #>_TC2QK!\8^(=(\4:YXE'_"*]B<9QP"*_?7]H'QAX_^&GP7^)OC
M_P"%'PQUSXR_$?PGX)\0ZQX3^$^@7^F6-_\ $/Q,NF$>'_# U;6N.6*\\<')
M["OX:?@=I7['/A7_ (*(?L!:S_P0R^$'[7&@^._^%OC1OVL;SXI_#/XC6'PY
M'[-&L:II \;C5M6^+>B$Z+G1#XA_XJ#PZ0<'@]Z_HPO/A!_P55_9-\=?'S]K
M/6_VM_\ AO#X;^'_  ]\8/%GPY_80\/_  :T'X6>(M>.L:X=8\$^#M)^)P\4
M^),:WX-T/(S_ ,(SGQ3_ &1@'=Q0!\U?LP_\%#/^"G?P]_;M_9E_93_X* _#
M?]G4?\-E_#KQS\1/#GA#]G^;7_\ A8W[-/\ PB.@_P#"2?V9\8A_PE/B16\+
M !?#X\0D-T(&!X=85XIX/_X*W_\ !4G]J?QMJ_QM_8P^$O[(?B;]F*V_:!\4
M?"#X=?LT^.?B+I?@_P#;#^/O@GP%KW]D>-_B-X(.M_$7PYX=T5E)!7?D9YP=
MIQ\J?";]H3X)_M5?\%4?V+/CO_P3/^%7QS\ ?M!_'#6?&]Q_P5?M_$'@SQG8
M^#]&^%^KZ'_Q47@[QMJ_Q!\*_P#"._VYX>UH8\)^(/!HQQX3)Y(Q^1A_9[_9
MU^#/[-O[3'['_CS]G;XZ?\/N_#G[7NGZ1^RKK_A+P'\1[_53X?'Q%\#?\(/J
MG@GQMHG_ !3_ /PKD:(?$'B#)'36/"0QD_* ?U2_\%%O^"G'[<'PS_;ET7]C
MO]BC2?V4+6ZTC]G30?C?\3]3_:[\9_\ "N=(T'4-9\8GPYI6EZ7XV&NCP\VN
MDG2?^) 0<$DCKS9_:4_X*#_\%)O@A\,?^"?O[.I^'/[-</\ P4Q_;G\>>/\
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MQ%_9L_::\;ZS\.O'GCK2OV=?$'[,W_"5?\8^?#KP\OA]A^S)XA\.>&!XJ/\
MP@FWQ@1_PDI- &?X]\2?\'%/Q5UBS\0_%?\ X)/?L%?$WQ%8:8VC6NO_ !!^
M'/@WQCJMI8'+'2QJNM?$8?\ $DSDG'<DGO6G\./B#_P<G?"+[=_PJC_@EM^P
MG\+O[3.=4_X5[X*\'>#/[3//_(6_L3XCC=GT.0>#C@5[E^RMXM^,/PZ\+_\
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ML_9]'AS_ (56-8^'0UCQN?V@]7/Q%;^QE\1:X WA/'7PNH&0":_>&@ HHHH
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M?[,_[<7Q]^$OA>[^.GC7]H?]NC5O'OQ _P""?_[17[3GASX=_MA?"OP;IWP
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M,T'Q#JWP^T/PY\,/B!KGPK_LG_A(/"0_X1H''B,^$?&!QX<K]6_V&O'GQO\
MA]^V-^UK^PY\8_C?XL_:7L/A)\.?@?\ '?X0_&/X@:-X-TKXC?\ "+_%\^//
M#?B'P;XV_P"%?^%/#7A_6O\ A'/%'@K=X4\0#PSN_P"$5U;;DCJ ?LS17Y-_
M$+_@IIX!^'_PL_;Y^+MS\-?B!?:;^PA\7M.^#'C+2+*_T'^U?&VH:Q_P@9_M
MWP/G.T$?$O201XAX_P").>=Q)KPG]H/_ (+ GX)ZE^T-XP\._L>?'/XW?LZ_
MLL?$73_@Q\:?C]X&\4?#BQTO0?B[JX\-C5=*TGP1K7BH>(/$^A^'3XW\.Z!X
ML\0#CPID*<]2 ?NU1699W N+6.;'_'Q;"Y_,=S^7K7Y-?!W_ (*H_!'XK?$O
MPIX5\._!W]I^'X0?$;5OB/X-^$/[5^H?"77;CX!?%/Q1\+1K/_";_P!DZMHH
M/B'1=#QX4U8>$_&/C'PSX6\*^*CHY'@]@,T ?KQ17XZ?#;_@K=\,?%WQ&\%?
M#CQI^SE^U/\  >'XP?#SXO\ Q/\ V?O%GQ@^'.A>#M)^-GA[X*>'F\=>-_[)
MT@^*?^$A\ ^*O^$8_P"*A'A_XJ>&?"9((^;&0WB7AS_@NK\&?'-Q\-K'P3^R
M7^W/XGU7X]>!-9^(O[,OA^R^"_@ZQU7]I;P_X#.?&^I^"!_PL=O[&/AW^U=)
M\0$^(_\ A%R.<$9((!]U?!']A[0O@[^S_P#M,? "V^(OBC6+#]I#XC?M+?$;
M4/%%S;Z987WA4_M'ZGK&K:MI6D@#YE\.C5B<'(R!D J#7Q?I7_!)WXJ?"GQA
M\%?&O[-O[=GC3X(^)_A?^Q5\(OV']9O;SX$?#CXC+XV\#?!4C5_#WC$_VY@Z
M+KASQC(^7&<[0>(_;E_X*8_'Z;_@FE8_MP?\$\OAKIVL>'_$?PZ\0>//$?Q2
M^-=UI?ANQ^ 5AX#U4^'/$6FZO\,B3X@^(/Q%.N?VMH'_  CW'A;/APG+'D<;
M_P %$_\ @I#\3OA#\=/@7^S)X%_:*L_V9)-=_9SUC]IGXC?&31_V<]?_ &M?
MB+K&=>_LC2?!G@CX(:-HAW:+_P A77_%?B Y_P"$6\*_V&1@$B@#]6?^&,/A
M3XZ^'=YHG[1GA;X;_M ?&'5_AUJ'PQ^(OQ_UGX0?#CP?\1O%>G>)-,U?1]8V
MZKHGA8?\(Q_Q(]6P#X>P0<$A@%#?%/PF_P""14FBZAX%L_VB_P!JCXD?M2?#
M'X%_L_\ Q1_9G_9^^'/C'PEX.\'_ /"%?#?XJ>##X!\:ZIXUUC1#CQ]\1#\.
MA_PK(>(=OA@#PIG*JQ('UQ^SM^TAXBUG]@SP!^TM\2/%OPX^-_BJ/X':C\5/
M%'B+]ER+7M3\#_$T>&]+U?6#JGPRT?62?$&[QF=(P?#[ $>*C_PB0R.#XQIW
M_!7K]BZ\\=_#KP+:>)?%@U;XJ_L,:A_P40T74SHP.E67P.T70CJX'B#&M!O^
M%B'0](U=CX?(<J?#K#<%*D '.?LL_P#!-'Q7\!_C!\'_ (H?%7]JWQW^T9I'
M[*_P7UG]G_\ 92\'>)? ?@[P?8_"SP1JX\-Z/X@UWQMJVB9_X6#\1?[$\*>'
M] _X2#'A@CPKHV I)R/T5^-?P0^&/QZ\+:=X&^+7AP>,/#=AXV\#_$73]*^W
MZG8D>*/A9XR\.>//!.JXT4Y_XI[Q5I&DGL"%R,'D?D;^S+_P4U^/'[5/Q9_;
M#T#X:?LC?%F\\"_##]GWX ?&_P#9PTSQ9:^#_AQ??$G6/BGX-;QUI6@^-]6U
MCQ9XA&B_\)G_ ,2G_A$B00/"VC:ZP 8*1X7I_P#P4=_;1\-?\$LO^"@/[3WQ
MJC^'^C_M2? O]IKXO? GP9HOP_\ ")\9^!OAOJ"^,? G@7P/I>DZ3_R'_BTW
MAU_&X.1SXJQ@8QD '[S?'_X66GQR^!'QH^!MWJL^A6/Q@^%GC?X4W/B"S/VV
M^T?3_'?@[6?#9UX<')"ZJ2!C!(P< DC\T/VE?^"/7P8_:3^&'[#'@37O'7B3
M0?'_ .PEK'P?;P%\7M T?2O^$D\4^%OA9_8_]K^#_&VE#*G1/&3>"=(UY@K%
M?^$JTA3D%ANA_P""5G[3'BKXXZC\=M*^(7[<VL_M+>,? @^'_P#;'PR\?_L9
MG]B;XB?!\:T?$7_$VU;P/K1&O:YX6^*14'PGXA(RHT@["22K>)?\%6OVI_VR
M/V1--\<_'WPC^U!\$_@?\#_"7A?PQ;?LZ_""\^$'_"X_%7[8OQPUK/B35?!O
MC?QK_P TDT/ TKP_X2\0>'<D_P!L'Q;XO\6<8H ^N-7_ ."6OP7\:?!W]N;X
M(_$[6]8\8>#/VW_V@?&W[1.M7DEAI6E>(_A;XV\2:5X;/A_4_ ^J\_\ $Z^%
MFN>"M*\0>%/$&1AE!PPQG[E_9[^'?C;X4_"+P)\.OB+\5==^.'C3PKX=T_0M
M:^*_B71],\.^(_&HT<!1JFJZ5HQ(76@H.0 %));@EMWX??\ !37]L7]N;]E[
MPM<?M,0_'?X,?L[_  OT[PC\,/\ A1G[.US\.!\:?$7[6/QPUG3/^$D\:_#?
MQI\3!M'PDT+:W_"/>$O$/AL'A?\ A+68E>?M'_@HU^U;\7_V;?V/?!WQ)^&]
M]X ^&WQ%^*_Q/^ 'P:'C[X@'_A(OAS\"#\;->T?P[JWQ&\0E2-!UK0O!K:L2
MP8_\(LQ_L-6#*: /O#X0? ;X8_!2?XHZA\-]"D\,WWQK^*?B#XT_$N62ZU.]
M.O?$?Q=IFC:-K^ND:R2?F_LC2>@P=I!Q@ _0U?ROZW_P4M_:F^%NJ_M)?L9Z
M7\?OA/\ M0?M+:%\;_V(O@Q\(/VK-&\!^#;'P[H(_;7U_5O#9UWXF_#'X?>*
MO^$?_MOX%?V1JOB'^P/#PSXJ_P"$DT$8Y-?I'^P=\;/VAM/_ &COVMOV%OVE
M/B+X>^-_Q(_9TTGX,?%;P=\=O#_PXTOX6'QK\./C7H7B(:3I?C?P3H>?#^B^
M*?#FN>"/$.@?\4[D'PM_8.<8R0#]?:0]#]#7YEP_\%+O@#+\(Q\9O[!^)'_"
M*S?MC?\ #$QMSX<TO^U?^%OGXQCX$C5!C7,_\(K_ &YC_BH,X[=*\#U;_@LI
M\ -)^(%CH,7P1_:@UGX/ZM^TUIW[(?@[]I_P_P##G0=7^ /B/XW:QXQ_X0/5
M-*TG5_\ A*?^$A&A^'-=_M_0CXA_X1G_ (1<-H^O9;'% /17/TQ_:%A,OP<^
M*L6?^/CP/JT6?0'3M8/4],#!SVK^?[_@AA\/?#]G\2/V@M5U+P]HFH:QH_A/
MX17.CZI>:9H-[?:/_P 3/XJ?\@G5=K'1^>< @YY)(R#_ $)_&F+SOA9XZAQC
MS_#VL8/N-+('7Z=?I7XE?\$FOAW#;_%GXPZK-K?BRQN=(\"_""Z&F:/XBU2Q
M\.ZQG7_BGDZMI0Q_;1QCD\<D=2!7\X<7YC[#QN\/\+=.^ Q^EU]J_2_WZ>I^
M^\#YI]4\#_$7+5=?VKF.17W=N25[RLUVL[VLMV?T1T4#H.WMZ45_1Y^!!111
M0 4444 %%%% !1110 4444 %%%% !1110 45^5__  5X_:<^+7[(/[#_ ,1/
MCS\#K[0]/^)/A?Q'X'T?1[SQ!HW_  D=C]@UCQEI&C:MNTD=1CL,C(]<5_(Z
M?^#AG_@JG+Q!XX^"0]1/\(-*'Z#Q4/>@#_0RHK_._@_X.)?^"K,W'_"<? O[
M3_;(L,?\*5TO&/3'_"5#Z?\ UJ^Y_!G_  6%_P""DNL_LR>/OB-K'Q4^ ?\
MPLG2O'NC>#?#A'PYTP>'+3^U]4\!C^U#@C(_L/5_&_!R ='S@$#!^NWGZ ?V
MLT5_G:ZK_P '%G_!5FTM]7G_ .$O^"7^C$VP_P"++:5QUR0?^$J]R,^]4-,_
MX.-_^"K%W_:0'C;X%XT^UL#_ ,D6TON3G(_X2KKSD^O\SRZ]NOW ?Z+-?(/Q
MK_91^'OQY^(7[-/Q4\;ZAXLB\0_LL_%74/C!\.[?P_K6FV.E7GBG6/!GB3P"
M?^$J4Z&QUC0_[#\5ZK\F1U)R6R:_C<^'O_!</_@JQXP\#_$OQ3/\3O@7;:EX
M+MM.-IHUG\%M+^W7AU?^V#GOWT@?C[XKQ;4/^#B7_@K#9R30_P#"?? K-O:_
M:B?^%(Z6,_\ EU=.<^E ']E_[0O_  3Q^#7[2WC3XE^/OB+K7Q(L-;^+'[(/
MCG]BCQ);^%_$FF6&E6?PH^*FO_\ "2^(M4TD?V&W_%;G6^1X@R2 0 .]9G[+
MW["NI_LW>*+&]M?VR?VU_C=X3\/>#O\ A$]+^%'QX^)/PY\9_#*TTU?^)1I>
M-(T/X/>"6_MWPZNE,JG_ (2;ACG:R\'^-[3?^#BO_@JQ>2>2?'WP3R=%.L9_
MX4AI><$YQG_A*LX]OTKV7X'_ /!>C_@J'X]^('@_1/%7C[X-VWAC6[H?VS>:
M/\(-+.JV6GC..O?W W#F@#^J[]I?_@GS\/?V@OBSX5^-'A7XH_'7]E_XN:7\
M.?%'P5\1?%']F?Q'I?@W5?&_P@\2:HVL:Q\./%?]M^%O$F@''BD#Q%X4\08'
MBKPKXIY7=R!Y)XI_X)%_L]ZQH7P^T#X._$3X_P#[+=Q\+_@$/V3+GQ)^S_X[
MTOPWXC\;?L\AS_Q1GC?5];\+>)?[:(US^W_$*^,"%\5>%?%FL:ZRLV?E_EEN
MO^#@S_@K%9ZI#8'Q_P# O%Q=?]$1TK/L/^1J]C_^NN/A_P"#CC_@JS-]@A_X
M3_X%_:;BZ-J3_P *1TO_ .:H^_\ 7W//IWZ?>!_?Q\%?A+X!^ WPL\ ?!;X7
MZ);>&? 'PN\&^&/ ?@W0++C[%X7\-Z8-'T@=2>G4].,X ( ]IK_/J^&__!?W
M_@JEXK\6^&-%U/Q_\$K:QUOQ'8:+<WMG\(-+[]3G/'IQGC@>E1>//^"__P#P
M5*\.>*?&&EZ/XY^"DVCZ%XDU#1[6\N/A#I@U0Z?_ &F1R!U&.V",X/4 @\^G
M?I]^P'^@U17^=-<?\''G_!5.SU"YBG\8? NYMK>_U"UX^"VE#.,XZ>*N?4CI
M@GC%;&E_\'%G_!5F]NK:'_A+_P!G[G.0?@^.G'7/BKG\>W'I@ _T0:*_@W_:
M,_X+Q_\ !2[X5^.M2T3P?\3OV?M8T&XT:PUG1O\ BU6EWNJV>[.=!U;_ (JK
M_D.'KSP3]!CP9?\ @XC_ ."K$UUY,/CCX%'_ $6PN?\ DD&EG@G)_P"9JYR>
MH[D9YZT ?Z!WB"PFUG1=8TJ'5K_0YM0TR_M?[3TPXU6S)X_M/2CD@G)X'&3@
M#!P3_/E\-/\ @B-JMY\6?%?CS]I;XW_#?X@1:G^SQ\<?V9-9U/X)_L^Z%\!_
MB9^T5X8^-FECPY_PF7[7?C?1?%)T#XM_$;P9H9'_  B9'ACPQ_Q5?_%6\D8/
MX^>$O^"[/_!1_6?@!\:?B!>>./A.?%/@?Q'\(+7PY>6?PKTL:2=/\>ZGK U;
M(& >-)QSGVKQG_B(@_X*I1_OO^$D^"=_US9_\*?TL'_U*C],]?3GJ ?T?Z;_
M ,$TOVMM=^#WQ#^ /Q[_ &^[GQ_\-T_91\<?LA?"'POX,^$/_"NO#EWH_C#P
M_HW@+2?C)^T'X=;Q7XC/Q9^,'AW0]( \*#PV/"WA4M_;Y(RQ8_L!\,_AW#X$
M^$7@/X6:C=_V]%X(^'7A?P'=7ES:C.O6WAOPPNC$C2^>"H!V]3@#MQ_"!'_P
M<7_\%2;R2VM8=4^!0EN+J_M?^24\\<CC_A*NW;GC';''V]KW_!9;_@H_IO[&
M?PN^/VF^*?@E?_$CQ9\5O%'@36/#_P#P@>E'2K.PT;^V.<#Q5USI/7K[@\T
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M ++7PX_9;N_#O[3/P^U/Q'XX^"A\#>#3\*_&_P 1/AH=%)\/^/\ _A(_"_\
MQ/\ _A'O&3C_ (1CQ8H 8C@_9?Q:_9,\=7W[!OAK]D7X$>._ \&M>"_AS\-_
MAQIEY\?_ (=:9\5/AS\3?"_@,:3I&K^#OC7X&UD%F\+_ !5T321X>\6#P\!X
MI\+#Q(2/?^)[P%_P='_\%9_%FH/I0\-?L[_:?LM]=$#P&?X3D?\ ,U?H>#^E
M3R?\'6__  5$L[JVTJ?X=?L[W-S<W7V7[9_PCFO6(_7O_GK0!_1GX4_X(U^+
MXOA?\;_& UO]FOX _M1>)?BO^RS\3/@/H'[._P +]>T_]E_X!']D'5AXB^&7
M@TZ2W_"->(/B!HGB+7=6\;?\+KU_HW_"2$ #_A&\G]#?V*OV5_C9\-OC7^U+
M^U7^U-XG^%_B/]H/]I*Y^&_A:YTCX+VWC&P^'/P^^#_P6T'5M'\$^#])U;QH
M?^$@UK6_[>\0^(M?\6:^PX.K\<8)_BOT;_@[J_X*1SR0_;/A#^SO<FYM0+:T
MN[75;!OMX/ RN#@<GK].N*]/\"_\';7_  4%UG6+#2;S]FSX"7-Q<W7V7C4-
M>L/S(.?ZGOVH _H+\1?\$O?VVO[0E^$'A3XW_L^6O[)=E_P4CTW]OC1O[8\)
M?$8_&^[_ .+[K\=O$/P<U8@_\(]@:X=5_P"$4\09!(7PH>0!7YJ>(='^/&J_
M$7X4?\$Y_@/KWB/Q!\,/A[_P5@\+?'<_ _QQ^R?\9?!_Q^^'_P .-'_:*U?X
M[^-M4\:?&, ?LX:W\ ?#NNG5]?\ "?Q0\/>)?^$I\4G6-"\(@9X'P?XX_P"#
ML'_@HSH&L:EI0^"OP+T^YM[K[+]C%KJNJ_9.,<G@G/OGI7G%U_P=8_\ !4V\
MU"_L+/PA\"[#[/=?9?M8\&_;N.F, _\ ZC^.0#_15^(]OY_@CQ9$3C[1X?OQ
MSW)T\?7KSSU&37Y3_P#!/W0/%^@?&OXA1:0- /AJ?X=?#+_A,/[0.J_\)%G^
MV_BG_9)TK'& I/WN,GCG%9'_  1W_:\^.?[='_!/33/CE^T3JGAK4_B1J^N>
M-M&NKWPIX<_X1RQ_L_2-3(THC2AT.TGGKU!X.:]O_9N;6/!_QN\9Z+8>#/$F
MMPZO\+/AU]JU_1YM!'AWPY_Q6'Q3XU;^VO%7_"0-SV\.^&O$V>N3BOXE\2LQ
M>'^E!X;86[UP..T3[JVJ3_-:W>Q^H\.YA]3\.N*\M=G_ &IC\O=FM(\MW=7V
MM;I:S2U/U4HIJ?='X_S-.K^UX?!'T/RX****L HHHH **** "BBB@ HHHH *
M*** "BBB@#\0?^#AO_E%S\9?^QV^#W_JQO#E?Y[EGU_ _P S7^A)_P '#/\
MRB^^+?\ V/?P>_\ 5BZ/7^?(LWDR8_#Z_P"<_P#UCV/75=@.>@MSYEK80_\
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MFG^/?['\0?\ (6L]0UCKW_SV]_!_V/\ 3?@GJ7Q2T?PK\5+#[?\ VAXCT_\
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MYB@Z?YYS5;_@HM\"_P#A4_BCPQXDAFN+FV^)'^E70^R_8?\ B8?VID?^4/\
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MGV&N?\3FUL[/_D%?\@OZ]N?R/X?V#?LF_!?]F_X;?L:^ /!_A"PQ;6_]G?\
M"1V=G:_\A[Q1_P Q;5/_  >>_P#];\>?^"LG@GX8^,/"/_%-^%;BP\<_!_\
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M_B9-_C^.2.>E?HK\._BCX$\$?&_Q7_PEGB.V\/7.N?#'X<VNCP&UU2^^U_\
M%9?%+!7^Q@<GCCIQD[@1@_FK_P &XJ^5_P $I_#WJ?$/Q$'/OJA_'M_.OTU_
M9-U+[9\:?B/W_P"+8_#K]/&'Q4'^<9S]:_A?Q2P__'57AKB>V QR^YJU_)I?
MJ=4,\6&PL<LO_P C7F?IRMM:?+?2VAV_C'XQ?&[1_'WC73_#?PNN/$.A:-XZ
M^$&C^'-4.@^,3!KWA_Q?JA'C?4QT_MD^#0=)SX@'_%+^%AJXR<#C[SH'09]*
M*_N6'P1]#E"BBBK **** "BBB@ HHHH **_*[_@LEXD\2>!_^"77[<WB?P?X
MC\0^#_$FA_L\>.+O1?$GA/6=4\.>(]!U #']IZ5XAT8[M%)R2" . 03TW?FA
M\7OV<-%_X)SZ!^PO^UY^S)\9?VD/#VM>-/VD?V0/@/\ &#X3_$W]HSXQ_'?X
M=?''X8?M':_HW@3QKI?_  A'Q:\4^)5_X6+X>&K?\)%X2\0>'F\*L!X:!VD[
MMH!_4!17\ROBS_@L;\2_"G[9/@7X+>)/#?[(=_X!\?\ [9NC_LEW7PT^'?QD
M\8^/_P!I3P3IVLZ]K&C^'_C'XW\1>&-"/P0T5<J/$)^%P\3#Q5X6_M< D^,/
MEKWSX3_\%2/B!\2M8_9M^"<WPN\$:?\ M;>/OVSOVB/V9OCY\+].\2:I>>&O
MA9X(_9:_MK5_B=\6=  (U]L^!V^&1\)AP06\? \NH( /WNHK^?K_ (+>?"OX
M5VWP7C^.6HW/[0^I?M'ZC=>!_P!F;]EOP!\)_P!IKXM?!;P[XK^.'QL\8CPU
MX&_M?P]\/_%GAO0-:;P[XIU;_A,/%A8$GPIX:Y(Q@_I?^Q5^SKJ7[+O[,?P3
M_9[\0_$WQI\8/$7PW\(V&C>+/B7X_P#%.O>(_$GC;Q1G^U_$.JG5M:*Z^5_M
MPZJ?"B]!X6'4G:: /AC_ (.&?^47WQ;_ .Q[^#W_ *L71Z_SVY?._P"6,.,9
MZ<?X?C^/J*_T)?\ @X5&_P#X)@?%Q>X\=_![_P!6+H_^?PK_ #[+/I^)_D:*
M7V?G^H>FOD?MM^PW\,?"'[7'[-/Q+T2'PWX3L/VAO _CSP/=>#?%FL8L=*&G
MZ/JFC_VL/^)+_P!#%H?]K>'\ ].G>OKKX@_MG?L_:=\+[WQ_9?#'XH7XT_\
M:"U#X(^+? _B#^R_!VJ_\2?2_P"V-6U3^UB/3&.>3^!/S-_P1G\*ZK#I?Q"\
M230W']GZYK)M/^OW3M']/6OZH(_A=\*_BIX'O/#?CSP!X'\<^&-0UG3]9NO#
M_B#PYI=]I7]H:/\ \@G5#_U'./\ ZPSS^N<*^(^4TLOP^6<290\5E>48^^7?
M[<XZV:QCMLM]+6Z6D?0Y7FN&7^S8W 6LKWOVZWOY=]C^27_@J3\;/A9^T1\!
M_AOXJ^''PK^+_P -X?A_XR\+_P!CZS\2_#G_  C>DZ]I_CS2^/\ A"-6)/\
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M[ON^^[]3_+ECFU7P'XVU*:\^T?;O ^L_V-=V=Y_49_S[5_:Q^TM\-_V?IO\
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M+-JL%_<V_P#9_P!JO+/_ *"'^&?PK^[K7O$E@/"?V"\L/LUM]E(M+P=_Y_\
MUOUK^(?_ (*7:'#H_P"U)<ZW##]F_P"$X\.?VS=?]A'Z]<']*Y\\SS%9MF^8
M8[$74<U^%*ZBKNZLM$M%T2ZCQ.(^L8GZQKZ7_3;^K'DO@6$_\,E_M)]?^1\_
M9W]NNJ>/,_\ UQU'O7S18?P?Y]*^E_ O_)JO[2</_4^? _/_ (-/'G'Z#N?P
MKYO4F&/SO_K_ $'^?U'%>2<Q^S'_  1O^!NN?$+QEXS\530W%MH__'M_;%G:
M^V?_ *_7T]Z_I2^&_P"QMX5\'QZWXQTW^T+FYURZ^U7-Q>W73\_7//IUKX/_
M ."%OPWU6T_95T_Q)#_HW]H>(]0NOMG\\_3COGO7] -W9S:;X7YA%S<?].?'
MVS_/)Z>^<4VFMTUZIK\T@VWT]=/S/XY_^"W7B32O#^C^!OAU#_U$+K1KR]_Y
M?,G^?U_*OS-_X)IV<.O_ +17@#P!XDO_ .Q_#'CGQ&/[9N[+_//O_P#7R/TP
M_P""\7@^_O/''A[5;S_1O^$:\-_:K6SO.O\ Q.-4]>X__7WKY'_X(]_!_P#X
M61^TMHVK30_:='^'^C:AK-UD]=0_/T]?IS2 _LY\/_"OPW_;USX;\'_:-8\'
MZ?=?9;"\O+K_ (E/_(+_ "/_ -?VS7Y"_P#!7[]F_P"'7AO]D'XNSZ#86]AX
MPT[_ $KQG>C.;S4?^83_ )Y_*OZ"OA3H\.F^![;3]'L/L%S]J'^AD=_\/3\J
M^'O^"O7@CPWK'[$_QCTG[!]FN=<M?LMU>>G^'_U^G:@#^3[_ (('?$_1/A[^
MUK?^#_$FE6]__P +(^'.H?\ "&_;/^059^*-'Z_\2G@^WT]:_I_^%/[)/B3X
MC>+/^$_O/%5Q_HUUJ'_"1V?_ #^:?_:GU^O?I7\C7_!+'X*ZWX\_;*\'S6=Y
M<6'_  J__B<ZQ>69_P"X/S_GWX/7_0F_9[LYM'\#VT/V"XMK:XQ]JX U7\3Z
M_0T ?S$_\%]OV8-?@^%^C^*O!-AJ&L7_ (&_L_6=9L]'M?\ C\\+_P"<>WKB
MOY9?@KIO]L?$#X/Z5YW_ !+]0^)?A>UO[//_ %$_\.OKV&*_T6?^"EVCZ7>?
M ?XBS6=C;P_V?X#U#[5=V?\ R^>V<=/J/KTK^"?]@_X>_P#"P/VJO@MX;^S6
M_E?\)EI^L@?]Q3_/I^8H _NW^$?PQ\ 0^%_#VB>%;"XL+:WM?M5II8NO^8AC
M_D*9&?\ )KQ_]K#]G[PK\0O@7\0O#=YHEQ<^.?[&U"__ .$@^RY%YSS^N/3L
M>O%?HU\(_A[?Z#(\T/\ I]L/_)/].G7^9Z5-\0(8=-TO6(;S-S<W%K]KNO\
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MK^G]O@7#9^%]2F\2PZ7;6V/LOB/6;,?]!@#_ ">F#UK\0/\ @@IX).F_LO\
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M#Q'_ &-=>(/LH_X1SPI_Q-/^)3I?.#U]/I7]:'A^'^Q_"]AYWV>VN;C^S_\
MC\[=*_DO_P""#?[17PE_X4O\>_ %YJMOX/\ $.H76GW7B.SO+KIJ&C_\Q3_N
M8L^@[C-?T6M\2=*\;? J:[\-^(+#6=7\*:Q8:-K+?:A]MLB"!JHY.23GLN!M
M.3G /%623DKW2=K]TG:_S2O\S$_-G_@J/^WE\'[S]BWX]ZWX!O\ 5[H:5XI\
M3_!'5+V\\.ZIX<)\;Z/J8T?Q#IFE#6@!K)W9& ", '()('\Z7_!%/PMX=U[X
MR:/JLT-O<^)_#=_X7NOMG/%AZ=OSS7Z"_P#!QY\;/AUH_P (?A!^S9X)U#3[
MGQ#J'B3_ (3+QE>:/==-/S_R%-6[=>?7G%?B3_P3S_:PL/V??BAX8F\83?V-
MX/\ ^/K^W[/_ )<SVS_/_P#56M3ZM9?5[WLM][Z7V\P/]%;X>WFMS>#=8\0Z
M1=V]B8#J%U]C]QR,]AR!@^N.Y%>1?'CXJ0Z/^S[\2_$FI6WV;QA;^#;_ %FT
ML[S\/T..*\N^!/[4GPQ\;:/J7DZKI_ABPN/ ?A?Q':^(+VZ_XE5YJ&L__K_
M]:_%[_@H]_P4Z^$NC_LT_'OX+?#>;^V/BC_8W]C?\+ ^U:7_ &5KW]LZI_Q-
MO[(XK$#\E_\ @F#X5L/B%\1KGXMZSQJ'_">6%W==_P#F/?VQZ^E?W@:##!9^
M%[;6_)^TVUQHWVK_ $P\=.W^?\:_S\?^"6_Q.\'^!_BAX/T/4O$GV#^W-9\+
MVVM:/K%U]ATH#^U/^)3JFD_I7]RWPW^)$/Q!\!^*O#=G?V__  D/@?\ XDVL
MZ/W';_'O_*@#B?VTOB=X;\!?LT_$OQS_ */<W-AX-U#6;7[&/RXX_IS7^<?J
MVO3>*O$GBKQ5>Y^WZYXCU#6>O7.?\>]?V??\%4/CEX6^$O['OC/PWK&MV]MX
MP^)'AS4-&T;1[.Z]NI[=J_B?TF'_ $6Y_P 1^G;ZY_"@#[Z_;!_Y0O\ [&/_
M &>;\8?_ %#=8K\+;B:'[!<PC_GUZ?\ ZOUQZ?6OW2_;!_Y0S?L43=/^,S/C
M!_ZA^KY'Y\>_O7Y&_LVVGA[6/VD/V?M$\8?9_P#A&-0^*OA?^V?MF#I7]G_V
MITXQWQSZY]* /[4?^"+?@'Q)\-_V+?AO#XVT_4=-U?7-&^U6MG>VO_'GI_/7
M_/K]:_H!\-WGD^%]'^V6UO;=/LG;[9^7/KZ'KGK7YRR>39ZQX/\ !^C_ /'A
MI]A]JM19_P"@_GWZ=N_3UKZBU#QA?P^%[F;SKC[3C[5]CL_^7/C([_7\: /Y
M5O\ @Y2TV^T'6/#US>?Z3]HM?"_V6]_\'''T_$\^U?>O_! 3X-?\*R_8]^#6
MJS?Z3_PLBVU#Q'Q_U&-4Z<]^W\ADFOGS_@XR^,G@#1]0\#:5>6'ANY\86'@W
MPOK.C>$M9M3??;-0T?//^?2O9O\ @G#^T]\,+S]DG]G[Q)X"U7^S]!T36M0M
M?['_ .7ZS_YB^K:7[$X'?\NM ']/_@70? 'A32[;5;R&WL+_ ,1VOVJYO/M7
M^>GTK^7+_@Z$^,'@_P *_#GX?_#O0;__ $_5[K4-9_X^O8G]<<^E?N/XE^,W
M@#XG>,O@_HGA7QAH]S8:Y_9_V71[/_E\]N#].GY&OXP?^#F?XD:'XD_;Q^'O
MPE\'W_V\_#CP)J%WXBL_3Q1JXQI.E]..<^YH ^P_^#:7X8^#]-^&?QR^/%YJ
MMO\ \)A/\1?"_@.ZL\_\@'3](/7G_H8@/K[>O]P?B#QAI_@_PG#XD-S_ *!;
M_P!G^W^/T[].:_SS/^"1_P 5_"G[)OB7QQX0O/C?\+_$_@GXH:-_9_Q&T;Q!
MK.J>'-5\$^.-(_Y!.J:3_P R_K1'&@?_ %C7]4/A7]O+X1?$+]G?QGXDFUNW
MN?#W@>UT_P 1:+K&CW1OO[>\+Y/_  D/O^7H* /S1_X.BOBG\3M1_8_T*_EL
M_L'AB_\ $-A:W5L<G(U?5/\ B4CD'\^Y%?S!_P#!(W2_#=Y_P4%_9XL/%</V
MG3[?6O$]S:V=X/\ F:/[,_XE/;WY_P#U5^DW_!?W_@K/\.OVR?AYX!_9O^#/
MAK.CV%SI^L>,O$%Y=_\ ,0T?_D%#GO\ YS7X]_ +]HCPW\,?&'PQUN'X8V]A
M??#_ ,1^%_$>C?$#P/K/V'XC6FH:/_S%/^)UCP_K0'0>'^_I0!_IP>"_B1-_
MPH?Q#?\ AN;^SM8\-Z-J'VJ\L_\ H(=2/\G^5?)'[1MGK?A6/X/7^O>)+C^P
M?'-K_;.LV=Y='K_9??OD^YXYK\IOV=?^"H,WQ>A^/6J?!^_MS86&C:A_;/A_
MQ9:_8;*T\+ZQI7_(Y:L/^PYUQ^=?E!_P4R_X*^?$OXP>!_ 'PE^%>MV^C_\
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M.1_97'_"R,D_\38XPP SSG&3@R?M8?\ !M=;_P#-DGQ?_P#",\9?_/'/\O\
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M>>.-8TW6,:GX>\._\+&)_L3;I)!(;'4[>=H^5M5_:L_X-JX?.FU']ASXO_\
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M_P"?/4?^83U_G_45^YW[7W[?7QC^!.J6WP6^%>JV]AKVG^#?"_\ PM7X@?\
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MQX6\:>__ %4C)'X_44 ?G3H?_!<;Q?H'Q1T>_P!!\*W&L?!"W\.>%_#FH?\
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M\GO@_P#"R1T[?TZT ?R,>"X?)T&V_P"OK[4!_/G_ #_,U^H'QO\ &'B3X/\
M['W[,/[/^CZKJFCW_P 2?#WBCXT_$6SLO^0K_9^KZICP3I>/^8+V\0<^IQ7[
M;67QL_X-:K.W\B']CCQE;6]N>,^&O&9_]Z1^&!7IWB+]I/\ X-P/C5XXL[_7
MOV1OB1XY\:ZA8:?H^BV4'@SQE?:M>:?H^F?V/I.E:3I0^(XX X7 XQDECF@#
M^&KXC6<,.J7,T(N+;O==>O\ G'I_*K.G_OI+*$]/\D=?\]?P_L]U;X@?\&M&
MI7M[#KW[%?C+[3;YMKG[;X:\9\ ]0?\ BY'Z\5!;_$S_ (-6H;JWAA_8W\5X
M^S9%Y_PC?C+@=<'_ (N1R>#R..F!B@#\&77_ (4;^P-X9BT&_P!0L?%'[7?Q
M%U"XUF\L[K_B:CX;_"P?V.=,S_U,6M\<]^WK^=WB+R;/1[F:'OC_ $SG_)_S
MZ<?VP7W[17_!M/X[\/\ @/P-K7[-OB2_T?X<:/\ \([\.?#Q\-^,<66G:QKV
M#I>D!?B,/^8X,G))&2.G%5?%'_$,7H^L>(/ _CS]DO5_ WB?0[_[+XC\)^+?
M"OQ'\.>(K2__ .HKI/\ PEG'L<GOQS1Y=>W7[M_P _@Z\/V?[O\ M7%Q;7-Q
MS:_8_P"OY_YSS^ZWQ@_:#\?Z7^PY^R5JV@^)-0TCQ#\1]-\<>&_$7B"SNO\
MF'^!!_8__$J&#_8NN<\8/\J_<72Y/^#4+S;/2F_9VTJP.?LMK]LT_P"(^?7
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M][MI;7>Y^DVK?LY^)-'_ &3_  ?JOC#6K^PN=<M?^$R\-Z/>_P#(*_YC/O\
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M4TJ,?]<LGS!O,H\RYL!E]N9>YS.24HM.-XJ\7=:6;V>3XG>ZU5_U[GP/?_\
M'OH__7K?_P Z^F/V.?@GJOQ^^/7@_P  6<-P+8#^V=9O+/\ Y<]/T<]^G?\
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M?4=>L[)LZ[\4P!JFE%U75VW $,VX<%=N6!'YD?\ !N#_ ,FS_MI_]E$\*_\
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M_P""#G[5VK>%-'ETC5?@I=?:,77V.\\=Z_C^SS[_ /"*X_EU]CC_ '0^BO\
M22\%.#O"+)\BXBSF.3YKE22>BNY\CWM%OF=FTY=;*Y\YG64<0XO/(XW+7@.3
MZ@KK'O2RM>RORN5D[65[V/R1^(&C^=X-%AX5AN-2MM/NOM5K>7?.J_V?_GH/
MY\UY-\,=8AM]4OX9OM-MK%QHVHVO]L#/]JWFGZP?^07G_/OGBOZ*?VO?^"26
ME_L;?LJ7_P 5=3^*<_CCXB:?XBT_[5906WV'PA_8&?\ D%Z2.=?_ +;Q_P S
M#G/; K^=#PSINMWGC+[!H,-Q<ZQJ%UJ&C6EG9VH_TP=?[+]__K=C7Y/XH<=^
M&O'?B3X?^*/#U7^U<I_UD_U?S!YEERIJHHU(?\*"<H1YHNZY9M*^KM&Q]S/#
M5UDM*HK.HJ<DTGM/DDK=U[RMY)H^AO@%^S9XP^/6HZ+=6=M8:1X.G\6_V.=4
MN+7GCD8_7CU[XJC\2->\?>"KB[_9\\4Z+X9TN;P9X[_MK6+T>$Q9>(]8O_[+
M_P"$:TG5#JP./[$_L/5<@'G'/0C/TKX%_: O_!/[$GCSX2V?B/PWX>\<^'/'
M?@>T\":S9W7V'Q'>>&/'FO\ ]L:MJG]DY']LGP[].W7(&=K2?^">?[;GQ)TC
M5/CIXI^%GQ&UW0;?PY_;&L>/O'%UH'AS[9I^CC^R.FM$>(/[<QU]ASQ7]0YC
MXB<-YI_:.*XWQW#&4</X:CC^'>#*68SIQQ\ZLZ=J>.P$?:Q4N?ZVH<O))MI<
MKE:27\0^&>3^,_$'B+Q3FF<J65<+Y5Q#/ 0P,D]:>"G+%X+')M:J4=-)-:ZW
MV/RWTV\E_MCP]-##;_Z1=8/VRU_M4=?\_7\:^E].T?3M9^%?Q#^(DOCVYTC4
M?A!=:#HWP[\#?:P!=?VOJ8.JYTGC.XG'X'/05X3#IL$VO?8[/_CV_P"$C_T7
MKCM_AV[_ $-?II\(/^"57[5OC_QE)/X0^#EQXG_XDPN[7Q!JFLZ9X=^'5Y?]
M#I>DZKK(+'7/H#CO7\I?1IXLX(X-XD\0JF><6</9)'"<3<[JM4US99&M*I*#
M=1--5::<9-7FHRE*%II2C_2G&/"7%?%.'R[!Y1B'A?[)QZS"6/3:<UI>.DE=
M.S5G=:V:U/DB#Q3HG/G6=O;:Q]E_TH6?_+Y_CS^F*\:U#1_[-UBV\20V%O<^
M'L_;[JS[_KZ]?IWS7TK\;?V//C=\)/BS?>!/B)X0\1^"M4L+K_2M,U/1LZ3>
M#_H*>'O$7/\ ;6A_AU/KDU[%^UI^R3XO_9M^'_PF\0^.-;\*?:/B>=0'_"$:
M./\ BHM((\':1JS?VJ>^""#Q@'O7]9?2"XF\%.(.$<BS'&9E'.9.W$'#4^'^
M6IS>S49RM*$:J:CRJ4O>44M[-Q3^XX+P/$V,GF"SS#K*LLRB-G+3_A1?+:]_
M-^\K;W/B98=5_P! O8?[/^P7&L_\)':WEG:_\37KC^R^A'^?R]W\*W>BVFK>
M'O\ A-M$_P"$G\,W-U8#Q%H%F/L6JZQI_KI.JC;_ &+K?Y9'?G-?0/[(O[ 7
M[1G[5=C<Z+X#L/ Y_P"$3\.:?K-U>>+-9/AXYUC_ )A?'3/Z?3FOZ&_A;_P1
M%\/^)/V0M$^$OQ9^*>KZ/\5[?XBW_P 5+KQ#X MM+OO#OA;Q1K'@[_A SX-_
MXG0_XG.A#0SQ_P BQG)X49)_.N)?I?\ A%D'A_P]DTLU>:/-H*CQ%&$>7,^'
MH2IRIK')046K))7Z-72O9/JX:R'+<CS/.,=+,7*.;-VC)\T5=O92;2WMHE]Q
M_)+^TMX;\ :==:/K?PQTO4+#P?XD\.?:K71]8UG_ (2/5=!U#G&EZKJWZ>_-
M?+N@Z7#>:?J4TV ;?\NW_P!;I^E?U=?M1_\ !''X=?#&#1YOA-JOC3QSJ7_"
M1^&-%\2>'_&_]EWVDZ]X7U?_ (D^K?\ ".G1=#_Y#GAT?\5 ??UK^8>Z\-S:
M;JG]E6?6WNM0M?7\!^'7_./Y/^C]@>#\?])/*>)N&LX>:Y5G&88^368JV/2F
MW*SB_A24GOMW/(X_H8=\/9C]3;YFI*/+>[;C):6L]W^)ZOX/\(>,/VGO&>EZ
M+H/A7PIH7B;_ (1[[!]C\$>'?L7AW1[#1^3JFJCJ=;' &/49() KS?Q)X:U7
MX5^+_&'AZ&P\ZPT^ZT_1KJ\N+7.J''IQ^'Z_7["_99_:JD_9E\,7]MH_P@@U
MGQ1JX_L_Q9XB\0:R+'^V#S_9.EZ2>W4=,<^N:X?]HCQM\3_BQXDUCX@?$CP-
M;^!K^X\&Z?HVC>']'T;5+$?\(OH^J?VQ_:G_ !.L_P!MC_J8/Q/M_H9XJ\:X
MK+:/%N29CE'#G^J&4\.9G'A['5,QR^68O'NG5M+ZC.I4F^9R;CS/G2ULM$OX
ME\-,M\8<9XHNG6R>IE7!>5MR_P!8)\_+.[;:]ZT7=62M??<^7=-FFFDO-0FF
M^TW5Q]/3\.?\XQ70_P#3S^O_ -C^G^<UCZ9_%_GUK8D_<QW)[_9<?C_G/I^%
M?\\G$.)6,XAQN*Q"23K5>7ELEK4J-<MK*ZNK)>6A_<:[7YFMVM;^>E]]_F?I
M?^P?^RO<_M?:/X\FN]$_X3#Q#H]UJ%_:V>L76J_V5>9TO_B4Z7_Q)?\ ZWTZ
MU]*_LX_MM?#O]COX/>#?@MJ'P<\=VWQ<T/Q)XW_X6[9Z_<_\(=_PBFH:QJF#
MI>E?VUQK6=$_LG&.@'/-?K'_ ,$1OA+I7P]_9>L-;&E?\5AXXNM0UFZO/2P'
M_()Z^_U["MK]LC_@BO\ #3]K_P"+?_"[M ^*&L?#+Q-K=T+GXG60T?\ X3'2
MM7&/['_M32B?^0+KG]ACKSX5Z<<&OZ3\$/%#A&>6X_@CQ=Q_$3X#@I3R^,92
ML\>HRY83@DW*DT]+VBI*%]$FO9P^/7U;ZLTFW;>S?FTWZ?=<_D>_;F^*EA\9
MOC!K'CFS\-:AX4L-0M?]%T?6-9^W<_E]>N:_5#_@A-]O^)GQ@?X;WFMV]A8>
M&_#FH:S8?Z*/],T\^O7]/>O@_P#X*#?L\^&_@W\8/$_A7PI]H^P>&]9_X0VU
M_MB_Q_R!SG^U#V_S[5^E_P#P0E_9S\?V?CJY^-.O:)KGAGP]_P (YI^C>'/M
MG^@_V]_;&1_:FD_3_.>WXIXEXC@^OQCF&)X(P+PF0I_\8\WU2=N:7=NU]GJ>
M?B_JWUE/#7Z7]?R_X)^L7[2W[//[-GQ\C^-/[-.I>,?!>C_M/^)/#?A?QD;+
M[+]N^(UGI^CX_P"$'U72O^@UH8QJP_$]>WY.?\%:?^"=.B?L8_LC_">PT+Q?
M<>-;;0]9L+JU\0:SC_3/[8_Y"VEZ3I.3_8NAX]SUZ\5_4MXA^&/PLT_QQXD_
M:Q'P:M_%GQP\-_"'7_!HO?">GC_A8WBKPQH^E_VP/!FDCOK9Z>%!UP2!BOYX
MOVTOVJM*_P""A?[#/QLU4_"7Q9\']2^#?Q+^R?\ "*>+-9^W>NL:3_9/_4<_
MZ&SP_P#A[UZF9\4\39SP1')<'G68K(LHBL?F$>:-O[0LDXQBY*:P:Y=$HJ+O
MM='9B'B:^&_V=K2U[VZ;[O;?\C^8_P (ZE_9LA\[[1]@N/\ CZL[/N?\G@X/
MMTKZ'\2>-O'/B2\O];GU4_VQKFC?V-K.L7%KI?\ R#_[+S_W!?\ D$]^,UE?
ML:_!C_A?G[0WPN^%<]_]@L-0UG^V=9N/LOV[.GZ/_P 3C5M+_P"YBZG-?W#^
M'O\ @E=_P3G\-S:%XJM/V:-+NM8M[7^V19ZGXL\8^(K$7_\ :>,'2=:\4GP]
MK9W9/IC QUK^FOHV?29X<\%>#\?A\9E68<29KG'-:=HJ.7S27*G*5K\TU&R3
M>WO621Z6'Q__  F_5GF"PE]TK._1ZJ[MNNNY_(3\,?@-\6=/MO@_\8O%7P[\
M5_\ "GM0^-'@;P[=>,_LP^Q8_M_2 #C_ * 61C_A(?4?G\*>/O%4VC_&3XJ:
MWIFJW'V"W_:"\477VS_J'?\ "9?\2GGU_H!7]\'[0-Y\+OB=;_$C]FS1_#6N
M?VSX3T;3M9NKVT\.:IX<\$6=_K'_ ""?[)U8_P#$@UO_ (1WO[]Z_@WU#X%Z
MKH/Q0^)?PE\23_9K_0_&7BBUNKR\_P ^_'''O7YMXY^-G$?C5F]#&0R7ZIF6
M53?LY4X2;Y,;;V2;Y7S5(I*_+>+:CR16J.',<1AWAL/A\+=NZN]6V^KNDVKO
M75WU/[D/V-?@7\)8? >C^)/A7HEO<_\ "[/#FG^//B_X@O+7_B:Z]J']E?\
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M_P 5/B+8?$CQ/H?B3QQK7VO0+75#I6D?VP/[8_LP:MK1_M_6@/0G.3TK\?\
MX"Z#K>O?$SX;Z5H,/VG6+CQYX7^RV1'KJ@_SSU[5^!\8Y*L+G,I83,'FN53E
M.>7<0VY?K]Y2;NFH[-N]U;331J_@8G#_ %=M[IMO[[M:J_<_KZ\6?M8?$7X*
M_!_Q)\0/B=X/\67_ ,']"T;_ (DP\/VOV[5;S_J*_P!K9_XDG7_F8NU?+G[6
MD/@[]N/]@:Q_:BT?P5J&L>&/"?V^TM;/Q9=?\(YXXT'Q1H_/_%/:L?\ D-:'
M^?\ PE73/K_07\%/A[HG_"+V$WB2V_MBP_X0W4-&_L?6/].TLZ?K/_(6_P")
M3S_T"?3\,U\Z_MW?"4:K^S3XPT3PW]GT?P_<:-]JNM'T:U^P_A_3VK/^T,GH
M<,_5?[&OGW]H?\E!]>5OJ-]OJ6OII?OH8^WPWU7^K?E^I_!S^S/X]A\$_&#1
M];\FWN;;4-9T_1M9^V6O-GI_]J>G3^1K^P_X$^#_ -HCXD>&]2TKPKJNG6'@
M;7/ ?V7P;_PD%I_PD?ARSU#&?^)MI/T.*_BNUS0/^$5\<>,]$A_T8>&]9U#[
M)[Y/7@?Y_&O]%7_@E'9ZY/\ LY?!#5?&$UO_ ,)C/\.K#[5;C_CR_P"09_R$
M^0<YQ@Y]^<\CYZA7]AB?K#LUT6FM^MO.]^OX'*?G'^UA^QO\1;SP'X]L+SPW
MI_B?1]<\&_V-XCLK/_D9+S4-'TK_ (E.J>OT'ZBOXKO$EG?Z/XH^P:Q;?9K_
M $ZZ^RW5G_U$-']S_3K_ #_U4OBI\-[#Q5_:7VR;_CX\.:A:^O\ GM^'Z_YW
MW_!1_P#95A_9Y_:.\210^,+?Q/;?$#Q%XG\1VNC_ &7[#?:#8?VGC\<^^>M>
MGDDXX[-Z>$=K3JPCI:[YJD$TO.TFDM[VT">(M;^OR7Z?,^/]-TV;Q)I>MS>3
M]F^T:S]JM?L?'_ZO\.!6[INKZ3X?U2_$WVBYN=0UG_2O[+_T'PY9ZA_9?_(+
MTG\_3\?7G-+O)M2TNPT2&P^T_9[K_2K>]NO^)5> ^W7U^G\_I7]DW]AK]H/]
MH+7]7_X4U\)M0\06%AHQ_P"$BUB]UK^RO!%H=8';5=:()]3QP .U?]$_"4N!
M>!?H^Y1A<]SG#9+1H\,8)I<0.A&\ZE#W;1DXRES3FDG:3=TE=M)_%XO&9S7X
MMR]8/*)J":YL?>7+9;W5^717U:T7WFA_P4;^%DW[/&I?L^_L^"\\-ZO;0> ]
M/\>>(]3T"UP;SQ1K&/\ F+>^AG_/ KYW\,ZQ801ZQ8>&OM-M?V]K]EM=8]/K
M^OY_2NH_;F\-?$7P=\;K7P!\2+_[=K'PW\.>&/"7]L?\_FGZ1I?7\QS_ $'7
MJOV,O@%X_P#VA_B5J/PK^&.B_P!O>,-=(NK"SO+K[%I5II^CZ7_S%=5Y.C>P
M'/X 5_F!]'#/^'L!XZ<68C,L=PV^%8SS+,<?Q!4C3_LY1]I4DK0FFDN76RBM
MG:[/U;#I8N>/PTDE[NNUUI9V?WZKK9Z'*>!-2U#X7W&CZKKVJ^+/!]A]D^RW
M6J>!]9^W>([S4. =4TDX/]BZ']/_ *]>\Z_\#H;C]F;Q+^UCXDL+?6+F_P#%
MM_X$\.WGVK_C\R?^0IJPX_XG@X_^M7W'JO\ P1._;DU^ZMK#6/#?@SP?;6UK
MJ'_$XO?BIIEZ?[/_ .@6/[& ^GX_GV_[9G[)MW^SC^PSK/PLT?Q5J'CF+PYK
M/_"1ZU>3VOV'2O\ B;_\A;G(P!USCWQC-?K'TTO$?P3XKX"P^&X3SCAW-^)X
MX_!*+X?4-, GOI%-;:VLM]%;7Q\#0Q6$P^8X*O9Y;>^7OZ]?'WUUW;M?I?;\
M/L?_ (-N_M/_  S3^V?YV<_\+1\+XQ_V)C?_ %\>WOBOU"_X)_WGB+3_ (V_
M$>QT[PS-JFD:AX ^&']L:^=8TFR_X1UO[<^*N%&DD'^V3DELKAOE],@_E_\
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M\4+SX.^,-4T2^\3^'/$8/_"0>'[K[=X=UW3_ .RO^)3JA]#[9_2N/U[PW?\
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M]"*Z'R8;R2VL)OM'V:X/^E?8_P!>G'^>X-;'C;_A74/Q,\>6WPEFU"Y^&_\
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M_!.KX/\ C"P\?Z?_ ,%!M+\0PV]M?Z?]CUGQ[\&QI5X-8TP \_VXW(7D#'.
M"1R1]?PYQKQID&(R^?#V85LJCE;<N6$:TDY/:2C&ZN[_ !6Z_$=6'QF/H7^K
MMN*?=VLOFUMKT/Y6_CY\6O WBJ33_AU\)?#?]C^ / ^L_:KK6+RZ^W>(_&WB
MC/\ 8_\ :FK?_,_D8^E0_ 7QYI4VCWG@[XGW^N6_@^VO_%&L^#=8\/VOV[5?
M"OB?6/\ F%_V3_S&M#\0_P!:_I+F_P""$G_!,J\NCY/_  4T@BN;BYS:V_\
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M-EX]^#1_MC^Q\?\ $T.=I!// # >O2OF"\_X(4?\$RM8<S?\/2=,/G]AX\^
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MG\.:AK-U9_\ ".:7_97Q(\4:QJG_ #%M6_Y&#VY[=:_-;P#INE:E)J4.O?\
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MMDK+1VV];;'\A/Q:^)TWQ"\67GQ%ATK7/#WC"XUG^V;KQ!_PF?\ PD>J]?\
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MWXZ]/6OZG_@+_P $E?\ @G5\$OBWX*^)_@[_ (*=:%J&O>!]8^U:?I=[X]^
M_P!AO."?[+/_ !.R0. ,@,?]FN>\3?\ !&__ ()F:QXEUW5I/^"E&A>'I-=\
M1ZAK,VC#XF? <BQ.L:IDZ7DZV"1DXS@'O@=N>\FFU?75I7LV]=;:7OI=_>)>
M77MU^[?\3^/'X@']Y8:?Y/\ I/V7[4+S_/\ CSZU]46>L?#'4KKPQ83>/_LU
M_J%II]KK.L:QX<U2_P##?A74/KHO_%0=/KQSU-?T1:Q_P0M_X)BZ]J'G3?\
M!433K6XM\VIM+/Q[\!QCH/\ H-GD_P"?>4_\$._^"8ME,WG?\%2=+MYL<B\\
M>_ <$>_.N8_4>@S7Z1X8^+'%?A;F[S?AG,)95F36L8N34D][I-W37=/<Z</7
M5"U[:;72?W73U]+'X]?%KX"S?!/0?^$J\5>-OA_K'@#7/#GVKP'XX\#_ .G_
M /"5>*>VEZ3I.M>OZ^P%>2W'QL_9OU+PGX>^&.I> /C)X?\ !_VK3]9\9?V/
MXRTN^^V^./\ D#_\)D?^@U_V+YY^O2OZ3OBA_P $P?\ @FI\3/"?P@\#7O\
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M17X">*[[QE8>*](^)GP<OO$FO'6-,.D$:N!KA5<<?,"=V>F%4GYDC_X(8?\
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MU_G7[T_L=_\ !9SQA\3M*\'_  FU+PK<:-X__P"$"^RZ-K%Y=?;O[>\4:/\
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M= _X*/\ AN[O_&?@/6? G]KWGQ,^ X.@Z?K /]K:H,ZW@YZ<E0.N0!SXTO\
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MGP*^C!PWDU/Q'P]/B'C+C!QRYY?+DP7^KV J-0682NFU;GOS-+9ZGR?%.?\
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MT2S^T6VI:A:Z?:ZS_HH_T/3SJ8_S[GTK\3XL\#>,,E\0,?P+1R;,?[2?$/\
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M%3/V6_BU^S[^T9X]A\8>#]#\'V'QDT;[5X-L[/63?:5_9_\ Q)_[6]_[<_7
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MOAC0? WA/1M8\9:AX+\)ZAH/ASQ%\2+_ ,!Z6 -4U;5M%'_"0?V'G))R0>
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M."2Q[DHO!X%:8C>Z72ZMJM+<?XDL];L_V(?VVO[8@_X^/VG/V5[JUP?^8?\
MV7X\SQ["ORX'_+#\?Z5^M'CS3M;L_P!@7]JJ;6)OM/VC]H+]F?[*/^X7X\^O
MJ/S[=*_*;381Y?;]?\GK^@'UY/I59?B<O\:LXPMK^_9^?O*Z?JM+/N?@.=J^
M/QME?:W9WMM;H_(]I^&-YX;A\-ZQ8>1<?\)/;W7VJUO/^H>!]>WIZBOU3^-_
M[3?QH_:)^$-OX,\.> ;>Q\ V]KX7T?6-7LKG7;[_ (2G4-'(_LG_ (0C21_R
M!<'ZD@\G/7\S?@#X;L]8A\9W]Y_Q\V]_]EYQ^?/_ -;]:^\/V<?B%K?[._Q
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M[$7X?:OK+:EX<\1^&/B1IGQ1\5VVGVOPC\"^'[0V/VNP()U74M5&!_Q)3M)
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M/'_&#4M$U#7/^$/\-^&]/\'_  W^%_\ :'@WP'H]G=8^V?V/JG_$VU35L_\
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M)X9> '%.,\1\AXBJ<5Y7F>#R[@[^W\LG/,)+'R<&_P"%*?*^;5_ROWG8_G'
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M3_L5>U>7?'SP?#^SKXH\23_$C6_#?CG6/B1=:A_Q2?A.Y_X2/5?^$'UC5/\
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M>17SA^Q#^T-X^^"?@WQ5;>&]$^'_ ,2/#VN:SIX\1^!_B!H__"1_V/J&C_\
M$XTG5-)_ZCG3U[9KN?&7Q4^)O[1WQJ\2>,[3P?J&L>/O$GAS3[;1M \*6OV[
MC1^>?UY-?Z)?1+RWQ"? TJ>=9GD*\,O]7'_9LZ=11S++\Q]F_K;Q<U)\D[\O
M)+I+E=FDS\*XA\2<XX-XNP&)J0S_  ^5KZ\LQCF,<&\MFU?ZC'!W3O&3LFFW
MI*SU-[7/A[XD^-7P_P#B9#X)\'V]_P"'M$/V7Q'X@_Y%S2O[0Y_LGP9X(TG_
M *#G_4O^IKRCX9? ?_A)/B%XAO-8\?Z'\-_#'@?X5>%[KQEXL^P:I??\2XZI
M_8VDC2=)Q_Q.M=\1:YVXX[U]H^+OVR/V>/#?[-'ACX+:;\$/$G]I?#>U_MGQ
ME>?VS_PAMC_PN#G^UM3U?MK7_$\_M;W]L5X!^RS^VQX5^$OBJYO]!\*P>/WU
M3PGI^C?$;PI><?8]/&J<CP\>@Z_E@^]?*\2\5^+F+S3BC"\.Y1P]E/&&4N4>
M"GCL:EC\RR_!.26.Q6UW)6<8IMOFCH?19?Q[_KAP/F&<9KE_$*C'B!O'Y!P_
ME^%P%\N6,;4L%C(Q7UR^#7,TK7N^I)XB\)2_"N\\"G_A/M+\?^"OB!:ZC=Z+
MXAT>T^P_8]0T<?\ $V\&ZMI.M?\ (%USZ]>U6K/X;P_&36M5L/#=_P"&_ /@
M;PV?^*R^)GCB[U3_ (0?PKJ&L=-*U;^Q/^*@UK7/$7'_ !3_ #VZUV'[4'Q@
M^!GC;P%\+_#?P!\#:AX8L/\ A(_%'CS6=(U/-]JMGJ&L?\2?TZ8_GP17I'[,
M_P 0?@/>?LO^-/A7\0OB=;_"CQ#;^/!XC^VV>B_\)'JOBO4-('_$I_M;2<_Y
MX]Z_4LXXV^D1D?T9:/%V*X16;^)K;R&IE\;M*,L79YBU9Z*+;4I)>ZD[[GPG
M#_B'D&?\19?PIFD.(.'N#\VXA67O/\QP$L;CLOP*DE[V#<=%?1S?G),_/?3?
M >JZ;^T'XG^&/ANPT_XD>)]0UG3]&\&^(/"=U]A\#Z]J'_,)_LG^VO\ H8O_
M *U>W^+/A[\8_@EK%@/BUX&M_ UAKG_(N:Q9W6E:KX<O-0Z_V7_:VBG_ )#G
M(_R:@^%-GX5^*7QX\5?#'PWK>AW-SJ'B/[+X-\0>(;7[#I6O>*-'\&_\4]_R
M&L?V+T_R37WO\4/@OXP^"O[,?QCO_C!?^&_^$>URUT^U\!^ +?Q'_P )']C\
M<'5/[8_X3+2?^9?T77/7//TK^??#+Z37C#PIQSX?\"8W@QYQE?$<HKB/,5!R
MCEN88_&IXZ/-&,L&OJ+E))73TT/W+Q.R/PLX6X?QO$.7<?\ #TLUX>S# 8#A
M[A[,HQ_M'B# /EOC\#%IN+>[MJKM-Z'Q.VN:5ING":\^T7-SJ/\ R![.SM?M
MVJWG^>W/X=Q\0?&#1]#\'^%[_5?[$^RW-QX\^U6O]L#[#JEG_P 2O_D%?]07
M\O0YK]0OV6?A+X_\:?#?QS\6OA[I^HW_ (_M_%NG^$M&M_#]UCQ'X*\+G_B<
M:OK_ (>_ZCGB+\^F:^'O^"BFFW.CR6%_XJFU&Y\<_P!L^%[7XC6>L7_V[5;/
MQQ_9FL?VMI?7 _XD?]DYZ>OK7Z5XT^-F5<0<><2>&<.'>(8YGP_ET<>N))QE
M_J_ESQW)9.<H<MHMIM<UM'HM#DX4SW,^+^"Y9_D^=</^Q6.QV7OAQ8^*S)/!
M1?+CG!/F6#O\-XJ[:2/L[Q?\$/BG^SUX$^'WQET7QL/%WADW/@BYU#7] T_5
M++Q%X*\;G^Q]8TH8Z:UH1'7Q!TYP<$UR&HW?C#XG^*],M8)K_P 3>/OB/K %
MS<:G_IPNP.-6U/50, ?\([H7 &.@HL_VL/&GC#]CG7O@AXPB\2>)[3_BA_\
MA5_B#_C^^R:?H_32\\$?3H<^HY\WTGQ?X_T'5/!/C_P?JMQX9\3^"/[0N;76
M/LF?L8.E]^._]>^*_;/"C*.*WX5YYC^+\?P[BL_]CF-+AWB*;IO!/A]TY2P-
M-MMR<;R5X2:7.G+V;=I/\BX.XU\4G@>,<CQ^72>(ROB%OAY\LG%Q;:YDY1M)
M<KNG=W5M3X>_:0^#.J_"7XL:Q83:KI]_INJ6I\1Z-K&CVNO6(U[3]8_XD_\
M:G]DZU_Q4&B\\^_Z5]D_LVV?@_4M!^%T/BK2M0O["XM?[%\1Z/X?NO\ A'-5
MO/\ B:?V/SJW4=1]/J.?AC]I#XL_%KXL?$#4O%7Q"O\ Q)K']H76GZ-_PD'B
M"U^PZK>:?H_T.?[#X_\ K=J_2#]BSXV^'O@GI_A*;QM\--#^)'PXUSPYI_\
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MMZ;#;W^I:?XC_P!*O/\ J(#\/U'IZXK^?3_@A1^RWJOQ"_:K\0?'W4M+N/\
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MQ%XUN-(NM!LO$6K^",^(Q_9G@@ZV/^$?UG7,_P!D@'/!Q@Y)J7]H+]H/XZ_
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M^,%OX;T_P;:_$#6./ ]GJ&C_ /$G\;^,O!&DZT?^0X/[)_Y&"OS(NO&'@_\
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M.]_$%?W*)_P23_X)G!_^3'_V<!;?93:C'PXT$\9''3\N>W)/-:EQ_P $I?\
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MX&_X2,^#_P!DWX%^%_\ A+]&_P"$<\2?V/X#TNQ_MCPQC']EZM\O(SG/3G&
M.:XR;_@D7_P3%NXA#/\ L*_LSW-O_P!DKT'!S[[<^_0<]J_<,9]._P 5L5P[
M@,DP^-M%+ES]RY6LP37+=+5QT=KV3W9SU\EX=;6)671<KW3Y8WYG]KX=&WK=
M:^9_E%^"]>L?#GBRVU;1]5U#_A'=0_X^LW?_ !-<>_Z_F>E??.M?&#QQ\7/
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MJ?QXUCXQ^'+G1_BA?ZAX<NOA-HUK_P )'XCO-/T?_F*?]07/M[YK^B[]F?\
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M#][HQ."!]W:>3Y1??\$C?^"8NL7VIZKK'[#/[,]]J6J71NM8O+CX8:#F\O\
MCD@K@$'.!@CCGK@4ZM>W*Y2Y>D7*7+VT6WW(1_F:7'Q.^(W@[]G/X#_!S0?'
M.N:/\-]<\&ZA\1M9T?1[K[#]L\4ZQXRUCU^GKQ7R!XXFL(=$MO)-N/\ 2O\
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M<C]L- _9)\,^&_%N@^-M'_8L_9_L?%_A.Z-UX=UBS^._C+.A:@?^)N&TD?\
M"G2H_P"03I6<K@$CH 0?K/X#?LP_L]_LP:'J?A_]GOX.?#_X/^']8NQK&L:1
M\/\ PYIGAS2KW4<'.J$+CC&3SD _-@ 5](T ?!Y^'/BZXLK:T3]E7X!VUM;G
M4#:_V9\4/L(L_P#A)"/^$A/_ !)?@>#N\0]/%ASCQ22.#QC+TGX(W^C^)-'\
M5:9^R7^SO8:]H>C:AHVC7%O\7]5'V.PUC^R!_9G_ "0__J$X'3OR<BOT$HH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_#ETVD,/[4!\0:(6TXD?Q$-P5!& 01ZM0 4444 %%%% !1110 4444 %%%%
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ML?%<Z^#3I9U@CQ)XD\4ZMJFK?\+%_L#_ (1=?AWX@^&?B$>'_#X/QG_XKO\
MXJ_PCX9\(A2G[*U_-=:?\$4/VX(K[^U5_P""Y'[9\6JF_P#[3_M*#P)\./MI
MU#^R_P#A'/[3_M;(_P")X-"SH)Y)P">HR=W_ (<V?\%!/^D^O[?'_A.>"_\
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MXAW:3H'BS7R3XJ.,H"0  #Z4U;_@I]^S9'I/P*\<_#B'QG\8/A+\:_$?Q/\
M#ES\6/ ^C_8O#GPXU#X5^#?'GCSQ%H/C?P]XG/AKQ#HOC?'@C5O#P\('PR/%
M><G''-?3OB!I7_!2/]B7X]:+/+\:_P!F'4M3E\4?#GQC<?#OQYH.E?%SP1J.
MD:!X<\=D^!_'&B_\))H /B+0M7T#\-8U\$C)S!^Q;^R#XT\)^!_%OB[]KSPQ
M\']8^,OQ(_:I^)_[6E[X0^'AU7Q%\,OA9XI\>^#-(^%0TKP5JNMCPVWB8?\
M"N=)U3_BH?$/AK=GQ)KPP#U^*_\ @NI^S#\'_AO_ ,$//VPO 7P[\'CP)X/\
M">%_"WQ&\.:1X(N6TD?\)3HWQ&\-:Q_:FK:H03K()R2"2W !W=@#\8OV=O"_
M@SQ'_P &L?A_X7^,?VJ!^R'I_BO]H'XK^'-+^,&N6OQ'O]*U?4=&_:H\=^(A
MX-\;?\*ET3_A(1HGC)=)8' (.?EPN ?ES]E;_@X7\7_\$E/V8_AW^R'>?"L?
MMW6_@#QYXXM=(_:17XV^,O#?@?Q7X'UCQD?$FDZ5X)_X3_X.#Q!HO_$DU;CP
M_P"(<8/3 SG^B[_@U+B@N?\ @B5^S?%=10S#_A//VB,B8 D_\7V\>$CD'.#G
MTYXK\S?BYX2_X(N_\%6_V@?V\OV6OV?] ^,GCC]O_0/#G[0_CWX7ZO\ $WXC
M_&2P^ 6K?M+^!!XDT<:I\,Q_PL=O#^C:'X=\5G2#G_A&O"OA0^$R2I. & /C
M'P5_P7Q_X*)?M._\%;OV/;?X?7?_  H7]E[X@^//@]X(\1?!/6+4^.?!W_"/
M^.]3V^.%^)GC?_A78UY/B(R\^$\*?^$59= (V[G-?Z(=?R_?\&V7[)G_  41
M_9,^ '[0'AK]O[1?%/AZ^\2_%_1O$?POT#X@_$72OBGXWL; Z!_8WB'5#JVB
M^+/&V@:+H08:2JE3N.==8A<D#^H&@ HHHR#T.: NMKJ_:ZO]P4444 %%%% !
M1110 4444 %%%% !111D=,\^E !129'3(SZ9I<CU% !1110 4444 %%%% !1
M110 4444GL_1_DP/Y-O^"B/P:_;,_:._;D^,?P$TS2/CI\2/V4O' _9G^(OQ
M/U#X)?&C3/#ECX)_9X^"O@[XO^._''[.O_"#Z+KGAOQ!X8^,/[5'QATKP]_P
MB?B 9_X2KPK_ ,(G_P 58!X;S7[+?\$GK?XG67_!._\ 9;'Q=\4P^+?'UO\
M#;.L:H/'N@_$:_LM/&O:P?#WA?Q%XWT0_P!@^*/%7@WPL-)\/^+-?&=WBG2-
M>4@KFOYN_P!I'_@G]^SWH?[<_P"UA\._V6?V!OV_OVO/&.AZ-\(/'WQHO/AG
M^V_H'[,WPY^%6H^/=+\=ZOX(\&^"?$7Q!\5>&O$/Q#']AC5< MXH'A0Y\(J%
M+$G^H#]@'X9Z)\(_V0O@I\-?#?[.FJ_LHZ7X'\)_V+I_[/?B#Q[I?Q&U7X?
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MW]KKXS7OQ-U'PZ/$7A3P_9^$_P!MP>!AXY\":$Q\$D>"M;^' ^%^C8;&=RH
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M&W]H'XGW'[+?[*\/@GPSX)^''CNZL_&?_!1GXR?"WP/\-] ^-6FGQWI&J?\
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M3=/_ &O?CY8VFL>&/[4_X1R]L /#.S5-(&MA=?\ [$8@%/\ A(1D?*22PW$
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M='X_S-.IJ?='X_S-.KRM]3P-]>^OWZA1110 5'_RS_S_ 'JDJ/\ Y9_Y_O4
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M^ _B/XL%W]N'BKQSX%\&Z-HOC?73JF.1XB\4Z3JS'<21SP<\ 'TW7PU^W/\
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MSKM8!X^-TKI;N*;Y;WL[6V2.?ZAA75^MV7]HVWTVZ].W^6Y\7_M,_P#)S?\
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M.2Q/8@ ?Q':U_P %-_\ @J9XU\*ZO\>]-_;/_P"">GP!\#?%#X7_ +:'Q?\
MA9\+_%'P7\&WW_"+>*?V5OB1_P (YXA^ ^J^-_$VA<?'[Q%H.K:1XO\ "8\1
M;AXK.L'/!VU_:!^QMX[/Q6_9-_9F^*-WXEO_ !A/\2/V?_A!X]/BS6?#NF>$
M=5\5KX[^'FDZRNO:MX*T?&@:(?$.5;_A'?#JD1YV(2 &H ^R:XG6M>TGPII&
MJZUK&JV&C:)H]A?ZQJFIZI=?8;&RT[1S_P 375-6U4\=.2<= ,CBNVK\\?\
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MRQW_ &6V^TX\_P H;LXQG^7T[]:_,#X7>&OAKXD_9[_:_L_C68+GX4#]IO\
M; U_QX+BYU_2ELO#_AKXM^)=8;5#JVB$:_HQ\/#2AKZZ_P"'SP1N .,5Y;BU
M)Q34GS.-UM)\SC>_52:3W>C1Z=*]51459R44H^;LDOODEJ>"?$[]H?\ 8I^.
MB_';PY^TM^SOX_-MHEUX7NKK_A8GPRUZPOO&NH_"OP9X#^*?A[00,YT7XB?"
MO_A<6?\ A'BQ8'/BW." NKJ'[37_  3\^+'ASP;X)U?X7>*_&W@71/AAI_@W
MX=_VQ\%_&>J:5=KX\7PV=)^ _@?5=C;OC'XC?P-I"_\ "'$IXJ_X2?P(6#94
M*>._8PUG_@FI_P %"_"/Q+T3X2^$?B/K]MX,\9_VIXRE\<>,?C+X;^(UWXG\
M>>#O FD?\+&/C?\ X6,WC'63XRT'X9^'L>(3XG'BDGPV<[<XKU?]HWX#?L3_
M  %^"\/@;5_&'@?]FZ\\2>,Q??"OQQXS\>:Y?"R^)!./#^J:5_PD_P 1_#?B
M#6BG_"0@D>'?$_A<^%@6V^*_#) \4CMG@<31J?4ZF D\3:^EWHUS;)/IK\[W
MZ';4RG,:-3ZE/ 2>963T3;LUS;)._NZW2:6YQOPN\:_\$P_C5\6OA1\*]!^$
M'A:P^*/V7^V?!OA_7_AG_P (?JWA7Q!X#TP?V3X.\;Z2<:]HFN#0O!&EZ_\
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M1IG'3_/Z^OUKXD^(/[!O[+?Q0_: \+_M+>-O@_I&N_&_P9_9_P#PCOC>XO\
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M=O<D+N_,@<$UZ!7GOBRRUK5/"VO:5X5U7^QM>U#1M0M?#GB 6HOAI&HMI?\
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M  4=^'W[+'[0'C?1_@1\4/''Q,TKPYXC^-?P \.Z#X#UCQOXG/Q-'A7^P?B
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M ?6BO*6R]%^2/1"BBBF 4444 %%%% !51_.\N;R\>=GCIU[?A_GUJW7XV_\
M!9#]JCX]?LL?L_?".Q_9>F\'Z=\=?VF/VF_@_P#LJ_#KQGX_T8>(O#O@F_\
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M%?I110!_*5\0?@M^T=J/_!0_]F#7=&^#OQS/Q  _8?\ $?PK^/\ IWAW4_\
MA4OP>_9_^%?PF\>Z-^UW\./'&K#7/^$?T7Q5XSUWQMI8_P"$0\1?\C4?$>A#
M_F637V!_P4VM/C;^P#_P1J^/>J_LT_&BX\)_&#X)^$M/\7:G\7O$'@[2?$.K
M^-[_ %?XC+K'Q-U75=)UL>)?#XUOXJ/JWB Y*G_A%?\ A)!C&1C]]:_&;_@O
M+H.K^*O^"3G[:_A2QG\-V-_XB^%0T^VU?Q1XK\'^#O#=G_Q6'AQ@-8\;>/\
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M&]9\?^+0O_"2>-=9\.Z6NCZMXR\0D'C6_$;9U\@Y)<CG:!GU^B@ HHK\W/\
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M^"4G_A"?&7_YIZ/[ _X.G?\ HH?_  2D_P#"$^,O_P T] '](M%?S)>*)_\
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M#6K,?$.MZX/$&M?\)%K6E:KXA( R/[8(7<1D_L[X$M=6\/\ A'POHGBC7O\
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M"V_X*#ZK\ ]8^-I\67YTV\_9OTSQ18_#L^"/[,TC^R@1XH&XZXNM_P!JEN
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M#4/B5\2$\4:E;RZ@NC^'/!G@?PYJGC'XC?$/Q N@ZOXD/@[X:>"=&']O>/\
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M)OQD_9C\<^(_$:^$[ WVK?#?P1K&J#P)I'C+Q#E@H_X2+Q5JQ'A/P_C/BO\
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MM?M]I]E:Z=I\-A9VUO;6-O;?9K6WM\XM+#!Q]0 ,_4<=ZWJ_.K]M[X^?M)_
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M (7"/AEXA/\ PAOAK_A2OBGPL#_PF'_"4#FOZ@M%\/Z)X?.I3:1H^GZ.=4U
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MOVA_&WQF^(GPH\1W_P"T1XS\#>+1H?P3\!^)_AS\.+[Q1X;TO6='\0_'?5?
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M1_;9_9[_ &@/@U^Q/!\1=>\-_"SXR>$](\9^(_#?BKXCC5#\"O!&J?M1Z/\
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MMI?B+]J']AC]I?1]+\.:SX)_:+U_P1HHSXT^#X^(FJ'0?%GA[QEG_BE02/\
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M?]I_2K;Q'X!^*/AOP3?_  @\62> +G3-)\$?&KX/WVA,-*^'7QN\%'1&\/\
MC70_!FM'^W_"( 'BKPJP*AO^$/8! #\H/^":O[&.K?'+6K7]L?XNV%AING3?
M%KQQ\5OAUJ_A_P 0Z_J'B+7_ (H>(R/ OQM\0?##XVCQ3_PD7Q<_X)N?M4Z'
MH^D_$_PC\#OCKX:_X2KPH6_X1(JWA#PUX5!_HVTG3=/T>QM]*TJPM[#3K"V^
MRV%G;VQLK*SL !G ^@Z#'0D@$DU:L[>&SCAM88;>&WMS]EM;>W_Y<^/\,>GI
M7RW^U9^TKX*_9/\ @?XR^/WQ-N;S3?!_@RPL/[0^QZ.2;S4-9UZS\.>'M+-V
M3CPS_P )%KNK:2O]O^(O^*6\*@G_ (2]AC% 'A_[8'[1\GATR_LC?#'XW>$/
M@A^W'^T/\%_B?K/[)=[X_P!-.J^';SQ3X$_LD,"./#QUI?[7TDCP\3R,X7Q.
M57/P1^R#K7[3_P"T!\7-%_9=^/WB;Q9X=\)?LO?"#1_%OQ&TCX/_ !0\8^)/
M$9^*'B32M8\!G]G/]KKXQZT<_%KXB^'=#U;_ (6?_P )A\"?$WA;PKXI\5C7
M\C'@GPL3POP5TKXN?\%#OB=\;OA_^V+\&_ GB'P[?_VCX"\>:-!I&E_"W]HS
M_@G9XHT;5/\ A._@C_PA7Q/T;7"?V@_AU\5#I.D_%#X)?''X5$L?%><D^#\U
M_0QX+\.-X0\)^&/#5SK6L>)KG0]'T[1_^$@\37/V[Q'K!TG303JFJ\8.N,V6
M<_>^8DX)S0!YM\'O@S\,OV>? [_#CX&^#X/"?AFWU._UDZ=9W.J:K?WGB?6V
M&KZOKVOZSK;>)->UK6_$!!:37_$)9SA1S\@-7]IC]HKX7?LF_!OQE\??C%XA
MN/#'PZ^'PT\^+/$$&CZGKG]D_P!KZGI.C#4SI.C;GP#JP).,Y(P3\V?HB>XA
MLXFFFF@AAZ_:)S@>GM^O?C':OY5/&'[86M_ME?\ !0"YMOV3/$NC_'+0?@7\
M.M/NM9_X)[_&3Q'JGPY\.?M+?\(?\1O'G@/QOXR_XN#X5_XM]\?OV=_B,=)\
M0?\ %9>&?%'A7Q5X5UCPEXN_X2S_ (IS_BEP#N/B/\7?V^/A_P#&7XH^%O\
MA<7A[QAX8_;3^/'@?P;^S)XY^%_B(>,?BYJ7[*_CW0AI!^(W[(?@G11XD^%_
MPCUW]E;1/&X\0^+?$'QW_P"$H_X72?[=\7GQ9X7(\+U^W'PG_9"^"_PJ\7:C
M\4/#%GKOB#XT:SX#T#P'XC^,OQ$\6>,OB-\1M=T#1M*T?1^?$.M:[_Q)6\1G
M2?\ A(?%9\&KX77Q5XJ'_"6'#$$Y/[,'[-G@_P#9B\+Z[X2^$]KK_@_P/XS\
M9ZA\1[?X0:AXC/B3P1\']1\28/C7P9\'%*_\4Q\.3XJ_M?Q%_P (^&'A=&\1
MZV?!Z^& 3C[CH *_G6^-'[8OQ%^/OBCX8_M9?L.?M&?">Y_9)^ >L_&'X<_M
M-#X@:CXS\':3\'OC?HV[1M(U_P#:#^&6B_\ ",_$_P"+/P[*M_PC_A3X8>'/
M^$6/_"5^)?"7QQ+>*?!P!KV__@HU^W+XK^"VH^(?@+^SKJ>J:/\ $OP?X,\#
M_%;]H+XL6W@C0?BG??LF_LT>)/&8T?Q!\>3\&];UOPWXA_:"T10OB >*_P#A
M##XH'@'^R#XM\8K@+76?L3_LG&.3X4_M2^+_ (<>%_@)\>?"?@CQ1\(?$\O[
M+GBS[%\ ?VJ/A!F\;X8_$75O ZE2="_XFW_"?_!)?&1'BSX,+XDU_P (9_X1
M Y(!)^R1\";/]J7X%_"7]IK]KS2?BAXW^)_Q'\6Z=^TWH_PW^+'B35;'P/\
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M">./VO\ X(?M!_VYXE\.CXQ?"O7-7/@_Q;^S!XA_X19C\/\ Q)R?^$P\1KM
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MV[5 '! /FS]K/]I[Q]^T+KFN_#']@;XW>$_^%B?L:_M Z>?VWOA/XA\1:_\
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M5\4_C[XD^#_[7/[$O[17PD_X9#^$$_Q?\&?M!?\ "R[[QEX/L?@]\7]&U/\
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MGQ>"5O?LD? C1/VGO'%]^T\G@6P^!7QN_P"$WT_Q%X\_:-_9\NO^%C?LS?\
M!23X ?%302/[*)^(9\2'6OAU_8FD;3\+_&8;Q5^S=XKTG_BC\CQ(37[C> ?
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MVC1$T7DD@X"^N,?SJ^,OVH_ /_!3/XT6'P3^)7['VE_'?]E71_%GA@VWP_\
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M?^"_!_A;P'H:>&?!/AK1_"FA6^HZCJ%KX?\ #NF:5HFE:;?ZQJIUC5,:3I
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MI]CJ$=M%I5J;WPK\'[#Q@-'U?QQ\)_V?-4\3'_A/_A_\ CXITK_A(/"GPO\
M$'B5AX58Y &!74_"#]@_]E3X!_%7QM\;_A'\'='\&?%#QK+XH&L:S9ZKXRU3
M2]'?QCJA\1>-?^$'\$:WXJ_X1OX?GQ)KA.O^*C\+O#7A?_A*6VC#%P!]V4 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
C!1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>vi_003.jpg
<TEXT>
begin 644 vi_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #J =D# 2(  A$! Q$!_\0
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M]CJ<@# ^E]0AE?3[Z&+ FN+;4,?4G [<]<#MR..<5_,?I'_!,+]I/P]^S/\
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MBL6SN(;R.&ZAFMYK>X/VJUN+?_E\X_PQZ^M;5 !1110 4444 %%%% !1110
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MUU>K 4?IOY>O;YV _ #_ ()]>#(O^"MG_!4?]IC_ (*6?&FU'B3]G/\ 8?\
MBCK'[+/_  3\^'^H6/\ Q3EEXH\!@?\ ";_&0Z5P#XJ&-)\0 A<Y\2Z!D >"
M?"^W^M*OYC/^#8W]AKX\_LB_L6:_JW[3Y\::%X_^*_Q#\<76C?"?Q;=D6/PW
M\#Z+XQU?1Q<_V6<XUOXI^*1XA\7GQ!@CQ3X5_P"$1Q\H&?Z<\@=3BC]=O/T[
M@%%%% !1110!@Z99:?IMK#8Z;9V]A86X_P!%M[.U^Q60Z] .I^@'3O6]110
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MG+\CXGE_PJJUI3;UV7U)N;O>VJ;:OM>]CXOZ5/T6\SX>P'_$2N&\ME[*7O\
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MX+&IV:2DXR;B[:<W]N?_  2I_P""EWAS]M'X</X;\?76GZ/\?/ .CZ?:^/\
M3(,6 UW3R0H^('A_Y@3H;,<^)P P\+>* T;!2$W_ +3PR?O'Z9/4#H?7!]/3
M^M?YA'PI^)/Q)_9M^*GA?XY?!WQ#<:+XI\&:Q]IMI[?_ )!5[IQ_Y"^E:M_T
M&M#\1#OU]Q7][_[ W[;OPU_;B^"VG^,= NO[.\5:?"-%\?>$3=#[=X1\3JI+
M#'&=&X)\*Z\ %*X93D,J_LWASQ]'B3 +"XK3-(JS3M:2BDD[/K9*Z7KU9_GC
M]+[Z,68^$/$=3B;A[+Y2X*SB<YQE%.7]F2G*<N5N*:C@6W^[D[6O[-O2G?\
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MO#7@N+78M"L!8#Q)XDUCQCK,GVGF\\0:T1_;^IC/0D[>V,XYX!KT"@ HHHH
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MO5NG'3O^=>F_"/XQ_&#]B3XZ>$OVB?@O>>3K'ANZ_P")SX?N-0QX<\;>%_\
MF+>#=5(Y&A^(CW!R.,5_4?\ \%W?^"3=S\;=,US]MW]F#1#_ ,+]\)Z6!\7?
M _A^T/\ Q>#P/HX_Y">DZ4>3\1?#NA]"3_Q57A;Y<] ?Y._!>NV'Q"\-_P!B
M7F/M]OG[+]L X_\ U]?6O]!.!^+.'?%/A-4,9&+FHVXAIR<9.ZC:T4VVXR:T
M:2NFG9--1_B+C/AO./#KBQYQA+O*I2OI?K)]$M];6Z,_9[XJ_LJ?'+_@LO\
M"+XH?\%+/ACJ_P -)/C!X<)\.^$O@!X M@?$=[X8\"LQU;P;XWU=CG_A8PT3
M'_")CQ#QXH#(%'A=!X9V_B5\,?'D.L1W/A7Q5#<6US;W1M;JSO+7_B:V>H9Z
M?Y_G7[A?\&YO@;]HGPU^W)XUF\"7^KV/[/!^'=_<_'*S./\ A'+S43D_#/';
M_A*QK8) ZGPJ/%HZ<UPW_!Q9^SO\+/@S^W%\*?'_ ,-]$;PQK'Q_\"ZUXQ^*
ML&F<:7K/B?1]?_L@:I_9"XSK?B'./%7<@ MD_,?D^%>.,1D/'\^ U4C5RF[_
M -7.6S>6P::6 DTYI^ZFXR;NTWS.]CZCB3AO!9[P,N+</%QS5)2=URZ_%?51
M?3_(^%OV3OVEOBS_ ,$]?V@M'^-_PON+V_\ "^H$:9\5/  U#'ASXA>" 0?[
M+SD?\3S _P"*4U\_\BL,@Y!(/^BI\)OCW\.OC!\!/!_[27AF\NX?AKXS^'6G
M_$;3[O6+4V-_:>&&TLZOG5=+R<$+N)4 D CH" ?\R+XI_P#(GV'_ %ZC_P!E
MK^_S]@'"?\$@/@<<G'_#'(&.2.?!>L$<>O0>G<U\/](WA;)Z6;<.YFJ:_M.M
M5A3JN*47RSE&-VXI7DE4DE>[2?W?2>!?$N<8C+LRPN*E?DC.S<F[.,9)-7D[
M?"GYV/XYO^"C?[=OC_\ X*;_ +0$FK6?]IZ5^SA\.+_4+7X+^ +P#D]/^%C:
MMCC^W/$(X /_ "*N!X1R3FOASQYXPTKP'H;Z5H\UO]I_Y>KT_KU/7Z<9KE?@
M+_Q[7G_7BO\ *OT&_P""._[.OPK_ &CO^"G'P[\!_&71?^$U\#>'/#GC?XBV
M'AC5!FQN_%'@0@:2=6R"NM:&,G_B0$8R,G(S7[E2>!\._#9XW 9=^XRJBJCY
M4E*<I4E*[:47)RG)-N3:;;;>Y^92P^)XX\17@,SS"\?:-):M<JG)6MJME8]Q
M_90_8#^.G[+?[/ND_P#!6_XD>*? 'P[\<_#'6-/^(WPZ^%'Q@T8$7?PW.=(_
MM1O[:Y'Q%\9C5?\ BD] ./%62H'BSPOXQ;CX=_:[_;/^-/\ P4E^/"?$OX@P
MGPQX&\-VQTSX5_"C3+_^U?#O@JP_YF'5"?\ H.>(L >*_$ P  %7   _>_\
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MU&V_MCX*^ -9L!G2-/&"/B%JVDD$#7'S_P 4JQ.=N?%:?/(CI^-O_!*GX+>
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MB_BK_P!3$5^D>"6)Q6:>)^2XK'RE*4IX^3DY.3DU'XG*3;;\WKM:UM/BO$O
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M7O\ X-\/^4KGA[_LB/Q6_P#3;X:K[OC_ /Y-1F__ &3<?_28'R/ /_)U*/\
MU\?_ *<D?Z$HZ#Z"HW &,#U_I7GGC7QGX5^'7AO5/&/C+Q#HGA+P?HEK]O\
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M_$^K_8!8'5-8M>?L'USCCT(X'/%>WT4 ?-G_  R)^S7_ -$;\$?^ '_UZ/\
MAD3]FO\ Z(WX(_\  #_Z]?2=% 'S9_PR)^S7_P!$;\$?^ '_ ->C_AD3]FO_
M *(WX(_\ /\ Z]?2=% 'S9_PR)^S7_T1OP1_X ?_ %Z/^&1/V:_^B-^"/_ #
M_P"O7TG10!\9>.?V*/V=O&OA37/#,'PVT+PQ#JD/V6YU30+ C5/L'II1&[ /
M &%..>IP*]A^$?PB\ ?!GP?#X*^'GANRT'PQ;_Z3#;V>;TWE^<9U0]<YZ]N@
M'O7ME% !1110 4444GL_1_DP/XPO^#EG_DNG[.G_ &('CC_U)O#5?SV^(?\
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M0>)-%^T:QXH\1D6W]OZP=,-]:6 Y&EZ5@C"\9P1@X Z9!=^UY\8O&'P%\)^
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M112>S]'^3 J]YOQ_]"K^(#_@Z,_Y.O\ V2_^R.>*?_4R6O[?^\WX_P#H5?Q
M?\'1G_)U_P"R7_V1SQ3_ .IDM?J'@-_R<')/\6/_ /26?FWBO_R1^8^D?U/P
M0^*?_(GV'_7J/_9:_O\ /V!/^4/7P)_[,[_]TS5J_@#^*?\ R)]A_P!>H_\
M9:_O\_8$_P"4/7P)_P"S._\ W3-6K^C/I)?[CPE_V4<?R@?@_@7_ +IQ7_@J
M?^DU#_/:_9]_X];K_KV_I7ZY?\&^?_*5_P ._P#9$OBQ_P"FSPU7Y&_L^_\
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MC5M6'_(:T/\ MWQMJW_$@"].O !K[HHH **** "BBB@ HHHH **** "BBB@
MHHHI/9^C_)@5>\WX_P#H5?Q ?\'1G_)U_P"R7_V1SQ3_ .IDM?V_]YOQ_P#0
MJ_B#_P"#HW_D[#]DG_LD/BK_ -3"OU#P&_Y.#DG^+'_^DL_-O%?_ )(_,?2/
MZGX&_%/_ )$^P_Z]1_[+7]_W[ G_ "AX^!'_ &9^O_J&ZK7\ /Q3_P"1/L/^
MO4?^RU_?]^P)_P H>/@1_P!F?K_ZANJU_1GTBO\ <^$U_P!5#%V\O<U]//\
M$_!? ]_N.*]=X3MYZ3V[_B?Y['[/O_'K=?\ 7M_2OU[_ .#?#_E*YX>_[(C\
M5O\ TV^&J_(3]GW_ (];K_KV_I7[ _\ !OK_ ,I7O#W_ &1/XN_^F[PS7WOB
M&TO"K-]5_P DY%+5*[Y(:+75^2OZ'R/ *?\ Q%2EO\<O_3DC^XSXS_!OX??M
M"?#N^^'OQ)T:76?#T^LZ?K5A]GUG7?#GB/0?%&CZG_:_A[QCX*\6:*!X@T37
M/#NN8?PIX@\.X8-P#MR#X[X5_8A_9RT3?>3:+XU\=^*#\5/AQ\7M9^(/C_XJ
M_$7QC\1]=\<?"PX^&.J:MXWUO7&U_6]%\.#_ )%/P_D^%">0O8?>HZ#Z"F2=
MOQ_I7^<Y_=]-VC%]D?!_Q!_8>^!7Q%^(&N_%O7+?QQX7^*?B37?#_B+_ (6'
M\/\ XC?$3X?^,-'U#P)X.UCP%X=.E:OX9US.C'_A76K>(/#OBH @>*MQ)!^7
M;[;\'?A/X ^#OP\\,?"+X;>&[?P]X \#VHL/#NCV9U.]VXSK&?[6UKG6M<.N
M9\0?V_D]L8Y(^AZ*"@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****3
MV?H_R8'\9'_!RS_R7?\ 9V_[$+QW_P"I/X8K^>?Q#_R K;_KP/\ 6OZ$/^#E
MO_DO7[.W_8A>.?\ U+O"]?SW^(?^0%;?]>!_K7\<^)G_ "6]?_$OSB?[_?0Y
M_P"49:?_ &3M=?/ZYC]/7RW/[Z_^"?'_ "BY^"?_ &;[9?\ IAU*OX!/ /W&
M^@K^_P _X)\\_P#!+KX+XYQ^S]8Y]O\ B1:KU_,?F*_@#\ _<;Z"OL/%'_DG
M>'/^Q!%?/_8M/7RW\C\-^@E_R=GQO\N)*K?H\PS-W?EKOMYGZY_\$)?^4D_@
M7_LGOCO_ -1M*_L"^+?[)7PG^+WC*P^).J6OQ'\,?$RW\.:AX2/C_P"$/QE^
M*/P5\<:]X&_M4:Q_PAWBS5_A[KGAS^VM#&M9('B(#_A%R0/![+DU_'[_ ,$)
M?^4D_@7_ +)[X[_]1M*_O3L/]3)]?Z&OT'P@O_JDM^O?^X?R7]/I+_B/&-22
M_P"2>RY65M[XW2RZ^5K^1\>^"?V*_P!FWX=>$/B5\._!7P[@\.>"?C9\.] ^
M%?CO0=(UG4[&RN_ ^D>#F\"Z3H.E8UK;HBC0M6U4 ^'L$_Q-O +<CK'[!O[.
M&L^,+3Q1>>'O&(_LL?"_^V?!%G\1?B-9?#GQK?\ P4_LD?#'5/B9X(/BC_A'
M?B%KO@S^R/#Q\)Z_XC#8/AS0<@CPV#7Z$T5^K'\3A1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 445^?WB;]M;P!X-U;]LO1=>TK4
M]-OOV,? ?ACQYXD%YJVF6!\;Z?K/PXUCXJKIG@K)& %T@^'6#+RVWE<8(!^@
M-%?)OAC]JKX(^)/A_H/Q$O/B'X/\,:1J]WI^CW5OK_B'2P-!\;GP>?'FJ^#-
M6)R#KOAW0A_;S=\_-\F1CS[P3^W_ /L4>--9T'PQX5_:.^"^L:OXD\1Z=X2\
M.6FD>/=*U2]O/%&LAO[)  R2?$/'_"*:^P \5;@020: /O.BOCS7OVVOV2-!
MUGQQX>UC]HGX3Z/K'PO.?'MEJGC+2[$>%1_:ND>&P=7R!@_VYJ^DZ!QR#J^!
MGI6?KW[87P6'[.GQ=_:5^&WBJP^-/P_^$_@WQSXSUG_A7^IZ7JM[>:A\+-"O
M=9U?P=GC^QM<SI&,>(3D9&1@T!OH?84W1_I_A7\RW_!=3_@F!^TA^V9XR^"'
MQI_9[M=&\3W_ ,*?#GB#PGXB\ 7FLZ7X=\17NGZSJG]K_P!IZ1J^M'^P>, ?
MV"P .1CK@?LQ#^VU^RW:ZQX8\'^*OC1\./!/C_Q+X<\+^(K7X=^)?%VEZ5XC
MLO\ A+]+.L:3I>"1_P 3LZ)_S !R3C@CD>;_  :_;"\8?%G7?!&K:=^R3\=-
M!^!7Q>&?A!\:KO4/!VJ_V]IYTD^(](U7QQ\,M$US_A(OA-X5\9:'I+CPEK_B
M,!6_XD)\8+X7;Q$I'KY!Q!F7#.:8#/,L2O!NUUU:U[;VL[6MMY/QN(,CPN>Y
M9++,5JI7_%-?KU/XXM1_X)!?\%"OB3_8_@_3?@%J&A7.!:W^O^,_$>E^'?#M
MGQGC51XJR>Q_XISGT%?VM_LU_LRW?P>_8N^%W[*^O^(;?5-8\#_ C1_A!K'B
MS3-/ LKS4%\'?V-JNJZ5I62,$_,H.#R.,YJ+QE^V'\'_ (;?&7XH_#3XH:WI
M_P .-'^%'PY^#_CS6OB7XXUG2]*\#W9^-OC/QYX#\$^#P<Y_MS^W/!)SDG_D
M+C;C'-;PS^WU^QUXDT_5[_1_VD?@QJ&G^&_ C?$?6;@>/-!%EH_@C1]4;2-5
MU[5^5&BCP[K8QXL!!/A7()QR1]5QEXI<1<;O+_K_ "X991)2BK;N,HN+=V[O
M1:VMYVNCY#@OPQRSA99C]7O::E?TDI)Z:7MS/77I\OXS+C_@B7_P4$^ GB76
M/#]S\)O^%F^'H+Z_L-%\<?#76=+O-+U[3R ?[3.D''B'1#CMXC /;K7Z=?\
M!&+_ ()2_M3_ +.G[65Q^U5\;M*T/P!H6G^ _%/AWP[X(O-3TSQ'XOU>_P#'
M+*'U3?H@*Z)HHSPK$$X;C"L1_0UX!_;;_9&^)WB+P]X&^'WQZ^%'BWQCXENO
M%&G^'?#^C>,]*OM5O;_1\?VOI@TK(QKBYS_8'#'!P/NUT?B3]I_]G#POX>\/
M>,/$GQO^%_A[PQXD\)Z?XR\.>(-8\9:#8Z5K'A?6->\-Z/I.J:3JW.="_MWQ
M#I/A\?\ 88'I7K9WXP\49WPY_JYBJ.7N'(H-I24I0Y5%WUY4VE>RT5]%HFO,
MRCPEX?RCB-\1X;'8_F<F[/9-MM]+V3;7H?6PZ#/7O17Q5>_MR_LA:?X#\'_$
MRY_:!^$]MX(^(&L:CX<\.:_/XRT$6-[J7AL@^(-+R>G_  C@4_\ "6?P^%L\
M\ 53^('[<7[+?PYUOQ)X/UWXT_#>Y^)&A^'/^$BL/AI;^+=+_P"$DUW_ (E>
ML:QI&EZ2",'7/$>B>'FQH'J1U!)K\H/UOTV/N&BOACPQ^VI\!=8A^!^E>(?B
MAX,^'WC_ /: \!^!_B%X#^&?BSQ'H%CXC_L_QYI7_"1Z1I7)&203X?&>/%6W
M/A CBN/_ &?O^"BW[*_QP\(#Q-IOQ1\&>"==M[4ZAXS\%^+/&6@?\)'X5QXQ
M'@(#Q"=P(/\ ;O\ 9&@ @$?\3;0AD9!H _1>BO@CXN?ME_#'X8^,=2^'=I;6
M_C;Q#IWPZ^.'BWQ&NF>(O"]GI/A74/@GX/\  /C'5?!WC?5=:!_X1?7?&6A_
M$SP\5/B$C )8C/([KPC^V%^SAXR^(UM\'/#?QH^&]_\ %VXM=0^U?#31_%VE
MZKXCM=0T?:=5TP  _P#$[\/9(.@':003C'- 'U[1110 4444 %%%% !1110
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M_$3PK\(M7^+7P^A^)'CBPT_4/"7@P^,M+_M77K#6<'P]@'/_ ",0S_PB?/\
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MXM?%3X0> RVC>"OASXU^&7]M^&?@EHI\0Z&-);Q;XA/B;Q2#_9 *>%/O"OU
M^,/Q.U7X:>%G\3Z)\(OB[\9KX:EI]A_PAGP?T;P;>^(I]V1_:8_X6!XK\$Z
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M%?&OQQ71/$7Q%U?P_P"'\^&V\+'PH3H)!KTG]D?XJ?';5?'OP(T3XF_%J_\
MBMI_[5?[&0_:DUC2[WP]X.TRR^%GC<Z[X!_XD'@D^&=$4CX>-HGQ-_X1T?\
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M%?%7A7^P0?%?A?\ X1ROB*X_8Q^.O@6]\$?L&_";P]KOC#X2Z'^TUI_Q?O\
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MB-*)^(/_  AQ\3GQ7XISXOQX8(*C^A>B@#\*]8_X)_?M#_$7Q)^T#\1OB/\
M$3X,:1XP^/'@3]K#PW_PCW@;3_&-]X=\*ZA\;?@3\!O@]X)/_"0ZWCQ!K0\.
M?\*<_P"$B\6_\4SX7R-8.T,< ^W_  O_ &&O%7@'5/A'>3>+_!DW_"M_VU_B
M_P#M2ZS+9Z/J8&O:?\5?AUX]\!:5I8).X:XH\;:23D $:0-I;D#]9:* "BBB
M@ HHHH **** "BBB@ K\W?C+\%/C?;_M&^&_VIOV;]8\"7/CK2_@_J'P7\>_
M##XQW?C+2O WC7P1_P )B/'>D:II'C;X?^%_$OB'1/B+X-UP:O@?\(QXI7Q5
MX6\1-DY(W?I%10!^#W[2'[#G[:_[07AI/#?C#X]?"K7M0\6?"OXH?#KQM]L_
MX3+X5^'='\0^//& \=Z4?#VD_#[_ (J#XM_#KP[H1_X1W_A6'Q5\3>&./#8\
M6Y\4[L5ZKX'_ ."<GC/PSX'^!'AZY\9_#B6_^$W@/]O#PWK-[;^'-3Q>ZA^V
M#KP\2:3JFD8.1_PCIR/%H.#XJ()QW/[&44 ?A%HO_!-[Q_'X_NYQKGPW\8>"
MO$FL_LK^)/B+>>+?&7QXT^^\-^*/V</!O@/1L>"?AEX9\4^'/AA\0,GP3I'B
M#PGK_C, ^%?[8X'BC&*Q_A%_P3A_:$_9]\:_#_XO^"?&'P8\=?%'X;Z-X6\.
M:7X3\;V'C+2? UWH_P#PIL_"OQMJA\1:+X5\1^(-%USC21X4 \,L?^$5.O>$
M2,'-?OK10!^3_A;]A_XA:/\ LN?L7_!"\\5> #XC_9X_:!^$'QI\9:IX?\-Z
MI8^"->L/ ?Q'\1^//$&E^"-(P#HN?[7_ .*4)(VD G@YKS?PK_P3=\4^$_AM
MH/@:\\6?#BZO]$_8>_:I_96-Y_PCFJ<>*/VC_B+X;\=GQED_\P/_ (E/_%5@
M'.<G&,D?7WQJ_::OO@/KL&DS?LW_ +5WQ7\.SVFG75]XY^"?PLTWX@>'=!U#
M5L8TL^']&\5GXA:WTY_X0[P/XI_X1<9W9R:_&WQI^W]^U)\//$/Q>^*\&K_$
M ?#K4?%W[:'A/P)<?$#PE\.;']G363\*]*\2#X(^#?AE_8F/BA_PN+P[XI\/
M>(!\;1XC_P"*6\5#P'\2@,X\+4 ?HC_PPGXJD\4R>))O$W@"]C_X;@^!_P"U
MGC_A'-4^VGPO\+/@1HWPK_L' '.NC7-(_P"$@\)G/ 8Y!(R/G67_ ()R_M$Z
M!IGQ0\$^"?'_ ,"CX)_: U#X;W/Q&U?Q)H_C+_A(_"O_  JO]HSQY\5=*_X0
MC2=%/_"/ZU_PF>A>*SH/_%0_\(N?"OBG.!XIZ'[+_9:UWXG>&OCS^T#\ OB1
M\2]9^.%CX(\)_ [XE>'/B'XLT?P;9>([._\ BF?'O]K>#M5'@#PMX:\.C1!K
MG@G_ (2+PK@9(\1X^8A17Y1^$O\ @H%\=_VA/V:)_"WA/Q_XT\ >/_ W[3?P
M/^!'Q/\ CM]ATS2OB->7_P 5/VJM6\"?\6R\#ZU\.O\ A'O%'PZ_X5T/[ 'Q
M1Q_PBWBCQ5H^O#P?_P )/_PA/BG('Z[^?KW^=SZO\<_\$Q_B!KOP?^ 7PYTS
MXA^!+'Q#\&#^TMK/VF?P=J5]X<\5>*/BK\>? ?QK\$G5M))']LZ$@\$_V!XN
M[XU<A58X!\V^*/P'_:-^!?QRO?VX-3\.>'O$OQZ^)X\<>!-:^&'PS^$'QD_:
M%^"^A>!_^%=:/I/A_4]7_P"%?Z%_PN__ (6+XB_X0@ ^(?\ A4)\+>*@3X1\
M8?\ "*X7Q6?2=2_:J^.W[(?Q:^*W[-_BKXF^&_VDKG1]&^"/B+X0_$#X\ZQI
M?PZ\26?_  M3_A< U7X<^-C\(_AUXDU_XM:X?^%9?\)#X3_X57\(/^$KQK'_
M !6 '@_PX?%0_3O]E/X]6'[3?P!^%/QZT[0]0\)P_%#P=IWB0>$]8_Y"N@WY
M&=6TL].<@X R1A6)!)H _([X$_\ !/G]HSP[X7_9'^*^D:I\,/#OQA^ /P(_
M9ITNV^$'Q*T;4[#P0/%/@/2OC;I/C?3-6'AC_A)/^$9SH7QL/_")Z_X<'BD^
M%O%?AP$J "1:M?\ @F]^U%X;NOCB=!\0?LP36_[6?PP\4> _CO\ :/#GC.S_
M .%>ZA\4OC'\5/'GC?5/@E@'^V?"OAW0_B8P\*>'_&9\+@^*]''BW.2 ?Z Z
M* /PJ\._\$\?VB?#2^#_ (=O\1/A!+\%O@^W[6W_  KG7Q:^,;[XM^*O^&J/
M!WCSPWI/_";9(\/:*/!>M^-\M_PCO_"5'Q4%^4>&#P=#X2?\$S?'_P .M=\3
M:]KWCOX<>(AJ'P8^-OPLT7['X=U139ZC\4_AS^S?X#_MXY(( 'P<\0EU)Y76
M-"7!R5K]Q:* /GWX _#Z\^%7P*^#/PKU:]L]2OOAG\*_A_X#O]3TR+%CJ6H>
M!?!VCZ.-3TD>YTK;CUZ=:^@J** "BOC_ /:X^*_C#X#?L^>.?C1X(\):?XPN
M?AA_9WC+Q9X?U/\ M0"\^&.C:_I!^)NJZ3_8F#_;GA[X=#5M?\*@DJ1H^,$;
M\Y7PO^/&J_%C]H3XL?#OP=IVC7_P?^%'PY^&%W=^/[/$^JZS\1_BII1\=^'M
M*THX.@_V'X=^'9TGQ >ASXZT'MD$ ^U:_GX_:X_8<_:(^(OBW]N7XW_ ;1+"
MV^->H:+X9T;X+2ZKXCTRQ\._'WX<ZQ^SN?A7\;?V=/&VJMSHV@G7,^(/"7B#
MQ#QX6^,^CZ#XN4@?\)-GU']HS_@J[\._V<?'/[=OPZ\?>)/A_P"&/&O[-'@3
MPQXD^!WA_5;?QE>WWQ3O]9^#9\=C2]5&B @XUT#P]C( 7+$DX#?5OQ#_ &U_
M!/P9\%_L\ZAX[\.>-]>^(7Q[T(:QX=^'?PS\.CQ)XCO#I&E:/K/C;4M)TG6M
M<\-_VR?#JZOI#?\ "/>'AXF\5$%?^$/\)^)\T ?CUH_[*O[9&J_%:#5M-^ .
MN^"]>TOPI\;_ (<^(_&^@:S\.OL/BGP/K'[(GB7P%\,],U7XF^*/C#XC^*&M
M _$?^RL?##P7X8\+^%?@QXJ.02"/%3>B7_["WQ.^%6I_#2VT+]GOQ%XL_9W/
MPJ_9+NOVI?@1X3\>Z7_:OQ^^(W@+3?BGH_C;_A(=*UKXBCP_\0-;\/:WJOPR
M\0>+?^$B\3 ?&<Z1C/BC_A&P6^X=6_X*)_#7P-XI^)GAGQ)HGQ0\?^(?"GB3
MXWZP=&^#?PA\9:K?>%OAO\$U\"GQOKOC?^W/%(_XGGAW_A.-)/12< >$?"IP
M%,7Q5_X*9_!O0_#7B=_"&C?%'Q1%(-0\)^!/BO9_#G7=5^ >L?%X_#G5_BEI
M7PZU?QL,8SX5TG_BK#QX5!SX1_X2P>+L4 ?F)-^Q;\=K;Q3XTUOQ/^Q[X\\?
MVOCKX'>(/!O[*5E;_$[X=7U]^QIX@UCX[?%/QY\'/!WC;^VOB/C1/^%5Z)XA
MTGQ!_P )?X,_X2G_ (5_SX1\'_,<CJKO]D+]M'5_"4/A'PYX!\:>&?VS]*UC
MXO:A\>/VYQ\5=+\.>'?VG_ NL:7K/]D_#K2M4T3Q5_PD/_%1_P!J^"O#_A/P
M?XR\,>&/"GP9/AO_ (2WPAT-?H_HO_!3OX+Z?;?#'P_XVA\0V'B?Q'X2^".M
M?%77]+T;/PZ^$'B;]H/2](U?P1H/C?5M:UM=?4^(FU;_ )E[PUXJ'A4>(]!_
MX3 >%\DCI/VO_P!M_P ._LM^'OBEI6B^"OB9\3?B;X4^"WB#X[W&C>!_ FN^
M,?#O@OPQC6-)\$ZI\3/$.BC.B^%O$/BG2?$.?^$=/BCQ5C1]?\78P,T ?FOX
MC^$<_P"SUX _:X_::\!?LSZ[^R18^"Y_V6?B]^SM\-?'WQ%\'6-[\5/C#\$_
M^$Z/C?X=:3I/P^^(WB7^Q!\5=$U<?#$>'F;/BOQ3K'_"7#=MS7[6?LB?#?Q5
M\,O@-X$T7QY=W&I?$G5;:_\ 'OQ/U>[ ^W7?Q&\>:I_PG?C8=><:WJW]@G/;
M1^A/7Y;UC_@I!^S;8:1=^(_B;HGCN'P3X3M?$VLV7Q6O/A5KU]\)?$7Q(^%G
M@[5_'GC;P;\,_$.#_;7Q%\/?\(]JX\)C!_X2O^Q]>'@[Q;XGP36QX5_X*=_
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1HH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>vi_004.jpg
<TEXT>
begin 644 vi_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #9 EH# 2(  A$! Q$!_\0
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M#_(@TM-0'!SR<GD#&1T'&2/N@8([>].I@%%%% !1110 4444 %%%% !1110
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M^ [;S;:&/Q#IV@SP6^L0J0ZHI<-\J?\ !#?]F#Q9\!OB'\>M:\0_\$D?!O\
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M=I"0.M4'G*HSJY8!0Q)((P0KC&"6!9#E!CGIQ4YD^4$AMY7.WCD\_+G=MWX
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M<%78$H&R%=B,#V*&X6XVNERDRX S _F!@21D-#O5@,9W9*@$9(YK^+O]B_\
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MG9>;/TS@DE^=7='(.58*PW*1UP2, =,9/-6 SG.-O'^R?_BJ^9]<_:U_9O\
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M/PBN;'PK-XK;Q%\4[C0?#N@7%O!*D<UE;7ES>Q!M0CWHS1-M)4DA21D?L]X
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MA#+*3(D2QK.BJ5;S%9F/(&WEBB,4(4H[!B#@C\^OC'^T_P#$&Z^'?[)_Q?\
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M -E?]LSX*_%7P+^VK^PY^TK^P[XR_87\,_M5?&']J7X2?&GXQ>*[>QT[P/\
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MVC+/X6:QN-,A^PVEJ;GPY+IU[/IRZ;C3I]+FFD@OK1GMKB.2,2!JOA?]D?\
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MZFU>ZC1;G5=,A37EBTNZG1?++:;';*59D=2H /Z/^"_">A>!O#GA_P '>'K
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M*5AB&,8C0$#ID#D#T53D+SSZG%2M'N9LG@CI_P#6_P _EP'JNU0O8 _S_K0
MZBBB@ HHHH ,@YP0<=?;ZU&9%!VDMD]\'O[^V>/TSBGX"[CZ\_D/\\U5=G:0
M;5! ST/3.1@].>__ .J@"UD=<C'KF@XP02!GUJF9XXPV'4_,N0Q!(!; )Z@#
MKR>/>JC7(8RC="RQE00)&4;FR4&2."1D@^V.I J7**7-+F4>ZC?\"5)-Z2BT
M](N[UELD^B5[7ZBW4@!+!0YCQ*$W8RXSL0D<@EER#Z9(R,U_,G^W)XX\6?\
M!5_]KJT_X)E_!/6+Z']F?X-:]HGB_P#;L^)>B3LVE:U#9W"ZEH_P6L[ZSG!N
M!K;6[6^MQPS%H9&S<1!8FQ]G_P#!7/\ ;E\;_ OPEX,_9<_9>MH_%?[:G[55
M\_@/X3:!:/\ :+GP;I6JYL/$'Q/\16UNS7&GZ+X<LVENH+^:-+4RQ';(<YKZ
M5_X)P_L'^!?V!OV</#'PF\.;-<\?ZAN\2_&CXE7D8E\0?$OXDZPK:AXC\1:K
MJ,I>ZNX#?7,L&E0S2F.QT^.&*)0[29]W!4X95@GC\1;VV*DHX*+TE%N<;5;;
M^ZM%HD]?(^ORZC3R; K-Z\4L5C%[/+(32]I&4)14\6XM/]W3]Z,+JTG)-ZJZ
M^0_V%/!7AOX?_P#!2O\ X*"> O"VC6>A^#_ ?PM_9=\,^$O#FG6\5MIVA:#I
MGA:\L[+2-.@@"Q0V5G H6&,HTOSL\DI)(K]Q;.(IYBR'Y4=?+0<A8BN47)YX
M&2>"><<<&OQL_9'"#_@K+_P4R!'S#P5^S?DDYR/^$<O& V_0CGU^E?M#" 3(
MQ ^8J?7@*,'/N/Y9[UCG=7ZWCH5Z\YU:L<-0Y'.3:5Z4%*R?J_ZW\OB*O7Q6
M81J8BI*JYX?#R;J-R:?LJ<DXMOW=7>R]"'[.HD+1KP3DM@YS@ X/'\NY&>M2
M.A &5W@8R2#G/IQT[_7\B;6 .@Q17DM7LK^ZNG]=#QG[UN;WFMK]NWH5%RN6
M12%[J0>O?''3I_G!J:.1G)RI4#/)!'?IS['VSSP*EHIZ6LDEZ!97NE;T"BBB
M@ HHHH **** *C\HIYQL5!@?-NW#H._&,=B<#O7\P'_!=C]MS7O#'BW0_P!D
M;P1^P1X1_;CB^'?P_P!(_;$^+=O\0O$5]X8\(_"GP_X0\5)IG@_Q/#)IDL%Y
M<:C!KA^TREO,M[>$.UP$BS7]/%Y*D-K<SR\P0VT\TH!(+1Q1/(X! )Y12..:
M_F/_ &<OVDO^"3G_  69_:9O?C5H_COQ;\,_VF/ GPS^,?[*/C/X$^,/%5GX
M*U/XP_!_Q;_:&BZH;[1A.VF^/=(AD%QJ>@-I=S/=:#J<:?;K6"9/EYXW]M#E
MVIM6?S5[]'Y=+V'';G6S5EZV/IW_ ()7_M_?MN_M9?'+X^_!C]LW]G/X7?LM
MZ_\ !7X=_#7Q=H/@'PKXLN_$_B[7M,^(T4NHZ%XG#W$EU9#PBVCPQV<,D)9E
MU6+9,!(C(/1OVF_^"*7[(?[2_P"T%X!_:<N]+\4?#_XL^&?CYX&^.OQ"U;PS
MXAU=(?B?J7@2T:VTSP]K&GS7XTVVM)U2WBFU#3XK6ZMH5F-L"\I4Z/\ P32_
MX)(^#/\ @G+XM^,?Q(?XZ_%W]HSXG?&&P\/^"X?'_P 7M7DU?6/"_P )?!<C
MOX&^'EG=/-.9K#0H962"4G(6,A%$> O[%J V20"&Y'?/)Y/8GT/I714BI2C+
M9K56>E_+[B$VVUV/QL_9N_X)&_#W]G7]I>P^.-A\7O'WBKX>_#OQ%\8?&/[.
MWP#UFRTRW\)_ _Q?^T#J4FI?%C4-/UZUC75O%MIK=W-/)IL&LF.31([B18&E
MWMG\_?VPOAY\/? ?_!QE_P $FY/ _@;PEX*O/%'PE_:7UWQ3>^%?#NE:'-XK
MUB:PG>34==;3K:W:^OF>2:1KRY$EP[O(9)&=MS?U*L !]T8[?7!P>F!]>O\
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MTM_P?NV_4_ME@7<\?FA@X?A>,G9\N&(53B,J^1P&)1LG*UK#KZ8)X'O@C/\
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MV" FO[R9TW031*YB-Q!+&9"NYE=D*"54P0S*QW!2#N  ]J_AX^!G[/W[;_\
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M<_,J^^/O_!7:[_;?UO\ 91T?Q-^R';M9>"D^,T&M7F@^,9;:R^&5YXS;0H-
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M_P &Z%JVG_"[2;V6ZDMV76/$5S90[1 D8N1]H^R12P$&&Y9BN?)]._X)D_\
M!5S_ (*/WZ^,O^"EG[6FL_ /X/ZM+<WUG^RQ^SIJ+:/=66D7=N/(TK7_ !-:
MO'%=N@$D5U'=R:A)(9F_>)@"OIL#X2XK!4:.:<<YYEG!V78AJI3IX]O$YU7I
MJTK8/(<#5GCZOM%:$)XIX2,7-2ER\MC+Z["3:HQG4<KJ$K-13V3<M%;?N?F+
M_P %@_VMO^"77A__ (*,?!*/P?\ LM?#'XYZI\,?&GB3QS^TGK'@W1/#6JZ1
M\:/$7C'PS<:/X0\$ZOJ,<LC:Q?6/BAM-NKZ9LPP2-'L7S,X_87X-_P#!-?\
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M-K-\L]N8;>'2#=7>F0^?");A(XS\KDU_&1_P4I_;<_X*"?L]ZOX%\<_M]_\
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MFBLW>;1+:0P2S1W9GNK= NRXMXXR1L8@_B/_ ,%J?V2_V_KOX6^"_&'[=?\
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M \DX55'+DGIT'7'YO_#W_@KK_P $Y/BMX\\-_#;X??M=_"GQ5XU\9ZS#X?\
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M]IC]GZ,ZMJ7PW\0W6G+]KTK7[BTETS0I7NYK!XX]\E8QTE&W\R\NJO?;SO\
M,3;L]]G^1_2C_P $R_$WQ5\=?L@?#KQ5\:_V@_@3^T]XVUF^UZ]3XO?LY6NG
MV7PJUW2C?LNG6^CVNGPP0QZAI]O_ */K:M!;RG4 QEA#9(_1&// (VX7H. >
M@S@<$GUK\H?^"17P!^'WP&_99DU'P)^T!\/_ -I63XW_ !"\3?&7Q=\2O@WI
MGA_PY\&;GQ7XPDAN+ZP^&G@CPO+)H?@+P]:QK$J>'[5+6:&X:0W<*SE@?U>4
M*"H!Y5..<GGDYY_&NB>Y%'X-=]=_Z^XEK^9W_@BG_P I*_\ @O1_V=E\._\
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MGDU7Q+KMQ=:I=LDSF*-I[B0^6$1#M10/H.!0FY5Z*J*/H 1WY[=^?6F^60,
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M-:M.>/D@^&7CMW0,VS<ZC2<(H.-S,0J[@2?F44V3_@Z,_P"",*#!_::UI>
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M_@NU_P $T/VT?C-X9_9\_9X^.EYXT^*?C"/4;C0O#\G@GQ1I$5Y'HUL;V_\
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MX8L[O43>W^K1SFXOM4U!YY9)P^:_IV@61(0"I&1R.3\V?G(#$G:6R5&3A<#
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MK-9V\&B)*L5U8PM&IKK?^#?#X;Z-\&OA]_P4*^$N@ZIXM\0Z1\./^"BGQO\
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M91/>:AJMDDNJ:O(GFWN9(=Y_I/NHGE0K\NPYW*XSGUP<%ESC/R_7CJ?YLO\
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MRK:D/$?@VUL%T/Q)?(RD:??ZG;R3Z>'(MR%!K[\M!(L;)(P=E. V KL#U+@
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M5?@W'J:7,(7X)W_Q<\4WOPXGT6VN@KVWABX\/M%-X:ACCCM(]'GL5M(TMO+
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MP*\4>*7\">';_2=.UK4_%FL?$"+F\\#6/@B"P/B:;Q58 !KO28K!IXU;YD&
M6I._?YZ ?I^\H&""%![O\J_]]$'D]%&.<'G-*9=HY5CP.<'&6Z9VAL+R 6Y
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MD:Y<7B(_F <'^JJU4#S(AY@\MPN78G<N<;@>,D\'/ (]*SE3:=TM7?M_6_\
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ME[:/\2WJW;HE^2/TH:3&3N 4;1GK]XGDC'"^_?!IAN%7(P6(8K\N.3C=GD@
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M:'[9?[2'PAN;3QS<ZSI"^-OAGX;\1Z7H/Q"\26&N:CI,6C?#SP'J,=UXLO\
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M,(!G+$*Q&>@&",]2*@DFCG&48;E8/@/Y;+MVD$Y PP.=T;@#Y2'&"#7Y;_\
M!67]M[QE^Q'^SOX6U7X0:3X>\3_M$_'KXR_#?]GKX ^'/$MM)>^'[SQY\0M=
MM=/&K:S;6\D4\^E>'M->[U2==Q4M!$LGROFN0^+_ /P6O_X)\?LP>*?B'\'O
MC_\ '>/2/C/\$+;PWI_Q<\*:/X*\5ZW=PZMJ^C65W=:WI%EI.GWL\WAF*></
M=:D66TTN!HH[R6+ARH/G2<;M._KIOI\KB;LOFOS/TS/PX^'3>'=:\&W7P_\
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MAC43&(1AO[\-*_U>K_\ 7^?_ $GDH;_D&V7_ %W3_P!"NZ'-QCLM_P ]/Z_
MB>R];?>?QB_"OX__  ;_ .":/QL_X*G?"C_@H/\ LO?%'XY^,_VL?CYI/Q?^
M".GZ)\$]2^,-M^U)\._$WA[3XM(\(Z3XB_LG4=/MKK1-4CB,VC:U<V\5@(F:
M> 31+GQ#]OKPQXE^%'_!3G7_ -J7XL_&;]K?]@[]G']IW]BKX9>&?A)XI^!G
MP$TGXK:G8_8]'^RZU^R_XM\,?V!KD?@:=+2>2.TT^PM+"VU&>=[&:Y15\Q?[
MK=2_UGA/_K[M/_14=6_$O_'G!_U_1_\ H+4)WC'O=_FEL7'KYK]$S^(3]EW]
MD[X=?";]OS_@A!\/?!-G\9OC%\"M(^#/[4?Q'\+>(?C]\)[KP[XC\*:KX@N+
MC5M-MO$'AR[MKW2O"1TS57EET:UDFMS:SW"SZ;&IVE./UOX/^/M9^ W_  =1
M>"O!'PL\2,_B3XKZ5JW@CPCIWA.2V@UDV,27^LZEX.MOL*Q:A,MO'<22SZ+#
M+.[R,%8RL,_W/-_R%-"_[!5Y_P"@6]6M,_X^M;_Z^6_]):MS:;V[!%>[+^OM
M'\6?[#?BCX>_M,_\%:/^"3GQ"\'?#_Q+J?@7X;?\$M=0\#WNI>,/A;JN@V6@
M?%/P6(=(\06\B:]I$=K8ZKI%Z]]#9ZBIANKQIY;BSED.6/QM_P %:/VF/C-\
M9]._X*U?LW>//AEX\^#OCK3_ !MHJ?"3X!? 3]E*VGE_:"^''AS4M-N[CX_?
M&_X\PZ)<ZEK>CZ3:V;W@M].NXIB\EB@,Z-+C_0"LON)_P+_TH6K=W_R%?^Y>
MN_\ T6E9I_O;]=_O3$MEZ+]#^*C6/&VF_!K_ (*1?#+Q?\0?"'BVW\'?M!_\
M$2_#7PF^%'BG2/AQKFO>'_$7Q3'PKN8;[1-3UBPTV>]T34(2B6MU=Z@(+K[1
M*EG*Y65:^8_@-X3\6_ K]DO_ (('?MI_%_X$^/?B9^RQ^R?>?'?0/V@_!>F>
M"=3\3:S\,?$?C/Q;J\?A3XQ:M\.I;-KS4K;0T=EBN7TR34(D4,!CRR?[X!]S
MPU_V"9/_ $9:UN6__(&N_P#KS/\ Z%<5$Y/V;\_^",_SY?V[M.O_ -KW0_\
M@L/^W]^S/\$_B'X)_9%^(_[/GP$^"OA>^O/AQK7A"Y_:,^)N@_$?2+CQ%\2-
M)\!26%EJ\^GZ-8)-:S:W=:6EZR(6 *FOU0^-_P ,%\*?\%#?^#;6;P-\._\
MA']+T+X2^(;#Q#JGA;P;_95IIL'_  JC0Q_9GB&_TG3XK+3H;B1IV2VU1K<&
M[DE<J)Y&6OZOW_Y%:V_ZY-_Z')4MU_Q_:-_NR_\ I%5KX(OR;_!,#^='_@NV
MEUI'[47_  13\?:S'(WPR\-?M_:+H_BB5HF6SL_$/B.T72_"%Y<S']S:)#JH
M(@DG9 V\;&ZY^?\ X!?">P\1?\%8?^#A+Q)XH^&S:I)/\!= T7P?K>O^"QJE
ME<VNI?#G5/[3LO#5[JNGO%=3:C>0A+RVTBZ87!"1S)O6,#ZV_P"#C'_DT/\
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E\4/5_D1U?I^MC0+$;NG&,?C3JC;^/_@-258PHHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>vi_005.jpg
<TEXT>
begin 644 vi_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $9 R # 2(  A$! Q$!_\0
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M9E\-:!;(\KZ_XMG@)AT33#'#.\<UTP+K!(54X7< ??M%?AMH?_!P#^PUXO\
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ME>/O@$J:=\0_@G:_#3QA8>/_  1K]]:7L^FCQKI5SI*2:)H#M8R_:M?<R:=
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MH'B>&XM4UG1-=T35+.QU*UU338KR"1H)8DCD65)(Y6C=7(!^_-%?S#?L*_\
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M/[PHHHH&%%%% !1110 4444 %%%% !37^XW^ZW\C3J1AE6'J"/S% '!^ ?\
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M=<1;EY5O+F#IN7^$XR#G%3I^WW^QE&BHG[1/PN5$ 553Q'8JJ@ 8555@J@#
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M(;NYC $<]UJVF3R)@Y CFG1G5 W(", #CUYO_P##?G[&:@*/VB?A@% "A?\
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M?Q)/!J4SI$\)3YW;99_9\_X)&?&K_@FI^V_?_%']@*#X6Z]^Q[\9+E[SXM_
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M  W]^QI_T<7\,/\ PI+/_P"+H_X;^_8T_P"CB_AA_P"%)9__ != '\[&J_\
M!(O_ (*+^)/&_P ;9/VA]0\!?M=Z5XPUG7/^%7:O=_M">-_@%X/\(:1>Q7<>
ME7.J?"OP!\.[I-0OM/>YBFFA?Q7,MTMLL37'[QWKRWX3?\$&_P!N'P)_P2-_
M:N_8"U*^^!Q^(OQ=_:';XN^"M?T[QKXEE\++HNI66@V5[INHS7?A<ZG:W6G+
MH2O;NRWAO!<;99(C&7D_IY_X;^_8T_Z.+^&'_A26?_Q='_#?W[&G_1Q?PP_\
M*2S_ /BZ /Y[_P!D7]@W_@MM^QY^P7:_L.^#=#_8-\6Z++H'B31[/Q=XCU;Q
MFMUX?B\5:MJL^J1ZOIB>%)K/Q=,MO?>;:WDXL/*#I:R03+;B63>\3?\ !O7\
M1M*_X)G_ +.W[,OP]^-WAV]_:&_9N^,P_:1\.:IXJT29OA5XF^(MQJ$NJW?A
M'6=+4W5S'X3BN+A[:WN1;32O%$)'LL2O$O[Y?\-_?L:?]'%_##_PI+/_ .+H
M_P"&_OV-/^CB_AA_X4EG_P#%T ?SH?\ !2/_ ()R_P#!9[_@I7^S?\,O@3\1
MM$_8;\ 6_P .O&7A/Q1>7GA3Q#XWGO\ Q!=Z'9WMI-<:5>W7A18_#&GJDD8?
M2(K:^-VTJL+RW2U\J;Z9_;!_X([_ +1OCOQM^PO^UY^S?X^^&5G^U5^QY\)_
M!OPUNOAQ\7+/4M>^"_C&WT*U'VF>"\M(%U+2+VWNKG4/*U*WTPW-Y&;,EK5K
M8;OV6_X;^_8T_P"CB_AA_P"%)9__ !='_#?W[&G_ $<7\,/_  I+/_XN@#\.
M?VIO^":?_!2C_@J-X^^ /AS]M.\_9>^!7P%^"WCW0OB7J%Q\#KOQ/XP^*WB3
M7=#<^;I.F:_K>C^'H_#NDZG"\B![=IY+2817,D=X8D0>_P#C/_@E[\>-3_X+
M5?!S]O30M4\$'X _#W]GJV^#^HV6HZ[J8\?27UK::U;K>0:>FCR6-PA^W6P:
M234X7;][)@, K?J/_P -_?L:?]'%_##_ ,*2S_\ BZ/^&_OV-/\ HXKX8?\
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MC'\9/VG_ -G+X5?"34Y([B]^&7Q1\2W]E/\ %;QO\*](M)])N?#45EX@DO\
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M^4?AW]HOQ]_P\P\9_!2_\47<_@5OAW97^D>&YA$+'3]9#(\US =BRM+-#EI
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M ,$^G_\ R/1_PBOAC_H7-!_\$^G_ /R/6]10!@_\(KX8_P"A<T'_ ,$^G_\
MR/1_PBOAC_H7-!_\$^G_ /R/6]10!@_\(KX8_P"A<T'_ ,$^G_\ R/1_PBOA
MC_H7-!_\$^G_ /R/6]10!@_\(KX8_P"A<T'_ ,$^G_\ R/1_PBOAC_H7-!_\
M$^G_ /R/6]10!^4G_!3/1-%T^U_8SGL-(TNQF/[;_P "D,UGI]I;2E#J=Z=G
MF11(VTD#(!P>.XK]6Z_+C_@I_P#\>'[&/_9\/P)_].5]7ZCT %%%% !1110
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M"R39=6TU]-/$T\OV2_BPH7^A?X1? _X0? /PCIO@/X,?#;P9\,O!^D0F#3]
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M? IW5U_7]6/Z3"BBBF 4444 %%%% !1110!^7'_!3_\ X\/V,?\ L^'X$_\
MIROJ_4>ORX_X*?\ _'A^QC_V?#\"?_3E?5^H] !1110 4444 %%%% !1110
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M=K>10:GXQ\;:N?LNDVD,1$ES+96]Q)'-J#VMO<2I;J=L9)%?3_[57[47P?\
MV./@=XW_ &@?CAXEMO#7@3P-IDM[=3RLK7NJ7[CR].T+1K3(EO\ 6-7NVBL[
M"SA#233RKT4$C\&?V(?V4OB-_P %2/V@-$_X*G_MY>&=7T7X>>'KMG_8?_9<
MUYV&C>#?"D,[R67Q2\<:,ZK!?>+->;R[W3H;B';:Q"*9_/5;/R0#Z-_X)$?\
M$_/%/A,ZI_P41_;&NW^('[<O[4&EVWBW6;_6K:;R/@OX,UZ%+[1?ACX.L+\-
M+H<>E:;+:VNIB)(9_-B:U8LD19_WCIB(J*J(JI'&%2-%  5$&U550,*H PN/
MX>!CBGT %%%% ",,C'/OC(/'(QCOG%(6S@CC()P1\QP#C [?7![#'-.I".F#
MC'M_G'3Z>H(I-7:?9/3U_I^HG>VA 2=Q&#N.!D8YXW8/'3  (Z_RH +$9!7@
M /D$C R.JD'D<<]>>2:G  _'@_Y& .O:C QC^I[Y[]>YI/166FF]EI;U%;RZ
M=6V0Y ="W#$'@GGGY<$8Z@D?-QD9] *F(R"#QD$<>_\ 6CY3S@'T. >AXY]C
MR/S%+1%6UT=^NU[Z[+3Y]1_U_7?]!B*RYRQ8$C&1TXP><D\G_.2:?115#"BB
MB@ HHHH **** "BBB@ HHHH **** "BBJ5]J%EI=M-?:E>6MA8VZ%Y[N]GCM
MH(5'5I)IF2)$'!W,W7([\ %VD) &2< <Y/0=LG\ZX\_$/P&((KK_ (3/PO\
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M098QK\ MF<E5VI'!LC0X.X*&//7^I#0#NTRQD8_>MXSR<_\ +,'CTY.>,DD
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M;1M,MX[6PT[3[*%+>VM;6WA5(HHHHD5555'3)R3FN@H **** "BBB@ HHHH
M****    8  'H.!1110 4444 %%%% !1110 4444 (<X..O;_/\ GZU\Y_M;
M?'V/]EO]G/XN_M 3^%]4\9P?"SP7K'BV3PUHY5;[4UTNV><PQN^5CC&-TTC
M^7$KOC"C'T;7Y*_\%0?@[^W;XK\"ZS\3?V._VCM4\ 3> /A_XCO)O@CI'PI\
M*^/[KXL>(889KFRLFU#Q/KVCP6<4Z*MD]MB?>K%DCEDVQ, ?@IX4_P"#E?\
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M:T/5KRUNDEDGN;&:[DLYKGRIWB:6&)T^CP,>OX_Y]J#G!(Y.#@'@$]LGK_\
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MY\TZOT/TU73K^/4_D#OZO\V%%%% !1110 4444 %%%% !1110 4444 %%%%
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MB'&[U=]?FG8_L#Z3-)OA3A"HUK2S/&T+*]M,FRR/S3<6K=/O/9U! Y(//;V
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M .G*^K]1Z_+C_@I__P >'[&/_9\/P)_].5]7ZCT %%%% !1110 4444 %(2
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MY."/[N.,Y_IQ^%/HHI+KJWKU5K:+3^O/L,****8!1110 4A( R3@>I_*EIK
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M^QE\0;:VM?MS:'XC^&/C*Y@1A_R#_!7Q'\,>*+^49( \BSTR63D\A<DU]M^
MO$5AXJ\$>#_$VE%I=,U[PWHVJV4F.3:WNGV\\!8#(!*2 GD <XS6\FN5Z^6]
MOEL_N.DZ_'(],DGKG//^3]:.<CTYS_3'^>F:,\9_SZ=.OX=?:DW8QP220#@'
MC/<YQQ[T)IQNK-6Z[/\ #]!:7WU>OGI^G^;'8[?SYIK%5Y.!SUQW/T'?%.HH
M5]&UK;H_/:WIU&-#*P)!&!G/&!ZG.<>O-*,8&,8[8Z8]L4$9!'J,?Y]Z ,
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MPO\ 2X8-3U72K:]O88M.U0#4K&..XFD5+6^_TJ!0(Y_WBM7^?S\//CW_ ,%
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MP.I0S"6SLK@:1]OCNIQ;B>>9V_M*_8:_;"O/BW^P/X+_ &H/CK%>>$]1\/\
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MN(FD9CN\]^I/'TK2'." <''&>@)S@G\10!^''A[]DO\ 9T_98_X*:?LZV7P
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MP.5"1QDMR. 3UK]3?A?8?V5\/_"-G@AH]%LRX 4-O= 6.,CYCD$GJ6/?.:^
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M5[XU^%MU<WFJ>+/A!'+*/M^M^$6=Y)7TZ*-VDEMR)(I(8BC S&)A_4O^SO\
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M[';("<9989)0<C(YYS7P.4N5#-\LJ--)XB-.;:=U&<:B:O;:ZC;?IY,_K3Q
MHT,Q\/N-L*OWE6.2U<70BI1NZV$Q&&K)VYD](3JV5KZ/O8_?M%8*,MD!L$8Z
MC+-UQUYZ>HXS4T:L&&<E3Q@@ #Y3Z'G<0",CZ<YID9R N=P."#@8Z #)ZY4K
M@G\P<\SC@ELD@]!@?+PHX/'3!SWQSC'-?L"DY)*SC91WZ^ZMO3KIOZ'^=-E&
M3U6LGTZ\W2VVEOGTT9+12?Y/7]..>_Z>M 8'IR2,XZ''3.#@X_SWIEBT444
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M[;G\-_3;RB7$W"O"O#5/$NC+&\28:K5Y7)^TH8:E.I4@U3?,U)7@U;9ZG4>
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M/P;X0U;Q)H'C/5O"GAK5?&'A*.]A\*>*]1T33[WQ+X9BU-5CU*/0=:N('O\
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M8W&BZ?-XKTS1KJ027.DV&O2P/JEGIMS(/,FLH+F."5OF="<UTQ'"D#H=V 0
M!CC QQ[G..O3)Q[&3Y'_ &;6Q56I5JU?:U7*BJE>M44*5TTG&;M&?,I.[;TM
MT>GR/%7&#XBP>48183"X=8'"<F+E0P6#P\J^*<IQE4Y\-2A*4/8NG'V<VTI)
MR6K3/E?QO\7KOX"_M">$_'=IHT>JPZ[X:3PO>12736@@M[C5M->2\#^5+O:$
M1DB,J-PS\R@ U^Z?A/6(]?T+2M7A4%+ZSM[M<'("W$22#G@$A6Z^PX&17\\/
M[9VEW%U/X'N;,;[QFOHHF(.?-A07*#*CMY).#GZ=Q^VG[+/B0^)_@OX"U/S
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M_&B*U\M98;^:[^%EU8W08X M[C2_B'?)(>[<@ @ -FO2=%^#_P"TWXMCCO=
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M\?I10.@HK[%;=?GO\_/N?SP%%%% !1110 4444 %%%% !1110 4444 %%%%
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M&3TZ8]?3J0'#@DD\'&!P,<8Z]\X_2M#)/Y6=M>XZBC'.>^,?Y'3O1C&?<Y-
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M$8BE.I5M!+FG34&H\SMJ[-,_ITM;CS=NW)3YCD8('&06.<KU(Y')/:K,@9N
M.#UY'7L3S^/ )(ZC@5\4_L4?'?7_ (Y_#%_$7B:*RAU:WU6^T^:.P1Q"$B8-
M"!N))(A= 6W L><+V^TTD"CIU)QGC'&0,^^,\ X';@5_*&=Y1B<@S7'93C4H
MXG!8BI0JQC-3BI4[W4):*2[/9W/]5N ^,,LX[X4R;BK*9RG@<VP='%T7./+/
MEJ13]Z*;Y6I7B]7:W4G!';U_,]?QXYS2U$ '))SA<H "0.>2>#SD$<\9].AI
MQ#*/EP0 /E.>@'1<9Y/'4'FO*7_!^_7]3[#HM/7I^ ^BD!S@\\C.#P1]1^AZ
M\TT*0Q8G)(Q@# '3/4GC(R.G4^M,9^7?_!3_ /X\/V,?^SX?@3_Z<KZOU'K\
MN/\ @I__ ,>'[&/_ &?#\"?_ $Y7U?J/0 4444 %%%% !49QD,#N PH"C=@]
M=Q(.< =1_C4E( !T 'T&/Y4FDU9K3L $ ]1FH7X;*DC(RW<-G..G/8^PXP#D
MU/3"BDY/(QC';J3]>_'8?EA<NC32U6KTM=6UM^7I;S _,O\ X*I?ML-^P[^R
MYKGQ'T.*UN/'OB74K7P3\/+6]8?8W\3:I!<W'VJ[&Y0(]-TVUO\ 4%1B4DDM
MHXG&'K^4[]G#_@G[^WC_ ,%0-.UG]H3Q=\7M5TCPSK^IZE+I/BSQCK&MW]OK
M^HVK 2+X:\,V5]8V.GZ%'*QLK:]LW2,2V]P&@:2-W;^VWXY_LW_!/]I'0M(\
M.?&OX=>&OB/H^AZH-;TG3/$VF0:E:6.JI;3VJWT$5RCI'.+:YFB\P8(65AGG
M%=A\-/A7X!^#O@G1?A]\-O"VD>#_  9X=@>WT7P[H=I'8Z=IT4TTEU+':VT*
M)'"CSRS2/M4!F=B>3S^?Y_PA6XCS>%7,,PK1R;#T$J6!PDYT93Q+:YJE:<;)
MI*[BO>V2T2;/R_B;@/%\79]"MFN9XFGD&'PJC1R[!UZF'E4Q3:;JUJE.47**
M5^57EJHKW5>_\-'PT^/_ .VA_P $;OVJM#^&_P :_$>L:O\ #/5+[3I_$?AS
M4]9OO$WAGQ+X%N;R.SG\3>#'U&5KG3]2TZ-WW6EI+#"E\C07$=RH9W_N^\.:
MY:>)- T?7K"0S6&KZ;9:I:NI!#V]];QW,1!3(/[MUR1GG."!DGP'XX?L>?LV
M_M&:IH^M?&CX0>"OB-JFAVKV.E7WB71+34KJQM)9&E>W@EGC>2.,S%I-BD N
M0V,\CZ&\.^'M'\+:)IGA[0;&WT[1M'LX-/TVQMD$=O9V-K$(K>W@0<)'%&JH
M@& $ Z5V\+\.XSA^>.PCQ\\7EDJRGE]/$3=3$8:+C%U*3J/XH+11WY59[RD>
MCP5POF7"M3,\%4S.MC\FG553*J.*J2K8G"0DESTI59*\H)KW%=I))V3E*^K$
M"V7Y4%C\N23QC )/8<G []^HJ?'^?\_Y':FJ!@X  R>G&??C'7U_6G5]GRJR
M7;;IZ72T?S_ ^_(R6$BC/RG.!QV4Y'KP<'D]\8XJ2BBJ22VT **** "BBB@
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M^UCXBN;PS1-+HOPOT6ST_2)D)S-&]YJ5N-0B!X13'M?'.Y<5^J'P>_X-X?\
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MV/<^F?U[TIQZ8]ODY^F?\?3KR: N^R_\"0\Y['&.O3^O^?<5$SL5.T<A@ 2
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M]F35[VYMX/BUX5AFM+IK.-+V]AT]=0E\B:X!TM[WRQJ<310R%9K)I(N%7)+
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M\&:?::C:KXNL/%ZW6J#Q%=:U>?V>;>\T>6S_ +(&GVZ%9$G2[,F Z9X'7O\
M@F5\2O%V@:A-XZ_;A^/FO?$5[+7++0/$5C>P:+X7TKSYIW\.2W'A*VD>._DT
MF/[,NI%K^(ZL\,CDVWF[5_83:.> ,]<<$]>I'7J>/>F-&I(.!@#[N ,GGN,8
MZ^G;W-52Q-:C4C4I34*D&K2]FM[6V<6G?6^Z.?$X*ABJ%7#5HRE1K*TX\\U=
M7O9-237R=_4_#F#_ ((^S0:-HUCI?[4WQ;MM6U'7+'5/BQJ4OV6Y@^(%M;6M
MTEW#;6K2K+HEU=7S6<\-V;J^%M;P2V_DN+C>GP_^T%_P2K_;<U+]J_P=\-?V
M:?B_=> _V9+KX4W_ (E\3_&#QYHFC^.[^R^*<&JW<%OX1&D-K.C:@VF:CIRV
M$IEC@E@MBD[[G=PE?U1B!!G"KGMP._4=< ')!'3O0 AQ\I..>5)YSD$#(Q_4
M8&#7M8?BC/<)"I3P>/JX:%9MU%1E"E&H];N2C25^Q\SF' 7"^;U\-B<WRJAF
MM;!TU3PLLP]IB94(1^&-+GQ"4>72W*E9H_B1^"G[!?\ P7X\>?&OXH?"_P"*
M'COX8_![X<>$K/7AX$^,L/@SPYXE\._$>\TZYEM]!MQHUKX@M]=T6QUJ-8[F
M6XNK&2:RBD*FWD==A_4+]B'_ ()T_M6>+O!/Q%B_;C^*7C3P_P"/O#GQ4\0^
M&/!]]X#ET30_#WC7X<::EJNC>+(M)L[K5OLG]KS27#)!=RQ7<$4:++"&//[#
M?MB_$7XM_"KX+77BSX+^&X_$?BI?%W@C2M2:72[K6AX=\&ZUXHTS3?&?BU-(
MM+FUGU&7PMX<N=1UJ.T291,]H(R'#%3+^R-\1_BM\5/A''XH^,/A3_A&_$)U
MO5K#3"--N=&?Q%X=M95CTCQ(^D75S=3Z:VK6^+@VLD\AB!X-8_ZQ9VVG+,\8
MY+57Q%1VNVVXWY4M=%I>*V74[H\(\,1@Z<<ARJ$))1G&.!H14E%.*C.RDY)=
M>9N^[M>Y^;^K?\$AO$FK?#B[TG4/VJ_'-S\4Q<:E_8_C2/0[.'P[IUK-K<EQ
MID$_A*.["W;6>@"#2[IVU*(7E[$VI%(C(8!H>-?^"/\ INMMX>N_#7[0_P 3
M]$O+'6-)&OSZA#INL_VOX7M986U31[59U@.G7U];+-%::N#</8O(DGV>8IM/
M[8LB  %"!]["C(! ]<C) Z>P/':D$>>@P,Y*OTP<%L $\$@\8Z]#P*Z'Q7G\
MHQA4S/%5(J[Y:E15%>^EU*$D[*UO>>JVZGF+P\X1IU:E;#9)@L+5G\53#TW1
MGK%PLG3JP24E=-*$;H_"U_\ @C3IMY\0I?[0^-?CV;X1P>&RNDZ>FIQ+XV@\
M6R747VB\FU7["(6THVGGQPVZ!7CED0Y(7FII/_!&+4]+\'>([.U_:X^+=GX]
MO[F__P"$7\56<<-EI&AZ=]I232+34O#L-X/[:GT^U\V&>Z:_M1>2R"8Q1,NT
M_O" .RX Z9&,$8.3SVP.<= !GBD(7/*\C).X9SC/3)Y'7'&2.X.36CXOXC<:
ME*6:8GDJ149PYH<LHI<MI+V=GH^7>[71''/PNX'G5H5IY!@Y5<)5=:A5E&HZ
MM*ISJ?/"?UB\6YKGTO9[\S/Q2B_X))^(#KF@I<_MG?M W/@ZU\./:>)=!?6F
M74];\5R[RFMV.N"X+:3I2;EW:(MK<*0&478W9KY-\1_\$POVO]+_ &@/@!\(
MY?VB_C1\2?V7O$6F_$;6/CUXZ@\0:;X>F\+ZM81P_P#"N]&\/:=-?7FHVYNS
M/-;ZI-#'>P7@A:2=8"R@?TO>4C8.W XR!C/3())YX)_K7S-^U_XW^,WPS^ W
MBKQE^S]X<TWQ5\3])O?#::-H.J:/?:Y:W]E>^(M-L];']GZ;J&F74D\.D3WE
MQ#(MT$AEB622.1%9#Y\<[S&DZ<J>)G%TI>TIVC3;4D[\R:I;W>W6R['O5N$L
MAKQQ:K8&G56.H/#XB,W4<:E*T5RM>V22M%*ZM):ZZMGY]W?_  2$^'>EZ9<1
MK^TO^T7HNB64%S+.8O'B6EK!:8:2ZFN7%M'"$,0)FD90O&3@ BN.^&__  2[
M^ WBW2]=7X9_M<?&S6M/97T/Q"OA_P ?:9>AAAI1;:HBV4CH[K(9K<L%$D<J
M31[TD5CZ;>?M'?MDZ]\9/AC\-M3^&<.F>$/'WA7P#:^*%A\(7DDUO_PE>D^,
MF^('B"+4+Z]O--L%\%WVE>&+:/3-1M+U)!KNVX6<,-OV=^S!^R9X:_9ENOBA
MJVC:Y?:WJ_Q7\4VWBGQ'YMK96&G17ECI%AHENVG:?9PQQ6336.GV\UY!;E+'
M[8\S6EK;1,L2]T>+>(H*<HYIB8.?+S.+IQE+DLX\W+25TGU;NFCY]^%? <XT
MZ=3AO+:M.DI^SIU:4JL(N:L^6-2M42W=TDDT]SXNTS_@D=X'L-*DT>'X]_'
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; HHHH **** "BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>vi_006.jpg
<TEXT>
begin 644 vi_006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #A X0# 2(  A$! Q$!_\0
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MO$<.FP6UM8Q:MJ*KY]U':PVEM'"CL$001D+E03WH&,^YS2T4 %%%% !1110
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M[0(FH6VG^!O,U'2YV52UMJ=C_P )?]ILKJ-CMDBF4%&. 6&UCZ<O@SX\$?\
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MG17VM:GI=E86=RCZ==R6L4UQ.\#^: ?T4KX+^/(8 _&3PR0<C ^',I/?D?\
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MEF7[485\Q,OY6/F7UH \U_X0OX\_]%E\,_\ ANI/_FLH_P"$+^//_19?#/\
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MIEMJ#0)\.YF2(W""0QJS>*D+! 0I;:-Q!88!%='_ ,(7\>?^BR^&?_#=2?\
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MZ--XQ@\+6WQ&L[:ZM9M'\/7(N2L.H:E,(+V9H40!I4(_N>,<<BD,JR(P*LK
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MCUF"1I5BE-L4"N" ?T+(A5G[@D$$G)[Y'08 SA>^.M24F1DCN ,_CG']:6@
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M/;W?QA\0VDLD.L6WP]B>V9M=L]"D>Q_MG4+$7,%FNI6+3"/S4#^HV'_!4?X
M^(?AY8>-/ _ACXS>/_$5[XUUWX<ZI\*?"WPWU_5/B+X.\9^%8-+N/$NE>-/#
M]M:RWWAJ+2(=9L))KW4($B9)4(0;7" 'Z845^(FK?\%D_ NN?$3]E'2_A%\,
MOB7XR^'GQTU;XI:#\1M8NO!6N6OB/X8:S\,[/PO=ZMI>IZ1Y8EM=2TR/Q$DV
ML1W,8-K;R64LB1"9<]7H/_!:[]F#Q9-X+MO"WPU_:BUQ?BM9ZY<_!:2R^!'C
M*0?%ZY\,2O#X@L_"#I:.MZ=+D:T%Q-;_ &E&6[B("E<. ?LA17Y37?\ P5[_
M &5KGPC\./$/@RU^*WQ$\0?$C0M7\4V?PV\%^ -9UCXA>%_#_AN>:#Q#?^-/
M#UI#/?\ AR+3GMKA5AOX$>X>WF5'4J=L'B+_ (+!?LJVJ>%X_ .F?&7XU:GX
MJ^&$WQ?T_2/A/\,M?\87VG^!;&]UBRUS4O$*:3#=-HMWH\FA:D+JPNXQ)FV9
M0RY#4 ?J_P#Y/7]..:6OR<^#?_!3/2?CU^VEX0_9]^&/@+Q1K7P;\<_LUZ-\
M=?#GQAD\.ZK!9WD^I^(_&?A^;3+F9E%KIUI:77A5[(O-O+:E'>VXDS"47]7X
M\D'Y@PW?*1TV@ 8ST."",C^?- $E%%% 'AG[1V?^%3ZWC_H(>'_R_MNQS^E=
MQJ?BFQ\%?#G4O&&J+*^E>$/ UUXGU-8%\RX:QT'09-5O$@C&2\K6MK)Y8 .Y
MRJ@$FN&_:+93\*-=[A;[02>W36;,XSZ\<C_&MWQOX8OO&_P7\8^#=,>*'4?%
M_P *]?\ "^G3S\0QWNO^$KO2[229LKB*.XNT:0EEP@/(X- 'Y^?#S_@JAX9\
M1VGPR\6?$+]GWXQ_";X3?&+Q7'X,\ _%K7=+NM2\)3:YJ'B&7PMX>@\3W$6D
M6$7A6/Q-KJP:;HLM_=2K=75Y:Q1[C*N?N'1_VE?V??$GBZ\\ ^'OC;\,-:\;
MV.I2Z+=^%=(\9:)?ZW;:RCF-],FL;6]EG2^C8C-L4$P/)0+S7Y,>$?V5?VW_
M (B_ +X"_L<_%3X>?#;X4_"/X;_$3PKXK^)/Q-T[QY8>//$'C+0_AQ\4HOB?
MX<TKPAX=TY=/F\+WNO7NF:?I^I7NH2:I]EM[JYV+'@M46C_\$Z_C=\)?@M\"
MKSX<^&_ WB7XM?!#]K[XF?'[4/"SZ[;Z OQ(\(^-?%7B*/3M%G\<WCW2:?JF
MF>$M5LY ^I1WUHM]9B)+-&("@'ZD_%OXH?LMIX4U&/XU>/OA##X2FUB;PAJ,
MGC'Q!HUI:_V]#;_:9]#DN[BX@FM]3AB'GSV\<JW$5L&F<+&&(\A\)_ 6QLM#
MLO'O[&OQUDT+PMK#R7ND^'9=2A^(?P6U*."22&9-+M+6XM+]8Q-'-;F=/$-P
MD4JN"GRLE?CCXK^$7QH_9)\9Q?';XQ>"/"WB_P 6_$GQ+\;-1@^$<JW/B+P'
MH.F>,M#\72Z<9/&;7#:#_P )?9C4X-+G@^QB;7K>(VVDQV$U[;RP?KE_P2M\
M&>,/ ?["_P &/#_CKPM)X+\275[\2/$5UX8DMKJS71;#Q7\4/&/BC2+:WM+Z
M2:[M[232-5L)[6&69S'!-&JN4"X .T;]HWXH?#)O[/\ VC/@GK5AI2J83\3O
MA?%=>./"-Y;LY1KK6]'LK1[KP=9LI/GG4M3OEBCR68J<U[OX!\1?!+XL:!:W
M7P\O_A_XTT#3+FYNHXM%&EZA;Z/J-\D\-ZSV<)D_L^^FAN[NWO PCE<S3H^1
M(ZM[-)#%-&T4T4<L3@*T4JK)&ZX'#QN"I'&,$'I7S+\1?V3/A#X^UI?%MIIV
MJ_#[Q]:LLECX^^'=\?#OB"SFC3;&Z(8KO1;D+PS?:-)F9R,%MQ.0#W:/PKX<
M5K=(]#TD):Z?<:3:LNG0*UMI=TQ:YTN J@\JQN&),ML,1R*6WJ3S6/J/PJ^'
M.KWV@ZEJG@?PM?WWA=(X?#MS<:-9R2:1#&H$<-H#&%2&)E5HHB&2,J&0!P&'
MS R?M??!92UH-"_:?\%V@<Q6MU<1>"?BM:VPYDGO=:FEOM%\27:)EH[/3O#N
MG3W!Q%'M8\]WX&_:W^$_BW5(/#.NWNJ?"OQM(4A/@OXJ:=-X*UJYNMP66'18
M]:%J=<C23*136,>V>(><H"\$ ^G$B,;*20Q^ZN%"@#:3C .-H(^4 # ]^OS]
M\!/^0E\7O^RD:U_Z67M?0A<,865@58AE8$%71E.&# XP<@C&<@^AKYZ^ A!U
M+XO8(/\ Q<G6AU[_ &R]X^M 'T71110!!("63#*-I)YR<-@A2P!&Y V 0""6
M(Y&#G^7+QCI-G)XH^)/A2QTO57_;TG_X*):KXD\*2Q1ZDGC)OA'-K7C"?PAK
ME@?M!C'@*V\)RR0278LVTZ-KNPCE9Y)877^I$%'YZ[21TSU]/7-9W]BZ,=1_
MM8Z1IO\ :JH(QJ9L+4ZAY8& @O?*-SL X"^;@#C% 'Y#?MK_  P\>?$C]O7]
MF"/P=\1_B9\)+32/V>OV@]1U7QC\-6BM-1N)[35/ ]WIVB2ZC?6.J:7$M[-
M"T-QI\L\\,<D<,D8)->/_L3?$W]K/]HOXY_!X?%3XM?$CPOX1\!_ W0/%?B;
MPWHVE0:#IOQ*\8M'IEM+)XREO;&]=X[@W-U<7>GVLEE)+*H:.2,1%3^\K6ML
M\BS-;P/,B.D<SQ(\B1RD&1$D8%U23:-Z*P5L#<#@4R"PL;5M]M9VMNX01[X+
M:&%O+&,)NC13L&.%!VCTZ4 3I&J,[#'SD$\=2,Y)Y.2<\G J2BB@!C]4_P!\
M?R:OG7XI_P#)8O@+_P!?_BW_ - T*OHM@3MQV8$_3!S_ )__ %5\Z?%/_DL7
MP&]K_P 6Y]OET+K0!]$)]^7ZK_6I:B3[\OU7^M2T 5I@6DCPNXJ'*G/R(P7I
M(/1QD*>,$&OY@=*\8_LQ_%W]JZXTO]FS2?#O@6[_ &<?CEKGQ-:?Q+XIN-!^
M,_[6/[1-BNCSGX=^&;;4IC)I7PSU.;3-)T[5O$<^FZQI?B"*[EMM/MM,ETR[
MDN/ZA2JL0Q )&0#Z9Z\CZ5@0^$O"L%VM_!X9\/P7R2F5+V'1=.BNTE8@M*ER
MELLRR,0-TBN&) .<B@#^=?\ 8"MOVD-/_P""J/Q>\7?M _!'Q_X:^(7Q8_93
M^'.L?$?Q1J?B9M9^'_AS5-*\:?$\Z;H'@V"+2;2SL],:S-M;PZ6MQ/>077VF
M>:[DCN(H8=SX_P"@_'#PO^U!_P %"_CG\,/B=\5_ %]\,?A/\%?$WA7PKX51
M'\*_$'6M-UKQE/=6'B"RN]/O9=8L;F!(;2YM-)N=,N$BEF62X99P$_HD^RVP
ME:X$$(G:);=[@QK]H:!&9XX3.1YC1(\CLL98HK.Y !8Y8^GV$AF:2RM':Y18
M[EGMH6:X1<[4G+(3,B[F(60L 6) R30!^6/["&M_'?XN?%_]IOXG_%SXH?$.
M7PWX3^)%KX#^'OPDGMK;2O =GH$GPX\%:[<ZXEI+8/?ZC?OK.NZK'#=#4DBA
M:W1#$QC;=^K*]!]!C\A4$-I:V_F?9[:"W\UQ)+Y$4<7FN%5 \GEJN]PJJH9L
MG:JC.  +% !7GWQ:_P"25_$K_L0O%_\ ZC^H5Z#7GWQ:_P"25_$K_L0O%_\
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M@^(?QC\5VU]?>%_ASX;O?$^L6VEQ-<7TUC8F,20V<:)*TLQ\P; J.3@X'>O
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M$.9=V6UVY656&XLHDE&!G*EE( &X,1T'K0!]VQ?MU_#N:>2"+PWXA8Q"/<5
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M'G@8SVJY#^VSX)F.%\+:\#DCF5.<8QC_ $;G.>,?2OR_MH8[LM</'/C>P#2
M"3"8XVA0 O.5.W)Y.35JZU4:9/I-L+6>Y74+E(91$C%[:/(!FD(4A44'() #
M8/I0!^HK?MD>$DMA<MX5US820 )DR2 #QFU&>O/I62O[</@0B0'PSKR21[,H
M\J+NW$C"L;;!(V\CKR.YKX!6Z,J0QN0H4@.H.0I)QA@V<<<M]T<^W&/J6BW5
MQ=1FU$4]L7E>X !#+E4V&)@0 !\V,[B3D=* /TLD_;(\(I"LI\+:VRF,2,%G
MC8JI]0+8Y/M_3%91_;>\%*06\)^(!'SNE:5 J#.,G_1>G7\J_/!;B6TMI))P
M))$58BD<BNXC)95WQ@LP?KG<!D8XQR<"^827,L(5XXT7=$TBDAPZ@GS$!!..
MV,$<GOB@#]*9OVY? $.2?#6N.IP-ZS)L(/HWV;&020>>.N<=,6X_X* ?#JW7
M=)X4\1[,[2P=-N>@&?LO.>V*_,5UO(K*5;HQRQ&1?*6!"&0%SM#99R>>H&"<
MX)%8-]'YF]@1MD0YB;#+A0<X'4-C !S]X9QZ@'ZC7'_!17X8VZ%V\*^)G VG
M$95R0QP,;;0YKSOQM_P4;^%?B7PGXI\*V?A;Q0M]XCT+6?#MK(RYAANM8TZ?
M3X)9F^R +%')<J\AR,*K99?O#\KKJ6Z^T2"2/$:,RQA00WECD;CC&<YP<8Z'
M&.:YVZL&AO;*5-GE2WUJ\B*H#;C.F&)'J< \8X]#B@#]Q/ ?[7WA#P]X+\-Z
M+<^'-;GN-*T:RM99HF"PRO'&%9XRUNQ*YSR"PR#@XZ=A%^VEX-F(\OPMKC Y
MY\^/M[?9OZ\5^:,4Q#6=K'%.)9K%2&1"T*JMNO4@$;EP6 S_ +3 Y%:T:&RB
MDN)5PL-L\A!.-S*&8@+QAB ".V2.#TH _2Z+]KKPO*^W_A%M;7*%P3,G("[N
MGV;(^IX R2<"LZY_;-\&6DC1S>&=<#J5&!*A^5@#NXMN!R>YS@8QDX^ O#6O
M_P!J:7!J+VMUI_VAI4CMKUT>8+"[PJP*QQ[8YA&9%5@6"L#DK@BYJ%B^I0--
M:F/[7@H&P"G)(!< Y&![CL10!]^V_P"V#X0NX_,M_#>L2#<%($\8P3C/)M\<
M9.?0C'6J=S^V7X/MC(DOA;728SA\2ICU&#]FY'N*_/K3M*O;.1&N)5C*KO>-
M3M25S\G'(.-W8'\Q574[U7B!,;IMF>-W8#;G<5P"1@Y/')[Y(Z4 ?H&/VVO
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M;/<4OF)@DL!V//UQT_'WSQZ4.7RU726W7I]UAV;V_IO;3Y,?D>H_,4 @]#3
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M'\]D_D.Z[K[UZ#Z,C.,C/IWK/FU33X)?L\U[;07!QMAFFCCE((!!$;L&(.<
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M*** "BBB@#PS]HW_ ))/KG_7_H'_ *>[&O7M"_Y >C?]@K3O_22&O(?VC?\
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M@']*_G)_9MEF'[0/PN4Q#)\6Z8"1TVDR_,._(QG/3'/-?T;T %%%% !1110
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M],O;ZYU[5[N_O],%Q;:;':EQ86UVEU>3/%'&'&]&_G0T3_@J!^W?\2_V(?\
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MU#1?B0TGB*\\8:IX=AOO"]@FLSR!O#26&IV$(B>(B4OY,S&YDE"L#@#T:_\
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MW&C$'2)[S1=,NIM*(.0=-EGM7>Q(/(-J8B#SUH _G-E^+/[=TFD_$3X^ZO\
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M5.#C-34Y[PY79<R4M+Z?UI;_ ()MAZE&G*;KT764H.,4I.*BW>TM-VC\_/\
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M+@(!@$[P V2><,>N>,"M"\\'2VVV>?4[120"L:HWF%<?Q,5P ,XP3G/&,9H
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M8@;M./O,!GG.,X],]N.X/]:P+CPMX>NGFDNO#V@W+W&1/)<:38322@]3+))
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M **** "BBB@#PG]HH!?A/KF1G_3] )4].=;LLG(Y&>OU4=J]AT+_ ) >C?\
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M2"<<;L '0:?<A9"A/EL<;50@DD\C[^0=S<X/0<#KBM>X2*]MW%P6-QNP"%4
M,. & 7 4>P!.!G/2N#-P(2ICE$A #!BAR%QUW.O4'C.<C=]:Q=5\6VNFI*;J
M\:-TW2E/,7>5+8#,%)+*2P!Z\G/O0!U=O$UCJL*$Y9U)#QJXA  SM>2, *>A
M"LVX@'WKJ+C6QAE+.J1K\H)VY8C&]2V#M8=,\X(SDU\8^-_VEM \+Q7"/J$6
MZ*,AP618]^< ,QPN\D]CO&"!WS\Z?\-LV+:F;=9[9BH;= S22/Y1( =2VY<8
M*X#'OG IOIK??Y;_ ')_F4H<UVFNC?GHK?UY'Z<#7HY;@0%XQ(5#I#YT?G.I
M&"PBW^8R\#+(N!QSZVI[W$(<A"23N&YMI!YSG@Y'IVSTXKXN\ ?'CP7XLU*T
MO+EHXM36"6UM;L3'<([AXG9=L;^5B,QHJEQN )V\$@_3J:S%<QX$T4L8"L&W
M*!F124*A=I)(!RW3C[W(%(DT;[4X6E-H)&6]6 21((V,;(<98R%?+R.,*6SR
M21D"N>N[9I76:4IO8JN^-W$0&&.2I.U7R!N! !_6JNIWC(%:W <@89PV2R\9
M"LS%L#C'3KCFH;&]27?&[;<@91@2,G///RY[^N.E 'I/P8"+\:?AHR;)"_B:
MU5Y 6V@,W)3MGT!X[5^Z-?A=\%5V_&7X:(% 0^)K<!@5QRW7!)QQV(_'L/W0
M'  ] * %HHHH **** "BBD8X!.,@ Y'_ .OC'7- &!K.LZ9X>M+G5M;U73=%
MTN!H8I]2U?4+/3-/MGN)HX(/.O+Z>WMXS/+)'!$ID#23R(D8+LH/P'\0?VQ_
MBS'^TQIOP9^ OP6\+_M!_#_1]&M]0^+/C/P9\7?AN_B3X>7=UJ%A8Q:;J'@V
MX\96VOB5(KV2^EEETAH!#:20^=]KE@BD^$/^"]7QN^!VK?L[:W^S%/\ M.^!
M/@U^T'<:CX3^)7A/P9XY3XDV.B>,K3P]JEIJ%OI6MZWX#\.ZK+:Z;+<-9W^$
MN-SSVD*2IMW _ES_ ,$*/@E\.]"_;JC^)/A;]ICX0?$?XAZ[\(/BCXM^.)^&
M\WQ5;7O'?C[XD?$'0_%4>@WL?C/PSHVER>$OAA!=WWA;2;PSB[GAM+)U20,[
M@ _M*B8$M&,%$"@'J<$9&< #D<C'(XSS7QW^VO\ MU_ 3]@+X7Z9\6_VA=;U
M/2?"^N^*K/P5H%OH&BZGXBUO6?$E_;WEW::98:1I5M=WUS/);6%U(3% R*(S
MN897/V/'M*@J !@#(X)P,<X_Q/KUK\<?^"P?[.VJ?'WX>?!R6']D77?VQ-'^
M'GQ*?Q5JO@'P=\6=8^$WCG1)/[!US3;'Q-X4U73_ !5X/L[[4+"YU"(&VO\
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MNY8GD8O))*)@P.]F!<*-N5V*V >-O6OV1\%PQVL%A;R2&.9EBC=B& E>-0
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M);OH[_/YE^SLVA@;9&D$7D+&DS881A1A4(.2.O)'(QZ=8!=2;6BGF#)R59
M#C'3&,XZ'.#Z#K4D]V98T5 1#M&]6&&7/4MC.YAC'&<9.<<UB79#. A) # A
M#@'/((Y QC/W>XQCK00>N_ FZ\WXY?"Y-H&_Q):@<8;@\$$<<C[PXZ ]1@_O
ME7\^OP!G#_'KX70KC(\3Z:,D E<^8.O8G'8]L]17]!5 !1110 4444 %%%''
M3\?R(_\ K4 ?+O[8GPP_9O\ C!^S[\1? W[6EMX7D^ ]]I*WGC:]\5ZBNB66
MCV^G7$%Y::Q9:X'BN=(U6PO8+:6QOK&:*^BG5!;$R.JM^>'_  3/_98_X)5?
M"+QMKWQ,_8?\>R_%_P")WBOPA/9S>,_''Q?\8_%WQQ9> ;74=/CNK+0+WX@7
M=SK.E>&%U*+2TGM].6.TEN%M68/@-5K_ (+W>$/ WB__ ()V?$FV^(/CN_\
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MG3;.KEN6UM:>-HINFVEB(.E)-4N>TI+GC?FWO>WO15VE?].O#_QA\#:XM_\
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M1^#-0EATS2X)+F\N(;6S\6S7-P$@B=U2&)V8[0 <@D _8+ (/ PV0<=^V?\
M#J>E,V* %)Q@$ \88$8PRY^8#/0\#J,<8_)7PE_P41_:0\:>&_#/BO0?^";7
M[3DNA^+=$TCQ#H]S=#P1:2/I>N6-OJ.GS7$-SXM2:V:2TNH9'CE57B+%7565
M@.0^&/\ P5*^-WQ?LO$VH^!O^"<7[4U[:^$_%>L>"]8?4+3PCIK1Z_H-U+9:
MI;P1WWBF)KB""XA=!/ KQ,"C!L.I(!^R$EN79LHC*"/+).TKE<$* " ,DGCJ
M_P W!JO+8),%$\:.$ 52Y\PLG4J0R\?-SG\\YK\>H_\ @J%\<)OBU<_!1/\
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MG6/I*4?;3O)WO[2:5N9-+33>*=[WW2LFT_O[X%^$X/ _PU\+>$HO!FG>!(-
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MC M$6VKG85SM7/086YL+:]A>VO(8;RVE4K+;W4:S0R#L'B<,CCK]X'':KM%
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MC?\ DD^N?]?^@?\ I[L:]>T+_D!Z-_V"M._])(: -6BBB@ I,=1V/]<YI:*
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M?SZGH^(7'F.X_P [J9QCJ5*E5E&,.6E%1CRI)):):?F;^G1S&UC6X3RF53M
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M"IEP,_Q9SRN.OY5_1@O3'IQ^5!@]WZO\Q:***!!1110 4444 %%%% !1110
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M%%% !1110 4444 %%%% !1110 4444 %%%% !112<^W^<_\ UOU]J %HHHH
M\(_:*9F^%&N=,C4= '3.?^)W9#GH!S@]_E'N<>Q:%_R ]&_[!6G?^DD-<5\5
M?!=W\0O!&L^%M/U6+1+W4#9O::G/:"_AM9[*[CN4>:T,T N(]\0#1>='O'&X
M9%<#9>$/VB;2TM;1/BQX%9+6W@ME8?#:092")(E) \3X!(4,0.!G &,4 ?1%
M%> ?\(Q^T7_T57P-_P"&WD_^:>C_ (1C]HO_ **KX&_\-O)_\T] 'O\ 17@'
M_",?M%_]%5\#?^&WD_\ FGH_X1C]HO\ Z*KX&_\ #;R?_-/0![_17@'_  C'
M[1?_ $57P-_X;>3_ .:>C_A&/VB_^BJ^!O\ PV\G_P T] 'O]%> ?\(Q^T7_
M -%5\#?^&WD_^:>C_A&/VB_^BJ^!O_#;R?\ S3T >^D\J,]6P?\ @()_F!^%
M?BYX]FA3XH?$U""SOXPU(OGD@M<W1&!_"!GIUV_AG])?^$7_ &C,G_BZW@8@
MXV@_#:3Y<$$Y_P"*GYR..HQG(Z&OG^[_ &-_%NM:SKWB+7?BAITVLZ_J\NJW
MCV/A,6EJ&D:4^7#;C59?*3$N3\YR5!XH ^ /$6CK?)*X9V:,EDBB&USAL88@
M\J1R?[W(/6O/5T9K)[F1HT82;'9LLJ(Q&=@B"D#+8R W)&3C%?IY)^Q-J[%]
MGQ*B4.#S_P (XN<YR!_R$N, =OK2C]B&\**LOQ%BF) W;O#J@9]?^0D<G&?K
MSS1\D_)[,#\T84>"(W$B*%Y1K95VNC')$P;GY!@@C SGK4D:I.X8R1E7C?'[
MS9P",8!!V[LYQGGT]?T6F_8.N)9)"/B+ JN1T\-KG;[C^TN>G R *S)OV +I
MXI(%^(\(CD8NQ'AP*V<^VIG!()R1U_.B[MKV];>@;;:6V:W_ #/SGP/WW[SR
M-Q,3.IWHB$CY67Y<E\ 9ST&/7$$]I((9([:)#%;EC(D8V$!SE9U09PO).P$^
MY&*_2 ?\$_)8[=;:+XDJJ;E<G_A'AD, V< ZB<G)ZY&>OM3A^P'?*-O_  LU
M69R3)*?#H#%?[H']I8P>._'O4\MMK+=)VU5[=;[Z;VUOT _+U;*"-9([EA&Q
M 0NX\B&16/-P[_/RY VK@DYX(I;V:*."*#RI(XX,QHA<N'48 "DA<CCKC'0X
M[U^F=]_P3UN[Z"6W;XG1"*78S))X9$@+I]TX_M0 $9)!R<=ATK*O/^"<M_=+
ML'Q8VC!4.?#08@=SM&JC)[=1W]JH#\N;SS-A*02JKAOWF254$#.3@9+<$#MC
MKTKH/AC+%%K]^[APPTN9<N3MW#:0R].F"<^F./3TOXA?\$6OVG?%/CWQ1XD\
M(_\ !1CQ)X)\'ZS!91Z%X @^$Z:AI_A*2W^T?:FL+W_A/+7[0;OS80Y-G;[?
MLZ\-GCT?]FS_ ()%?''X,>+O%_B+XD_MN:O\;=/\0Z78Z?I'A_5_ANFB6WAB
MYMOM)NKVSF'C#53<->^=#YD7D0%/LRX9PWR@''W2QWBYE&[.6CVD@ +G(8 ?
M-_#^(_+E)(U6Y"LH#>9E25(P#G@=N<9SZ=A7Z.3_ +"&KRKA?BC%$0/X/#0P
MQ( .[_B:#KBJR_L#ZKO+2_%)92%^4GPZ%8'GO_:9P/\ .>M 'YFW=JVZ1F&<
ML0I&?4GKQ@G\<8[U@W6F)(R!R#N(; RKAL]2<>W.1W_&OU+'_!/^^8[F^* 0
MDDMM\.*1]?\ D)C)&2?QJFW_  3UOR6Q\5 "QZ_\(V"0I&#C_B9CGDCT/K1V
MNDTG?U]?T#I\OG>VW_!/RP;38%G;:';D$1 >83CW..#@[N.@^E2O;"%0 HCC
M<C]V>F!SP.,'GK_A7ZA#_@G7>*3CXKJ"S9,@\++G!P,!?[6Y^N1].]57_P""
M<VH2."?BOM&2-W_"-!OEYQE?[4&>221G SQ0!^6,PWW*IG"X!(&0"0Q('/'H
M#^O:L\W$<@:2/<1 [PL77!$F!GN<@;ACZ&OU2E_X)L7DJMO^+8#9^4CPN.!G
MCG^UA@\]NA]:IS_\$R[N=23\8BC]!L\)*.,\Y;^V<\CJ,'/KVH _(J_N))7D
M &X;2,;<X())&><<$=N2<UYYJ[DND8#LOF*Q900$(8$@^N3QS@#J,\5^GGQS
M_P""._Q&^)7@P>'OAO\ M?:M\&/$HUG3]1;Q?I'P_CUF[ETVUN8IKO1WLF\5
MZ5_H^H11R6TLPNR469B(GVX/S%>?\$$?VHK\:8)?^"G/BNW^QWFE7%X]M\'X
M]^H6]AJ"W=W92$_$)/+BU*V4V4S?O-D;%MCXVD ^D=)D272=.@))SI.G,23@
M\6<)(SZ@ \>]9]Y:QLKJB!SD;F(X"=\J<YXQT..^/7[FT_\ 8;UFQT[3+$_$
MZ"YDL=.L;&>Z_P"$;$;74MG:0VTETZ?VF^U[DQ&9UW,5,A7<<!JFD_8=U61P
MQ^)B,N"&1O#HP?3G^TCT]QV]Z"U-I6M?L?G+J,($8C7(!8C SA1U 4XR,=1C
MI^=<?=Z.EP0DH=LYP<D$G!X)QR-O?U[9%?J4?V&+TJ<_$B,L> #X<7 ]3G^T
MCUX'X9QZ9%S^P->W2D-\28D;/RLOAX$C:?\ L(C@]"/Y#@@_:>7KK^7_  3\
MJY?#5M%DO&6D4Y7O\IR,>N<=?\,U=CT188<B% 6QR?O\X)&<9Q@8'J,#'-?I
M\O\ P3]O0.?B@J]>%\.#'UYU,8/_ .OZ!_X)^7A&#\4=P]#X<7'?TU/_ #G/
M6G?3:S?9Z6M9I+S[@JC3O9/6Y^74\,D:A2-H7DE!R O0!00"<<$9Y)SQ49D1
M9$A$BFX>/S%A .YD!VY;C$; ]0"PK].W_P""=]V[,W_"U" W\/\ PC:D#MQ_
MQ,QVXJE/_P $Y;Z?(_X6SM4XP5\,*&QC!!(U7D$\_@*14JBDT^7MN^Q^66HS
M*TDBD*64 ,.<AL< '_9ZG@=,^]<9J4LJJZLN 8@/NG<?F4#MTVY/IG\Z_5S6
M/^"9&HZEIVIV5K\:Y-,NKO3[VUM+^/PJLLVGWES:2PVVHHO]LQF26SF=)XXR
M\>\Q@;UZU\!VO_!"C]K>.Q>ROO\ @J%XMU23S;UX[RY^#J+<QQ7,LLEI 2/B
M))E-/1TBAYPXA1L)T 0YW5K?B>H?LVRJGPXN JN[GQ#?(8R")%43W)5LD<=
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M]T?^A/1110!*G0_7^@I]%% !1110 4444 %%%% %27K)]8_YK5NBB@ HHHH
M*0]5^O\ 0T44 +1110 4444 ,D^XWTJ!OX?]X?UHHH GC^XOTI]%% !1110!
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>ex5-1_001.jpg
<TEXT>
begin 644 ex5-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  \ *P# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#[3_;2\5ZU
MX/\ AAIMYH>JWFD73ZJD3364[1.R&*4[25(.,@''L*^7]$\6?'8^$V\86&L>
M(KS0HMS->-=-.BA#AB48G@8Y)&*^B_V]O^21:5_V&(__ $3-7SYX+_:CN/ W
MP2N/ MEH22W,Z7$3:C-<955ESDB/;R0&[MCV[5\KCII8J2G-Q5M+=S^A^$\/
M5EP]2GA<+"M-U6I<Z7P=7=]M._HSZ>_94_:!O/C)H^H6&N1QKKVF!6>>)=JW
M$;9 ;:. P(P<<<C'<#WJODO]@KPSI5IH^NZXFKVUWK-WMA?3XF/F6L2L3EP0
M/OG'(R,*.<D@<1^T'\:_%GQ6^)LO@#P7-<QZ?#<&Q6"S?8][,IP[.W'R @X&
M=N!N/MWTL8Z.$A4J^])[=W_7]:GQ^8<,4\SXCQ.#RZU*C3]Z3:M&.BO9::7O
M;96V?*KGW4K!L[2#C@X-,N>+>7_=/\J^%H/V8/B_\*+)?$^@ZS;R:A:KY\MG
MIURYE( R1M90LG&<KDYZ &L?]E'Q=K/B+X[P-J&HW,ZS0W<KPM,QCW&)S]W.
M,#M5+,)*<:=2DXN3,I<%X>>%KX[!8^-6%*+;M'6Z3=FKZ7MH];ZZ:&K^Q3K^
MIZE\:[R"[U&ZNH5TNX(2:9G&1)%@\GWK[PK\]?V,]6L]!^+^LZEJ%Q':6-IH
MUU-//*<+&@DBR36AXY^)_B_]J/XJVN@>#I+K3]&A=EMU21HP(P?GN)B/PX[<
M 9)^;BP>+6'PR35Y-Z(^HXGX<JYSGU249*E1ITXN<VO=6_I=_IJ??5-WKNV[
MANZXSS7Q#\8/'VK?#*:Q^$/P^O;Z?5#Y:ZGJBR,UW=W4H7$:'.4&"OW3W SP
M=S(_V(OB#/IO]J2^)[)-=(\W[.TTA;=UP9<?>_3/?O7>\=-R<*5)R:WUV?;S
M/CZ?"6$IT88C'X^-&-36G>+<I1Z2:3]U/=:O1J]GH?<=%?'_ .S+\=?%&B^/
MG^&GCV2>:YWM;VLUXVZ:"90?W;-SN5@."2><8)!X\A\1^(_&ES^T!XJT#PUJ
MUU%>ZIJUWIL(:X8+&LD[*<'/R@#N.@SBE+,H*G&<8MW=K=4RZ' N)GC*V$JU
MHQ4(*:GO&46][]%O??;MJ?HZ&#9P0<<'%+7C_P"SE\#KSX+Z/K,>IZE%JFI:
MC<*[3PEMHC5?E'S=]S/D^F*]@KTZ4I3@I3C9]CX+'T*&&Q,Z.%J^U@MI6M?3
MM=]= HHHK4\\**** "BBB@ HHHH ^:OV]O\ DD6E?]AB/_T3-5/]ESX9^"O%
M?P$L+GQ#X?TF\E>:X$EW<P()0H<C_6\,,#WXKJ_VPO")\9_#?3;(:UHVA[-3
M27[1KE\MI"V(I1M5FX+<YQZ ^E?,N@?L>^./$VEQW.C:]X;U33)&*K<6.J&:
M$D'G#(A!P>N*^=Q"J0QCJ1I\ZM8_;LEG@\5PS3P=7&K#251ROK?KINM[WWZ"
M_!>2V\'?M96]AX4O&N]&;49[*-T;>);8[AR?X@  V>^T&I?V<M2M/!7[3\MO
MK[K;3F>[L1+.<!)SN49)Z$D%?JU?0OP _9AT_P"!TMUXG\0ZG;7NL1POB<'9
M;64>/G;<V,G&<L0,#([DUQWQJ^!?A?X^Z]=:]\.?%>A7GB,1A[ZQMKZ.5)@.
M!)E"Q1N@.1@\=#DGGCA*].G&HE[RE?E\M/\ (]JKQ'E6.QV(P<JC]C4HJDZU
MG\2YM7IL^;=Z7\M3ZMU+4K71]/N+Z^N([6SMXVEFGE;:J*!DDFOS_P#V8+^V
MU3]IFXO;-/*M+C[?+"F,;4:.0J,>P(KH]'_98^,?BV2WT?Q1X@GLO#T;#>+G
M4VN4"@_P1*Q!/H#M^HKL/@/^RMXL^%WQ737+V6PDT>*.XB0QW!:4AD94)7:!
MGD9YK>K*OBJM*7LFE%]?D>/@*&49!EN84%CX5:M6FTE';:5DGJG)M[=/F?,'
MPW^&^K_%'7-;TG1)PE_%82WBVY) N@CI^ZSTR<@C/&5'3J/<_P!C#XIZ'X#U
MS4/!VNZ?%I.JZA<!(]2E4H[2#Y1;RY^[SG;T^8D'DBNZ_9I_9J\7?";XEW.O
M:X^G-926,MN!:W#.^]G0C@J./E-5/C_\(?!GQJ\2QW7@?Q9X<3QRTACN=.74
M8MUWM!W$JI+"10#GCD YZ5RT,)6H0C7@O?3V?5>1]#FW$.6YOB:V3XBI?#3C
M%JI'[$E_-;=:+?;KIJO#/C!X:EO/VH-;TO4=4&A?;-4RNHS*2L*R8:-C@CC#
M+SGC\*]?'[#?B@@$?$)2#W\B3_XNG^.?V?M5\1^ +:X^)&O:'X=\1Z2J6EEX
MBN+\"&]BYVPW!8*0ZX.'&203D$C-<#X:^&7QA\1Z;/HOAGQS;:WHUMB*7^R/
M$R36\0/12%DRH(!X('3I4^PY)RE4I.7-JK-W7DT;_P!K2Q.%HPP68TZ+I)0G
MS1BXRM9*49-=5]F^FSLUKZ)X!_8SU'2/&FC>)XO'-EJG]G:A%<2&*%G+F*12
MR;MYP?EQ[5YWX(59/VX)LCC_ (2&^./H9B/Y5]#_ +-?[-MW\&C<ZGK&M/>Z
MK=)L-I9RN+6,<9)SCS&XX)  YQGK7(>%_P!FGQ?I'[2<GCJX?3O[%.JW5X%2
MX8R^7)YFWY=O7YQD9KJ>%DHTG"G;WDVKW/GZ?$-*I7S"&)QJJKV,H0ERJ%VT
M_=26^O7KTT/JJBBBOI3\'"BBB@ HHHH **** "BBB@#X2_X*C^)O*TGP)X?1
MCF6:YOI%]-JHB'_Q^2D_X)A?$@W&F^*_ US+EX'75K-6/.UL1S >P(B/_ C7
MF7_!1'59O%W[1^F>'K8[WLM/MK-(Q_SUE=I/U$B?E6?X9LA^R3^VY:Z8))(]
M#6]6U\R4\/97*@*Q/<)O4GWCKR7-JNY]+V/W.A@:=?AF&7_\O)0E4BO22?X\
MR7S/KW]OGXC?\('^SYJ=E#)LOO$,J:7$!U\MLM,?IL4K_P #%?(/_!./Q*='
M_:&%@TF$U;2[FU"D]67;,/TB/YUTW_!0KQ;=?$?X[^'/A]I)^T/ID<5NL*M]
MZ\N64X_[Y\D?B:XC1?#=O^SQ^W)HFBV[2+8Z=K-K;)+(>3%<1HI8_P# 9C14
MFW64NB:0LHP-.EP]/!R_B5H3J6\E91_]M:^9^JFHZE::18S7M_=0V5G I>6X
MN)!''&OJS$@ >YKQR_\ VT/@QIU^;27QU:22 [2\%O/+'_WVD94CW!KY$_;;
M^*'B7XQ?'2W^$WAZ63^S;.Z@LDM$?:MU>OMR\A]%+!1GA=K'O7K7AO\ X)C>
M"8/#T<6N^(]:N]:9!YEQ8M%# CXYV(R,2,^IY]JZG5J3DXTEL?&4LCRS X2E
MB,XK2C*JKQC!:I=W=/\ 3YZGU?X.\=^'?B%I(U/PUK5EK=B3M,UE,) I]& Y
M4^QP:_,+]FF_MM*_;52]O;B.ULK2^U:>:>9@J1(L%P68D\   U]3?LW_ +$V
MM? CXFWWB$^.9)=*4M%!8V46TWL)' N V0,'LN>1D,.E?G5X\2Y?XB>*OLPE
M9A?W9?R@<[/,;=G';&<USUYRM"4E9IGU7#F7X.4\=A,'7YZ<X)<UFFN;F5G>
MUVOZL>^?&WXG^)/VV/C=IOA3PC%-_P (_!.T.FP/E4V_\M+R;TX!//W5  &2
M<_HA\'?A+H'P&^'EIX>TK8D%LAFO;^7"M<RX^>:0]NG'/RJ .@KY:_X)CMX,
M/ASQ&MHA'CL2#[8TY!8V>1L\KT3=][ONVYXVXR?^"DOQLU.SU+2OAMI5V]G9
M36RW^J-&Q4S[F*QQ,?[HVEB.AW+_ ':N#4(.O+5LX,RH5<RS"GPW@U[.C2WO
MUTNY/OOIW;N]]/I36?VQ/@YH6I-8W/CJP>=6VL;6.6XC!_WXT9?R->C>#/'W
MASXB:4-2\,ZW9:W99VM+9S!]A]& Y4^Q -?GMX!^#7[,%CX4@C\6_$QM3\02
MQAKB:REDBAA<CE8AY1R >,MG/7 Z5YMX?\=6'[+/Q^M-0\!>,%\5^$9&C-R\
M09//M6;#PRJ0!YBX)! QG:PQDK36(E&SG:WDS"7"N#Q4:E+ RJJI%-KGA:,K
M=$[*U^E_N/TT\0?'CP!X5\6CPOJWBFQL=?+Q1_8)"WF;I "@X&.0R_G6%XL_
M:O\ A-X)UV31]6\:V,6H1/Y<L4"27 B;N&:-64$=P3D=Z_/?]NB.;5/VK-83
M3R9)[B.P%N8SRS-;Q;<'ZD5[=XM_X)PZ!X;^#6J:F/$.HS^,=/T^2^DDRGV.
M21(R[1!-NX*<$!MV<X..U/VU63DH):&*X?R?#4,+6QU><76BM$ENTKN]G9*_
M9L^VM*\9Z%KOA@>(M-U:TO\ 0S"T_P!OMY0\6Q02QR/3!R.HQ7G?_#7/P>'_
M #/VE?F__P 37R9_P36U.ZUW_A8G@J[N)3HMY8+,8E;_ %3MF)V3T+*PR?\
M87TK3_:+_8\^#_P(^%VJ>)I]0\0S:@1]GTZUDO8<3W+ [ <1 [1@LV/X5/?%
M5[:<H*<4O,Y?[!R["YE4RW%U)N5XJ'*EJI*^M]K?YL^J](_:C^%6OZK9Z;IW
MC;3KR_O)DM[>WBWEY)&8*J@;>I) KYN^&NF:M%^UH9I?C;8ZQ:?VU?G_ (15
M-3O'DQB;$/E,GEY3CC.!LXZ"N8_X)O? ?^TM5N_B=J]OFVLB]GI"R#AIB,2S
M#_=4[ ?5F[K7GOP1_P"4@[?]C-J_\KFLG4E-0E);L]NEE6$P57'X;!U&_9TG
MS-J+UL]%II;JUK?T/TP\8>.?#WP_TAM4\2:S9Z)8 [?/O9A&&;^ZN>6/L,FO
M-M)_;'^#6M:@ME;^.[%)F;:&N8IH(R?]^1%4?B:_/CQ_\0+;]I_]HBXE\8^+
M4\+^#+>:6.VFF#.MM:(V%6- #F1^"2>Y)/"@5Z9XP^#'[+.H>&I+?P[\3I-*
MUM$/DWEU))-'(^./,3RAP3W7&/0]*KZQ*3;A:WFSCAPK@\+3IPQ[JNI-7?)"
M\8W[NSOYV^[9O]';>YBO+>.>"5)X)5#I+&P974C(((X(/K4E?G]_P3?^-.I_
M\)#JGPSU.\:]TX6[WNF,S[A"Z,!)&A/\+!MP'0%2?XC7Z UUTJBJQYD?$9SE
M=3)\9+"U'>VJ?=/9_H_,_+:Y ^*__!0XH<SPKXH"D=C'9G!_#;!7I_\ P4]^
M')23PGX\MH\'YM)NW4=QF2$_^CA^ KT3X"?LX^&O"'QL/C""^U6]U@BYF)O)
M8FCWR@AVPL:G.';OWKW#]H+X=:3\4_A1K.@ZSYRVDGES++;,%EC='5@5)! Z
M$'CH37%&GSTIM[MW/T/%YHL%G6 C33Y(0C"W=.\7^C]4? '[$V@ZI\;?VGV\
M8>()7U"72D?5KJXD P\_"1 ^X9@P_P"N=:'_  45TF;PI^T3HWB&V&QKW3K>
MZ5Q_SVBD9/T"1U]<_LE? _P[\'-!UYM$>\N)M0N4$T]\Z.^U%^5051> 78_C
M6;^US\!_#OQAF\,W6LW&H6LU@MQ'&UA(B;E8QGYMR-G!7C&.II>S_P!G\]SH
MAF\7Q0DHVIQAR)>7+S;;;_@?'7QQU&Z^#?[7.G?$7[%)=:-J5S:^)+,]!<02
M*K2(K=-P.]?;Y3W%??VA_M2_"C7] BU>'QWHMM;N@=H;V[2">/C[K1,0P/;I
M],U5N_@#X0^)OP6\->$?$MI+JEGIUC##:7LCA;N#8@0,LB@8)"C(Q@X&0:_/
M7XA_L\>&_"7Q';P_9WFJ260D*;YYHS)CZB,#]*'*5!W6SU)HX;!<44H4:[E"
MIAUR75K.*VWZ_K??I^@WPQ_:T^&WQ;\7WWAK0M:/]IPR%+9;N,PK?@#):#/W
ML8/!PV 3C'-?!'[-%A;:K^VLME>01W5G<WVK03P2J&21&@N RL#U!!(K[E_9
MP_9?\"?!S3;;6]&LI[S7+N %M2U*199HU8<K'A55![@9/0DUYM\(_P!FGPQX
M._: @\6V5_JTFI)=W<PCGFB,),B2*P($8./G..>PJI<\^1R[G'@I8+ K,J&#
M4N7V=O>M>]I7>G0^9/BEX-\0_L._M$6.N>'S))HDDC7.FO(QV7-L3B6VE/<J
M#M/?E&X)&+7[;MU9>//$_@[XJZ0K7WA7Q'ID<><X,5Q"Q$MNY'W6 *CWPV,X
MS7Z _M$_"3P]\8OAM>:5X@AE*6[+=6]S;,JS02+QE&((Y!*D$'(/J 1X]\#?
MV;/"=EX;\1^!KZ74=>\+:F@NGT_4Y8V6"=2%$T+(BM&^#C(/.!43I-2=-;/5
M'H8#/(5L-3S:O%NK2]R;7VXNWXIM/UNM+Z<+X"^!_P"REX_\*V^MVVLIIP>,
M//9ZCKHMY[9L<JZN0>#QD<'L357P7\)/V2O'GC.?PQH^J7DNJI*(8!+?2I%=
ML>T+D8?GC'4]LCFO&_C=^S7X7^'7Q&_L/2[S57LGE S<3QLX!/0$1C^5?97[
M+G[+/@/X9:5I_BNPM+C4?$%U &6]U*196M\C!$055"YZ9P6QD9P32I^_)1Y5
MYFV:*678.>,^N5WS? N9:-[7=]5Z'R)^U'9167[;UC:1 ^3%=:/$H8Y.T10
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D]!_TQKJYG22BDM3XA8*CGE6MB*E>HU!\L>:TI6\W==;['__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
